<SEC-DOCUMENT>0001178913-23-000670.txt : 20241204
<SEC-HEADER>0001178913-23-000670.hdr.sgml : 20241204
<ACCEPTANCE-DATETIME>20230221061048
ACCESSION NUMBER:		0001178913-23-000670
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		73
CONFORMED PERIOD OF REPORT:	20221231
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230221
DATE AS OF CHANGE:		20230221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		23645128

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zk2329164.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:cmmb="http://www.anchiano.com/20221231"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>Chemomab Therapeutics Ltd. - 1534248 - 2023</title></head><body>
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20220101to20221231"  id="FFact_0000000000489" >0001534248</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20220101to20221231"  id="FFact_0000000000490" >FY</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20220101to20221231"  id="FFact_0000000000491" >false</ix:nonNumeric></ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="cmmb-20221231.xsd"/>
        </ix:references></ix:header></div><div>
  <div>
    <div>
      <div>
        <div>
          <div style="text-align:center;line-height:1.25;font-family:David, sans-serif;font-size:11pt">
            <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;margin-left:auto;margin-right:auto;text-align:center" />
          </div>
          <div style="text-align:center;line-height:1.25;font-family:David, sans-serif;font-size:11pt">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">UNITED STATES</span></span></div>
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-size:14pt;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt">SECURITIES AND EXCHANGE COMMISSION</span></span></div>
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">WASHINGTON, D.C. 20549</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-size:14pt;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt">FORM <ix:nonNumeric id="Fxbrl_20230213103251859" name="dei:DocumentType" contextRef="C_20220101to20221231">8-K</ix:nonNumeric></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CURRENT REPORT</span></span></div>
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to Section 13 or 15(d)</span></span></div>
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of the Securities Exchange Act of 1934</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Date of Report (Date of earliest event reported): February 21, 2023</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-size:16pt;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:16pt"><ix:nonNumeric id="Fxbrl_20230213104107012" name="dei:EntityRegistrantName" contextRef="C_20220101to20221231">Chemomab Therapeutics Ltd.</ix:nonNumeric></span></span></div>
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Exact name of Registrant as Specified in Its Charter)</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:33.44%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">State of <ix:nonNumeric id="Fxbrl_20230213103334932" name="dei:EntityIncorporationStateCountryCode" contextRef="C_20220101to20221231" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:33.26%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103327514" name="dei:EntityFileNumber" contextRef="C_20220101to20221231">001-38807</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:33.3%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103321571" name="dei:EntityTaxIdentificationNumber" contextRef="C_20220101to20221231">81-3676773</ix:nonNumeric></span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:33.44%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(State or Other Jurisdiction</span></span></div>
              </td>
              <td style="width:33.26%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Commission</span></span></div>
              </td>
              <td style="width:33.3%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(IRS Employer</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:33.44%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of Incorporation)</span></span></div>
              </td>
              <td style="width:33.26%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">File Number)</span></span></div>
              </td>
              <td style="width:33.3%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identification No.)</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:50.17%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103343937" name="dei:EntityAddressAddressLine1" contextRef="C_20220101to20221231">Kiryat Atidim</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20230213103349322" name="dei:EntityAddressAddressLine2" contextRef="C_20220101to20221231">Building 7</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:49.83%;vertical-align:bottom">
                <div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:50.17%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103356096" name="dei:EntityAddressCityOrTown" contextRef="C_20220101to20221231">Tel Aviv</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20230213103401995" name="dei:EntityAddressCountry" contextRef="C_20220101to20221231" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:49.83%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103406445" name="dei:EntityAddressPostalZipCode" contextRef="C_20220101to20221231">6158002</ix:nonNumeric></span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:50.17%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Address of principal executive offices)</span></span></div>
              </td>
              <td style="width:49.83%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Zip Code)</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric id="Fxbrl_20230213103413807" name="dei:CityAreaCode" contextRef="C_20220101to20221231">972</ix:nonNumeric>-<ix:nonNumeric id="Fxbrl_20230213103419762" name="dei:LocalPhoneNumber" contextRef="C_20220101to20221231">77-331-0156</ix:nonNumeric></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Former name or former address, if changed since last report)</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></span></div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:6.14%;vertical-align:top">
                <div style="line-height:1.25;font-family:'Segoe UI Symbol', sans-serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213104227091" name="dei:WrittenCommunications" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:93.86%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:6.14%;vertical-align:top">
                <div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:93.86%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:6.14%;vertical-align:top">
                <div style="line-height:1.25;font-family:'Segoe UI Symbol', sans-serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213104232182" name="dei:SolicitingMaterial" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:93.86%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:6.14%;vertical-align:top">
                <div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:93.86%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:6.14%;vertical-align:top">
                <div style="line-height:1.25;font-family:'Segoe UI Symbol', sans-serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213104235288" name="dei:PreCommencementTenderOffer" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:93.86%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:6.14%;vertical-align:top">
                <div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:93.86%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:6.14%;vertical-align:top">
                <div style="line-height:1.25;font-family:'Segoe UI Symbol', sans-serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213104238408" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:93.86%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities registered pursuant to Section 12(b) of the Act:</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:63.83%;vertical-align:bottom;border-bottom:#000000 2px solid;white-space:nowrap">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Title of each class</span></span></div>
              </td>
              <td style="width:0.69%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:16.04%;vertical-align:bottom;border-bottom:#000000 2px solid">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trading<br />Symbol(s)</span></span></div>
              </td>
              <td style="width:0.69%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:18.74%;vertical-align:bottom;border-bottom:#000000 2px solid">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name of each<br />exchange<br />on which registered</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:63.83%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103433506" name="dei:Security12bTitle" contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:0.69%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>
              </td>
              <td style="width:16.04%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103437662" name="dei:TradingSymbol" contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">CMMB</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:0.69%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>
              </td>
              <td style="width:18.74%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103445669" name="dei:SecurityExchangeName" contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:63.83%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>
              </td>
              <td style="width:0.69%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>
              </td>
              <td style="width:16.04%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>
              </td>
              <td style="width:0.69%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>
              </td>
              <td style="width:18.74%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:63.83%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103508728" name="dei:Security12bTitle" contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">Ordinary shares, no par value per share</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:0.69%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>
              </td>
              <td style="width:16.04%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103458685" name="dei:TradingSymbol" contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">N/A</ix:nonNumeric></span></span></div>
              </td>
              <td style="width:0.69%;vertical-align:bottom">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>
              </td>
              <td style="width:18.74%;vertical-align:top">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230213103452851" name="dei:SecurityExchangeName" contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market*</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* Not for trading; only in connection with the registration of American Depositary Shares.</span></span></div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></span></div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Emerging growth company <span><ix:nonNumeric id="Fxbrl_20230213103758108" name="dei:EntityEmergingGrowthCompany" contextRef="C_20220101to20221231" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></span></span></div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span><ix:nonNumeric id="Fxbrl_20230213103815992" name="dei:EntityExTransitionPeriod" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></span></div>
        </div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:100%;vertical-align:top">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item 2.02. Results of Operations and Financial Condition.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-indent:28.35pt;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Therapeutics Ltd. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or the &#8220;Company&#8221;) is disclosing its consolidated audited financial statements for the fiscal year ended <ix:nonNumeric id="Fxbrl_20230213161546834" name="dei:DocumentPeriodEndDate" contextRef="C_20220101to20221231" format="ixt:date-monthname-day-year-en">December 31, <ix:nonNumeric id="Fxbrl_20230213174811365" name="dei:DocumentFiscalYearFocus" contextRef="C_20220101to20221231">2022</ix:nonNumeric></ix:nonNumeric> and the corresponding Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. The Company intends to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 no later than March 31, 2023.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="text-align:justify;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With respect to the presentation of financial results for historical periods that preceded the Merger (as defined below), the terms &#8220;we&#8221;, &#8220;us,&#8221; &#8220;our,&#8221; or &#8220;the Company&#8221; refer to the financial results of the Company&#8217;s wholly owned subsidiary, Chemomab Ltd. (the &#8220;Subsidiary&#8221;), which was the accounting acquirer in the Merger. References to the &#8220;Merger&#8221; refer to the merger involving Anchiano Therapeutics Ltd., or Anchiano, and the Subsidiary, whereby a wholly owned subsidiary of Anchiano merged with and into the Subsidiary, with the Subsidiary surviving as a wholly owned subsidiary of Anchiano. Upon consummation of the Merger on March 16, 2021, Anchiano changed its name to &#8220;Chemomab Therapeutics Ltd.&#8221; and the business conducted by the Subsidiary became primarily the business conducted by the Company.</span></span></div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></span></div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements. Some of the information contained in this discussion and analysis, particularly with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. You should read &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; and Item 1A &#8220;Risk Factors&#8221; of our Annual Report on Form 10-K filed on March 30, 2022 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Overview</span></span></div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="text-indent:35.25pt;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We are a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet needs. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, we developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity. We believe CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-indent:35.25pt;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have pioneered the therapeutic targeting of CCL24, a chemokine that promotes various types of cellular processes that regulate inflammatory and fibrotic activities through the CCR3 receptor. The chemokine is expressed in various types of cells, including immune cells, endothelial cells and epithelial cells. We have developed a novel CCL24 inhibiting product candidate with dual anti-fibrotic and anti-inflammatory activity that modulates the complex interplay of both of these inflammatory and fibrotic mechanisms, which drive abnormal states of fibrosis and clinical fibrotic diseases. This innovative approach is being developed for difficult to treat rare diseases, also known as orphan indications or diseases, such as primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc) for which patients have no established disease-modifying treatment options. We estimate that there are approximately 77 thousand patients suffering from PSC in the U.S., EU and Japan, representing over a $1 billion market opportunity, and approximately 170 thousand patients suffering from SSc in those same markets, representing over a $1.5 billion market opportunity.</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-indent:35.25pt;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CM-101, our lead clinical product candidate, is a first-in-class humanized monoclonal antibody that attenuates the basic function of the soluble chemokine CCL24, also known as eotaxin-2, as a regulator of major inflammatory and fibrotic pathways. We have demonstrated that CM-101 interferes with the underlying biology of inflammation and fibrosis through a novel and differentiated mechanism of action. Based on these findings, we are actively advancing CM-101 in Phase 2 clinical studies directed toward two distinct clinical indications that include patients with liver or skin, and/or lung fibrosis. We are currently conducting a Phase 2 clinical study in PSC, a rare obstructive and cholestatic liver disease. The study is actively recruiting patients in the U.S., Europe and Israel and is being expanded by adding clinical sites, an additional high dose arm (20mg/kg) as well as an open label extension. We had earlier proposed to add both low and high dose arms to the study but the recent encouraging results reported from our Phase 2 liver fibrosis trial in NASH patients, dosed at 5mg/kg, along with the positive Phase 1b data we previously reported in non-alcoholic fibrotic liver disease (NAFLD) patients dosed at 5mg/kg and 2.5mg/kg, are seen as providing us sufficient data on the performance of the lower dose to drop it from the current trial, which is focusing on the 10mg/kg and 20g/kg doses. We believe this change will facilitate timely conduct and completion of the trial. If regulators in the future do not agree that the existing low dose data is sufficient, we always have the option to add a lower dose group as part of the Phase 3 clinical program.</span></span></div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">- 2 -</span></span></span></div>
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-indent:35.25pt;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We are also planning to open a Phase 2 clinical trial in SSc in the first half of 2023. The trial in SSc, a rare autoimmune rheumatic disease characterized by fibrosis in the skin and lung and other organs, will focus on establishing biological and clinical proof of concept in this patient population. Although our primary focus is on these two rare indications, as we noted, an additional Phase 2 clinical study in patients with liver fibrosis due to non-alcoholic steatohepatitis (NASH) has recently been completed. This trial provided safety and pharmacokinetic (PK) data and was informative in determining whether we will advance the development of our current subcutaneous formulation of CM-101. Additionally, the trial measured a number of biomarkers that may be relevant to the potential activity of CM-101 in other fibro-inflammatory conditions. We recently reported results from this trial, which showed that the trial met its primary endpoint of safety and tolerability, and that CM-101 demonstrated encouraging activity in secondary endpoints that include a range of liver fibrosis biomarkers and physiologic assessments.</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Components of Operating Results</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To date, we have not generated any revenue from product sales and do not expect to generate any revenue from product sales in the near future. If development efforts for our product candidates are successful and result in our receipt of necessary regulatory approvals, or if our development efforts otherwise lead to any commercialized products or additional license agreements with third parties, then we may generate revenue in the future from product sales.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and Development Expenses, net</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses consist primarily of costs incurred in connection with the development of our product candidates. These expenses include:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#8226;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">expenses incurred under agreements with clinical research organizations and contract manufacturing organizations, as well as investigative sites and consultants that conduct our clinical trials, preclinical studies and other scientific development services;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#8226;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">manufacturing scale-up expenses and the cost of acquiring and manufacturing preclinical and clinical trial materials;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#8226;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">employee-related expenses, including salaries, related benefits, travel and share-based compensation expenses for employees engaged in research and development functions, as well as external costs, such as fees paid to outside consultants engaged in such activities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#8226;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">license maintenance fees and milestone fees incurred in connection with various license agreements;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#8226;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">costs related to compliance with regulatory requirements; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#8226;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">depreciation and other expenses.</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We recognize external development costs based on an evaluation of the progress to completion of specific tasks using information provided to us by our service providers.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We do not allocate employee costs or facility expenses, including depreciation or other indirect costs, to specific programs because these resources are deployed across multiple programs and, as such, the related costs are not separately classified. We use internal resources primarily to oversee our research, as well as for managing our preclinical development, process development, manufacturing and clinical development activities. Our employees work across multiple programs; therefore, we do not track the related expenses by program.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development activities are fundamental to our business. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. As a result, we expect that our research and development expenses will increase substantially over the next several years as we continue to advance the development of our product candidates. We also expect to incur additional expenses related to milestone and royalty payments payable to third parties with whom we have entered into license agreements.</span></span></div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">- 3 -</span></span></span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and Administrative Expenses</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses consist primarily of salaries and related benefits, share-based compensation expenses for personnel in executive and administrative functions, insurance and professional fees for legal, consulting, accounting and audit services.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We anticipate that our general and administrative expenses will increase in the future due to increased headcount and professional fees to support our continued research activities and development of our product candidates. We also anticipate that we will continue to incur accounting, audit, legal, regulatory, compliance, director and officer insurance costs, as well as investor and public relations expenses associated with being a public company. Additionally, once we believe that regulatory approval of a product candidate appears likely, we will begin to incur a material increase in payroll and related expenses as a result of preparation for commercial operations, particularly in respect of sales and marketing.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing Expenses, Net</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing expenses, net consist primarily of income or expenses related to revaluation of foreign currencies and interest income on our bank deposits.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div>
          <div>
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Results of Operations</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes our results of operations for the years ended December 31, 2022 and 2021:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating Expenses:</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">(in thousands</span>)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%" valign="bottom">
                    <div style="text-align:justify;text-indent:-8.65pt;margin-left:17.3pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,977</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,334</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;text-indent:-8.65pt;margin-left:17.3pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,556</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,033</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                    <div style="text-align:justify;text-indent:-8.65pt;margin-left:25.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating expenses </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,533</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,367</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing (income) expense, net </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(353</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">111</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before taxes</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,180</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,478</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes on income (benefit)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(534</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8212;</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27,646</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,478</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our results of operations have varied in the past and can be expected to vary in the future due to numerous factors. We believe that period-to-period comparisons of our operating results are not necessarily meaningful and should not be relied upon as indications of future performance.</span></span></div>
          </div>
        </div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31, 2022 Compared to the Year Ended December 31, 2021</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses increased by approximately $10.7 million, or 168%, to approximately $17.0 million for the year ended December 31, 2022 compared to approximately $6.3 million for the year ended December 31, 2021. The increase resulted primarily from an increase in headcount and payments to consultants and subcontractors for clinical and pre-clinical activities.</span></span></div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">- 4 -</span></span></span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses increased by approximately $5.6 million, or 92%, to approximately $11.6 million for the year ended December 31, 2022 compared to approximately $6.0 million for the year ended December 31, 2021. This increase was primarily due to increase in headcount and professional fees and insurance expense and share-based compensation.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing (income) expense, net</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing expenses, net, increased by approximately $464 thousand, or 418%, to net income of $353 thousand for the year ended December 31, 2022 compared to a net loss of $111 thousand for the year ended December 31, 2021. Financing expense, net for the year ended December 31, 2022 was primarily related to foreign currency exchange rate differences, offset by interest income on deposits. Financing income, net for 2021 was primarily related to interest income on deposits, offset by foreign currency exchange rate differences.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes on Income</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes on income, net, for the year ended December 31, 2022 were $534 thousand. The tax benefit is related to a tax return of Chemomab Therapeutics Inc., a wholly owned subsidiary of the Company, derived by carryback of net operating losses. Chemomab Therapeutics Inc. received $351 thousand in December 2022 on account of previous years and expects to receive the remainder $183 thousand in 2023.</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic;font-weight:bold">&#160;</div>
        <div>
          <div>
            <div style="text-align:justify;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash Flows</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes our cash flows for the years ended December 31, 2022 and 2021:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended<br />December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase/(decrease)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$ </span></span></td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div>
                      <div style="line-height:1.25">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                      </div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(in thousands)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in operating activities </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20,370</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,374</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,996</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by (used in) investing activities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,533</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(45,186</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">64,719</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(143</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by (used in) financing activities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(808</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,074</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(61,882</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(101</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;padding-bottom:4px" valign="bottom">
                    <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net increase (decrease) in cash, cash equivalents and restricted cash</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,645</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,514</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,159</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(147</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating activities</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in operating activities for the year ended December 31, 2022 was approximately $20.4 million and included net loss of $27.6 million, partially offset by net cash used by changes in operating assets and liabilities of approximately $4.0 million and non-cash charges of $3.3 million, which mainly included share-based compensation expenses.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in operating activities for the years ended December 31, 2021 was approximately $12.4 million and included net loss of $12.5 million, partially offset by net cash provided by changes in operating assets and liabilities of $1.9 million and non-cash charges of $2.0 million, which mainly included share-based compensation expenses.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investing activities</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by investing activities for the year ended December 31, 2022 was approximately $19.5 million, which was primarily related to investment in short-term deposits offset by purchasing of fixed assets.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in investing activities for the year ended December 31, 2021 was $45.2 million, which was primarily related to purchase of fixed assets and investment in bank deposits.</span></span></div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">- 5 -</span></span></span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing activities</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in financing activities for the year ended December 31, 2022 was approximately $0.8 million, consisting of $0.3 million of proceeds from the sale of ADSs, $0.1 million of proceeds from the exercise of stock options offset by the repurchase of shares in the amount of $1.2 million.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by financing activities for the year ended December 31, 2021 was $61.1 million, consisting of $58.7 million of proceeds from the sale of ADSs, primarily from the Private Placement (as defined and described below) and issuances under the Sales Agreement with Cantor, and $2.4 million of cash acquired in the Merger.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Funding Requirements</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We expect our expenses to increase substantially as we advance the clinical trials of our product candidate. In addition, we expect to continue to incur additional costs associated with operating as a public company.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We believe that our existing cash, cash equivalents and bank deposits will enable us to fund our operating expenses and capital expenditure requirements at least through March 31, 2024. We have based these estimates on assumptions that may prove to be wrong, and we could expend our capital resources sooner than we expect. If we receive regulatory approval for any of our product candidates, we expect to incur significant commercialization expenses related to product manufacturing, sales, marketing and distribution.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Until such time, if ever, that we generate product revenue sufficient to achieve profitability, we expect to finance our cash needs through the sales of our securities and through other outside funding sources. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional funds through government and other third-party funding, collaboration agreements, strategic alliances, licensing arrangements or marketing and distribution arrangements, then we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, then we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market products or product candidates that we would otherwise prefer to develop and market.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liquidity and Capital Resources</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In connection with the Merger, on March 15, 2021, we entered into Securities Purchase Agreements with certain investors, pursuant to which we agreed to sell approximately $45.5 million of the ADSs in a private placement transaction (the Private Placement). The Private Placement closed on March 22, 2021, at which time we sold 2,619,270 ADSs together with warrants to purchase up to 261,929 ADSs at an exercise price of $17.35 per ADS. The warrants expire five years from the date of issuance, and, if exercised in full, will provide proceeds of approximately $4.5 million.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 30, 2021, we entered into the Sales Agreement with Cantor Fitzgerald &amp; Co. (Cantor). Pursuant to the Sales Agreement, we may offer and sell, from time to time, &#160;ADSs having an aggregate offering price of up to $75 million through Cantor (the ATM Facility). Sales of &#160;ADSs, if any, under the Sales Agreement will be issued and sold pursuant to our Registration Statement on Form S-3 which was declared effective on May 17, 2021 and will be made in sales deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) promulgated under the Securities Act. &#160;Pursuant to the Sales Agreement, Cantor has agreed to act as sales agent on a best efforts basis and use commercially reasonable efforts to sell on our behalf all of the ADSs we requested to be sold in accordance with the Sales Agreement, consistent with Cantor&#8217;s normal trading and sales practices, on mutually agreed terms.</span></span></div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>
        <div style="line-height:1.25">
          <div style="text-align:justify;text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000">On April 25, 2022, we filed a prospectus supplement with the SEC for the issuance and sale of up to $18,125,000 of ADSs in connection with the reactivation of the ATM Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject to certain exceptions, limits the amount of securities we are able to offer and sell under such registration statement during any twelve month period to one-third of our unaffiliated public float.</span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-size:13.5pt">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',serif;text-indent:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">During the year ended December 31, 2022, </span>we <span style="color:rgb(0, 0, 0)">sold 130,505 ADSs at an average price of USD 2.11 per ADS, through the ATM facility, resulting in gross proceeds of $275,000.</span></span></span></div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As shown in the accompanying consolidated financial statements, we have incurred losses and cash flow deficits from operations since inception, resulting in an accumulated deficit at December 31, 2022 of approximately $64 million. We have financed operations to date primarily through public and private placements of equity securities. We anticipate that we will continue to incur net losses for the foreseeable future. We believe that our existing cash, cash equivalents and bank deposits will be sufficient to fund our projected cash needs only through March 31, 2024. To meet future capital needs we would need to raise additional capital through equity or debt financing or other strategic transactions. However, any such financing may not be available to us on favorable terms or at all. Our failure to obtain sufficient funds on commercially acceptable terms when needed would have a material adverse effect on our business, results of operations and financial condition.</span></span></div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">- 6 -</span></span></span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current Outlook</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We estimate that our current cash resources will allow us to execute our business plans at least through March 31, 2024.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Developing drugs, conducting preclinical and clinical trials, obtaining commercial manufacturing capabilities and commercializing products is expensive, and we will need to raise substantial additional funds to achieve our strategic objectives. We will require significant additional financing in the future to fund our operations, including if and when we progress into clinical trials of our product candidates, obtain regulatory approval for one or more of our product candidates, obtain commercial manufacturing capabilities and commercialize one or more of our product candidates. Our future capital requirements will depend on many factors, including, but not limited to:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the progress and costs of our preclinical and clinical trials and other research and development activities;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the scope, prioritization and number of our preclinical and clinical trials and other research and development programs;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the amount of revenues and contributions we receive under future licensing, collaboration, development and commercialization arrangements with respect to our product candidates;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the costs of development and expansion of our operational infrastructure;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the costs and timing of obtaining regulatory approval for one or more of our product candidates;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">our ability, or that of our collaborators, to achieve development milestones, marketing approval and other events or developments under potential future licensing agreements;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the costs and timing of securing manufacturing arrangements for clinical or commercial production;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the costs of contracting with third parties to provide sales and marketing capabilities for us or establishing such capabilities ourselves;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the costs of acquiring or undertaking development and commercialization efforts for any future products, product candidates or technology;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">the magnitude of our general and administrative expenses; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top;font-family:'Times New Roman', serif">&#9679;</td>
              <td style="width:auto;vertical-align:top">
                <div style="font-family:'Times New Roman', serif">any additional costs that we may incur under future in- and out-licensing arrangements relating to one or more of our product candidates.</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Until we can generate significant recurring revenues, we expect to satisfy our future cash needs through capital raising or by out-licensing and/or co-developing applications of one or more of our product candidates. We cannot be certain that additional funding will be available to us on acceptable terms, if at all. If funds are not available, we may be required to delay, reduce the scope of or eliminate research or development plans for, or commercialization efforts with respect to, one or more of our product candidates and make the necessary change to our operations to reduce the level of our expenditures in line with available resources.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We are a development-stage company and it is not possible for us to predict with any degree of accuracy the outcome of our research and development efforts. As such, it is not possible for us to predict with any degree of accuracy any significant trends, uncertainties, demands, commitments or events that are reasonably likely to have a material effect on our net loss, liquidity or capital resources, or that would cause financial information to not necessarily be indicative of future operating results or financial condition. However, to the extent possible, certain trends, uncertainties, demands, commitments and events are described in this item.</span></span></div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">- 7 -</span></span></span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Critical Accounting Estimates</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our financial statements are prepared in accordance with generally accepted accounting principles in the United States (GAAP). The preparation of our financial statements and related disclosures in accordance with GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements, we believe that the following accounting estimates are those that include a higher degree of judgment or complexity and are reasonably likely to have a material impact on our financial condition or results of operations and are therefore considered critical accounting estimates.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-Based Compensation</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We apply Accounting Standard Codification (ASC) 718-10, &#8220;Share-Based Payment,&#8221; which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees and directors, including employee options under our option plans based on estimated fair values.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ASC 718-10 requires that we estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The fair value of the award is recognized as an expense over the requisite service periods in our statements of comprehensive loss. We recognize share-based award forfeitures as they occur, rather than estimate by applying a forfeiture rate.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In June 2018, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-07, &#8220;Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting&#8221;, which simplifies the accounting for nonemployee share-based payment transactions by aligning the measurement and classification guidance, with certain exceptions, to that for share-based payment awards to employees. The amendments expand the scope of the accounting standard for share-based payment awards to include share-based payment awards granted to non-employees in exchange for goods or services used or consumed in an entity&#8217;s own operations and supersedes the guidance related to equity-based payments to non-employees. We adopted these amendments on January 1, 2019.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We recognize compensation expenses for the fair value of non-employee awards over the requisite service period of each award.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We estimate the fair value of options granted as equity awards using a Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire). We determine the fair value per share of the underlying stock by taking into consideration our most recent sales of stock, as well as additional factors that we deem relevant. Our board determined the fair value of ordinary shares based on valuations performed using the Option Pricing Method subject to relevant facts and circumstances. We have historically been a private company and lack company-specific historical and implied volatility information of our stock. Expected volatility is estimated based on volatility of similar companies in the biotechnology sector. Historically, we have not paid dividends and have no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using the &#8220;simplified&#8221; method. Grants to non-employees are based on the contractual term. Changes in the determination of each of the inputs can affect the fair value of the options granted and our results of operations.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Quantitative and Qualitative Disclosures about Market Risks</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign Currency Exchange Risk</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;text-indent:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our functional currency is the U.S. Dollar. We are exposed to foreign exchange rate risk. We are located in Israel, where part of our general and administrative expenses costs is incurred in New Israeli Shekels. During each of the years ended December 31, 2022 and 2021, we recognized foreign currency transaction loss of $609 thousand and $176 thousand, respectively. These foreign currency transaction gains and losses were recorded in financial expenses. We believe that a 10% change in the exchange rate between the U.S. Dollar and New Israeli Shekel would not have a material impact on our financial position or results of operations.</span></span></div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25;font-family:'Times New Roman',serif;text-indent:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As we continue to grow our business, our results of operations and cash flows will be subject to fluctuations due to changes in foreign currency exchange rates, which could adversely impact our results of operations. To date, we have not entered into any foreign currency hedging contracts to mitigate our exposure to foreign currency exchange risk.</span></span></div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">- 8 -</span></span></span></div>
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;color:#000000">
            <p style="margin:0pt"><strong style="font-size:1rem"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item 9.01 Financial Statements and Exhibits.</span></span></strong></p>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(d) Exhibits</span></span></div>
          <div style="line-height:1.25">&#160;</div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:8.5%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exhibit</span></span></div>
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
              </td>
              <td style="width:1.38%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:90.12%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exhibit Description</span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:8.5%;vertical-align:top">
                <div style="line-height:1.25;color:#0000FF;font-family:'Times New Roman', serif"><span style="text-decoration:underline"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-1.htm">99.1</a></span></span></span></div>
              </td>
              <td style="width:1.38%;vertical-align:top">&#160;</td>
              <td style="width:90.12%;vertical-align:top">
                <div style="line-height:1.25;color:#0000FF;font-family:'Times New Roman', serif"><span style="text-decoration:underline"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_99-1.htm">Consolidated Financial Statements as of December 31, 2022</a></span></span></span></div>
              </td>
            </tr>
            <tr>
              <td style="width:8.5%;vertical-align:top">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">104</span></span></div>
              </td>
              <td style="width:1.38%;vertical-align:top">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:90.12%;vertical-align:top">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="clear:both;margin-top:10pt;margin-bottom:0pt">
            <div style="text-align:center;margin-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">- 9 -</span></span></span></div>
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SIGNATURE</span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:48.89%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td colspan="2" style="width:42.71%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHEMOMAB THERAPEUTICS LTD.</span></span></div>
              </td>
              <td style="width:8.4%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:48.89%;vertical-align:middle">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:3.94%;vertical-align:middle">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:38.78%;vertical-align:middle">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:8.4%;vertical-align:middle">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:48.89%;vertical-align:top">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Date: February 21, 2023</span></span></div>
              </td>
              <td style="width:3.94%;vertical-align:top">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">By:</span></span></div>
              </td>
              <td style="width:38.78%;vertical-align:top;border-bottom:#000000 2px solid">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">/s/ </span>Donald Marvin</span></span></div>
              </td>
              <td style="width:8.4%;vertical-align:middle">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:48.89%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:3.94%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:38.78%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name: Donald Marvin</span></span></div>
              </td>
              <td style="width:8.4%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width:48.89%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:3.94%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
              <td style="width:38.78%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Title: Executive V.P., Chief Financial Officer and Chief Operating Officer</span></span></div>
              </td>
              <td style="width:8.4%;vertical-align:bottom">
                <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
      </div>
      <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">- 10 -</span></span></span></div>
      <div style="text-align:center">
        <div style="page-break-after:always">
          <hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;width:100%;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
        </div>
      </div>
    </div>
  </div>
</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:cmmb="http://www.anchiano.com/20221231"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>Chemomab Therapeutics Ltd. - 1534248 - 2023</title></head><body>
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="us-gaap:LeaseExpirationDate1" contextRef="C_20200501to20200510"  id="Fxbrl_20230131233234992" >2023-05-31</ix:nonNumeric><ix:nonNumeric name="us-gaap:LeaseExpirationDate1" contextRef="C_20211001to20211024"  id="Fxbrl_20230131233722905" >2024-10-31</ix:nonNumeric><ix:footnote id="FN20230201025135527" xml:lang="en-US">The weighted average share price is based on the Company&#8217;s ordinary share valuation as at the grant date. </ix:footnote>
<ix:footnote id="FN20230201025203207" xml:lang="en-US">Expected life for the periods presented was determined according to the simplified method since, at the date of grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#8217; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated.</ix:footnote>
<ix:footnote id="FN20230201025249960" xml:lang="en-US">Expected volatility is based on historical volatility over the most recent period commensurate with the expected term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#8217;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#8217;s expected term.</ix:footnote>
<ix:footnote id="FN20230201025314607" xml:lang="en-US">The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards.</ix:footnote>
</ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="cmmb-20221231.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20220101to20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtCurrencyAxis_currencyUSD"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_srtCurrencyAxis_currencyUSD"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtCurrencyAxis_currencyILS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_srtCurrencyAxis_currencyILS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtCurrencyAxis_currencyXXX"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_srtCurrencyAxis_currencyXXX"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200510"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-05-10</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200501to20200510"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-10</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211001to20211024"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-10-24</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211024"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-10-24</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211212"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-12</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cmmb:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cmmb:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapSoftwareDevelopmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapSoftwareDevelopmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_countryUS_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtStatementGeographicalAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_srtStatementGeographicalAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtStatementScenarioAxis_srtScenarioForecastMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_usgaapCapitalAdditionsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:CapitalAdditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220701to20220731"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-07-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_cmmbCapitalAdditionsOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cmmb:CapitalAdditionsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230113_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-01-13</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cmmb:TwoThousandsFifteenPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cmmb:TwoThousandsSeventeenPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220901to20220919_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:RepurchaseArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-09-19</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220930_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:RepurchaseArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221101to20221116_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:RepurchaseArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-11-01</xbrli:startDate>
        <xbrli:endDate>2022-11-16</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtmAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtmAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-23</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210315_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cmmb:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cmmb:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210316"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-03-16</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-03-16</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="Share"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_Per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<ix:relationship fromRefs="FFact_0000000000373" toRefs="FN20230201025135527"/><ix:relationship fromRefs="FFact_0000000000377" toRefs="FN20230201025203207"/><ix:relationship fromRefs="FFact_0000000000378" toRefs="FN20230201025203207"/><ix:relationship fromRefs="FFact_0000000000379" toRefs="FN20230201025249960"/><ix:relationship fromRefs="FFact_0000000000380" toRefs="FN20230201025249960"/><ix:relationship fromRefs="FFact_0000000000381" toRefs="FN20230201025314607"/><ix:relationship fromRefs="FFact_0000000000382" toRefs="FN20230201025314607"/></ix:resources></ix:header></div><div><div style="text-align:center;line-height:1.25;font-weight:bold"><hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" /><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="text-decoration:underline">Exhibit 99.1</span></p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</p></div><div><div><div><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:100%;vertical-align:top"><div style="line-height:1.25;font-family:Times New Roman, Times, serif;font-size:12pt;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:12pt"><span><span><span><span><span>Chemomab Therapeutics Ltd. and</span></span></span></span></span></span></span></div><div style="line-height:1.25;font-family:Times New Roman, Times, serif;font-size:12pt;font-weight:bold;margin-bottom:0px;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:12pt"><span><span><span><span><span>its subsidiaries</span></span></span></span></span></span><span style="font-size:10pt"><span><span><span><span style="line-height:1.25">&#160;</span></span></span></span></span></span></div><div style="line-height:1.25;font-family:Times New Roman, Times, serif;font-size:12pt;font-weight:bold;margin-top:0px;text-align:center">&#160;</div><div style="line-height:1.25;font-family:Times New Roman, Times, serif;font-size:12pt;font-weight:bold;margin-top:0px;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:12pt"><span><span><span><span><span>Consolidated&#160;</span></span></span></span></span><span><span><span><span><span>Financial Statements</span></span></span></span></span><span><span><span><span><span style="line-height:1.25">&#160;</span></span></span></span></span></span></span></div><div style="margin-top:0pt;margin-bottom:10px;line-height:1.25;font-family:Times New Roman, Times, serif;font-size:12pt;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:12pt"><span><span><span><span><span>As of December&#160;31, 2022</span></span></span></span></span></span></span></div></td></tr></table></div></div></div><div><div><div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></span></span></div><div style="text-align:right;line-height:1.25">&#160;</div><div style="line-height:1.25"><div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Consolidated Financial Statements as of December 31, 2022</span></span></span></span></span></span></span><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-top:0pt" /></div></div><div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div><div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Contents</span></span></span></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div><div style="text-align:right;text-indent:12pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Page</span></span></span></span></span></span></div><div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div><div style="line-height:1.25;margin-bottom:10pt"><table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;color:#000000;width:100%" width="100%"><tr><td style="font-family:Times New Roman,Times,serif"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="line-height:1.25;text-align:left"><span><span><span><span><span><span style="line-height:1.25;text-align:left"><span><span><a href="#reportOfIndependentRegisteredPublicAccountingFirm_integixAnchor"><span><span><span><span style="line-height:1.25;text-align:left"><span><span><span><span><span><span style="line-height:1.25;text-align:left"><span><span>Report of Independent Registered Public Accounting Firm</span></span></span></span></span></span></span></span></span></span></span></span></a></span></span></span></span></span></span></span></span></span></span></span></span></span></span></p></td><td style="font-family:Times New Roman, Times, serif;width:10%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>F - 2</span></span></span></span></span></span></td></tr><tr><td style="font-family:Times New Roman, Times, serif"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span style="color:rgb(33, 37, 41)">(PCAOB ID 1057)</span></strong></span></span></p></td><td style="font-family:Times New Roman, Times, serif;width:10%">&#160;</td></tr><tr><td style="font-family:Times New Roman, Times, serif"><div><div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><a href="#consolidatedBalanceSheets_integixAnchor"><span><span><span><span><span><span>Consolidated Balance Sheets</span></span></span></span></span></span></a></span></span></span></span></span></span></span></span></div></div></td><td style="font-family:Times New Roman, Times, serif;width:10%"><div style="text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>F - 3</span></span></span></span></span></span></div></td></tr><tr><td rowspan="1" style="font-family:Times New Roman, Times, serif">&#160;</td><td rowspan="1" style="text-align:right;font-family:Times New Roman, Times, serif;width:10%">&#160;</td></tr><tr><td rowspan="1" style="font-family:Times New Roman, Times, serif"><div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span><span><span><a href="#consolidatedStatementsOfOperationsForTheYearEnded_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span><span><span>Consolidated Statements of Operations</span></span></span></span></span></span></span></span></span></span></span></span></span></span></a></span></span></span></span></span></span></span></span></span></span></span></span></span></span></div></td><td rowspan="1" style="text-align:right;font-family:Times New Roman, Times, serif;width:10%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>F - 4</span></span></span></span></span></span></span></span></span></span></span></span></td></tr><tr><td rowspan="1" style="font-family:Times New Roman, Times, serif">&#160;</td><td rowspan="1" style="text-align:right;font-family:Times New Roman, Times, serif;width:10%">&#160;</td></tr><tr><td rowspan="1" style="font-family:Times New Roman, Times, serif"><div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span><a href="#consolidatedStatementsOfChangesInEquity_integixAnchor"><span><span><span><span><span><span><span><span><span><span>Consolidated Statements of Changes in Equity</span></span></span></span></span></span></span></span></span></span></a></span></span></span></span></span></span></span></span></span></span></span></span></div></td><td rowspan="1" style="text-align:right;font-family:Times New Roman, Times, serif;width:10%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>F - 5</span></span></span></span></span></span></td></tr><tr><td rowspan="1" style="font-family:Times New Roman, Times, serif">&#160;</td><td rowspan="1" style="text-align:right;font-family:Times New Roman, Times, serif;width:10%">&#160;</td></tr><tr><td rowspan="1"><div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><a href="#statementsOfCashFlows_integixAnchor"><span><span><span><span><span><span>Consolidated Statements of Cash Flow<span>&#160;</span></span></span></span></span></span></span></a></span></span></span></span></span></span></span></span></div></td><td rowspan="1" style="text-align:right;font-family:Times New Roman, Times, serif;width:10%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>F - 6</span></span></span></span></span></span></td></tr><tr><td rowspan="1" style="font-family:Times New Roman, Times, serif">&#160;</td><td rowspan="1" style="text-align:right;font-family:Times New Roman, Times, serif;width:10%">&#160;</td></tr><tr><td rowspan="1" style="font-family:Times New Roman, Times, serif"><div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span><a href="#notesToTheFinancialStatements_integixAnchor"><span><span><span><span><span><span><span><span><span><span>Notes to the Consolidated Financial Statements</span></span></span></span></span></span></span></span></span></span></a></span></span></span></span></span></span></span></span></span></span></span></span></div></td><td rowspan="1" style="text-align:right;font-family:Times New Roman, Times, serif;width:10%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>F - 7</span></span></span></span></span></span></span></span></span></span></span></span></td></tr></table><p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div><div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:center;margin-bottom:10pt;margin-top:0pt"><div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always" /><p style="text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="text-align:left"><img alt=" " src="cmmb_img01.jpg" style="width:114px;height:55px" /></p></div><div style="margin-top:10pt"><table border="0" cellpadding="0" cellspacing="0" style="width:100%"><tr><td style="width:80%;text-align:left"><p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Somekh Chaikin</span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>KPMG Millennium Tower</span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>17 Ha&#8217;arba&#8217;a Street, PO Box 609</span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Tel Aviv 61006, Israel</span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>+972 3 684 8000</span></span></span></span></span></span></span></p></td></tr></table></div><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span id="reportOfIndependentRegisteredPublicAccountingFirm_integixAnchor" style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><strong style="margin-top:0pt;margin-bottom:0pt">Report of Independe</strong></span></span></span></span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><strong style="margin-top:0pt;margin-bottom:0pt">nt Registered Public Accounting Firm</strong></span></span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">To the Shareholders and Board of Directors, </span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Chemomab Therapeutics Ltd.:</span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="line-height:12pt;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><i style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-weight:normal;margin-top:0pt;margin-bottom:0pt">O</span></span></i></span></span></span><i style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">pinion on the Consolidated Financial Statements</span></i></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="line-height:12pt;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-weight:normal;margin-top:0pt;margin-bottom:0pt">We </span></span></span></span></span><span style="margin-top:0pt;margin-bottom:0pt">have audited the accompanying consolidated balance sheets of Chemomab Therapeutics Ltd. (the Company) as of December 31, 202</span><span style="margin-top:0pt;margin-bottom:0pt">2</span><span style="margin-top:0pt;margin-bottom:0pt"> and 202</span><span style="margin-top:0pt;margin-bottom:0pt">1</span><span style="margin-top:0pt;margin-bottom:0pt">, the related consolidated statements of operations, changes in equity, and cash flows for each of the years in the two-year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 202</span><span style="margin-top:0pt;margin-bottom:0pt">2</span><span style="margin-top:0pt;margin-bottom:0pt"> and 202</span><span style="margin-top:0pt;margin-bottom:0pt">1</span><span style="margin-top:0pt;margin-bottom:0pt">, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles</span><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-weight:normal;margin-top:0pt;margin-bottom:0pt">.</span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="line-height:12pt;margin-top:0pt;margin-bottom:0pt"><i style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Basis for Opinion</span></i></span></span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="line-height:12pt;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">These&#160;</span></span></span></span><span style="margin-top:0pt;margin-bottom:0pt">consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion</span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">. </span></span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="line-height:12pt;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-weight:normal;margin-top:0pt;margin-bottom:0pt">Our</span></span></span></span></span><span style="margin-top:0pt;margin-bottom:0pt">&#160;audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></span></span></p><p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-right:57pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="line-height:12pt;margin-top:0pt;margin-bottom:0pt">Somekh Chaikin</span></span></span></span></span></p><p style="margin-top:0pt;margin-right:57pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0pt;margin-right:0px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="line-height:12pt;margin-top:0pt;margin-bottom:0pt">Member Firm of KPMG International</span></span></span></span></span></p><p style="margin-top:0pt;margin-right:0px;margin-bottom:0px;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p><p style="margin-top:0px;margin-right:0px;margin-bottom:0px;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:12pt"><span>We have served as the Company&#8217;s auditor since </span></span><span>2015</span></span><span>.</span></span></span></span></p><p style="margin-top:0pt;margin-right:0px;margin-bottom:0px;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:12pt">Tel Aviv, Israel</span></span></span></span></span></p><p style="margin-top:0pt;margin-right:0px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal"><span>February 20, 2023</span></span></span></span></span></span></p><p style="margin-top:10pt;margin-right:57pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:8pt"><span style="font-family:Times New Roman,Times,serif"><span>&#169; 2</span></span></span><span style="font-size:8pt">023 KPMG Somekh Chaikin, an Israeli partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserve</span><span style="font-size:8pt"><span style="font-family:Times New Roman,Times,serif"><span>d.</span></span></span></p></div><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>F - 2</span></span></span></span></p></div><div style="clear:both;margin-top:0pt;margin-bottom:10pt"><div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000" /></div></div></div></div>
  <table cellpadding="0" style="border-spacing:0;margin:auto" width="100%">

      <tr>
        <td style="width:100%;vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">Chemomab Therapeutics Ltd. and its subsidiaries</p>
        </td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom">&#160;</td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom;border-bottom:1.5pt solid #000000">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:4pt"><span id="consolidatedBalanceSheets_integixAnchor"><span style="font-weight:bold">Con</span></span><span><span style="font-weight:bold">solidated Balance Sheets as of</span></span></p>
        </td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:4pt;margin-bottom:0pt">In USD thousands (except share and per share amounts)</p>
        </td>
      </tr>

  </table>
  <div style="margin-top:0px">
    <p style="text-align:center;margin-bottom:0px">&#160; &#160;</p>
    <table border="0" cellpadding="0" cellspacing="0" style="width:100%" width="100%">

        <tr>
          <td style="vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom">&#160;</td>
          <td style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note</span></p>
          </td>
          <td style="vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom">&#160;</td>
          <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
          </td>
          <td style="vertical-align:bottom;text-align:right">&#160;</td>
          <td style="vertical-align:bottom;text-align:right">&#160;</td>
          <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
          </td>
          <td style="vertical-align:bottom">&#160;</td>
        </tr>


        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Assets</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Current assets</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Cash and cash equivalents</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">3</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000038" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,519</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000039" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,186</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Short-term bank deposit</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000040" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,374</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000041" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,975</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Restricted cash</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230213102216110_Fact_0000000000040" name="us-gaap:RestrictedCashCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction></strong></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><ix:nonFraction id="Fxbrl_20230213102216110_Fact_0000000000041" name="us-gaap:RestrictedCashCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Other receivables and prepaid expenses</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">4</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000042" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,766</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000043" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,527</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Total current assets</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000044" name="us-gaap:AssetsCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,736</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000045" name="us-gaap:AssetsCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,688</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Non-current assets</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted cash</span></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230207200450049_Fact_0000000000050" name="us-gaap:RestrictedCashNoncurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></strong></td>
          <td style="vertical-align:bottom;width:1%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;text-align:right;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230207200450049_Fact_0000000000051" name="us-gaap:RestrictedCashNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></span></td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Long-term prepaid expenses</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000048" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">733</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span><ix:nonFraction id="Fxbrl_20230131220311598" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">908</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Property and equipment, net</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">5</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000052" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">367</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000053" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">357</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Operating lease right-of-use assets</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">6</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000054" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">227</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000055" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Total non-current assets</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000056" name="us-gaap:AssetsNoncurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,327</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000057" name="us-gaap:AssetsNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,665</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Total assets</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000058" name="us-gaap:Assets" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,063</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000059" name="us-gaap:Assets" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,353</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Current liabilities</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Trade payables</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000060" name="us-gaap:AccountsPayableTradeCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,688</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000061" name="us-gaap:AccountsPayableTradeCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,336</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Accrued expenses</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000062" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,378</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000063" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">555</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Employee and related expenses</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000064" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,560</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000065" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">653</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Operating lease liabilities</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">6</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000066" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000067" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">106</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Total current liabilities</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000068" name="us-gaap:LiabilitiesCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,749</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000069" name="us-gaap:LiabilitiesCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,650</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Non-current liabilities</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Non-current operating lease liabilities</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">6</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000070" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">91</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000071" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">237</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Total non-current liabilities</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000072" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">91</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000073" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">237</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Commitments and contingent liabilities</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">7</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><ix:nonFraction id="Fxbrl_20230207202310124" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20221231" unitRef="usd" xsi:nil="true"></ix:nonFraction></td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><ix:nonFraction id="Fxbrl_20230207202348403" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20211231" unitRef="usd" xsi:nil="true"></ix:nonFraction></td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Total liabilities</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000074" name="us-gaap:Liabilities" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,840</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000075" name="us-gaap:Liabilities" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,887</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Shareholders' equity</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">8</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;text-indent:-10pt;padding-left:10pt;margin-bottom:0pt">Ordinary Shares <ix:nonFraction id="Fxbrl_20230201163052384" name="us-gaap:CommonStockNoParValue" contextRef="C_20211231" unitRef="USD_Per_Share" scale="0" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="Fxbrl_20230131220607422" name="us-gaap:CommonStockNoParValue" contextRef="C_20221231" unitRef="USD_Per_Share" scale="0" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> par value - Authorized: <ix:nonFraction id="Fxbrl_20230131221123913" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230131221114549" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">650,000,000 </ix:nonFraction></ix:nonFraction>shares as of December 31, 2022 and 2021;&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;text-indent:-10pt;padding-left:10pt;margin-bottom:0pt">Issued and outstanding: <ix:nonFraction id="Fxbrl_s_20230213101830929" name="us-gaap:SharesOutstanding" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230213101830930" name="us-gaap:CommonStockSharesIssued" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">232,636,700</ix:nonFraction></ix:nonFraction> Ordinary shares at December 31, 2022 and <ix:nonFraction id="Fxbrl_s_20230131221353660" name="us-gaap:SharesOutstanding" contextRef="C_20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230131221353661" name="us-gaap:CommonStockSharesIssued" contextRef="C_20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,090,300</ix:nonFraction></ix:nonFraction> Ordinary shares at December 31, 2021</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="Fxbrl_20230131221528825" name="us-gaap:CommonStockValue" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="Fxbrl_20230131221535249" name="us-gaap:CommonStockValue" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, serif">Treasury share at cost (<ix:nonFraction id="Fxbrl_20230207202558860" name="us-gaap:TreasuryStockShares" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">11,640,460</ix:nonFraction> shares as of </span><span style="font-size:10pt;font-family:Times New Roman, serif">December 31, 2022</span><span style="font-size:10pt;font-family:Times New Roman, serif">)</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><strong><span style="font-size:10pt;font-family:Times New Roman, serif">(<ix:nonFraction id="Fxbrl_20230207202444619" name="us-gaap:TreasuryStockValue" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,218</ix:nonFraction></span></strong></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">)</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;text-align:right;background-color:rgb(255, 255, 255)"><ix:nonFraction id="Fxbrl_20230207202534021" name="us-gaap:TreasuryStockValue" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Additional paid-in capital</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000086" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,260</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000087" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,639</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Accumulated deficit</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000088" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">63,819</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-weight:bold">)</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(<ix:nonFraction id="FFact_0000000000089" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,173</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt">)</p>
          </td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Total shareholders&#8217; equity</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000090" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,223</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000091" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,466</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Total liabilities and shareholders&#8217; equity</span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000092" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,063</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
          <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000093" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,353</ix:nonFraction></p>
          </td>
          <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>

    </table>
  </div>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:16pt;margin-bottom:0pt">_____________________&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;_____________________</p>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt">Chief Executive Officer&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; Chief Financial Officer</p>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt">&#160;</p>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt">Date of approval of the financial statements: February 20, 2023</p>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0px">&#160;</p>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px">The accompanying notes are an integral part of the consolidated financial statements.</p>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:center">&#160;</p>
  <div>
    <div style="width:100%;clear:both">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0px">F - 3</p>
    </div>
    <hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-bottom:10pt" />
  </div>

  <table cellpadding="0" style="border-spacing:0;margin:auto" width="100%">

      <tr>
        <td style="width:100%;vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Therapeutics Ltd. and its subsidiaries</span></span></p>
        </td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom">&#160;</td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom;border-bottom:1.5pt solid #000000">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:4pt"><strong><span id="consolidatedStatementsOfOperationsForTheYearEnded_integixAnchor"><span>Consolidated Statements of Operations for the year ended</span></span></strong></p>
        </td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:4pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In USD thousands (except share and per share amounts)</span></span></p>
        </td>
      </tr>

  </table>
  <div style="margin-top:0px;margin-bottom:0px">
    <p style="margin-bottom:0px;text-align:center">&#160; &#160; &#160; &#160;</p>
    <table border="0" cellpadding="0" cellspacing="0" style="width:100%" width="100%">

        <tr>
          <td style="vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom">&#160;</td>
          <td style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Note</span></span></span></p>
          </td>
          <td style="vertical-align:bottom">&#160;</td>
          <td style="vertical-align:bottom">&#160;</td>
          <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
          </td>
          <td style="vertical-align:bottom;text-align:right">&#160;</td>
          <td style="vertical-align:bottom;text-align:right">&#160;</td>
          <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
          </td>
          <td style="vertical-align:bottom">&#160;</td>
        </tr>


        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Operating expenses</span></span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000094" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,977</ix:nonFraction></span></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000095" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,334</ix:nonFraction></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative</span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000096" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,556</ix:nonFraction></span></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000097" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,033</ix:nonFraction></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Total operating expenses</span></span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000098" name="us-gaap:OperatingExpenses" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,533</ix:nonFraction></span></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000099" name="us-gaap:OperatingExpenses" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,367</ix:nonFraction></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:65%">&#160;</td>
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Financing (income) expenses, net</span></span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);border-bottom:1.5pt solid black;width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);border-bottom:1.5pt solid black;width:9%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230131223230473" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">353</ix:nonFraction>)</span></span></strong></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);border-bottom:1.5pt solid black;width:1%">&#160;</td>
          <td style="vertical-align:top;text-align:right;background-color:rgb(204, 238, 255);border-bottom:1.5pt solid black;width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230131223237304" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">111</ix:nonFraction></span></span></span></td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:65%">&#160;</td>
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>Loss before taxes</span></strong></span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><strong><span style="font-size:11pt;font-family:Times New Roman, serif"><ix:nonFraction id="Fxbrl_20230207212310873_Fact_0000000000102" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">28,180</ix:nonFraction></span></strong></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);text-align:right;width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);text-align:right;width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);text-align:right;width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:11pt;font-family:Times New Roman, serif"><ix:nonFraction id="Fxbrl_20230207212310873_Fact_0000000000103" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,478</ix:nonFraction></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:65%">&#160;</td>
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Taxes on income (benefit)</span></span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center">11</p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(<ix:nonFraction id="Fxbrl_20230131223639023" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">534</ix:nonFraction></span></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></strong></td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000101" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt">&#160;</p>
          </td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Net loss for the year</span></span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000102" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">27,646</ix:nonFraction></span></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000103" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,478</ix:nonFraction></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic and diluted loss per Ordinary Share</span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%;border-bottom:3pt double black">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%;border-bottom:3pt double black">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="Fxbrl_20230131213305203" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_0000000000104" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.121</ix:nonFraction></ix:nonFraction></span></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%;border-bottom:3pt double black">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%;border-bottom:3pt double black">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230131213312166" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_0000000000105" name="us-gaap:EarningsPerShareBasic" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.060</ix:nonFraction></ix:nonFraction></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average number of Ordinary Shares outstanding, basic, and diluted</span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:9%">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%;border-bottom:3pt double black">&#160;</td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:3pt double black">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="Fxbrl_20230214141238310" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_0000000000106" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220101to20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">227,589,288</ix:nonFraction></ix:nonFraction></span></span></span></p>
          </td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:3pt double black">&#160;</td>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:3pt double black">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230131213329528" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_0000000000107" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">207,468,650</ix:nonFraction></ix:nonFraction></span></span></p>
          </td>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>

    </table>
  </div>
  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, serif;font-size:10pt;color:black">The accompanying notes are an integral part of the consolidated financial statements.</span></p>
  <div>
    <div style="width:100%;clear:both">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F - 4</span></span></p>
    </div>
    <hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-bottom:10pt" />
  </div>

  <table cellpadding="0" style="border-spacing:0;margin:auto" width="100%">

      <tr>
        <td style="width:100%;vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">Chemomab Therapeutics Ltd. and its subsidiaries</p>
        </td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom">&#160;</td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom;border-bottom:1.5pt solid #000000">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:4pt"><span id="consolidatedStatementsOfChangesInEquity_integixAnchor"><span style="font-weight:bold">Consolidated S</span></span><span><span style="font-weight:bold">tatements of Changes in Equity</span></span></p>
        </td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:4pt;margin-bottom:0pt">In USD thousands (except share amounts)</p>
        </td>
      </tr>

  </table>
  <div style="margin-top:0px">
    <table border="0" cellpadding="0" cellspacing="0" style="width:100%">

        <tr>
          <td style="height:15px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px" valign="bottom">&#160; &#160;</td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px">&#160;</td>
          <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center">&#160;</p>
          </td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center">&#160;</td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center">&#160;</td>
          <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center">&#160;</p>
          </td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
          <td style="height:15px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px" valign="bottom">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center">&#160;</p>
          </td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center">&#160;</td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center">&#160;</td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center">&#160;</td>
          <td style="height:15px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px" valign="bottom">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center">&#160;</p>
          </td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
          <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center">&#160;</p>
          </td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center">&#160;</td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center">&#160;</td>
          <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center">&#160;</p>
          </td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center">&#160;</td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center">&#160;</td>
          <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center">&#160;</p>
          </td>
          <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
          <td colspan="6" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);border-bottom:2px solid black">
            <p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">Ordinary</span></p>
            <p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">Shares</span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
          <td colspan="6" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong>Treasury<br />share</strong></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);text-align:center">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);text-align:center">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);text-align:center;border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong>Additional<br />paid in<br />capital</strong></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);text-align:center">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);text-align:center">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);text-align:center;border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong>Accumulated Deficit</strong></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);text-align:center">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);text-align:center">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);text-align:center;border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><strong>Total Shareholders'<br />equity</strong></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">Number</span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255);border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">USD</span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255);border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">Number</span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255);border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">USD</span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255);border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">USD</span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255);border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">USD</span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255)">&#160;</td>
          <td colspan="2" rowspan="1" style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;text-align:center;background-color:rgb(255, 255, 255);border-bottom:2px solid black">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">USD</span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(204, 238, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>Balance as of January 1, 2021 </strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207232832534" name="us-gaap:SharesOutstanding" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">9,274,838</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004148281" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004108785" name="us-gaap:SharesOutstanding" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004208753" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207232638785_Fact_0000000000128" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,497</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong>(<ix:nonFraction id="Fxbrl_20230207232638785_Fact_0000000000129" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">23,695</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <p style="margin:0px;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:left;margin:0px"><strong>)</strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207232638785_Fact_0000000000130" name="us-gaap:StockholdersEquity" contextRef="C_20201231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,802</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px">&#160;</p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right">&#160;</p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right">&#160;</p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right">&#160;</p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right">&#160;</p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right">&#160;</p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right">&#160;</p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right">&#160;</p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(204, 238, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Share-based compensation</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right">-</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004236209" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right">-</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004232608" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207232932528" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,019</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004229458" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207232938175" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,019</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Effect of reverse capitalization transaction</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207232946871" name="cmmb:EffectOfReverseCapitalizationTransactionShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">152,299,702</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004310594" name="cmmb:EffectOfReverseCapitalizationTransaction" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004631164" name="cmmb:EffectOfReverseCapitalizationTransactionShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004302609" name="cmmb:EffectOfReverseCapitalizationTransaction" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207232952864" name="cmmb:EffectOfReverseCapitalizationTransaction" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,476</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004258843" name="cmmb:EffectOfReverseCapitalizationTransaction" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207232958504" name="cmmb:EffectOfReverseCapitalizationTransaction" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,476</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(204, 238, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Issuance of shares and warrants, net of issuance costs</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207233006128" name="cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">66,381,520</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004339738" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004626295" name="cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004335122" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207233012248" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,637</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004332317" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207233018475" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,637</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Exercise of options</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207233039147" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">134,240</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004521301" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004621028" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004724885" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207233033563" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230208004807831" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><ix:nonFraction id="Fxbrl_20230207233028090" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(204, 238, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Net loss for the year</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>-</strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208004352160" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>-</strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208004349447" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><ix:nonFraction id="Fxbrl_20230208004345432" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">(<ix:nonFraction id="Fxbrl_20230207233044479" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,478</ix:nonFraction></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:0px;padding:0in 0in 1pt;text-align:left;margin:0px;border-top:0px">
              <p style="margin:0px;border:none;padding:0px 0in 0in;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">)</span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">(<ix:nonFraction id="Fxbrl_20230207233049858" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,478</ix:nonFraction></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:0px;padding:0in 0in 1pt;text-align:left;margin:0px;border-top:0px">
              <p style="margin:0px;border:none;padding:0px 0in 0in;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">)</span></span></span></p>
            </div>
          </td>
        </tr>
        <tr style="height:15px;background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;padding:0px;vertical-align:bottom;background-color:rgb(255, 255, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>Balance as of December 31, 2021</strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230207234506438" name="us-gaap:SharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,090,300</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208004359870" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="top">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><ix:nonFraction id="Fxbrl_20230208004449318" name="us-gaap:SharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="top">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208004357072" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230207233106443" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,639</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>(</strong><strong><ix:nonFraction id="Fxbrl_20230207234203847" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,173</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px 0px 2pt;background-color:rgb(255, 255, 255);width:1%">
            <div style="padding:0in 0in 1pt;text-align:left;margin:0px">
              <p style="margin:0px;padding:0px 0in 0in;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>)</strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230207233116634" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,466</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="background-color:rgb(204, 238, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:30%" valign="bottom">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="top">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>Balance as of January 1, 2022 </strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207234515566" name="us-gaap:SharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,090,300</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004830175" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004835440" name="us-gaap:SharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="top">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208004846448" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233129314" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,639</ix:nonFraction> </strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong>(<ix:nonFraction id="Fxbrl_20230207233133644" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,173</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>)</strong></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233141194" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,466</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(204, 238, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Share-based compensation</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong>-</strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004855201" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong>-</strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="top">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004852649" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233154315" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,211</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004943313" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233147476" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,211</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Issuance of shares, net of issuance costs</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233201211" name="cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">2,576,400</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004904248" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004910523" name="cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="top">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208004901083" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233210018" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">267</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004950211" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233216009" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">267</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(204, 238, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Exercise of options</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233237975" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,970,000</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004927217" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004915442" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="top">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004923369" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233227671" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004959684" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230207233221400" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
        <tr style="height:15px;background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Treasury share at cost</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong>- </strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004938057" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong>(<ix:nonFraction id="Fxbrl_20230207233301376" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">11,640,460</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">
            <p style="margin:0px;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:left;margin:0px"><strong>)</strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="top">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong>(<ix:nonFraction id="Fxbrl_20230207233406606" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,218</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">
            <p style="margin:0px;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:left;margin:0px"><strong>)</strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004934609" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong><ix:nonFraction id="Fxbrl_20230208004932393" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:right"><strong>(<ix:nonFraction id="Fxbrl_20230207233411324" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,218</ix:nonFraction></strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">
            <p style="margin:0px;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%;text-align:left;margin:0px"><strong>)</strong></span></span></span></p>
          </td>
        </tr>
        <tr style="height:15px;background-color:rgb(204, 238, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%">Net loss for the year</span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>-</strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208005011611" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>-</strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="top">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208005008418" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208005005802" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>(<ix:nonFraction id="Fxbrl_20230207233416622" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">27,646</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:0px;padding:0in 0in 1pt;text-align:left;margin:0px;border-top:0px">
              <p style="margin:0px;border:none;padding:0px 0in 0in;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>)</strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:2px solid black">&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(204, 238, 255);width:7%" valign="bottom">
            <div style="border-bottom:2px solid black;padding:0in 0in 1pt;text-align:right;border-top:0px">
              <p style="margin-top:0px;margin-bottom:0pt;border:none;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>(<ix:nonFraction id="Fxbrl_20230207233422744" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">27,646</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;padding:0px;background-color:rgb(204, 238, 255);width:1%">
            <div style="border-bottom:0px;padding:0in 0in 1pt;text-align:left;margin:0px;border-top:0px">
              <p style="margin:0px;border:none;padding:0px 0in 0in;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>)</strong></span></span></span></p>
            </div>
          </td>
        </tr>
        <tr style="height:15px;background-color:rgb(255, 255, 255)">
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:30%" valign="bottom">
            <p style="margin-top:0px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>Balance as of December 31, 2022</strong></span></span></span></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230207233430996" name="us-gaap:SharesOutstanding" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">232,636,700</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230208005022333" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>(<ix:nonFraction id="Fxbrl_20230207233657770" name="us-gaap:SharesOutstanding" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">11,640,460</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;padding:0px 0px 3pt;background-color:rgb(255, 255, 255);width:1%;vertical-align:bottom">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>)</strong></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="top">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>(<ix:nonFraction id="Fxbrl_20230207233728393" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,218</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;padding:0px 0px 3pt;background-color:rgb(255, 255, 255);width:1%;vertical-align:bottom">
            <div style="padding:0in 0in 1pt;text-align:left;margin:0px">
              <p style="margin:0px;padding:0px 0in 0in;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>)</strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230207233439472" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,260</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong>(<ix:nonFraction id="Fxbrl_20230207233445148" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">63,819</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;padding:0px 0px 3pt;background-color:rgb(255, 255, 255);width:1%;vertical-align:bottom">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong>)</strong></p>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">
            <div>&#160;</div>
          </td>
          <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:7%" valign="bottom">
            <div style="padding:0in 0in 1pt;text-align:right">
              <p style="margin-top:0px;margin-bottom:0pt;padding:0px 0in 0in;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:115%"><strong><ix:nonFraction id="Fxbrl_20230207233450251" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,223</ix:nonFraction></strong></span></span></span></p>
            </div>
          </td>
          <td style="font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;padding:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>

    </table>
  </div>
  <div>
    <div style="width:100%;clear:both">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:0px">F - 5</p>
    </div>
    <hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-bottom:10pt" />
  </div>

  <table cellpadding="0" style="border-spacing:0px;margin-top:auto;margin-bottom:auto" width="100%">

      <tr>
        <td style="width:100%;vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p>
        </td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom">&#160;</td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom;border-bottom:1.5pt solid #000000">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:4pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span id="statementsOfCashFlows_integixAnchor"><span style="font-weight:bold">Statem</span></span><span><span style="font-weight:bold">ents of Cash flows for the year ended</span></span></span></span></span></span></p>
        </td>
      </tr>
      <tr>
        <td style="width:100%;vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:4pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In USD thousands</span></span></span></span>&#160;</p>
        </td>
      </tr>

  </table>
  <p style="margin-bottom:0px;text-align:center">&#160; &#160; &#160; &#160;</p>
  <table border="0" cellpadding="0" cellspacing="0" style="width:100%" width="100%">

      <tr>
        <td style="vertical-align:bottom">&#160;</td>
        <td style="vertical-align:bottom">&#160;</td>
        <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">December&#160;31, </span></span></span></span></span></p>
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">2022</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;text-align:right">&#160;</td>
        <td style="vertical-align:bottom;text-align:right">&#160;</td>
        <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">December&#160;31, </span></span></span></span></span></p>
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">2021</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Cash flows from operating activities</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net loss for the year</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000149" name="us-gaap:ProfitLoss" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">27,646</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">)</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="FFact_0000000000150" name="us-gaap:ProfitLoss" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,478</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></p>
        </td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:0px">&#160;</p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Adjustments for operating activities:</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000151" name="us-gaap:Depreciation" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000152" name="us-gaap:Depreciation" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">34</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based compensation</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000153" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,211</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000154" name="us-gaap:ShareBasedCompensation" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,019</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Change in other receivables and prepaid expenses</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000155" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">64</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">)</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="FFact_0000000000156" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,058</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></p>
        </td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Change in trade payables</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000157" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">352</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000158" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,175</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Change in accrued expenses</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000159" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,823</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230201002431792" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,279</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></p>
        </td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Change in employees and related expenses</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000161" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">907</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000162" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">215</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:baseline;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Change in operating leases&#160;</span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000163" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">)</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(<ix:nonFraction id="Fxbrl_20230201002424683" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></p>
        </td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Net cash used in operating activities</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000165" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">20,370</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">)</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="FFact_0000000000166" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,374</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></p>
        </td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Cash flows from investing activities</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Investment in deposits</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000167" name="cmmb:PaymentsForInvestmentInDeposits" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,601</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="FFact_0000000000168" name="cmmb:PaymentsForInvestmentInDeposits" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,951</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></p>
        </td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Long-term lease deposit</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000169" name="cmmb:LongTermLeaseDeposit" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230131235620864" name="cmmb:LongTermLeaseDeposit" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Sale of asset held for sale</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000171" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230131235631064" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Purchase of property and equipment</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000173" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">68</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">)</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="FFact_0000000000174" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">239</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></p>
        </td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Net cash provided by (used in) investing activities</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000175" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,533</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="FFact_0000000000176" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">45,186</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></p>
        </td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Cash flows from financing activities</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash acquired in Merger</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000177" name="cmmb:CashAcquiredInMerger" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><ix:nonFraction id="Fxbrl_20230131235649216" name="cmmb:CashAcquiredInMerger" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,427</ix:nonFraction></span></span></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exercise of options</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><span><ix:nonFraction id="FFact_0000000000179" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></span></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonFraction id="Fxbrl_20230131235658097" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Treasury share at cost</span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">(<ix:nonFraction id="Fxbrl_20230201000241409" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,218</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">)</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000182" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issuance of shares and warrants, net of issuance costs</span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000183" name="us-gaap:ProceedsFromOtherEquity" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">267</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000184" name="us-gaap:ProceedsFromOtherEquity" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,637</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Net cash provided by (used in) financing activities</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">(<ix:nonFraction id="Fxbrl_20230201002754453" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">808</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">)</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:baseline;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000186" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,074</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Change in cash, cash equivalents and restricted cash</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">(<ix:nonFraction id="Fxbrl_20230201002721687" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,645</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">)</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000188" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,514</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Cash, cash equivalents and restricted cash at beginning of the year</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000189" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,241</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000190" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20201231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,727</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Cash, cash equivalents and restricted cash at end of the year</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000191" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,596</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000192" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,241</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span style="text-decoration:underline">Supplementary cash flows information:</span></strong></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cash paid and received during the year for:</span></strong></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income taxes received</span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="border-bottom:4px double black;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="border-bottom:4px double black;vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214142748754" name="cmmb:IncomeTaxesReceived" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">351</ix:nonFraction></span></span></strong></td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="border-bottom:4px double black;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="border-bottom:4px double black;vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214143241770" name="cmmb:IncomeTaxesReceived" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Income taxes paid</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="border-bottom:4px double black;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="border-bottom:4px double black;vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-bottom:0pt;margin-top:0pt;text-align:right"><span style="font-weight:bold">(<ix:nonFraction id="Fxbrl_20230214142431448" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></span></span></td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">)</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="border-bottom:4px double black;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="display:none">&#160;</span>&#160;</span></span></td>
        <td style="border-bottom:4px double black;vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-bottom:0pt;margin-top:0pt;text-align:right"><ix:nonFraction id="Fxbrl_20230207233750059" name="us-gaap:IncomeTaxesPaidNet" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Interest received</span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black">&#160;</td>
        <td style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230207233819452" name="cmmb:InterestReceived" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">972</ix:nonFraction></span></span></strong></td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black">&#160;</td>
        <td style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230207233829491" name="cmmb:InterestReceived" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></span></span></td>
        <td style="background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">B.&#160; &#160; &#160; &#160; &#160;Significant non- cash transaction:</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:normal">Right-of-use asset recognized with corresponding lease liability</span></span></span></span></span></strong></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000193" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction></span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_0000000000194" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:normal">Liabilities assumed, net of non-cash assets received in Merger</span></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000195" name="us-gaap:LiabilitiesAssumed1" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></strong></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        <td style="vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:9%">
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230131235456185" name="us-gaap:LiabilitiesAssumed1" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></span></span></span></p>
        </td>
        <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
      </tr>

  </table>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt">&#160;</p>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The accompanying notes are an integral part of the consolidated financial statements.</span></span></span></span></p>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px">&#160;</p>
  <div>
    <div style="width:100%;clear:both">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>F - 6</span></span></span></span></p>
    </div>
    <hr style="border-top:1.5pt solid #000000;page-break-after:always;margin-bottom:10pt" />
  </div>
  <div>
    <table cellpadding="0" style="border-spacing:0" width="100%">

        <tr>
          <td style="width:100%;vertical-align:top">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p>
          </td>
        </tr>
        <tr>
          <td style="width:100%;vertical-align:top">&#160;</td>
        </tr>
        <tr>
          <td style="width:100%;vertical-align:top">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:4pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span id="notesToTheFinancialStatements_integixAnchor"><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></span></p>
          </td>
        </tr>
        <tr>
          <td style="width:100%;vertical-align:top">
            <hr style="height:1.5pt;border-width:0px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0);width:100%;margin-top:-1.34pt;text-align:left" />
          </td>
        </tr>
        <tr>
          <td style="width:100%;vertical-align:top">
            <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#160;&#8201;</span></span></span></span></p>
          </td>
        </tr>

    </table>
  </div>

  <ix:nonNumeric id="FFact_0000000000208" name="us-gaap:NatureOfOperations" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 1 - General</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt">1.<span style="padding-left:28.5pt">Chemomab Therapeutics Ltd. (hereinafter - "the Company") is an Israeli-based company incorporated under the laws of the State of Israel in September 2011. The Company&#8217;s registered office is located in Kiryat Atidim, Tel Aviv, Israel.&#160;</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt;text-align:justify"><br />The Company is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0px;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><br />The wholly owned subsidiaries of the Company are: Chemomab Ltd. ("Chemomab"), Chemomab Therapeutics Israel Ltd. and Chemomab Therapeutics Inc.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt">2.<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="padding-left:28.5pt">The Company currently has no products approved for sale. The Company&#8217;s operations are funded primarily by its Shareholders. The Company has incurred operating losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval for its products. Continuation of the Company&#8217;s development programs depend on its future ability to raise sources of financing.</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.<span style="padding-left:28.5pt">Since </span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 2020, the COVID-19 pandemic has dramatically expanded into a worldwide pandemic, creating macro-economic uncertainty and disruption in the business and financial markets. Many countries around the world, including Israel, had taken&#160; measures designated to limit the continued spread of the COVID-19 pandemic, including the closure of workplaces, restricting travel, prohibiting assembling, closing international borders and quarantining populated areas. The Company's clinical trial sites have been affected by the COVID-19 pandemic, and as a result, commencement of the enrollment in our clinical trials of CM-101 in PSC was delayed, and the enrollment rate has been, and is still, affected as well. As a result, The Company expanded its patient recruiting efforts to additional territories. In addition, after enrollment in these trials, patients might still drop out because of possible COVID-19 implications. Based on management&#8217;s assessment, the extent to which the lingering effects of the COVID-19 pandemic will further impact the Company's operations will depend on future developments. These developments, which are highly uncertain and cannot be predicted with confidence,including the duration and severity of the impact on patient enrollment following the attenuation of the outbreak The Company is carefully monitoring the impacts arising from&#160; the COVID-19 pandemic and will adjust activities accordingly<span><span><span>.</span></span></span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.<span style="padding-left:28.5pt">On </span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 14, 2020, the Company (formerly known as Anchiano Therapeutics Ltd.) entered into an Agreement and Plan of Merger (the "Merger" and &#8220;Merger Agreement&#8221;) with Chemomab Ltd., an Israeli limited company, and CMB Acquisition Ltd., an Israeli limited company and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;). On March 16, 2021, (the &#8220;Effective Time&#8221;), the Company consummated the Merger pursuant to the Merger Agreement Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Chemomab Ltd., with Chemomab Ltd. surviving the Merger as the Company's wholly owned subsidiary. In connection with the Merger, on March 16, 2021, the Company changed its name from &#8220;Anchiano Therapeutics Ltd.&#8221; To &#8220;Chemomab Therapeutics Ltd" and the business conducted by Chemomab Ltd. became primarily the business conducted by the Company.</span></span></p>
    <div>
      <div style="width:100%;clear:both">
        <p style="margin:0pt">&#160;</p>
      </div>
    </div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0px;padding-left:72pt;margin-bottom:10pt">At the Effective Time(a) each Chemomab Ltd. ordinary share outstanding immediately prior to the Effective Time was converted solely into number of American Depository Shares equal to the exchange ratio described in the Merger Agreement, and each outstanding Chemomab Ltd. option was assumed by the Company, based on the same exchange ratio.</p>
    <div><ix:exclude>
      <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;7</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><br /><strong>Note 1 - General (cont&#8217;d)</strong></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">4. (cont'd)</p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For&#160;<span>accounting purposes, Chemomab Ltd. is considered to have acquired the Company based upon the terms of the Merger as well as other factors. The Merger has been accounted for as an asset acquisition (reverse recapitalization transaction) rather than a business combination, as the assets acquired, and the liabilities assumed by Chemomab Ltd. do not meet the definition of a business under U.S. GAAP. The net assets acquired in connection with the Merger were recorded at their estimated acquisition date fair market value as of March 16, 2021, the date of completion of the Merger.</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">The exchange ratio was calculated by a formula that was determined through arms-length negotiations between the Company and Chemomab Ltd. The combined Company assumed all of the outstanding options of Chemomab Ltd., vested and not vested, under the Chemomab&#160;Share Incentive Plan (the &#8220;2015 Plan&#8221;), with such options representing the right to purchase a number of ADSs equal to approximately <ix:nonFraction id="Fxbrl_20230131220949272" name="cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger" contextRef="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">12.86</ix:nonFraction> multiplied by the number of Chemomab Ltd. ordinary shares previously represented by such options.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:11pt">The following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion of the Merger (in USD thousands):</p>
    <div style="margin-left:72pt">
      <ix:nonNumeric id="Fxbrl_20230201024915457" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Cash and cash equivalents</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000202" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="C_20210316" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,427</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Asset held for sale</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000203" name="cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" contextRef="C_20210316" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Prepaid and other assets</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000204" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="C_20210316" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">236</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Accrued liabilities</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(<ix:nonFraction id="FFact_0000000000205" name="cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" contextRef="C_20210316" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,187</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt">)</p>
              </td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Net acquired assets</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000206" name="cmmb:EstimatedFairValueOfNetAssetsAcquired" contextRef="C_20210316" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,476</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
  </ix:nonNumeric>
  <div>
    <div style="width:100%;clear:both">
      <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;8</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <ix:nonNumeric id="FFact_0000000000234" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 2 - Summary of Significant Accounting Policies</span></p>
    <ix:nonNumeric id="FFact_0000000000209" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Basis of Preparation</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S GAAP&#8221;).</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000210" name="us-gaap:UseOfEstimates" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">B.</span><span style="font-weight:bold;padding-left:26.83pt">Use of estimates</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000211" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">C.</span><span style="font-weight:bold;padding-left:26.28pt">Foreign currency</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;dollar&#8221; or &#8220;$&#8221;), thus; the dollar is the functional currency of the Company.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000212" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">D.</span><span style="font-weight:bold;padding-left:26.28pt">Cash and cash equivalents</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000213" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">E.</span><span style="font-weight:bold;padding-left:26.83pt">Restricted cash</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt">Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="Fxbrl_20230201130501547" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">F.</span><span style="font-weight:bold;padding-left:28.31pt">Property and equipment</span></p>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.</p>
        <div>
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt">Annual rates at depreciation are as follows:</p>
          <div style="margin-left:36pt">
            <ix:nonNumeric id="Fxbrl_20230201131108956" name="cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock" contextRef="C_20220101to20221231" escape="true">
              <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">%</span></p>
                    </td>
                    <td style="vertical-align:bottom">&#160;</td>
                  </tr>


                  <tr style="background-color:#CCEEFF">
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Computers</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000214" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">33</ix:nonFraction></p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Laboratory equipment</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000215" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:#CCEEFF">
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Furniture and equipment</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000216" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">7</ix:nonFraction></p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Leasehold improvement - <ix:nonNumeric id="FFact_0000000000217" name="cmmb:AnnualRatesOfDepreciation" contextRef="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember">over the shorter of the lease term or the estimated useful life of the improvement</ix:nonNumeric></p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>

              </table>
            </ix:nonNumeric>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <div><ix:exclude>
      <div>
        <div style="width:100%;clear:both">
          <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;9</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
    </ix:exclude></div>
    <ix:nonNumeric id="FFact_0000000000220" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">G.</span><span style="font-weight:bold;padding-left:25.72pt">Impairment of long-lived assets</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company&#8217;s property and equipment are reviewed for impairment in accordance with ASC 360, &#8220;Property and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2022 and 2021, no impairment losses have been recorded.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000221" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">H.</span><span style="font-weight:bold;padding-left:25.72pt">Research and Development</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000222" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">I.</span><span style="font-weight:bold;padding-left:26.83pt">Income taxes</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000223" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">J.</span><span style="font-weight:bold;padding-left:28.5pt">Fair value of financial instruments</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price.</p>
      <div><ix:exclude>
        <div>
          <div style="width:100%;clear:both">
            <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;10</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
            <p style="margin:0pt">&#160;</p>
          </div>
        </div>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">J.</span><span style="font-weight:bold;padding-left:28.5pt">Fair value of financial instruments (cont&#8217;d)</span></p>
      </ix:exclude></div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#8217;s own credit risk.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#8217;s non<span style="font-weight:bold">- </span>financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000224" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">K.</span><span style="font-weight:bold;padding-left:25.72pt">Share-based compensation</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The fair value for the Company&#8217;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt">The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000225" name="cmmb:GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">L.</span><span style="font-weight:bold;padding-left:26.83pt">Government-sponsored research and development</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Chemomab records grants received from the office of the Israel Innovation Authority (the &#8220;IIA&#8221;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses.</p>
    </ix:nonNumeric>
    <div><ix:exclude>
      <div>
        <div style="width:100%;clear:both">
          <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;11</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
    </ix:exclude></div>
    <ix:nonNumeric id="FFact_0000000000229" name="cmmb:SeverancePayPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">M.</span><span style="font-weight:bold;padding-left:24.06pt">Severance pay</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to Section 14 of the Severance Compensation Law, 1963 ("Section 14"), all employees of the Company are entitled only to monthly deposits, at a rate of <ix:nonFraction id="Fxbrl_20230215220314714" name="cmmb:PercentageOfMonthlyDepositsRate" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">8.33</ix:nonFraction>% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately $<ix:nonFraction id="Fxbrl_20230215220321806" name="us-gaap:SeveranceCosts1" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">142</ix:nonFraction> thousand and $<ix:nonFraction id="Fxbrl_20230215220329094" name="us-gaap:SeveranceCosts1" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">116</ix:nonFraction> thousand for the year ended December 31, 2022 and 2021, respectively.</span></span></p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000230" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">N.</span><span style="font-weight:bold;padding-left:26.28pt">Concentrations of credit risk:</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash <span>and cash equivalents and short- term deposits are invested in banks. Management believes that the financial institutions that hold the Company&#8217;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments</span>.</span></span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</p>
    </ix:nonNumeric>
    <ix:nonNumeric id="Fxbrl_20230213125125767" name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">O.</span><span style="font-weight:bold;padding-left:25.72pt">Leases</span></p>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Under </span></span>Topic 842, the Company determines if an arrangement is a lease at inception. Right-of-use (ROU) assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be <ix:nonFraction id="Fxbrl_20230213132631771" name="cmmb:IncrementalBorrowingRateOfLeases" contextRef="C_20221231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction>% and <ix:nonFraction id="Fxbrl_20230213132641931" name="cmmb:IncrementalBorrowingRateOfLeases" contextRef="C_20211231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.2</ix:nonFraction>% in 2022 and 2021, respectively. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company's lease agreements generally do not contain any residual value guarantees or restrictive covenants<span><span>.</span></span></span></span><br />&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></span><br />&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#8211; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G).</span></span></p>
      </div>
    </ix:nonNumeric>
    <div><ix:exclude>
      <div>
        <div style="width:100%;clear:both">
          <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;12</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 2 - Summary of Significant Accounting Policies (cont&#8217;d)</span></p>
    </ix:exclude></div>
    <ix:nonNumeric id="FFact_0000000000232" name="us-gaap:ConsolidationPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">P.</span><span style="font-weight:bold;padding-left:28.31pt">Principles of consolidation</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The <span>consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.</span></span></span></p>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_0000000000233" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">Q.</span><span style="font-weight:bold;padding-left:25.72pt">Earnings per ordinary share</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt">Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. &#160;Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options.</p>
    </ix:nonNumeric>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_0000000000244" name="us-gaap:CashAndCashEquivalentsDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 3 - Cash and Cash Equivalents</span></p>
    <ix:nonNumeric id="FFact_0000000000243" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">In USD</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000235" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231_srtCurrencyAxis_currencyUSD" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,663</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000236" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231_srtCurrencyAxis_currencyUSD" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,720</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">In NIS</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000237" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231_srtCurrencyAxis_currencyILS" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,756</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000238" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231_srtCurrencyAxis_currencyILS" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,116</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">In other currencies</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000239" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231_srtCurrencyAxis_currencyXXX" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000240" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231_srtCurrencyAxis_currencyXXX" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,350</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000241" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,519</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000242" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,186</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </div>
    </ix:nonNumeric>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_0000000000252" name="cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 4 - Other Receivables and Prepaid Expenses</span></p>
    <ix:nonNumeric id="FFact_0000000000251" name="cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Government institutions</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000245" name="cmmb:ReceivablesFromGovernmentInstitutions" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">459</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000246" name="cmmb:ReceivablesFromGovernmentInstitutions" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">179</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Prepaid expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000247" name="us-gaap:PrepaidExpenseCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,307</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000248" name="us-gaap:PrepaidExpenseCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,348</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000249" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,766</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000250" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,527</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </div>
    </ix:nonNumeric>
  </ix:nonNumeric>
  <div>
    <div style="width:100%;clear:both">
      <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;13</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <ix:nonNumeric id="FFact_0000000000270" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 5 - Property and Equipment, Net</span></p>
    <ix:nonNumeric id="FFact_0000000000269" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Cost:</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Computers</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000253" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">70</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000254" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">43</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Furniture and equipment</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000255" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000256" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Laboratory equipment</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000257" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">399</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000258" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">364</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Website development</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000259" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapSoftwareDevelopmentMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000260" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapSoftwareDevelopmentMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Leasehold improvements</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000261" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000262" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><strong><strong><strong><ix:nonFraction id="Fxbrl_20230201032006902" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">532</ix:nonFraction></strong><strong> </strong></strong><strong> </strong></strong><strong> </strong></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000264" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">464 </ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Less - accumulated depreciation</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000265" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">165</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-weight:bold">)</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(<ix:nonFraction id="FFact_0000000000266" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">107</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt">)</p>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><strong><strong><strong><ix:nonFraction id="Fxbrl_20230201033845372" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">367</ix:nonFraction></strong><strong> </strong></strong><strong> </strong></strong><strong> </strong></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000268" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">357 </ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>

        </table>
      </div>
    </ix:nonNumeric>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_0000000000294" name="us-gaap:LesseeOperatingLeasesTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 6 - Leases</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">On May 10, 2020, Chemomab entered into an office and lab space lease agreement (hereinafter &#8211; &#8220;The Agreement&#8221; .(According to the Agreement, Chemomab &#160;rented a space in Atidim Park, Tel-Aviv for a period of <ix:nonNumeric id="Fxbrl_20230131233210356" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_20200510" format="ixt-sec:durwordsen">three years</ix:nonNumeric>, through <span style="-sec-ix-hidden:Fxbrl_20230131233234992">May 2023</span>. Chemomab was granted an option to extend the lease term by additional <ix:nonNumeric id="Fxbrl_20230131233301410" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="C_20200501to20200510">three years</ix:nonNumeric>.&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">On October 24, 2021, Chemomab signed an amendment to the Agreement ("The Amendment"). According to the Amendment, On December 12, 2021 Chemomab returned the previous office and lab space to the property owner and rented a larger space in Atidim Park Tel-Aviv, for a term of <ix:nonNumeric id="Fxbrl_20230131233734834" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_20211024" format="ixt-sec:duryear">3</ix:nonNumeric> years, through <span style="-sec-ix-hidden:Fxbrl_20230131233722905">October 2024</span>. In addition, Chemomab was granted an option to extend the lease term by additional <ix:nonNumeric id="Fxbrl_20230201000916081" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="C_20211001to20211024">three years</ix:nonNumeric>. The annual rent and management fees are approximately $<ix:nonFraction id="Fxbrl_20230131234005244" name="cmmb:AnnualRentAndManagementFees" contextRef="C_20211001to20211024" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">122</ix:nonFraction> thousand. Pursuant to the Amendment, the bank guarantee issued in 2020 was canceled and a substitute bank guarantee of approximately $<ix:nonFraction id="Fxbrl_20230131234014829" name="cmmb:BankGuaranteesToPropertyOwner" contextRef="C_20211001to20211024" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction> thousand was issued to the property owner during 2022.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The above operating leases are included in &#8220;Operating lease right-of-use assets&#8221; on the Company&#8217;s Consolidated Balance sheets as of December 31, 2022 and 2021 and represent the Company&#8217;s right to use the underlying asset for the lease term. The Company&#8217;s obligations to pay lease payments are included in the current liabilities as &#8220;Operating lease liabilities&#8221; and in the non-current liabilities as &#8220;Non-current operating lease liabilities&#8221; on the Company&#8217;s Consolidated Balance sheets as of December 31, 2022 and 2021. Based on the present value of the lease payments for the remaining lease term of the Company&#8217;s existing lease agreement, the Company recognized operating right-of-use assets and operating lease liabilities of approximately $<ix:nonFraction id="Fxbrl_20230131234456429" name="cmmb:OperatingRightOfUseAssetsAndOperatingLeaseLiabilities" contextRef="C_20211212" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction> thousand on December 12, 2021.&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">During the years ended December 31, 2022 and 2021, the Company recognized an increase in right of use assets of $<ix:nonFraction id="Fxbrl_20230131234508150" name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction> thousand and $<ix:nonFraction id="Fxbrl_20230131234513790" name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction> thousand, respectively.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As&#160;of December 31, 2022, and 2021 operating right-of-use asset was $<ix:nonFraction id="Fxbrl_20230214143811730" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">227</ix:nonFraction> thousand and $<ix:nonFraction id="Fxbrl_20230214143818906" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction> thousand, respectively. The operating lease liabilities were $<ix:nonFraction id="Fxbrl_20230214143827206" name="us-gaap:OperatingLeaseLiability" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">214</ix:nonFraction> thousand and $<ix:nonFraction id="Fxbrl_20230214143833566" name="us-gaap:OperatingLeaseLiability" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">343</ix:nonFraction> thousand, respectively.</span></span></p>
    <div><ix:exclude>
      <div>
        <div style="width:100%;clear:both">
          <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;14</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 6 - Leases (cont&#8217;d)</span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">As most of the Chemomab&#8217;s leases do not provide an implicit rate, Chemomab uses its incremental borrowing rate based on the information available at the commencement date of each lease in determining the present value of lease payments. Chemomab&#8217;s incremental borrowing rate is a hypothetical rate based on its estimation of what its credit rating would be the rate was <ix:nonFraction id="Fxbrl_20230131234937485" name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction>% in 2022 and <ix:nonFraction id="Fxbrl_20230131234957047" name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" contextRef="C_20210101to20211231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.2</ix:nonFraction>% in 2021.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt">Maturities of lease liabilities under noncancellable leases as of December 31, 2022, are as follows: (in thousands):</p>
    <div style="margin-left:40pt;margin-bottom:11pt">
      <ix:nonNumeric id="Fxbrl_20230201025037730" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">2023</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000288" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">126 </ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">2024</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000289" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">93 </ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Total future minimum lease payments</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000290" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">219 </ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Less imputed interest:</p>
              </td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000291" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px"><span style="font-weight:bold">)</span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Present value of operating lease liabilities</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000292" name="us-gaap:OperatingLeaseLiability" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">214 </ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_0000000000311" name="us-gaap:CommitmentsDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-weight:bold">Note 7 - Commitments and Contingent Liabilities</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Exclusive License Agreement (hereinafter- &#8220;the License Agreement&#8221;)</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">In December 2011, Chemomab entered into a License Agreement with the Medical Research, Infrastructure, Health Services Fund of the Tel-Aviv Souraski Medical Center (&#8220;Fund&#8221;), pursuant to which it was granted with an exclusive license to certain inventions (as defined in the License Agreement) including patents, knowhow and products and the right to sublicense to third parties the rights granted, pursuant to and subject to certain terms and limitation fully set in the License Agreement.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">Chemomab has agreed to pay the Fund a non-refundable and non-creditable sublicense fees as a percentage of all Attributed Income (as such term defined in the License Agreement), and shall further pay the Fund royalties from sales made by sublicensee;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt">(i)<span style="padding-left:26.56pt">Royalties in percentage of the Net sales or Service Income (as defined in the License Agreement), subject to </span>certain additional terms set forth therein.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:108pt;margin-bottom:0pt"><span>In addition, with respect to each Licensed Product (as defined therein), Chemomab has agreed to &#160;pay the Fund the following non-refundable, non-creditable amounts:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:144pt;margin-bottom:11pt">(a)<span style="padding-left:24.9pt"><ix:nonNumeric id="Fxbrl_20230215222406006" name="us-gaap:LongTermPurchaseCommitmentDescription" contextRef="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_usgaapCapitalAdditionsMember">$100 thousand upon submission of a New Drug Application (&#8220;NDA&#8221;), Biological License Application (&#8220;BLA&#8221;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#8220;FDA&#8221;), $100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than $300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;</ix:nonNumeric></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0pt;text-indent:-36pt;padding-left:144pt;margin-bottom:0pt">(b)<span style="padding-left:24.34pt"><ix:nonNumeric id="Fxbrl_20230215222519809" name="us-gaap:LongTermPurchaseCommitmentDescription" contextRef="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_cmmbCapitalAdditionsOneMember">$200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than $600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.</ix:nonNumeric></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:108pt;margin-bottom:0pt">As of December 31, 2022&#160;no payments were made to the Fund.</p>
    <div><ix:exclude>
      <div>
        <div style="width:100%;clear:both">
          <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;15</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 7 - Commitments and Contingent Liabilities (cont&#8217;d)</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Exclusive License Agreement (hereinafter- &#8220;the License Agreement&#8221;) (cont&#8217;d)</span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">In addition to the payments described above, <ix:nonNumeric id="Fxbrl_20230215222713212" name="us-gaap:OtherCommitmentsDescription" contextRef="C_20220101to20221231">upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab, if any), but in any event not more than $3,000 thousand.</ix:nonNumeric></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="padding-left:26.83pt">&#160; &#160;Chemomab partially financed its research and development expenditures under programs sponsored by the Israel </span>Innovation Authority (&#8220;IIA&#8221;) for the support of certain research and development activities conducted in Israel.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">In return for the IIA&#8217;s participation, Chemomab is committed to pay royalties at rate of <ix:nonFraction id="Fxbrl_20230201002925810" name="cmmb:PercentageOfRoyaltyPaymentsOnSaleOfProduct" contextRef="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_usgaapCapitalAdditionsMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">3</ix:nonFraction>% of sales of the developed product (linked to U.S. dollar), up to <ix:nonFraction id="Fxbrl_20230201002935951" name="cmmb:MaximumPercentageOfPaymentsOfRoyalties" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the amount of grants received (100% plus interest at LIBOR). In addition, the IIA may impose certain conditions to transfer technology or development out of Israel.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt">Chemomab did not receive any grants from the IIA in the years ended December 31, 2022, and 2021.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">Since Chemomab &#8217;s incorporation through December 31, 2022 Chemomab received $<ix:nonFraction id="Fxbrl_20230201002951961" name="cmmb:CumulativeAmountsOfGrantsReceivedAndRecognized" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,227</ix:nonFraction> thousand from the IIA, which were recognized as a reduction of research and development expenses.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">As of December 31, 2022, Chemomab has no commitment for royalties payable.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="font-weight:bold">B.</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="padding-left:26.28pt">In </span></span></span>June 2015, Chemomab entered into a license agreement with subcontractor (&#8220;the Subcontractor&#8221;), under which the Subcontractor granted to Chemomab certain licenses to use proprietary rights of the subcontractor, materials and know how in the techniques and use of the same, for purposes of research and development of Chemomab 's product CM-101, as well as commercialization thereof. Further to the agreement, the Subcontractor also provides manufacturing services of intermediates and active pharmaceutical ingredients. According to the related manufacturing agreement, the manufacturing of the product is carried out by the Subcontractor in accordance with Chemomab's specifications and timeline.&#160; From time to time, Chemomab and the Subcontractor have been signing additional agreements for additional manufacturing and final process lock of the product for clinical use Under the agreement, Chemomab is also obligated to pay the Subcontractor royalties determined as a percentage of net sales of each licensee product.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:0pt;padding-left:72pt;margin-bottom:0pt">During 2022 and 2021, Chemomab recorded expenses related to the above agreements in the amounts of $<ix:nonFraction id="Fxbrl_20230213125722009" name="us-gaap:RoyaltyExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,222</ix:nonFraction> thousand and $<ix:nonFraction id="Fxbrl_20230213125731080" name="us-gaap:RoyaltyExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,590</ix:nonFraction> thousand, respectively. The expenses were recorded under research and development expenses.</p>
    <div><ix:exclude>
      <div>
        <div style="width:100%;clear:both">
          <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;16</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 7 - Commitments and Contingent Liabilities (cont&#8217;d)</span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:11pt"><span style="font-weight:bold">C.</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="padding-left:26.28pt">As&#160;</span></span>of December 31, 2022, the bank imposed restriction on a bank deposit in the amount of $<ix:nonFraction id="Fxbrl_20230213125744104" name="us-gaap:RestrictedInvestments" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction> thousand for the purpose of secure lease payments under an office lease agreement.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">D.</span><span><span style="padding-left:26.28pt">During&#160;</span></span><span>2022, the Israeli tax authority ("ITA&#8221;) notified the Company that it had initiated a routine VAT audit to include tax years 2017 through 202</span><span>2</span><span>. The ITA raised several claims, mainly in respect with the recoverability of VAT with respect to Merger Agreement related expenses and the classification of the Company as a holding company. On July 2022, the ITA proposed a settlement, which the Company rejected. As a result, the ITA issued assessments in the aggregate amount of $<ix:nonFraction id="Fxbrl_20230207215117039" name="cmmb:RecoverabilityOfVatAmount" contextRef="C_20220701to20220731" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,046</ix:nonFraction> thousand. The Company filed an appeal against the ITA&#8217;s assessments. The Company has recorded an appropriate provision which considers inherent uncertainty of these matters and the judicial process. Therefore, the outcome may differ from the estimated liability recorded by the Company during the period</span><span>.</span></span></span></p>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_0000000000385" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 8 - Share Capital</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Right attached to shares</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-weight:bold;font-style:italic">Ordinary shares</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:72pt;margin-bottom:0pt">All of the issued and outstanding ordinary shares of the Company are duly authorized, validly issued, fully paid and non-assessable. The ordinary shares are not redeemable, and each ordinary share is entitled to one vote. The holders of the ordinary shares have the right to vote and participate in shareholders' meetings, the right to receive profits, and the right to participate in the accumulated earnings when the Company is dissolved.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt"><span style="font-weight:bold">1.</span><span style="font-weight:bold;padding-left:28.5pt">Voting</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-bottom:0pt;margin-left:108pt">The holders of ordinary shares are entitled to vote on all matters submitted to shareholders for a vote.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt"><span style="font-weight:bold">2.</span><span style="font-weight:bold;padding-left:28.5pt">Dividends</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-bottom:0pt;margin-left:108pt">The holders of the ordinary shares are entitled to receive dividends, when and as declared by the Board of Directors, and out of funds legally available.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-bottom:0pt;margin-left:108pt">Since its inception, the Company has not declared any dividends.</p>
    <div><ix:exclude>
      <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;17</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
      <p style="margin:0pt">&#160;</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 8 - Share Capital (cont&#8217;d)</span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="font-weight:bold">B.</span><span style="padding-left:26.83pt;font-weight:bold">Financing rounds</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span><span style="padding-left:28.5pt">In&#160;</span></span></span>connection with the Merger, on March 15, 2021, the Company entered into Securities Purchase Agreements with certain purchasers, pursuant to which the Company agreed to sell approximately $<ix:nonFraction id="Fxbrl_20230213133908909" name="cmmb:ProceedsFromSaleOfAdss" contextRef="C_20210301to20210315_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="usd" scale="6" decimals="-5" format="ixt:num-dot-decimal">45.5</ix:nonFraction> million of its American Depositary Shares (ADSs)&#160;in a private placement transaction, (or "The Private Placement"). The Private Placement closed on March 22, 2021, at which time the Company sold to the purchasers <ix:nonFraction id="Fxbrl_20230213133843633" name="cmmb:NumberOfWarrantsPurchaseUpAdss" contextRef="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">2,619,270</ix:nonFraction> ADSs together with warrants to purchase up to <ix:nonFraction id="Fxbrl_20230213133849363" name="cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" contextRef="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">261,929</ix:nonFraction> ADSs at an exercise price of $<ix:nonFraction id="Fxbrl_20230213133830904" name="cmmb:SaleOfStocksPricePerShare" contextRef="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">17.35</ix:nonFraction> per ADS. The warrants will expire five years from the date of issuance, and if exercised in full, will provide to the Company proceeds of approximately $<ix:nonFraction id="Fxbrl_20230213133820824" name="cmmb:ProceedsFromSaleOfAdss" contextRef="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="usd" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.5</ix:nonFraction> million. 20 Ordinary Shares are equal to 1 American Depositary Share (ADS).</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>2.</span><span style="padding-left:28.5pt">On&#160;</span></span></span>April 30, 2021, the Company entered into an At the Market Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &amp; Co., ("Cantor"). According to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $<ix:nonFraction id="Fxbrl_20230213133808746" name="cmmb:AggregateOfferingPriceOfAtMarketOfferingAgreement" contextRef="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember" unitRef="usd" scale="6" decimals="-6" format="ixt:num-dot-decimal">75</ix:nonFraction> million through Cantor or the ATM Agreement. From April 30, 2021, through December 31, 2022, the Company issued <ix:nonFraction id="Fxbrl_20230213133801744" name="cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" contextRef="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">699,806</ix:nonFraction> ADSs at an average price of $<ix:nonFraction id="Fxbrl_20230213133754484" name="cmmb:SaleOfStocksPricePerShare" contextRef="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">22.75</ix:nonFraction> per ADS under the ATM Agreement, resulting in gross proceeds of $<ix:nonFraction id="Fxbrl_20230213133747440" name="cmmb:ProceedsFromSaleOfAdss" contextRef="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,917</ix:nonFraction> thousand.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>3.</span><span style="padding-left:28.5pt">On </span></span></span></span></span></span>April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $<ix:nonFraction id="Fxbrl_20230213133711976" name="cmmb:AggregateOfferingPriceOfAtMarketOfferingAgreement" contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember" unitRef="usd" scale="0" decimals="0" format="ixt:num-dot-decimal">18,125,000</ix:nonFraction>&#160;of its ADSs in connection with the reactivation of the ATM Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject to certain exceptions, limits the amount of securities the Company is able to offer and sell under such registration statement to one-third of our unaffiliated public float. During the year ended &#160;December 31, 2022, the Company issued&#160;<ix:nonFraction id="Fxbrl_20230213133726969" name="cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">130,505</ix:nonFraction> ADSs at an average price of $<ix:nonFraction id="Fxbrl_20230213133719951" name="cmmb:SaleOfStocksPricePerShare" contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">2.11</ix:nonFraction> per ADS under the ATM Agreement, resulting in gross proceeds of $<ix:nonFraction id="Fxbrl_20230213133734136" name="cmmb:ProceedsFromSaleOfAdss" contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">275</ix:nonFraction> thousand.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>4.</span><span style="padding-left:28.5pt">On&#160;</span></span></span></span>September 19, 2022, the Company entered&#160; into a share purchase agreement (the &#8220;Repurchase Arrangement&#8221;) with Dr. Adi Mor, co-founder of Chemomab Ltd., Chief Scientific Officer and a director of the Company and Professor Kobi George, co-founder of Chemomab Ltd. (together with Dr. Adi Mor, the &#8220;Co-Founders&#8221;), whereby the Company agreed, subject to the requisite court approval required under Section 303(a) of the Israeli Companies Law, 5759-1999 (the &#8220;Companies Law&#8221;), which the Company received on November 14, 2022, to repurchase up to <ix:nonFraction id="Fxbrl_20230213133614438" name="cmmb:RepurchaseOfAmericanDepositaryReceiptsShares" contextRef="C_20220901to20220919_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">582,023</ix:nonFraction> of the Company's ADSs owned by the Co-Founders, for consideration not to exceed an aggregate amount of $<ix:nonFraction id="Fxbrl_20230213133621142" name="cmmb:RepurchaseOfAmericanDepositaryReceipts" contextRef="C_20220930_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember" unitRef="usd" scale="0" decimals="0" format="ixt:num-dot-decimal">2,500,000</ix:nonFraction>, depending on the market price of the ADSs at the time of any repurchase. Accordingly, on November 16, 2022, the company repurchased the entire amount of <ix:nonFraction id="Fxbrl_20230213133633159" name="cmmb:RepurchaseOfAmericanDepositaryReceiptsShares" contextRef="C_20221101to20221116_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">582,023</ix:nonFraction> ADSs from the Co-Founders at a weighted average price of $<ix:nonFraction id="Fxbrl_20230213133700406" name="cmmb:WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts" contextRef="C_20221101to20221116_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember" unitRef="USD_Per_Share" scale="0" decimals="4" format="ixt:num-dot-decimal">2.0848</ix:nonFraction> and for total consideration of approximately $<ix:nonFraction id="Fxbrl_20230213133643190" name="cmmb:TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts" contextRef="C_20221101to20221116_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,218</ix:nonFraction> thousand.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-bottom:0pt;margin-left:108pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:110%">The Company accounted for the repurchased shares as treasury share&#160;in accordance with ASC 505-30, "Treasury Stock".</span></span></span></p>
    <div><ix:exclude>
      <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;18</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
      <p style="margin:0pt">&#160;</p>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 8 - Share Capital (cont&#8217;d)</span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">C.</span><span style="font-weight:bold;padding-left:26.28pt">Share-based compensation</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt">(1)<span style="padding-left:24.34pt">Share-based compensation plan:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:108pt;margin-bottom:0pt">The Company maintains (i) the 2011 Share Option Plan (the &#8220;2011 Plan&#8221;), (ii) the 2017 Equity-Based Incentive Plan (the &#8220;2017 Plan&#8221;) and (iii) the Chemomab 2015 Share Incentive Plan (the &#8220;2015 Plan&#8221;), which was assumed by the Company from Chemomab upon the effectiveness of the Merger. At that time, outstanding options under the 2015 Plan became exercisable for such number of ADSs of the Company as was determined based on the exchange ratio in the Merger Agreement, with a reciprocal adjustment to exercise price.<br />&#160;</p>
    <p style="margin-top:0pt;margin-left:108pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>As of December 31, 2022, a total of <ix:nonFraction id="Fxbrl_20230207224906305" name="cmmb:NumberOfStockReservedForIssuance" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">28,443,060</ix:nonFraction> of our Ordinary Shares (equal to <ix:nonFraction id="Fxbrl_20230207223247056" name="cmmb:NumberOfStockAdssResveredForIssuance" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,422,153</ix:nonFraction> of ADSs) were reserved for issuance under the 2015 Plan, of which <ix:nonFraction id="Fxbrl_20230207225529762" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">3,445,520</ix:nonFraction> Ordinary Shares (equal to <ix:nonFraction id="Fxbrl_20230207223254041" name="cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">172,276</ix:nonFraction> ADSs) had been issued pursuant to previous exercises options, and <ix:nonFraction id="Fxbrl_20230207225556251" name="cmmb:NumberOfOptionsIssuableOutstanding" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">23,460,740</ix:nonFraction> &#160;Ordinary Shares (equal to <ix:nonFraction id="Fxbrl_20230207223300376" name="cmmb:NumberOfAdssOptionsIssuableOutstanding" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,173,037</ix:nonFraction> ADSs) were issuable under outstanding options. Of such outstanding options, options to purchase <ix:nonFraction id="Fxbrl_20230207225618055" name="cmmb:NumberOfOptionsVestedAndExercisable" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">12,400,720</ix:nonFraction> Ordinary Shares (equal to <ix:nonFraction id="Fxbrl_20230207223309640" name="cmmb:NumberOfAdssVestedAndExercisable" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">620,036</ix:nonFraction> ADSs) had vested and were exercisable as of that date, with a weighted average exercise price of $<ix:nonFraction id="Fxbrl_20230207224602275" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.30</ix:nonFraction> per Ordinary Share (or $<ix:nonFraction id="Fxbrl_20230207223316544" name="cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">5.96</ix:nonFraction> per ADS). During the year ended December 31, 2022, options to purchase <ix:nonFraction id="Fxbrl_20230207224845387" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,240,120</ix:nonFraction> Ordinary Shares (equal to <ix:nonFraction id="Fxbrl_20230207223324626" name="cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">62,006</ix:nonFraction> ADS) were canceled.</span></span></span></p>
    <p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
    <p style="margin-top:0pt;margin-left:108pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>As of December 31, 2022, a total of <ix:nonFraction id="Fxbrl_20230207225827725" name="cmmb:NumberOfStockReservedForIssuance" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">12,511,620</ix:nonFraction> of our Ordinary Shares (equal to <ix:nonFraction id="Fxbrl_20230207225729518" name="cmmb:NumberOfStockAdssResveredForIssuance" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">625,581</ix:nonFraction> of our ADSs) were reserved for issuance under the 2017 Plan, of which <ix:nonFraction id="Fxbrl_20230207225858382" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">11,730,800</ix:nonFraction> Ordinary Shares (equal to <ix:nonFraction id="Fxbrl_20230207225738550" name="cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">586,540</ix:nonFraction> ADSs) were issuable under outstanding options. Of such outstanding options, options to purchase <ix:nonFraction id="Fxbrl_20230207225916606" name="cmmb:NumberOfOptionsVestedAndExercisable" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">427,540</ix:nonFraction> Ordinary Shares (equal to <ix:nonFraction id="Fxbrl_20230207225743877" name="cmmb:NumberOfAdssVestedAndExercisable" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">21,377</ix:nonFraction> ADSs) had vested and were exercisable as of that date, with a weighted average exercise price of $<ix:nonFraction id="Fxbrl_20230207225929980" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.35</ix:nonFraction> per Ordinary Share (or $<ix:nonFraction id="Fxbrl_20230207225750293" name="cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">6.98</ix:nonFraction> per ADS). During the year ended December 31, 2022 no options were canceled.</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:11pt">(2)<span style="padding-left:24.34pt">The expenses that were recognized in the consolidated statements of operations for services received from employees </span>and service providers are as follows:</p>
    <div style="margin-left:108pt">
      <ix:nonNumeric id="Fxbrl_20230201040228557" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Research and development</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000338" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">448</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000339" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">137</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">General and administrative</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000340" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,763</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000341" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,882</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Total share-based compensation expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000342" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,211</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000343" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,019</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
    <div><ix:exclude>
      <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;19</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
      <p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
      <p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">Note 8 - Share Capital (cont&#8217;d)</span></p>
      <p style="margin-top:11pt;margin-bottom:0pt;text-align:left;text-indent:36pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">C.</span><span style="padding-left:26.28pt;font-weight:bold">Share-based compensation (cont&#8217;d)</span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:11pt">(3)<span style="padding-left:24.34pt">The number and weighted average exercise price of options are as follows:</span></p>
    <div style="margin-left:108pt">
      <ix:nonNumeric id="Fxbrl_20230201040244110" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted </span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">exercise </span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">price</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Number of </span><span style="font-weight:bold">options</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average </span><span style="font-weight:bold">remaining </span><span style="font-weight:bold">contractual </span><span style="font-weight:bold">life (in years)</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average </span><span style="font-weight:bold">exercise price</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Number of </span><span style="font-weight:bold">options</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average </span><span style="font-weight:bold">remaining </span><span style="font-weight:bold">contractual </span><span style="font-weight:bold">life (in years)</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Outstanding at January 1</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000345" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.38</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000346" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">27,003,260</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_0000000000347" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20210101to20211231" format="ixt-sec:duryear">8.12</ix:nonNumeric></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000348" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20201231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.07</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000349" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20201231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">10,455,580</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_0000000000350" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20200101to20201231" format="ixt-sec:duryear">7.8</ix:nonNumeric></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Acquired in Merger</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%;text-align:right"><ix:nonFraction id="Fxbrl_20230214225414206" name="cmmb:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000351" name="cmmb:StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" contextRef="C_20220101to20221231" unitRef="Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><ix:nonFraction id="Fxbrl_20230201024457584" name="cmmb:StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">609,535</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Exercised</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000352" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.07</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000353" name="cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="C_20220101to20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,970,000</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">)</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">-</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230201024523067" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.08</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230201024530820" name="cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">134,220</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Forfeited</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000356" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.32</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000357" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_20220101to20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,240,120</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">)</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>-</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000358" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">1.25</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(<ix:nonFraction id="FFact_0000000000359" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">1,712,275</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">)</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Granted</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000360" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.16</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000361" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">11,398,400</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonNumeric id="FFact_0000000000362" name="cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" contextRef="C_20220101to20221231" format="ixt-sec:duryear">7.8</ix:nonNumeric></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000363" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.62</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000364" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">17,784,640</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_0000000000365" name="cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" contextRef="C_20210101to20211231" format="ixt-sec:duryear">9.79</ix:nonNumeric></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Outstanding at December 31</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000366" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.33</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000367" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">35,191,540</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonNumeric id="FFact_0000000000368" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20220101to20221231" format="ixt-sec:duryear">7.42</ix:nonNumeric></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:10%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000369" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.38</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000370" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">27,003,260</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_0000000000371" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20210101to20211231" format="ixt-sec:duryear">8.12</ix:nonNumeric></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt">(4)<span style="padding-left:24.34pt">Fair value measurement:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:108pt;margin-bottom:11pt">The fair value of the options is measured at the grant date using the Black-Scholes Option pricing model and the assumptions used to calculate the fair value of the options are as follows:</p>
    <div style="margin-left:108pt">
      <ix:nonNumeric id="Fxbrl_20230201040432498" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">2022&#160;grants</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Weighted average share price (in U.S. dollar)<sup>(a)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000373" name="us-gaap:SharePrice" contextRef="C_20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.16</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Exercise price (in U.S. dollar)</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000375" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_srtRangeAxis_srtMinimumMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.10</ix:nonFraction></span><span style="font-weight:bold">-</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000376" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_srtRangeAxis_srtMaximumMember" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.257</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Expected life of options (in years)<sup>(b)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold"><ix:nonNumeric id="FFact_0000000000377" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember" format="ixt-sec:duryear">5.51</ix:nonNumeric></span><span style="font-weight:bold">-</span><span style="font-weight:bold"><ix:nonNumeric id="FFact_0000000000378" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember" format="ixt-sec:duryear">6.28</ix:nonNumeric></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Expected volatility<sup>(c)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000379" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">83.69</ix:nonFraction></span><span style="font-weight:bold">%-</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000380" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">84.31</ix:nonFraction></span><span style="font-weight:bold">%</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Risk-free interest rate<sup>(d)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000381" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="font-weight:bold">%-</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000382" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.14</ix:nonFraction></span><span style="font-weight:bold">%</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Dividend yield</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000383" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_20220101to20221231" unitRef="Pure" decimals="INF" format="ixt:num-dot-decimal">0</ix:nonFraction></span><span style="font-weight:bold">%</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
    <div><ix:exclude>
      <div>
        <div style="width:100%;clear:both">
          <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;20</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 8 - Share Capital (cont&#8217;d)</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">C.</span><span style="font-weight:bold;padding-left:26.28pt">Share-based compensation (cont&#8217;d)</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4. (cont'd)</span></span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt">(a)<span style="padding-left:24.34pt">The weighted average share price is based on the Company&#8217;s Ordinary Share valuation as at the grant date.</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt">(b)<span style="padding-left:24.34pt">Expected life for the periods presented was determined according to the simplified method since, at the date of </span>grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#8217; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt">(c)<span style="padding-left:24.34pt">Expected volatility is based on historical volatility over the most recent period commensurate with the expected </span>term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#8217;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#8217;s expected term.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:11pt">(d)<span style="padding-left:24.34pt">The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the </span>yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards.</p>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_0000000000399" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 9 - Research and Development</span></p>
    <ix:nonNumeric id="FFact_0000000000398" name="cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Consultants and subcontractors</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000386" name="cmmb:ConsultantsAndSubcontractorsExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,052</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000387" name="cmmb:ConsultantsAndSubcontractorsExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,894</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Salaries and related expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000388" name="us-gaap:OfficersCompensation" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,867 </ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000389" name="us-gaap:OfficersCompensation" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,789</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Rent and maintenance</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000390" name="cmmb:RentAndMaintenanceResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">245</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000391" name="cmmb:RentAndMaintenanceResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">114</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Share-based compensation</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000392" name="cmmb:ShareBasedCompensationResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">448</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000393" name="cmmb:ShareBasedCompensationResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">137</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Other expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000394" name="us-gaap:OtherResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000395" name="us-gaap:OtherResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">400</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000396" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,977</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000397" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,334</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </div>
    </ix:nonNumeric>
  </ix:nonNumeric>
  <div>
    <div style="width:100%;clear:both">
      <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;21</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <ix:nonNumeric id="FFact_0000000000417" name="cmmb:GeneralAndAdministrativeDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 10 - General and Administrative&#160;</span></p>
    <ix:nonNumeric id="FFact_0000000000416" name="cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Salaries and related expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000400" name="us-gaap:SalariesAndWages" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,435</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000401" name="us-gaap:SalariesAndWages" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">943</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Professional services</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000402" name="us-gaap:ProfessionalFees" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,596</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000403" name="us-gaap:ProfessionalFees" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,695</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Share-based compensation</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000404" name="cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,763</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000405" name="cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,882</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Fees to Directors</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000406" name="us-gaap:NoninterestExpenseDirectorsFees" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">231</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span><ix:nonFraction id="Fxbrl_20230201004651041" name="us-gaap:NoninterestExpenseDirectorsFees" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">244</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Insurance</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000408" name="us-gaap:GeneralInsuranceExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,084</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000409" name="us-gaap:GeneralInsuranceExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,024</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Rent and maintenance</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000410" name="cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000411" name="cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Other expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000412" name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,423</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000413" name="us-gaap:OtherGeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">216</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000414" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,556</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000415" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,033</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>

        </table>
      </div>
    </ix:nonNumeric>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_0000000000458" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Note 11 - Income Taxes</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Tax rates</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary taxable income in Israel is subject to a corporate tax rate of <ix:nonFraction id="FFact_0000000000418" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryIL" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction>%.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s US subsidiary, Chemomab Therapeutics Inc. ("Chemomab Inc.) is taxed separately under the U.S. tax laws.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Inc. is subject to a federal flat tax rate of <ix:nonFraction id="FFact_0000000000419" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryUS_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">21</ix:nonFraction>% and state tax as applicable.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital gain is subject to capital gain tax according to the corporate tax rate in the year the assets are sold.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">B.</span><span style="font-weight:bold;padding-left:26.83pt">Tax assessments</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022, the Company&#8217;s tax reports through December 31, 2017&#160;are considered closed to audit inspections by the Israeli Tax Authority (&#8220;ITA&#8221;) due to statute of limitation rules effective in Israel.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has not yet been assessed by the ITA since inception.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">C.</span><span style="font-weight:bold;padding-left:26.28pt">Losses for tax purposes carried forward to future years</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2022, the Company and its subsidiaries had approximately $<ix:nonFraction id="Fxbrl_20230213140532094" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="C_20221231_srtStatementGeographicalAxis_countryIL" unitRef="usd" scale="6" decimals="-6" format="ixt:num-dot-decimal">159</ix:nonFraction> million&#160;(approximately $<ix:nonFraction id="Fxbrl_20230213140537759" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="C_20211231_srtStatementGeographicalAxis_countryIL" unitRef="usd" scale="6" decimals="-6" format="ixt:num-dot-decimal">143</ix:nonFraction> million as of December 31, 2021) of net operating loss carryforwards which are available to reduce future taxable income with no limitation on the period of use.</span></span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On March 27, 2020 and December 27, 2020, the President of the United States signed and enacted into law the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and the Consolidated Appropriations Act, 2021 (CAA). Among other provisions, the CARES Act and the CAA provide relief to U.S. federal corporate taxpayers through temporary adjustments to net operating loss rules, changes to limitations on interest expense deductibility, and the acceleration of available refunds for minimum tax credit carryforwards. The CARES Act also includes provisions for a carryback of any net operating loss (NOL) arising in a taxable year beginning after December 31, 2017, and before January 1, 2021, to each of the five taxable years preceding the taxable year in which the loss arises (carryback period).</span></span></span></p>
    <div><ix:exclude>
      <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;22</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">Note 11 - Income Taxes (cont&#8217;d)</span></p>
      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">C.<span style="font-weight:bold;padding-left:26.28pt">Losses for tax purposes carried forward to future years (cont'd)</span></span></span></span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Chemomab Therapeutics Inc., a wholly owned subsidiary of the Company, filed an application with the US Internal Revenue Service to carryback net operating losses. Chemomab Therapeutics Inc received $<ix:nonFraction id="Fxbrl_20230213140710654" name="cmmb:ReceivedAmountOfChemomabTherapeuticsInc" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">351</ix:nonFraction> thousand in December 2022 on account of 2016 and 2017 and expects to receive the remainder $<ix:nonFraction id="Fxbrl_20230213140716671" name="cmmb:ExpectsToReceiveAmountOfChemomabTherapeuticsInc" contextRef="C_20230101to20231231_srtStatementScenarioAxis_srtScenarioForecastMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">183</ix:nonFraction> thousand in 2023. Accordingly, a tax benefit in the total amount of $<ix:nonFraction id="Fxbrl_20230213140722797" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">534</ix:nonFraction> thousand was recorded in the Company&#8217;s statement of operations during 2022.</span></span></span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">D.</span><span style="font-weight:bold;padding-left:26.28pt">Deferred taxes</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In respect of:</span></span></p>
    <div style="margin-left:72pt">
      <ix:nonNumeric id="Fxbrl_20230201025152633" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net operating loss carry-forwards</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000422" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,550</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000423" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,396</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation expense</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000424" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,774</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000425" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,147</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000426" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,858</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000427" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,449</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000428" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000429" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">38</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross deferred tax assets</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000430" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,195</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000431" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,030</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less - Valuation allowance</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000432" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,195</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000433" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,030</ix:nonFraction>)</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net deferred tax assets</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230201010225989_Fact_0000000000426" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230201010225989_Fact_0000000000427" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has established a valuation allowance to offset deferred tax assets on December 31, 2022 and 2021 due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The net change in the total valuation allowance for the year ended at December 31, 2022 was an increase of approximately $<ix:nonFraction id="Fxbrl_20230201010356964" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_20220101to20221231" unitRef="usd" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.2</ix:nonFraction> million.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">E.</span><span style="font-weight:bold;padding-left:26.83pt">Roll forward of valuation allowance</span></span></span></p>
    <div style="margin-left:72pt">
      <ix:nonNumeric id="Fxbrl_20230201025212924" name="us-gaap:SummaryOfValuationAllowanceTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1, 2021</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">$</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000438" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20201231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,200</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency transaction loss</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000439" name="cmmb:CurrencyTransactionLossValuationAllowance" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,425</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax assets acquired through merger</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230201010515039" name="cmmb:TaxAssetsAcquiredThroughMergerValuationAllowance" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,535</ix:nonFraction></span></span></strong></td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000440" name="cmmb:IncomeTaxExpenseValuationAllowance" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,870</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2021</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">$</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000441" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,030</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency transaction Income</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(<ix:nonFraction id="Fxbrl_20230201010936607" name="cmmb:CurrencyTransactionLossValuationAllowance" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,316</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000444" name="cmmb:IncomeTaxExpenseValuationAllowance" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,481</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2022</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">$</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000445" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,195</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
    <div><ix:exclude>
      <div>
        <div style="width:100%;clear:both">
          <p style="margin:0pt">&#160;</p>
          <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;23</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Note 11 - Income Taxes (cont&#8217;d)</span></span></span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">F.</span><span style="font-weight:bold;padding-left:28.31pt">Reconciliation of theoretical income tax expense to actual income tax expense</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A reconciliation of the Company&#8217;s theoretical income tax expense to actual income tax expense is as follows:</span></span></p>
    <div style="margin-left:72pt">
      <ix:nonNumeric id="Fxbrl_20230201025228669" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income taxes</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(</span><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000447" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">28,180</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000448" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,478</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statutory tax rate</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000449" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">%</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000450" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_20210101to20211231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Theoretical tax benefit</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000451" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,481</ix:nonFraction></span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000452" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,870</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in temporary differences for which deferred taxes were not recognized</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(<ix:nonFraction id="Fxbrl_20230213113429979_Fact_0000000000453" name="cmmb:ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,696</ix:nonFraction></strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213113429979_Fact_0000000000454" name="cmmb:ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,332</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax rate differential</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="Fxbrl_20230213113425908_Fact_0000000000453" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213113425908_Fact_0000000000454" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">101</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="Fxbrl_20230213113423827_Fact_0000000000453" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">744</ix:nonFraction></strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213113423827_Fact_0000000000454" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">239</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="Fxbrl_20230213113421604_Fact_0000000000453" name="cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,879</ix:nonFraction></strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213113421604_Fact_0000000000454" name="cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,064</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Actual income tax expense (Benefit)</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span>(<ix:nonFraction id="Fxbrl_20230219165815757" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">534</ix:nonFraction></span></span></span></strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:1.5px">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230201011121606_Fact_0000000000454" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">G.</span><span style="font-weight:bold;padding-left:25.72pt">Accounting for uncertainty in income taxes</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31, 2022, the Company did not have any unrecognized tax benefits and does not expect that the amount of unrecognized tax benefits will change significantly within the next 12 months. The Company&#8217;s accounting policy is to accrue interest and penalties related to unrecognized tax benefits as a component of income tax expense.</span></span></p>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_0000000000477" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 12 - Related Parties Balances and Transactions</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:10.28pt">Balances with Related Parties:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt">The following Related Party payables are included in the consolidated Balance Sheets:</p>
    <div style="margin-left:36pt">
      <ix:nonNumeric id="Fxbrl_20230207220029774" name="cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <div>
          <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td colspan="2" style="vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
                </td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
                </td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
                </td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>


              <tr style="background-color:#CCEEFF">
                <td style="vertical-align:bottom;width:76%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Employee and related expenses</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000459" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">891</ix:nonFraction></span></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000460" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">278</ix:nonFraction></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:76%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Accrued expenses</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000461" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000462" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">72</ix:nonFraction></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
              </tr>
              <tr style="background-color:#CCEEFF">
                <td style="vertical-align:bottom;width:76%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:76%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
                <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000463" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">949</ix:nonFraction></span></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
                <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000464" name="us-gaap:DueToRelatedPartiesCurrent" contextRef="C_20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">350</ix:nonFraction></p>
                </td>
                <td style="vertical-align:bottom;width:1%">
                  <p>&#160;</p>
                </td>
              </tr>

          </table>
        </div>
      </ix:nonNumeric>
      <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On September 19, 2022, the Company entered into a share purchase agreement with the Company's Co- Founders, see Note 8B(4).</span></span></span></p>
    </div>
    <div><ix:exclude>
      <div>
        <div style="width:100%;clear:both">
          <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;24</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
        </div>
      </div>
      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-weight:bold">Note 12 - Related Parties Balances and Transactions (cont'd)</span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">B.</span><span style="font-weight:bold;padding-left:10.83pt">Transactions with Related Parties:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt">The following transactions with related parties are included in the consolidated Statements of Operations:</p>
    <div style="margin-left:36pt;margin-bottom:11pt">
      <ix:nonNumeric id="Fxbrl_20230201025305978" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Salaries and related expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000466" name="cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,409</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000467" name="cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,255</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Share-based payments</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000468" name="cmmb:RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,466</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000469" name="cmmb:RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,775</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Professional Services</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000470" name="cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">231</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000471" name="cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">244</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Research and development</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000472" name="cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000473" name="cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000474" name="us-gaap:RelatedPartyCosts" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,142</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000475" name="us-gaap:RelatedPartyCosts" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,310</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_0000000000488" name="us-gaap:EarningsPerShareTextBlock" contextRef="C_20220101to20221231" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Basic net loss per share is computed by dividing the net loss available to common stockholders by the weighted-average number of ordinary shares outstanding. Diluted net loss per share is computed similarly to basic net loss per share except that the denominator is increased to include the number of additional ordinary shares that would have been outstanding if the potential ordinary shares had been issued and if the additional ordinary shares of were dilutive. Diluted net loss per share is the same as basic net loss per share of ordinary share, as the effect of potentially dilutive securities is antidilutive.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt">The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented:</p>
    <div style="margin-left:36pt">
      <ix:nonNumeric id="Fxbrl_20230201025331788" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">In USD thousands, except share and per </span><span style="font-weight:bold">share data</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Numerator:</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Net loss</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000478" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">27,646</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000479" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,478</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Denominator:</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;text-indent:-10pt;padding-left:10pt;margin-bottom:0pt">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="Fxbrl_s_20230215224008037" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230215224008037" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220101to20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">227,589,288</ix:nonFraction></ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="Fxbrl_20230131213429326" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_0000000000481" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20210101to20211231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">207,468,650</ix:nonFraction></ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Net loss per share attributable to ordinary shareholders, basic and diluted</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="Fxbrl_20230131213444247" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_0000000000482" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.121</ix:nonFraction></ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="Fxbrl_20230131213458553" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_0000000000483" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="C_20210101to20211231" unitRef="USD_Per_Share" decimals="INF" format="ixt:num-dot-decimal">0.060</ix:nonFraction></ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
    <div><ix:exclude>
      <div style="width:100%;clear:both"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>F -&#160;25</span></span></span></span></p></div><hr style="border-top:1.5pt solid #000000;page-break-after:always" /><div style="margin-top:10pt"><table cellpadding="0" style="border-spacing:0" width="100%"><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Chemomab Therapeutics Ltd. and its subsidiaries</span></span></span></span></p><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">&#160;</p></td></tr><tr><td style="width:100%;vertical-align:top"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:5pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:bold">Notes to the Financial Statements as at December 31, 2022</span></span></span></span></span></p></td></tr><tr><td style="width:100%;vertical-align:top"><hr style="height:1.5pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-top:-1.34pt;margin-left:0pt;text-align:left" /></td></tr></table></div>
      <p style="margin:0pt">&#160;</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders (cont'd)</span></p>
    </ix:exclude></div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt">The potential number of ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented since including them would have been anti-dilutive are as follows:</p>
    <div style="margin-left:36pt">
      <ix:nonNumeric id="Fxbrl_20230201025347421" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="C_20220101to20221231" escape="true">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:center">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:center">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:center">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Number of shares</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Outstanding options to purchase ordinary shares</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonFraction id="FFact_0000000000485" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">35,191,540</ix:nonFraction></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="FFact_0000000000486" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_20210101to20211231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">27,003,260</ix:nonFraction></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </ix:nonNumeric>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>

  <ix:nonNumeric id="Fxbrl_20230201020943165" name="us-gaap:SubsequentEventsTextBlock" contextRef="C_20220101to20221231" escape="true">
    <div>
      <p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Note 14&#160;- Subsequent Events</span></span></span></p>
      <p style="margin-top:11pt;margin-bottom:0pt;padding-left:36pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">On January 13, 2023 the Company filed with the SEC a registration statement on form S-1 for the issuance and sale of up to $<ix:nonFraction id="Fxbrl_20230213104715713" name="cmmb:SaleOfStockValueOfSharesIssuedInTransaction" contextRef="C_20230113_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember" unitRef="usd" scale="0" decimals="0" format="ixt:num-dot-decimal">20,000,000</ix:nonFraction> of its ADSs.</p>
    </div>
  </ix:nonNumeric>
  <p style="margin:11pt 0pt 0pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">F - 26</span></span></p>
  <div>
    <div style="width:100%;clear:both">
      <hr style="height:0.75pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-left:0pt;text-align:left" />
      <hr style="height:3pt;border-width:0;color:#000000;background-color:#000000;width:100%;margin-left:0pt;text-align:left" />
    </div>
  </div>
</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cmmb-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:cmmb="http://www.anchiano.com/20221231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" targetNamespace="http://www.anchiano.com/20221231" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>0002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
        <link:definition>0003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementsOfOperations" id="StatementsOfOperations">
        <link:definition>0004 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementsOfChangesInEquity" id="StatementsOfChangesInEquity">
        <link:definition>0005 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
        <link:definition>0006 - Statement - Statements of Cash flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/General" id="General">
        <link:definition>0007 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>0008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/CashAndCashEquivalents" id="CashAndCashEquivalents">
        <link:definition>0009 - Disclosure - Cash and Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpenses" id="OtherReceivablesAndPrepaidExpenses">
        <link:definition>0010 - Disclosure - Other Receivables and Prepaid Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
        <link:definition>0011 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/Leases" id="Leases">
        <link:definition>0012 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/CommitmentsAndContingentLiabilities" id="CommitmentsAndContingentLiabilities">
        <link:definition>0013 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/ShareCapital" id="ShareCapital">
        <link:definition>0014 - Disclosure - Share Capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/ResearchAndDevelopment" id="ResearchAndDevelopment">
        <link:definition>0015 - Disclosure - Research and Development</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/GeneralAndAdministrative" id="GeneralAndAdministrative">
        <link:definition>0016 - Disclosure - General and Administrative</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>0017 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactions" id="RelatedPartiesBalancesAndTransactions">
        <link:definition>0018 - Disclosure - Related Parties Balances and Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders" id="NetLossPerShareAttributableToOrdinaryShareholders">
        <link:definition>0019 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/EventsAfterBalanceSheetDate" id="EventsAfterBalanceSheetDate">
        <link:definition>0020 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>0021 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/GeneralTables" id="GeneralTables">
        <link:definition>0022 - Disclosure - General (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
        <link:definition>0023 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/CashAndCashEquivalentsTables" id="CashAndCashEquivalentsTables">
        <link:definition>0024 - Disclosure - Cash and Cash Equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables" id="OtherReceivablesAndPrepaidExpensesTables">
        <link:definition>0025 - Disclosure - Other Receivables and Prepaid Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
        <link:definition>0026 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/LeasesTables" id="LeasesTables">
        <link:definition>0027 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/ShareCapitalTables" id="ShareCapitalTables">
        <link:definition>0028 - Disclosure - Share Capital (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/ResearchAndDevelopmentTables" id="ResearchAndDevelopmentTables">
        <link:definition>0029 - Disclosure - Research and Development (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/GeneralAndAdministrativeTables" id="GeneralAndAdministrativeTables">
        <link:definition>0030 - Disclosure - General and Administrative (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <link:definition>0031 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables" id="RelatedPartiesBalancesAndTransactionsTables">
        <link:definition>0032 - Disclosure - Related Parties Balances and Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables" id="NetLossPerShareAttributableToOrdinaryShareholdersTables">
        <link:definition>0033 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/GeneralDetails" id="GeneralDetails">
        <link:definition>0034 - Disclosure - General (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails" id="GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails">
        <link:definition>0035 - Disclosure - General (Schedule of net assets acquired based on their estimated fair value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" id="SummaryOfSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0036 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails" id="SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails">
        <link:definition>0037 - Disclosure - Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/CashAndCashEquivalentsDetails" id="CashAndCashEquivalentsDetails">
        <link:definition>0038 - Disclosure - Cash and Cash Equivalents (Schedule of Cash and Cash Equivalents) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails" id="OtherReceivablesAndPrepaidExpensesDetails">
        <link:definition>0039 - Disclosure - Other Receivables and Prepaid Expenses (Schedule of Other Receivables and Prepaid Expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
        <link:definition>0040 - Disclosure - Property and Equipment, Net (Schedule of Property and Equipment, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/LeasesNarrativeDetails" id="LeasesNarrativeDetails">
        <link:definition>0041 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails" id="LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails">
        <link:definition>0042 - Disclosure - Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails" id="CommitmentsAndContingentLiabilitiesDetails">
        <link:definition>0043 - Disclosure - Commitments and Contingent Liabilities (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/ShareCapitalNarrativeDetails" id="ShareCapitalNarrativeDetails">
        <link:definition>0044 - Disclosure - Share Capital (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails" id="ShareCapitalShare-basedCompensationExpensesDetails">
        <link:definition>0045 - Disclosure - Share Capital (Schedule of Share-based Compensation Expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails" id="ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails">
        <link:definition>0046 - Disclosure - Share Capital (Schedule of Number and Weighted Average Exercise Prices of Option) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails" id="ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails">
        <link:definition>0047 - Disclosure - Share Capital (Schedule of Assumptions Used to Calculate the Fair Value of the Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails" id="ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails">
        <link:definition>0048 - Disclosure - Research and Development (Schedule of Research and Development) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails" id="GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails">
        <link:definition>0049 - Disclosure - General and Administrative (Schedule of General and Administrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
        <link:definition>0050 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails" id="IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails">
        <link:definition>0051 - Disclosure - Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails" id="IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails">
        <link:definition>0052 - Disclosure - Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails" id="IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails">
        <link:definition>0053 - Disclosure - Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails" id="RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails">
        <link:definition>0054 - Disclosure - Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails" id="RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails">
        <link:definition>0055 - Disclosure - Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails" id="NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails">
        <link:definition>0056 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails" id="NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails">
        <link:definition>0057 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails" id="EventsAfterBalanceSheetDateNarrativeDetails">
        <link:definition>0058 - Disclosure - Subsequent Events (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AdditionalWorkOrderAmount" id="cmmb_AdditionalWorkOrderAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregateAmountCommitmentToPay" id="cmmb_AggregateAmountCommitmentToPay" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AggregateAmountOfCommitmentPaid" id="cmmb_AggregateAmountOfCommitmentPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AggregateOfferingPriceOfAtMarketOfferingAgreement" id="cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmericanDepositarySharesMember" id="cmmb_AmericanDepositarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AnnualRatesOfDepreciation" id="cmmb_AnnualRatesOfDepreciation" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AnnualRentAndManagementFees" id="cmmb_AnnualRentAndManagementFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AtmAgreementMember" id="cmmb_AtmAgreementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BankGuaranteesToPropertyOwner" id="cmmb_BankGuaranteesToPropertyOwner" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CantorMember" id="cmmb_CantorMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CapitalAdditionsOneMember" id="cmmb_CapitalAdditionsOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CashAcquiredInMerger" id="cmmb_CashAcquiredInMerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashPaidAndReceivedDuringYearForAbstract" id="cmmb_CashPaidAndReceivedDuringYearForAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized" id="cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConsultantsAndSubcontractorsExpense" id="cmmb_ConsultantsAndSubcontractorsExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CumulativeAmountsOfGrantsReceivedAndRecognized" id="cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CurrencyTransactionLossValuationAllowance" id="cmmb_CurrencyTransactionLossValuationAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" id="cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EarningsPerShareCalculationNumeratorAbstract" id="cmmb_EarningsPerShareCalculationNumeratorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectOfReverseCapitalizationTransaction" id="cmmb_EffectOfReverseCapitalizationTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EffectOfReverseCapitalizationTransactionShares" id="cmmb_EffectOfReverseCapitalizationTransactionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EstimatedFairValueOfNetAssetsAcquired" id="cmmb_EstimatedFairValueOfNetAssetsAcquired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExpectsToReceiveAmountOfChemomabTherapeuticsInc" id="cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FinanceIncomeExpensesNet" id="cmmb_FinanceIncomeExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FormerChemomabSecurityHoldersMember" id="cmmb_FormerChemomabSecurityHoldersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralAndAdministrativeDisclosureTextBlock" id="cmmb_GeneralAndAdministrativeDisclosureTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock" id="cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncomeTaxDisclosureLineItems" id="cmmb_IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncomeTaxDisclosureTable" id="cmmb_IncomeTaxDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="IncomeTaxesReceived" id="cmmb_IncomeTaxesReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxExpenseValuationAllowance" id="cmmb_IncomeTaxExpenseValuationAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncrementalBorrowingRateOfLeases" id="cmmb_IncrementalBorrowingRateOfLeases" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InterestReceived" id="cmmb_InterestReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InvestorsMember" id="cmmb_InvestorsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LaboratoryEquipmentMember" id="cmmb_LaboratoryEquipmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LienOnBankDeposit" id="cmmb_LienOnBankDeposit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LongTermLeaseDeposit" id="cmmb_LongTermLeaseDeposit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" id="cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MaximumPercentageOfPaymentsOfRoyalties" id="cmmb_MaximumPercentageOfPaymentsOfRoyalties" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" id="cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NatureOfOperationsDisclosureAbstract" id="cmmb_NatureOfOperationsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAdsIssuedAndOutstandingAfterMerger" id="cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAdssOptionsIssuableOutstanding" id="cmmb_NumberOfAdssOptionsIssuableOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAdssVestedAndExercisable" id="cmmb_NumberOfAdssVestedAndExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOptionsIssuableOutstanding" id="cmmb_NumberOfOptionsIssuableOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOptionsVestedAndExercisable" id="cmmb_NumberOfOptionsVestedAndExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesConsistedInDs" id="cmmb_NumberOfOrdinarySharesConsistedInDs" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfStockAdssResveredForIssuance" id="cmmb_NumberOfStockAdssResveredForIssuance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfStockReservedForIssuance" id="cmmb_NumberOfStockReservedForIssuance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfVestedAndExercisable" id="cmmb_NumberOfVestedAndExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsPurchaseUpAdss" id="cmmb_NumberOfWarrantsPurchaseUpAdss" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingRightOfUseAssetsAndOperatingLeaseLiabilities" id="cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherAccountsReceivableAndPrepaidExpensesTextBlock" id="cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" id="cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PaymentsForInvestmentInDeposits" id="cmmb_PaymentsForInvestmentInDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PercentageOfMonthlyDepositsRate" id="cmmb_PercentageOfMonthlyDepositsRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfRoyaltyPaymentsOnSaleOfProduct" id="cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProceedsFromSaleOfAdss" id="cmmb_ProceedsFromSaleOfAdss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReceivablesFromGovernmentInstitutions" id="cmmb_ReceivablesFromGovernmentInstitutions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReceivedAmountOfChemomabTherapeuticsInc" id="cmmb_ReceivedAmountOfChemomabTherapeuticsInc" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RecoverabilityOfVatAmount" id="cmmb_RecoverabilityOfVatAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RelatedPartyMember" id="cmmb_RelatedPartyMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" id="cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" id="cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" id="cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty" id="cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RentAndMaintenanceGeneralAndAdministrativeExpense" id="cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RentAndMaintenanceResearchAndDevelopmentExpense" id="cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RepurchaseArrangementMember" id="cmmb_RepurchaseArrangementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RepurchaseOfAmericanDepositaryReceipts" id="cmmb_RepurchaseOfAmericanDepositaryReceipts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RepurchaseOfAmericanDepositaryReceiptsShares" id="cmmb_RepurchaseOfAmericanDepositaryReceiptsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SaleOfStockLineItems" id="cmmb_SaleOfStockLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SaleOfStocksPricePerShare" id="cmmb_SaleOfStocksPricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SaleOfStockTable" id="cmmb_SaleOfStockTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="SaleOfStockValueOfSharesIssuedInTransaction" id="cmmb_SaleOfStockValueOfSharesIssuedInTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ScheduleOfAnnualRateOfDeprecationTableTextBlock" id="cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfGeneralAndAdministrativeTableTextBlock" id="cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" id="cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfRelatedPartyPayablesTableTextBlock" id="cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfResearchAndDevelopmentTableTextBlock" id="cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" id="cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeverancePayPolicyTextBlock" id="cmmb_SeverancePayPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod" id="cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" id="cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" id="cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice" id="cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationGeneralAndAdministrativeExpense" id="cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareBasedCompensationResearchAndDevelopmentExpense" id="cmmb_ShareBasedCompensationResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareholdingPercentageImmediatelyFollowingMerger" id="cmmb_ShareholdingPercentageImmediatelyFollowingMerger" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantsIssuedDuringPeriodNewIssues" id="cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantsIssuedDuringPeriodValueNewIssues" id="cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" id="cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" id="cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesStockOptionsExercised1" id="cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxAssetsAcquiredThroughMergerValuationAllowance" id="cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts" id="cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TwoThousandsFifteenPlanMember" id="cmmb_TwoThousandsFifteenPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoThousandsSeventeenPlanMember" id="cmmb_TwoThousandsSeventeenPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts" id="cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>cmmb-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#StatementsOfOperations" roleURI="http://www.anchiano.com/role/StatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#StatementsOfCashFlows" roleURI="http://www.anchiano.com/role/StatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails" roleURI="http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#OtherReceivablesAndPrepaidExpensesDetails" roleURI="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#PropertyAndEquipmentNetDetails" roleURI="http://www.anchiano.com/role/PropertyAndEquipmentNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails" roleURI="http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails" roleURI="http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails" roleURI="http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails" roleURI="http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails" roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails" roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_24"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_RestrictedCashCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsNoncurrent_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_8" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_11" xlink:to="loc_us-gaap_Liabilities_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_12" xlink:to="loc_us-gaap_LiabilitiesCurrent_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_13" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_14" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_15" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_12" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_17" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_17" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_17" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_11" xlink:to="loc_us-gaap_CommitmentsAndContingencies_20" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_11" xlink:to="loc_us-gaap_StockholdersEquity_21" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21" xlink:to="loc_us-gaap_CommonStockValue_21" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21" xlink:to="loc_us-gaap_TreasuryStockValue_22" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21" xlink:to="loc_us-gaap_AdditionalPaidInCapital_23" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_24" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" xlink:to="loc_us-gaap_OperatingExpenses_3" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_4" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="loc_cmmb_PaymentsForInvestmentInDeposits_10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LongTermLeaseDeposit" xlink:label="loc_cmmb_LongTermLeaseDeposit_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CashAcquiredInMerger" xlink:label="loc_cmmb_CashAcquiredInMerger_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_18"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_Depreciation_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ShareBasedCompensation_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10" xlink:to="loc_cmmb_PaymentsForInvestmentInDeposits_10" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10" xlink:to="loc_cmmb_LongTermLeaseDeposit_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_12" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_13" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15" xlink:to="loc_cmmb_CashAcquiredInMerger_15" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_16" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_17" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_15" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_18" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_0" xlink:to="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_0" xlink:to="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivablesFromGovernmentInstitutions" xlink:label="loc_cmmb_ReceivablesFromGovernmentInstitutions_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_cmmb_ReceivablesFromGovernmentInstitutions_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/PropertyAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ConsultantsAndSubcontractorsExpense" xlink:label="loc_cmmb_ConsultantsAndSubcontractorsExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaap_OfficersCompensation_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xlink:label="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationResearchAndDevelopmentExpense" xlink:label="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_OtherResearchAndDevelopmentExpense_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_0" xlink:to="loc_cmmb_ConsultantsAndSubcontractorsExpense_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_0" xlink:to="loc_us-gaap_OfficersCompensation_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_0" xlink:to="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_0" xlink:to="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_0" xlink:to="loc_us-gaap_OtherResearchAndDevelopmentExpense_5" order="40" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaap_SalariesAndWages_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaap_ProfessionalFees_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseDirectorsFees" xlink:label="loc_us-gaap_NoninterestExpenseDirectorsFees_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralInsuranceExpense" xlink:label="loc_us-gaap_GeneralInsuranceExpense_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_7"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_us-gaap_SalariesAndWages_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_us-gaap_ProfessionalFees_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_us-gaap_NoninterestExpenseDirectorsFees_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_us-gaap_GeneralInsuranceExpense_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_7" order="60" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent_0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent_0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyCosts" xlink:label="loc_us-gaap_RelatedPartyCosts_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RelatedPartyCosts_0" xlink:to="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RelatedPartyCosts_0" xlink:to="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RelatedPartyCosts_0" xlink:to="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RelatedPartyCosts_0" xlink:to="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_4" order="30" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>cmmb-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#StatementsOfChangesInEquity" roleURI="http://www.anchiano.com/role/StatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#GeneralDetails" roleURI="http://www.anchiano.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails" roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#CashAndCashEquivalentsDetails" roleURI="http://www.anchiano.com/role/CashAndCashEquivalentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#PropertyAndEquipmentNetDetails" roleURI="http://www.anchiano.com/role/PropertyAndEquipmentNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#LeasesNarrativeDetails" roleURI="http://www.anchiano.com/role/LeasesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#CommitmentsAndContingentLiabilitiesDetails" roleURI="http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ShareCapitalNarrativeDetails" roleURI="http://www.anchiano.com/role/ShareCapitalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ShareCapitalShare-basedCompensationExpensesDetails" roleURI="http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails" roleURI="http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#IncomeTaxesDetails" roleURI="http://www.anchiano.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails" roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails" roleURI="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#EventsAfterBalanceSheetDateNarrativeDetails" roleURI="http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_49"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentInformationTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_AmericanDepositarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityCentralIndexKey_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AmendmentFlag_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentType_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentFiscalYearFocus_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentPeriodEndDate_13" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentAnnualReport_14" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_DocumentTransitionReport_15" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityFileNumber_16" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityRegistrantName_17" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_18" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityTaxIdentificationNumber_19" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine1_20" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine2_21" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressCityOrTown_22" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressCountry_23" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityAddressPostalZipCode_24" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_CityAreaCode_25" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_LocalPhoneNumber_26" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName_27" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_Security12bTitle_28" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_TradingSymbol_29" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_SecurityExchangeName_30" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_31" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityVoluntaryFilers_32" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityCurrentReportingStatus_33" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_34" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityFilerCategory_35" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntitySmallBusiness_36" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_37" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityExTransitionPeriod_38" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_39" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityShellCompany_40" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityPublicFloat_41" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_42" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AuditorName_43" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AuditorLocation_44" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_AuditorFirmId_45" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_WrittenCommunications_46" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_SolicitingMaterial_47" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_PreCommencementTenderOffer_48" order="420" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_0" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_49" order="430" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_23"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_TreasuryStockMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquity_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SharesOutstanding_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_14" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_cmmb_EffectOfReverseCapitalizationTransaction_15" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_16" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_17" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_18" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_19" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_20" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_21" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_22" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_23" order="150" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOrdinarySharesConsistedInDs" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_FormerChemomabSecurityHoldersMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_14" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AnnualRatesOfDepreciation" xlink:label="loc_cmmb_AnnualRatesOfDepreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="loc_cmmb_LaboratoryEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_cmmb_AnnualRatesOfDepreciation_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3" order="20" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_ComputerEquipmentMember_3" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_cmmb_LaboratoryEquipmentMember_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_6" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/CashAndCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD" xlink:label="loc_currency_USD_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX" xlink:label="loc_currency_XXX_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_USD_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_ILS_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_XXX_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/PropertyAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="loc_cmmb_LaboratoryEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_cmmb_LaboratoryEquipmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_12" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/LeasesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AnnualRentAndManagementFees" xlink:label="loc_cmmb_AnnualRentAndManagementFees_9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BankGuaranteesToPropertyOwner" xlink:label="loc_cmmb_BankGuaranteesToPropertyOwner_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities" xlink:label="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_ILS_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_LeaseExpirationDate1_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_cmmb_AnnualRentAndManagementFees_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_cmmb_BankGuaranteesToPropertyOwner_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_OperatingLeaseLiability_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_15" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAdditionsMember" xlink:label="loc_us-gaap_CapitalAdditionsMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CapitalAdditionsOneMember" xlink:label="loc_cmmb_CapitalAdditionsOneMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAgreementsMember" xlink:label="loc_us-gaap_LeaseAgreementsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR" xlink:label="loc_currency_EUR_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentDescription" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentDescription_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDescription" xlink:label="loc_us-gaap_OtherCommitmentsDescription_21"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xlink:label="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_22"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MaximumPercentageOfPaymentsOfRoyalties" xlink:label="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_23"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xlink:label="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xlink:label="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateAmountCommitmentToPay" xlink:label="loc_cmmb_AggregateAmountCommitmentToPay_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateAmountOfCommitmentPaid" xlink:label="loc_cmmb_AggregateAmountOfCommitmentPaid_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AdditionalWorkOrderAmount" xlink:label="loc_cmmb_AdditionalWorkOrderAmount_31"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LienOnBankDeposit" xlink:label="loc_cmmb_LienOnBankDeposit_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestments" xlink:label="loc_us-gaap_RestrictedInvestments_33"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RecoverabilityOfVatAmount" xlink:label="loc_cmmb_RecoverabilityOfVatAmount_34"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_us-gaap_OtherCommitmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:to="loc_us-gaap_CapitalAdditionsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:to="loc_cmmb_CapitalAdditionsOneMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:to="loc_us-gaap_LeaseAgreementsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_srt_CurrencyAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_7" xlink:to="loc_currency_AllCurrenciesDomain_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_7" xlink:to="loc_currency_EUR_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_7" xlink:to="loc_currency_ILS_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_7" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_12" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_12" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_srt_StatementScenarioAxis_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_15" xlink:to="loc_srt_ScenarioUnspecifiedDomain_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_15" xlink:to="loc_srt_ScenarioForecastMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_15" xlink:to="loc_srt_ScenarioUnspecifiedDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentDescription_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_us-gaap_OtherCommitmentsDescription_21" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_22" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_23" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_24" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_25" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_26" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_27" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_us-gaap_RoyaltyExpense_28" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_cmmb_AggregateAmountCommitmentToPay_29" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_cmmb_AggregateAmountOfCommitmentPaid_30" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_cmmb_AdditionalWorkOrderAmount_31" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_cmmb_LienOnBankDeposit_32" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_us-gaap_RestrictedInvestments_33" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_cmmb_RecoverabilityOfVatAmount_34" order="150" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockLineItems" xlink:label="loc_cmmb_SaleOfStockLineItems_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockTable" xlink:label="loc_cmmb_SaleOfStockTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CantorMember" xlink:label="loc_cmmb_CantorMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_InvestorsMember" xlink:label="loc_cmmb_InvestorsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AtmAgreementMember" xlink:label="loc_cmmb_AtmAgreementMember_7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandsFifteenPlanMember_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsSeventeenPlanMember" xlink:label="loc_cmmb_TwoThousandsSeventeenPlanMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement" xlink:label="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ProceedsFromSaleOfAdss" xlink:label="loc_cmmb_ProceedsFromSaleOfAdss_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xlink:label="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfWarrantsPurchaseUpAdss" xlink:label="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStocksPricePerShare" xlink:label="loc_cmmb_SaleOfStocksPricePerShare_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockReservedForIssuance" xlink:label="loc_cmmb_NumberOfStockReservedForIssuance_31"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockAdssResveredForIssuance" xlink:label="loc_cmmb_NumberOfStockAdssResveredForIssuance_32"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdssOptionsIssuableOutstanding" xlink:label="loc_cmmb_NumberOfAdssOptionsIssuableOutstanding_33"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsIssuableOutstanding" xlink:label="loc_cmmb_NumberOfOptionsIssuableOutstanding_34"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfVestedAndExercisable" xlink:label="loc_cmmb_NumberOfVestedAndExercisable_35"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdssVestedAndExercisable" xlink:label="loc_cmmb_NumberOfAdssVestedAndExercisable_36"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsVestedAndExercisable" xlink:label="loc_cmmb_NumberOfOptionsVestedAndExercisable_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_38"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_41"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_42"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_43"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceiptsShares" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_44"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_45"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_46"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_SaleOfStockTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cmmb_SaleOfStockTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_cmmb_CantorMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cmmb_SaleOfStockTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" xlink:to="loc_cmmb_InvestorsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" xlink:to="loc_us-gaap_PrivatePlacementMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" xlink:to="loc_cmmb_AtmAgreementMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" xlink:to="loc_cmmb_RepurchaseArrangementMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cmmb_SaleOfStockTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_12" xlink:to="loc_us-gaap_ClassOfStockDomain_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_12" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_12" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cmmb_SaleOfStockTable_1" xlink:to="loc_us-gaap_PlanNameAxis_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_16" xlink:to="loc_us-gaap_PlanNameDomain_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_16" xlink:to="loc_cmmb_TwoThousandsFifteenPlanMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_16" xlink:to="loc_cmmb_TwoThousandsSeventeenPlanMember_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_16" xlink:to="loc_us-gaap_PlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_22" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_23" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_24" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_25" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_26" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_ProceedsFromSaleOfAdss_27" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_28" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_29" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_SaleOfStocksPricePerShare_30" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_NumberOfStockReservedForIssuance_31" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_NumberOfStockAdssResveredForIssuance_32" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_NumberOfAdssOptionsIssuableOutstanding_33" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_NumberOfOptionsIssuableOutstanding_34" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_NumberOfVestedAndExercisable_35" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_NumberOfAdssVestedAndExercisable_36" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_NumberOfOptionsVestedAndExercisable_37" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_38" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_39" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_40" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_41" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_42" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_43" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_44" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_45" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_SaleOfStockLineItems_0" xlink:to="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_46" order="250" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharePrice_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9" order="80" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9" xlink:to="loc_srt_RangeAxis_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9" xlink:to="loc_srt_RangeMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9" xlink:to="loc_srt_MinimumMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9" xlink:to="loc_srt_MaximumMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9" xlink:to="loc_us-gaap_AwardTypeAxis_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxDisclosureLineItems" xlink:label="loc_cmmb_IncomeTaxDisclosureLineItems_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxDisclosureTable" xlink:label="loc_cmmb_IncomeTaxDisclosureTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="loc_country_IL_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_country_US_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivedAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_18"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_0" xlink:to="loc_cmmb_IncomeTaxDisclosureTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cmmb_IncomeTaxDisclosureTable_1" xlink:to="loc_srt_StatementScenarioAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1" xlink:to="loc_srt_ScenarioForecastMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cmmb_IncomeTaxDisclosureTable_1" xlink:to="loc_srt_StatementGeographicalAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5" xlink:to="loc_srt_SegmentGeographicalDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5" xlink:to="loc_country_IL_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5" xlink:to="loc_country_US_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5" xlink:to="loc_srt_SegmentGeographicalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cmmb_IncomeTaxDisclosureTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_10" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_10" xlink:to="loc_us-gaap_DomesticCountryMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_10" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_0" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_0" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_0" xlink:to="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_0" xlink:to="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_19" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_20" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyMember" xlink:label="loc_cmmb_RelatedPartyMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4" order="30" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4" xlink:to="loc_us-gaap_RelatedPartyDomain_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4" xlink:to="loc_cmmb_RelatedPartyMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4" xlink:to="loc_us-gaap_RelatedPartyDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockValueOfSharesIssuedInTransaction" xlink:label="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_0" xlink:to="loc_us-gaap_SubsequentEventTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1" xlink:to="loc_us-gaap_SubsequentEventMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0" xlink:to="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_6" order="10" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cmmb-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AdditionalWorkOrderAmount" xlink:label="loc_cmmb_AdditionalWorkOrderAmount_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AdditionalWorkOrderAmount" xlink:label="loc_cmmb_AdditionalWorkOrderAmount_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AdditionalWorkOrderAmount" xlink:label="loc_cmmb_AdditionalWorkOrderAmount_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateAmountCommitmentToPay" xlink:label="loc_cmmb_AggregateAmountCommitmentToPay_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateAmountCommitmentToPay" xlink:label="loc_cmmb_AggregateAmountCommitmentToPay_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateAmountOfCommitmentPaid" xlink:label="loc_cmmb_AggregateAmountOfCommitmentPaid_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateAmountOfCommitmentPaid" xlink:label="loc_cmmb_AggregateAmountOfCommitmentPaid_7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement" xlink:label="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement" xlink:label="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement" xlink:label="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AnnualRatesOfDepreciation" xlink:label="loc_cmmb_AnnualRatesOfDepreciation_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AnnualRatesOfDepreciation" xlink:label="loc_cmmb_AnnualRatesOfDepreciation_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AnnualRatesOfDepreciation" xlink:label="loc_cmmb_AnnualRatesOfDepreciation_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AnnualRentAndManagementFees" xlink:label="loc_cmmb_AnnualRentAndManagementFees_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AnnualRentAndManagementFees" xlink:label="loc_cmmb_AnnualRentAndManagementFees_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AtmAgreementMember" xlink:label="loc_cmmb_AtmAgreementMember_18"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AtmAgreementMember" xlink:label="loc_cmmb_AtmAgreementMember_19"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BankGuaranteesToPropertyOwner" xlink:label="loc_cmmb_BankGuaranteesToPropertyOwner_20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BankGuaranteesToPropertyOwner" xlink:label="loc_cmmb_BankGuaranteesToPropertyOwner_21"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_22"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_23"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_24"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CantorMember" xlink:label="loc_cmmb_CantorMember_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CantorMember" xlink:label="loc_cmmb_CantorMember_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CapitalAdditionsOneMember" xlink:label="loc_cmmb_CapitalAdditionsOneMember_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CapitalAdditionsOneMember" xlink:label="loc_cmmb_CapitalAdditionsOneMember_31"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CapitalAdditionsOneMember" xlink:label="loc_cmmb_CapitalAdditionsOneMember_32"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CashAcquiredInMerger" xlink:label="loc_cmmb_CashAcquiredInMerger_33"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CashAcquiredInMerger" xlink:label="loc_cmmb_CashAcquiredInMerger_34"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CashPaidAndReceivedDuringYearForAbstract" xlink:label="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_35"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CashPaidAndReceivedDuringYearForAbstract" xlink:label="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_36"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CashPaidAndReceivedDuringYearForAbstract" xlink:label="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_37"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized" xlink:label="loc_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_38"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized" xlink:label="loc_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_39"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized" xlink:label="loc_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_40"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ConsultantsAndSubcontractorsExpense" xlink:label="loc_cmmb_ConsultantsAndSubcontractorsExpense_41"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ConsultantsAndSubcontractorsExpense" xlink:label="loc_cmmb_ConsultantsAndSubcontractorsExpense_42"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ConsultantsAndSubcontractorsExpense" xlink:label="loc_cmmb_ConsultantsAndSubcontractorsExpense_43"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xlink:label="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_44"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xlink:label="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_45"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xlink:label="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_46"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CurrencyTransactionLossValuationAllowance" xlink:label="loc_cmmb_CurrencyTransactionLossValuationAllowance_47"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CurrencyTransactionLossValuationAllowance" xlink:label="loc_cmmb_CurrencyTransactionLossValuationAllowance_48"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CurrencyTransactionLossValuationAllowance" xlink:label="loc_cmmb_CurrencyTransactionLossValuationAllowance_49"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xlink:label="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_50"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xlink:label="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_51"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xlink:label="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_52"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EarningsPerShareCalculationNumeratorAbstract" xlink:label="loc_cmmb_EarningsPerShareCalculationNumeratorAbstract_53"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EarningsPerShareCalculationNumeratorAbstract" xlink:label="loc_cmmb_EarningsPerShareCalculationNumeratorAbstract_54"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EarningsPerShareCalculationNumeratorAbstract" xlink:label="loc_cmmb_EarningsPerShareCalculationNumeratorAbstract_55"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_56"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_57"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_58"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_59"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_60"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_61"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_62"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_63"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_64"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_65"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_66"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_67"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_68"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_69"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_70"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_71"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_GeneralAndAdministrativeDisclosureTextBlock" xlink:label="loc_cmmb_GeneralAndAdministrativeDisclosureTextBlock_72"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_GeneralAndAdministrativeDisclosureTextBlock" xlink:label="loc_cmmb_GeneralAndAdministrativeDisclosureTextBlock_73"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_GeneralAndAdministrativeDisclosureTextBlock" xlink:label="loc_cmmb_GeneralAndAdministrativeDisclosureTextBlock_74"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock" xlink:label="loc_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_75"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock" xlink:label="loc_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_76"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock" xlink:label="loc_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_77"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxDisclosureLineItems" xlink:label="loc_cmmb_IncomeTaxDisclosureLineItems_78"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxDisclosureLineItems" xlink:label="loc_cmmb_IncomeTaxDisclosureLineItems_79"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxDisclosureTable" xlink:label="loc_cmmb_IncomeTaxDisclosureTable_80"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxDisclosureTable" xlink:label="loc_cmmb_IncomeTaxDisclosureTable_81"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxesReceived" xlink:label="loc_cmmb_IncomeTaxesReceived_82"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxesReceived" xlink:label="loc_cmmb_IncomeTaxesReceived_83"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxesReceived" xlink:label="loc_cmmb_IncomeTaxesReceived_84"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxExpenseValuationAllowance" xlink:label="loc_cmmb_IncomeTaxExpenseValuationAllowance_85"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxExpenseValuationAllowance" xlink:label="loc_cmmb_IncomeTaxExpenseValuationAllowance_86"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxExpenseValuationAllowance" xlink:label="loc_cmmb_IncomeTaxExpenseValuationAllowance_87"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncrementalBorrowingRateOfLeases" xlink:label="loc_cmmb_IncrementalBorrowingRateOfLeases_88"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncrementalBorrowingRateOfLeases" xlink:label="loc_cmmb_IncrementalBorrowingRateOfLeases_89"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncrementalBorrowingRateOfLeases" xlink:label="loc_cmmb_IncrementalBorrowingRateOfLeases_90"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_InterestReceived" xlink:label="loc_cmmb_InterestReceived_91"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_InterestReceived" xlink:label="loc_cmmb_InterestReceived_92"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_InterestReceived" xlink:label="loc_cmmb_InterestReceived_93"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_InvestorsMember" xlink:label="loc_cmmb_InvestorsMember_94"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_InvestorsMember" xlink:label="loc_cmmb_InvestorsMember_95"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="loc_cmmb_LaboratoryEquipmentMember_96"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="loc_cmmb_LaboratoryEquipmentMember_97"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="loc_cmmb_LaboratoryEquipmentMember_98"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LienOnBankDeposit" xlink:label="loc_cmmb_LienOnBankDeposit_99"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LienOnBankDeposit" xlink:label="loc_cmmb_LienOnBankDeposit_100"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LongTermLeaseDeposit" xlink:label="loc_cmmb_LongTermLeaseDeposit_101"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LongTermLeaseDeposit" xlink:label="loc_cmmb_LongTermLeaseDeposit_102"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LongTermLeaseDeposit" xlink:label="loc_cmmb_LongTermLeaseDeposit_103"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xlink:label="loc_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_104"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xlink:label="loc_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_105"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xlink:label="loc_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_106"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MaximumPercentageOfPaymentsOfRoyalties" xlink:label="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_107"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MaximumPercentageOfPaymentsOfRoyalties" xlink:label="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_108"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MaximumPercentageOfPaymentsOfRoyalties" xlink:label="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_109"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_110"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_111"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_112"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_113"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_114"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_115"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_116"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_117"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdssOptionsIssuableOutstanding" xlink:label="loc_cmmb_NumberOfAdssOptionsIssuableOutstanding_118"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdssOptionsIssuableOutstanding" xlink:label="loc_cmmb_NumberOfAdssOptionsIssuableOutstanding_119"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdssVestedAndExercisable" xlink:label="loc_cmmb_NumberOfAdssVestedAndExercisable_120"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdssVestedAndExercisable" xlink:label="loc_cmmb_NumberOfAdssVestedAndExercisable_121"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsIssuableOutstanding" xlink:label="loc_cmmb_NumberOfOptionsIssuableOutstanding_122"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsIssuableOutstanding" xlink:label="loc_cmmb_NumberOfOptionsIssuableOutstanding_123"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsIssuableOutstanding" xlink:label="loc_cmmb_NumberOfOptionsIssuableOutstanding_124"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsVestedAndExercisable" xlink:label="loc_cmmb_NumberOfOptionsVestedAndExercisable_125"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsVestedAndExercisable" xlink:label="loc_cmmb_NumberOfOptionsVestedAndExercisable_126"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsVestedAndExercisable" xlink:label="loc_cmmb_NumberOfOptionsVestedAndExercisable_127"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOrdinarySharesConsistedInDs" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_128"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOrdinarySharesConsistedInDs" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_129"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOrdinarySharesConsistedInDs" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_130"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockAdssResveredForIssuance" xlink:label="loc_cmmb_NumberOfStockAdssResveredForIssuance_131"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockAdssResveredForIssuance" xlink:label="loc_cmmb_NumberOfStockAdssResveredForIssuance_132"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockAdssResveredForIssuance" xlink:label="loc_cmmb_NumberOfStockAdssResveredForIssuance_133"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockReservedForIssuance" xlink:label="loc_cmmb_NumberOfStockReservedForIssuance_134"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockReservedForIssuance" xlink:label="loc_cmmb_NumberOfStockReservedForIssuance_135"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockReservedForIssuance" xlink:label="loc_cmmb_NumberOfStockReservedForIssuance_136"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfVestedAndExercisable" xlink:label="loc_cmmb_NumberOfVestedAndExercisable_137"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfVestedAndExercisable" xlink:label="loc_cmmb_NumberOfVestedAndExercisable_138"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfVestedAndExercisable" xlink:label="loc_cmmb_NumberOfVestedAndExercisable_139"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfWarrantsPurchaseUpAdss" xlink:label="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_140"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfWarrantsPurchaseUpAdss" xlink:label="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_141"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfWarrantsPurchaseUpAdss" xlink:label="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_142"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities" xlink:label="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_143"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities" xlink:label="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_144"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities" xlink:label="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_145"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_146"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_147"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" xlink:label="loc_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_148"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" xlink:label="loc_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_149"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" xlink:label="loc_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_150"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xlink:label="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_151"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xlink:label="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_152"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xlink:label="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_153"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="loc_cmmb_PaymentsForInvestmentInDeposits_154"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="loc_cmmb_PaymentsForInvestmentInDeposits_155"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="loc_cmmb_PaymentsForInvestmentInDeposits_156"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PercentageOfMonthlyDepositsRate" xlink:label="loc_cmmb_PercentageOfMonthlyDepositsRate_157"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PercentageOfMonthlyDepositsRate" xlink:label="loc_cmmb_PercentageOfMonthlyDepositsRate_158"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xlink:label="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_159"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xlink:label="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_160"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xlink:label="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_161"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ProceedsFromSaleOfAdss" xlink:label="loc_cmmb_ProceedsFromSaleOfAdss_162"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ProceedsFromSaleOfAdss" xlink:label="loc_cmmb_ProceedsFromSaleOfAdss_163"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivablesFromGovernmentInstitutions" xlink:label="loc_cmmb_ReceivablesFromGovernmentInstitutions_164"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivablesFromGovernmentInstitutions" xlink:label="loc_cmmb_ReceivablesFromGovernmentInstitutions_165"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivablesFromGovernmentInstitutions" xlink:label="loc_cmmb_ReceivablesFromGovernmentInstitutions_166"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivedAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_167"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivedAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_168"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivedAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_169"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RecoverabilityOfVatAmount" xlink:label="loc_cmmb_RecoverabilityOfVatAmount_170"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RecoverabilityOfVatAmount" xlink:label="loc_cmmb_RecoverabilityOfVatAmount_171"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RecoverabilityOfVatAmount" xlink:label="loc_cmmb_RecoverabilityOfVatAmount_172"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyMember" xlink:label="loc_cmmb_RelatedPartyMember_173"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyMember" xlink:label="loc_cmmb_RelatedPartyMember_174"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_175"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_176"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_177"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_178"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_179"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_180"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_181"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_182"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_183"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_184"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_185"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_186"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_187"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_188"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_189"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xlink:label="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_190"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xlink:label="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_191"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xlink:label="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_192"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_193"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_194"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_195"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_196"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_197"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_198"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceiptsShares" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_199"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceiptsShares" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_200"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceiptsShares" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_201"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockLineItems" xlink:label="loc_cmmb_SaleOfStockLineItems_202"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockLineItems" xlink:label="loc_cmmb_SaleOfStockLineItems_203"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStocksPricePerShare" xlink:label="loc_cmmb_SaleOfStocksPricePerShare_204"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStocksPricePerShare" xlink:label="loc_cmmb_SaleOfStocksPricePerShare_205"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStocksPricePerShare" xlink:label="loc_cmmb_SaleOfStocksPricePerShare_206"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockTable" xlink:label="loc_cmmb_SaleOfStockTable_207"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockTable" xlink:label="loc_cmmb_SaleOfStockTable_208"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockValueOfSharesIssuedInTransaction" xlink:label="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_209"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockValueOfSharesIssuedInTransaction" xlink:label="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_210"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockValueOfSharesIssuedInTransaction" xlink:label="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_211"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" xlink:label="loc_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_212"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" xlink:label="loc_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_213"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" xlink:label="loc_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_214"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" xlink:label="loc_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_215"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" xlink:label="loc_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_216"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" xlink:label="loc_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_217"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" xlink:label="loc_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_218"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" xlink:label="loc_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_219"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" xlink:label="loc_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_220"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" xlink:label="loc_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_221"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" xlink:label="loc_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_222"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" xlink:label="loc_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_223"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" xlink:label="loc_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_224"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" xlink:label="loc_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_225"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" xlink:label="loc_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_226"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_227"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_228"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SeverancePayPolicyTextBlock" xlink:label="loc_cmmb_SeverancePayPolicyTextBlock_229"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SeverancePayPolicyTextBlock" xlink:label="loc_cmmb_SeverancePayPolicyTextBlock_230"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SeverancePayPolicyTextBlock" xlink:label="loc_cmmb_SeverancePayPolicyTextBlock_231"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_232"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_233"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_234"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_235"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_236"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_237"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_238"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_239"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_240"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice" xlink:label="loc_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_241"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice" xlink:label="loc_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_242"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice" xlink:label="loc_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_243"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_244"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_245"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_246"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationResearchAndDevelopmentExpense" xlink:label="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_247"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationResearchAndDevelopmentExpense" xlink:label="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_248"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationResearchAndDevelopmentExpense" xlink:label="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_249"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_250"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_251"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_252"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_253"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_254"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_255"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_256"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_257"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xlink:label="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_258"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xlink:label="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_259"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xlink:label="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_260"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" xlink:label="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_261"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" xlink:label="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_262"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" xlink:label="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_263"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xlink:label="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_264"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xlink:label="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_265"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xlink:label="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_266"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" xlink:label="loc_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_267"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" xlink:label="loc_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_268"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" xlink:label="loc_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_269"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_270"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_271"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_272"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandsFifteenPlanMember_273"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandsFifteenPlanMember_274"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandsFifteenPlanMember_275"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsSeventeenPlanMember" xlink:label="loc_cmmb_TwoThousandsSeventeenPlanMember_276"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsSeventeenPlanMember" xlink:label="loc_cmmb_TwoThousandsSeventeenPlanMember_277"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsSeventeenPlanMember" xlink:label="loc_cmmb_TwoThousandsSeventeenPlanMember_278"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_279"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_280"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_281"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_282"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_283"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_284"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_285"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_286"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_287"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_288"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_289"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_291"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_292"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_293"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_294"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_295"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_296"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_297"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_298"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_299"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_301"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_302"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_303"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_304"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_305"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_306"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_307"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_308"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_309"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_311"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_312"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_313"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_314"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_315"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_316"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_317"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_318"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_319"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_321"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_322"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_323"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_324"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_325"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_326"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_327"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_328"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_329"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_330"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_331"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_332"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_333"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_334"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_335"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_336"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="loc_country_IL_337"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_country_US_338"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR" xlink:label="loc_currency_EUR_339"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_340"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_341"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD" xlink:label="loc_currency_USD_342"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX" xlink:label="loc_currency_XXX_343"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_344"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_345"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_346"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_347"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_348"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_349"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_350"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_351"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_352"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_353"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_354"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_355"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_356"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_357"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_358"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_359"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_360"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_361"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_362"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_363"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_364"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_365"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_366"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_367"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_368"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_369"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_370"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_371"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_372"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_373"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_374"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_375"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_376"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_377"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_378"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_379"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_380"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_381"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_382"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_383"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_384"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_385"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_386"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_387"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_388"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_389"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_390"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_391"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_392"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_393"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_394"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_395"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_396"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_397"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_398"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_399"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_400"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_401"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_402"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_403"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_404"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_405"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_406"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_407"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_408"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_409"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_410"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_411"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_412"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_413"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_414"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_415"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_416"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_417"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_418"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_419"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_420"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_421"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_422"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_423"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_424"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_425"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_426"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAdditionsMember" xlink:label="loc_us-gaap_CapitalAdditionsMember_427"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_428"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_429"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_430"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_431"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_432"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_433"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_434"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_435"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_436"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_437"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_438"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_439"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_440"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_441"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_442"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_443"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_444"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_445"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_446"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_447"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_448"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_449"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_450"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_451"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_452"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_453"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_454"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_455"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_456"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_457"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_458"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_459"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_460"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_461"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_462"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_463"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_464"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_465"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_466"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_467"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_468"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_469"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_470"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_471"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_472"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_473"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_474"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_475"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_476"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_477"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_478"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_479"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_480"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_481"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_482"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_483"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_484"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_485"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_486"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_487"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_488"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralInsuranceExpense" xlink:label="loc_us-gaap_GeneralInsuranceExpense_489"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_490"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_491"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_492"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_493"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_494"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_495"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_496"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_497"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_498"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_499"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_500"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_501"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_502"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_503"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_504"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_505"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_506"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_507"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_508"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_509"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_510"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_511"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAgreementsMember" xlink:label="loc_us-gaap_LeaseAgreementsMember_512"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_513"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_514"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_515"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_516"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_517"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_518"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_519"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_520"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_521"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_522"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_523"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_524"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_525"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_526"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_527"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_528"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_529"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_530"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_531"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_532"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_533"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_534"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_535"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_536"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_537"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="loc_us-gaap_LiabilitiesAssumed1_538"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="loc_us-gaap_LiabilitiesAssumed1_539"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_540"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_541"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_542"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_543"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_544"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_545"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_546"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_547"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_548"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentDescription" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentDescription_549"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_550"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_551"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_552"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_553"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_554"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_555"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_556"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_557"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_558"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_559"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_560"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_561"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseDirectorsFees" xlink:label="loc_us-gaap_NoninterestExpenseDirectorsFees_562"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaap_OfficersCompensation_563"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_564"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_565"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_566"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_567"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_568"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_569"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_570"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_571"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_572"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_573"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_574"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_575"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_576"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_577"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDescription" xlink:label="loc_us-gaap_OtherCommitmentsDescription_578"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_579"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_580"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_581"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_582"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_OtherResearchAndDevelopmentExpense_583"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_584"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_585"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_586"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_587"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_588"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_589"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_590"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_591"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_592"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_593"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_594"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_595"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_596"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_597"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_598"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_599"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="loc_us-gaap_ProceedsFromSaleOfTreasuryStock_600"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="loc_us-gaap_ProceedsFromSaleOfTreasuryStock_601"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_602"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_603"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaap_ProfessionalFees_604"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_605"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_606"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_607"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_608"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_609"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_610"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_611"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_612"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_613"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_614"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_615"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_616"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_617"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_618"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_619"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyCosts" xlink:label="loc_us-gaap_RelatedPartyCosts_620"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyCosts" xlink:label="loc_us-gaap_RelatedPartyCosts_621"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_622"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_623"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_624"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_625"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_626"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_627"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_628"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_629"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_630"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_631"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_632"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_633"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_634"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_635"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_636"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestments" xlink:label="loc_us-gaap_RestrictedInvestments_637"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_638"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_639"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_640"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_641"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_642"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_643"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_644"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaap_SalariesAndWages_645"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaap_SalariesAndWages_646"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_647"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_648"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_649"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_650"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_651"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_652"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_653"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_654"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_655"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_656"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_657"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_658"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_659"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_660"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_661"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_662"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_663"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_664"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_665"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_666"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_667"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_668"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_669"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_670"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_671"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_672"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_673"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_674"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_675"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_676"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_677"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_678"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_679"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_680"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_681"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_682"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_683"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_684"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_685"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_686"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_687"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_688"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_689"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_690"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_691"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_692"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_693"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_694"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_695"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_696"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_697"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_698"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_699"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_700"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_701"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_702"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_703"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_704"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_705"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_706"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_707"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_708"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_709"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_710"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_711"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_712"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_713"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_714"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_715"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_716"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_717"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_718"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_719"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_720"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_721"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_722"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_723"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_724"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_725"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_726"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_727"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_728"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_729"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_730"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_731"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_732"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_733"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_734"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_735"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_736"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_737"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_738"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_739"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_740"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_741"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_742"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_743"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_744"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_745"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_746"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AdditionalWorkOrderAmount_0" xml:lang="en-US">Additional work order amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AdditionalWorkOrderAmount_1" xml:lang="en-US">Additional Work Order Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_AdditionalWorkOrderAmount_2" xml:lang="en-US">Additional work order</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AggregateAmountCommitmentToPay_0" xml:lang="en-US">Aggregate amount commitment to pay.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AggregateAmountCommitmentToPay_1" xml:lang="en-US">Aggregate amount commitment to pay</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AggregateAmountOfCommitmentPaid_0" xml:lang="en-US">Aggregate amount of commitment paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AggregateAmountOfCommitmentPaid_1" xml:lang="en-US">Aggregate amount of commitment paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_0" xml:lang="en-US">It represents as a aggregate offering price of at the market offering agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_1" xml:lang="en-US">Aggregate Offering Price Of At Market Offering Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_2" xml:lang="en-US">Aggregate offering price of at the market offering agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmericanDepositarySharesMember_0" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmericanDepositarySharesMember_1" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AnnualRatesOfDepreciation_0" xml:lang="en-US">Annual rates of depreciation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AnnualRatesOfDepreciation_1" xml:lang="en-US">Annual Rates Of Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_AnnualRatesOfDepreciation_2" xml:lang="en-US">Annual rates of depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AnnualRentAndManagementFees_0" xml:lang="en-US">Annual rent and management fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AnnualRentAndManagementFees_1" xml:lang="en-US">Annual rent and management fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AtmAgreementMember_0" xml:lang="en-US">ATM agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AtmAgreementMember_1" xml:lang="en-US">ATM agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_BankGuaranteesToPropertyOwner_0" xml:lang="en-US">Bank guarantees to property owner.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_BankGuaranteesToPropertyOwner_1" xml:lang="en-US">Bank guarantees to property owner</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_0" xml:lang="en-US">The amount of of asset held for sale recogized prior to the completion of merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_1" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Asset Held For Sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2" xml:lang="en-US">Asset held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0" xml:lang="en-US">Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1" xml:lang="en-US">Accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CantorMember_0" xml:lang="en-US">Represents about Cantor.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CantorMember_1" xml:lang="en-US">Cantor [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CapitalAdditionsOneMember_0" xml:lang="en-US">FDA or equivalent agency marketing approval [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CapitalAdditionsOneMember_1" xml:lang="en-US">Capital Additions One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_CapitalAdditionsOneMember_2" xml:lang="en-US">FDA or equivalent agency marketing approval [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CashAcquiredInMerger_0" xml:lang="en-US">Cash acquired in merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CashAcquiredInMerger_1" xml:lang="en-US">Cash acquired in Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CashPaidAndReceivedDuringYearForAbstract_0" xml:lang="en-US">n/a</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CashPaidAndReceivedDuringYearForAbstract_1" xml:lang="en-US">Cash Paid And Received During Year For [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_CashPaidAndReceivedDuringYearForAbstract_2" xml:lang="en-US">A. Cash paid and received during the year for:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_0" xml:lang="en-US">It represents as a change in temporary differences for which deferred taxes were not recognized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_1" xml:lang="en-US">Change In Temporary Differences For Deferred Taxes Not Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_2" xml:lang="en-US">Change in temporary differences for which deferred taxes were not recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ConsultantsAndSubcontractorsExpense_0" xml:lang="en-US">Consultants and subcontractors expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ConsultantsAndSubcontractorsExpense_1" xml:lang="en-US">Consultants And Subcontractors Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_ConsultantsAndSubcontractorsExpense_2" xml:lang="en-US">Consultants and subcontractors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_0" xml:lang="en-US">The cumulative amounts of grants received from the IIA and recognized by the company, as of the balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_1" xml:lang="en-US">Cumulative Amounts Of Grants Received And Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_2" xml:lang="en-US">Cumulative amounts of grants received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CurrencyTransactionLossValuationAllowance_0" xml:lang="en-US">Amount of increase (decrease) in the valuation allowance due to currency transaction loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CurrencyTransactionLossValuationAllowance_1" xml:lang="en-US">Currency Transaction Loss Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_CurrencyTransactionLossValuationAllowance_2" xml:lang="en-US">Currency transaction income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_0" xml:lang="en-US">Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_1" xml:lang="en-US">Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_2" xml:lang="en-US">Denominator:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EarningsPerShareCalculationNumeratorAbstract_0" xml:lang="en-US">Earnings Per Share Calculation Numerator Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EarningsPerShareCalculationNumeratorAbstract_1" xml:lang="en-US">Earnings Per Share Calculation Numerator [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_EarningsPerShareCalculationNumeratorAbstract_2" xml:lang="en-US">Numerator:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransaction_0" xml:lang="en-US">The amount of effect due reverse capitalization transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransaction_1" xml:lang="en-US">Effect of reverse capitalization transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_0" xml:lang="en-US">The number of shares isued due to effect of reverse capitalization transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_1" xml:lang="en-US">Effect Of Reverse Capitalization Transaction Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_2" xml:lang="en-US">Effect of reverse capitalization transaction (In shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_0" xml:lang="en-US">The amount of estimated fair value of the net assets acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_1" xml:lang="en-US">Estimated Fair Value Of Net Assets Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_2" xml:lang="en-US">Net acquired assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_0" xml:lang="en-US">The amount expects to receive of Chemomab Therapeutics Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_1" xml:lang="en-US">Expects To Receive Amount Of Chemomab Therapeutics Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_2" xml:lang="en-US">Expects to receive amount of Chemomab Therapeutics Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_0" xml:lang="en-US">The net amount of finance income earned and finance expenses incurred during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_1" xml:lang="en-US">Financing expenses (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_2" xml:lang="en-US">Finance Income (Expenses), Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_FormerChemomabSecurityHoldersMember_0" xml:lang="en-US">This represents former Chemomab security holders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_FormerChemomabSecurityHoldersMember_1" xml:lang="en-US">Former Chemomab Security Holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_GeneralAndAdministrativeDisclosureTextBlock_0" xml:lang="en-US">The entire disclosure of general and administrative expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_GeneralAndAdministrativeDisclosureTextBlock_1" xml:lang="en-US">General And Administrative Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_GeneralAndAdministrativeDisclosureTextBlock_2" xml:lang="en-US">General and Administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_1" xml:lang="en-US">Government Sponsored Research And Development [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_2" xml:lang="en-US">Government-sponsored research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_IncomeTaxDisclosureLineItems_0" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_IncomeTaxDisclosureLineItems_1" xml:lang="en-US">Income Tax Disclosure [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_IncomeTaxDisclosureTable_0" xml:lang="en-US">Disclosure of information pertaining to income taxes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_IncomeTaxDisclosureTable_1" xml:lang="en-US">Income Tax Disclosure [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_IncomeTaxesReceived_0" xml:lang="en-US">It represents income taxes received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_IncomeTaxesReceived_1" xml:lang="en-US">Income Taxes Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_IncomeTaxesReceived_2" xml:lang="en-US">Income taxes received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_IncomeTaxExpenseValuationAllowance_0" xml:lang="en-US">Amount of increase (decrease) in the valuation allowance due to income tax expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_IncomeTaxExpenseValuationAllowance_1" xml:lang="en-US">Income Tax Expense Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_IncomeTaxExpenseValuationAllowance_2" xml:lang="en-US">Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_IncrementalBorrowingRateOfLeases_0" xml:lang="en-US">It represents incremental borrowing rate of leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_IncrementalBorrowingRateOfLeases_1" xml:lang="en-US">Incremental Borrowing Rate Of Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_IncrementalBorrowingRateOfLeases_2" xml:lang="en-US">incremental borrowing rate of leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_InterestReceived_0" xml:lang="en-US">The amount of interest received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_InterestReceived_1" xml:lang="en-US">Interest Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_InterestReceived_2" xml:lang="en-US">Interest received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_InvestorsMember_0" xml:lang="en-US">Investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_InvestorsMember_1" xml:lang="en-US">Investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_LaboratoryEquipmentMember_0" xml:lang="en-US">Laboratory equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_LaboratoryEquipmentMember_1" xml:lang="en-US">Laboratory Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_LaboratoryEquipmentMember_2" xml:lang="en-US">Laboratory equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_LienOnBankDeposit_0" xml:lang="en-US">Lien on bank deposit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_LienOnBankDeposit_1" xml:lang="en-US">Lien on bank deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_LongTermLeaseDeposit_0" xml:lang="en-US">Long-term lease deposit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_LongTermLeaseDeposit_1" xml:lang="en-US">Long Term Lease Deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_LongTermLeaseDeposit_2" xml:lang="en-US">Long-term lease deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_0" xml:lang="en-US">Represents losses and benefits for tax purposes for the year, for which deferred taxes were not recorded.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_1" xml:lang="en-US">Losses And Benefits For Tax Purposes For The Year For Which Deferred Taxes Were Not Recorded</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_2" xml:lang="en-US">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_MaximumPercentageOfPaymentsOfRoyalties_0" xml:lang="en-US">The maximum percentage of royalties payable on the amount of the grant received (dollar linked), plus interest at annual rate based on LIBOR.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_MaximumPercentageOfPaymentsOfRoyalties_1" xml:lang="en-US">Maximum Percentage Of Payments Of Royalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_MaximumPercentageOfPaymentsOfRoyalties_2" xml:lang="en-US">Maximum percentage of payments of royalties (as a percent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_0" xml:lang="en-US">This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1" xml:lang="en-US">Merger Agreement With Cmb Acquisition Ltd Subsidiary Of Ours And Chemomb [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_2" xml:lang="en-US">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NatureOfOperationsDisclosureAbstract_0" xml:lang="en-US">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NatureOfOperationsDisclosureAbstract_1" xml:lang="en-US">Nature Of Operations Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_NatureOfOperationsDisclosureAbstract_2" xml:lang="en-US">NATURE OF OPERATIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_0" xml:lang="en-US">Number of ADS issued and outstanding after the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_1" xml:lang="en-US">Number of ADS issued and outstanding after the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfAdssOptionsIssuableOutstanding_0" xml:lang="en-US">Number of ADSs options issuable outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfAdssOptionsIssuableOutstanding_1" xml:lang="en-US">Number of ADSs options issuable outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfAdssVestedAndExercisable_0" xml:lang="en-US">Number of ADSs vested and exercisable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfAdssVestedAndExercisable_1" xml:lang="en-US">Number of ADSs vested and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfOptionsIssuableOutstanding_0" xml:lang="en-US">It represents number of options issuable outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfOptionsIssuableOutstanding_1" xml:lang="en-US">Number Of Options Issuable Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_NumberOfOptionsIssuableOutstanding_2" xml:lang="en-US">Number of options issuable outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfOptionsVestedAndExercisable_0" xml:lang="en-US">It represents number of options vested and exercisable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfOptionsVestedAndExercisable_1" xml:lang="en-US">Number Of Options Vested And Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_NumberOfOptionsVestedAndExercisable_2" xml:lang="en-US">Number of options vested and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDs_0" xml:lang="en-US">Represent the number of ordinary shares consisted in one American depository share (ADS).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDs_1" xml:lang="en-US">Number Of Ordinary Shares Consisted In Ds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDs_2" xml:lang="en-US">Number of ordinary shares represented by each ADS (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfStockAdssResveredForIssuance_0" xml:lang="en-US">Number of stock option ADSs resvered for issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfStockAdssResveredForIssuance_1" xml:lang="en-US">Number Of Stock Adss Resvered For Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_NumberOfStockAdssResveredForIssuance_2" xml:lang="en-US">Number of stock option ADSs reversed for issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfStockReservedForIssuance_0" xml:lang="en-US">It represents number of stock resvered for issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfStockReservedForIssuance_1" xml:lang="en-US">Number Of Stock Reserved For Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_NumberOfStockReservedForIssuance_2" xml:lang="en-US">Number of stock reserved for issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfVestedAndExercisable_0" xml:lang="en-US">It represents number of vested and exercisable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfVestedAndExercisable_1" xml:lang="en-US">Number Of Vested And Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_NumberOfVestedAndExercisable_2" xml:lang="en-US">Number of vested and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfWarrantsPurchaseUpAdss_0" xml:lang="en-US">Number of warrants purchase ADS's.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfWarrantsPurchaseUpAdss_1" xml:lang="en-US">Number Of Warrants Purchase Up Adss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_NumberOfWarrantsPurchaseUpAdss_2" xml:lang="en-US">Number of warrants purchase ADS's</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_0" xml:lang="en-US">Operating right-of-use assets and operating lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_1" xml:lang="en-US">Operating Right Of Use Assets And Operating Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_2" xml:lang="en-US">Operating right-of-use assets and operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OrdinarySharesNoParValuePerShareMember_0" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OrdinarySharesNoParValuePerShareMember_1" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_0" xml:lang="en-US">Other accounts receivable and prepaid expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_1" xml:lang="en-US">Other Accounts Receivable And Prepaid Expenses [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_2" xml:lang="en-US">Other Receivables and Prepaid Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_0" xml:lang="en-US">Payment on commencement of agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_1" xml:lang="en-US">Payment On Long Term Purchase Commitment Commencement Of Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_2" xml:lang="en-US">Payment on commencement of agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_PaymentsForInvestmentInDeposits_0" xml:lang="en-US">The amount of payments for investm,ents in deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_PaymentsForInvestmentInDeposits_1" xml:lang="en-US">Investment in deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_PaymentsForInvestmentInDeposits_2" xml:lang="en-US">Payments for Investment in Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_PercentageOfMonthlyDepositsRate_0" xml:lang="en-US">Percentage of monthly deposits rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_PercentageOfMonthlyDepositsRate_1" xml:lang="en-US">Percentage of monthly deposits rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_0" xml:lang="en-US">The percentage of royalty payments on sale of product developed with funding received from the IIA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_1" xml:lang="en-US">Percentage Of Royalty Payments On Sale Of Product</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_2" xml:lang="en-US">Royalty payments on sale of product (as a percent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ProceedsFromSaleOfAdss_0" xml:lang="en-US">Proceeds from sale of ADS's.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ProceedsFromSaleOfAdss_1" xml:lang="en-US">Proceeds from sale of ADS's</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ReceivablesFromGovernmentInstitutions_0" xml:lang="en-US">Government institutions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ReceivablesFromGovernmentInstitutions_1" xml:lang="en-US">Receivables From Government Institutions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_ReceivablesFromGovernmentInstitutions_2" xml:lang="en-US">Government institutions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_0" xml:lang="en-US">The received amount of Chemomab Therapeutics Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_1" xml:lang="en-US">Received Amount Of Chemomab Therapeutics Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_2" xml:lang="en-US">Received amount of Chemomab Therapeutics Inc</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RecoverabilityOfVatAmount_0" xml:lang="en-US">It represents recoverability of VAT amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RecoverabilityOfVatAmount_1" xml:lang="en-US">Recoverability Of Vat Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_RecoverabilityOfVatAmount_2" xml:lang="en-US">Recoverability of VAT amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RelatedPartyMember_0" xml:lang="en-US">Related Party [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RelatedPartyMember_1" xml:lang="en-US">Related Party [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_0" xml:lang="en-US">Related party expenses related to professional services.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_1" xml:lang="en-US">Related Party Transaction Professional Services From Transactions With Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_2" xml:lang="en-US">Professional services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_0" xml:lang="en-US">Related party expenses related to research and develeopment expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_1" xml:lang="en-US">Related Party Transaction Research And Development Expense From Transactions With Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_2" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_0" xml:lang="en-US">Related party expenses related to salaries and related expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_1" xml:lang="en-US">Related Party Transaction Salaries And Related Expenses From Transactions With Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_2" xml:lang="en-US">Salaries and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_0" xml:lang="en-US">Related party expenses related to share based payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_1" xml:lang="en-US">Related Party Transaction Share Based Payments From Transactions With Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_2" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative related rent and maintenance expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_1" xml:lang="en-US">Rent And Maintenance General And Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_2" xml:lang="en-US">Rent and maintenance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development related rent and maintenance expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_1" xml:lang="en-US">Rent And Maintenance Research And Development Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_2" xml:lang="en-US">Rent and maintenance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RepurchaseArrangementMember_0" xml:lang="en-US">This member stands for Repurchase Arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RepurchaseArrangementMember_1" xml:lang="en-US">Repurchase Arrangement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_RepurchaseArrangementMember_2" xml:lang="en-US">Repurchase Arrangement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_0" xml:lang="en-US">Represents the amount of repurchase of american depositary receipts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_1" xml:lang="en-US">Repurchase Of American Depositary Receipts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_2" xml:lang="en-US">Repurchase of ADSs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_0" xml:lang="en-US">It represents repurchase of American Depositary Receipts shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_1" xml:lang="en-US">Repurchase Of American Depositary Receipts Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_2" xml:lang="en-US">Number of shares repurchase of ADSs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SaleOfStockLineItems_0" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SaleOfStockLineItems_1" xml:lang="en-US">Sale Of Stock [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SaleOfStocksPricePerShare_0" xml:lang="en-US">Per share amount received by the company for each share of common stock issued or sold in the stock transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SaleOfStocksPricePerShare_1" xml:lang="en-US">Sale Of Stocks Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_SaleOfStocksPricePerShare_2" xml:lang="en-US">Share price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SaleOfStockTable_0" xml:lang="en-US">Different names of stock transactions and the different attributes of each transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SaleOfStockTable_1" xml:lang="en-US">Sale Of Stock [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_0" xml:lang="en-US">Represents the amount of sale of stock value of shares issued in transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_1" xml:lang="en-US">Sale Of Stock Value Of Shares Issued In Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_2" xml:lang="en-US">Issuance and sale of of ADS upto</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_0" xml:lang="en-US">Tabular disclosure of the annual rate of deprecation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_1" xml:lang="en-US">Schedule Of Annual Rate Of Deprecation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_2" xml:lang="en-US">Schedule of annual rate of deprecation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_0" xml:lang="en-US">Tabular disclosure of general and administrative expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_1" xml:lang="en-US">Schedule Of General And Administrative [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_2" xml:lang="en-US">Schedule of general and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_0" xml:lang="en-US">Schedule of other accounts receivable and prepaid expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_1" xml:lang="en-US">Schedule Of Other Accounts Receivable And Prepaid Expenses [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_2" xml:lang="en-US">Schedule of other accounts receivable and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_0" xml:lang="en-US">Tabular disclosure of related party payables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_1" xml:lang="en-US">Schedule Of Related Party Payables [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_2" xml:lang="en-US">Schedule of related party payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_0" xml:lang="en-US">Tabular disclosure of research and development expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_1" xml:lang="en-US">Schedule Of Research And Development [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_2" xml:lang="en-US">Schedule of research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_0" xml:lang="en-US">This represents security holders of Anchiano as of immediately prior to the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_1" xml:lang="en-US">Security holders of Anchiano as of immediately prior to the merger [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SeverancePayPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy for severance pay.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SeverancePayPolicyTextBlock_1" xml:lang="en-US">Severance Pay [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_SeverancePayPolicyTextBlock_2" xml:lang="en-US">Severance pay</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_0" xml:lang="en-US">It represents Share Based Compensation Arrangement By Share Based Payment Award ADS Forfeitures In Period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Ads Forfeitures In Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_2" xml:lang="en-US">Options to purchase ordinary shares cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_0" xml:lang="en-US">It represents Share Based Compensation Arrangement By Share Based Payment Award ADS Outstanding Period Increase Decrease Weighted Average Exercise Price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Ads Outstanding Period Increase Decrease Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_2" xml:lang="en-US">Weighted average exercise price of ADSs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_0" xml:lang="en-US">Weighted average remaining contractual term for option awards granted during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants In Period, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_0" xml:lang="en-US">Weighted average price of shares acquired in merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_1" xml:lang="en-US">Share Based Compensation Arrangements By Share Based Payment Award, Options, Acquired In Merger, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_2" xml:lang="en-US">Acquired in Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative related share-based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_1" xml:lang="en-US">Share Based Compensation General And Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development related share-based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_1" xml:lang="en-US">Share Based Compensation Research And Development Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_2" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_0" xml:lang="en-US">shareholding percentage immediately following the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_1" xml:lang="en-US">Shareholding percentage immediately following the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_0" xml:lang="en-US">it represents number of shares and warrants issued during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_1" xml:lang="en-US">Stock And Warrants Issued During Period New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_2" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs (In shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_0" xml:lang="en-US">Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_1" xml:lang="en-US">Stock And Warrants Issued During Period Value New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_2" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_0" xml:lang="en-US">Number of new stocks of American Depository Shares ("ADS") issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_1" xml:lang="en-US">Stock Issued During Period American Depository Shares New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_2" xml:lang="en-US">Number of ADSs issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_0" xml:lang="en-US">Number of options acquired, including both vested and non-vested options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_1" xml:lang="en-US">Stock Issued During Period Shares Stock Options Acquired In Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_2" xml:lang="en-US">Acquired in Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_0" xml:lang="en-US">Number of share options (or share units) exercised during the current period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_1" xml:lang="en-US">Exercise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_2" xml:lang="en-US">Stock Issued During Period Shares Stock Options Exercised 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_0" xml:lang="en-US">Amount of increase (decrease) in the valuation allowance due to tax assets acquired through merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_1" xml:lang="en-US">Tax Assets Acquired Through Merger Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_2" xml:lang="en-US">Tax assets acquired through merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_0" xml:lang="en-US">It represents Total consideration of repurchase of american depositary receipts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_1" xml:lang="en-US">Total Consideration Of Repurchase Of American Depositary Receipts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_2" xml:lang="en-US">Total consideration of repurchase of ADSs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_TwoThousandsFifteenPlanMember_0" xml:lang="en-US">2015 plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_TwoThousandsFifteenPlanMember_1" xml:lang="en-US">Two Thousands Fifteen Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_TwoThousandsFifteenPlanMember_2" xml:lang="en-US">2015 plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_TwoThousandsSeventeenPlanMember_0" xml:lang="en-US">2017 plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_TwoThousandsSeventeenPlanMember_1" xml:lang="en-US">Two Thousands Seventeen Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_TwoThousandsSeventeenPlanMember_2" xml:lang="en-US">2017 plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_0" xml:lang="en-US">It represents weighted average price of repurchase of american depositary receipts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_1" xml:lang="en-US">Weighted Average Price Of Repurchase Of American Depositary Receipts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_2" xml:lang="en-US">Weighted average price of repurchase of ADSs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0" xml:lang="en-US">Less - accumulated depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0" xml:lang="en-US">Less - valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_1" xml:lang="en-US">Balance at December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_2" xml:lang="en-US">Balance at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_3" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0" xml:lang="en-US">Loss before income tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xml:lang="en-US">Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" xml:lang="en-US">Loss before income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3" xml:lang="en-US">Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5" xml:lang="en-US">Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncomeTaxesPaidNet_0" xml:lang="en-US">Income taxes paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxesPaidNet_1" xml:lang="en-US">Income Taxes Paid, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxesPaidNet_2" xml:lang="en-US">Income taxes paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0" xml:lang="en-US">Change in other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0" xml:lang="en-US">Less imputed interest:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_NetIncomeLoss_0" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_1" xml:lang="en-US">Net loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss_2" xml:lang="en-US">Net loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_0" xml:lang="en-US">Financing (income) expenses, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_1" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_2" xml:lang="en-US">Financing expenses (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_3" xml:lang="en-US">Nonoperating Income (Expense), Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts_0" xml:lang="en-US">Treasury share at cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts_1" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xml:lang="en-US">Options to purchase ADS cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_TreasuryStockValue_0" xml:lang="en-US">Treasury share at cost (11,640,460 shares as of December 31, 2022)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockValue_1" xml:lang="en-US">Treasury Stock, Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockValue_2" xml:lang="en-US">Treasury stock (11,640,460 shares as of December 31, 2022)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xml:lang="en-US">Outstanding at the end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xml:lang="en-US">Outstanding at the beginning</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xml:lang="en-US">Outstanding at the end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xml:lang="en-US">Outstanding at the beginning</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesOutstanding_0" xml:lang="en-US">Ending balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesOutstanding_1" xml:lang="en-US">Beginning balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesOutstanding_2" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity_2" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity_3" xml:lang="en-US">Total shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_0" xml:lang="en-US">Taxes on income (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_1" xml:lang="en-US">Actual income tax expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_2" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_3" xml:lang="en-US">Income tax benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_IL_0" xml:lang="en-US">Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_US_0" xml:lang="en-US">U.S. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_EUR_0" xml:lang="en-US">Euro [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_ILS_0" xml:lang="en-US">ILS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_currency_ILS_1" xml:lang="en-US">NIS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_USD_0" xml:lang="en-US">USD [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_XXX_0" xml:lang="en-US">Other currencies [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorFirmId_0" xml:lang="en-US">Auditor Firm Id</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorLocation_0" xml:lang="en-US">Auditor Location</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorName_0" xml:lang="en-US">Auditor Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAnnualReport_0" xml:lang="en-US">Document Annual Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationLineItems_0" xml:lang="en-US">Document Information [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationTable_0" xml:lang="en-US">Document Information [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2_0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod_0" xml:lang="en-US">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInformationFormerLegalOrRegisteredName_0" xml:lang="en-US">Entity Information, Former Legal or Registered Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityPublicFloat_0" xml:lang="en-US">Entity Public Float</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany_0" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitySmallBusiness_0" xml:lang="en-US">Entity Small Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityTaxIdentificationNumber_0" xml:lang="en-US">Entity Tax Identification Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityVoluntaryFilers_0" xml:lang="en-US">Entity Voluntary Filers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_0" xml:lang="en-US">Entity Well Known Seasoned Issuer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_IcfrAuditorAttestationFlag_0" xml:lang="en-US">Auditor Attestation Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_0" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_PreCommencementTenderOffer_0" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Name of Exchange on which Security is Registered</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SolicitingMaterial_0" xml:lang="en-US">Soliciting Material</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_WrittenCommunications_0" xml:lang="en-US">Written Communications</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CurrencyAxis_0" xml:lang="en-US">Currency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioForecastMember_0" xml:lang="en-US">Forecast [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioUnspecifiedDomain_0" xml:lang="en-US">Scenario [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementGeographicalAxis_0" xml:lang="en-US">Geographical [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementScenarioAxis_0" xml:lang="en-US">Scenario [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis_0" xml:lang="en-US">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_0" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent_0" xml:lang="en-US">Trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_0" xml:lang="en-US">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_0" xml:lang="en-US">Recognized liability for royalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital_0" xml:lang="en-US">Additional paid-in capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0" xml:lang="en-US">Additional Paid In Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_1" xml:lang="en-US">Additional paid in capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_0" xml:lang="en-US">Exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments for operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_0" xml:lang="en-US">Share-based compensation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0" xml:lang="en-US">Outstanding options to purchase ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract_0" xml:lang="en-US">ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent_0" xml:lang="en-US">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0" xml:lang="en-US">Current assets:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsCurrentAbstract_1" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrent_0" xml:lang="en-US">Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsNoncurrent_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardTypeAxis_0" xml:lang="en-US">Award Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0" xml:lang="en-US">Basis of presentation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" xml:lang="en-US">Basis of Presentation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_0" xml:lang="en-US">Business Acquisition [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0" xml:lang="en-US">Prepaid and other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalAdditionsMember_0" xml:lang="en-US">New Drug Application and Biological License Application [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract_0" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US">Cash and Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_0" xml:lang="en-US">Cash and Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_0" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xml:lang="en-US">Change in cash, cash equivalents and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain_0" xml:lang="en-US">Class of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies_0" xml:lang="en-US">Commitments and contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock_0" xml:lang="en-US">Commitments and Contingent Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember_0" xml:lang="en-US">Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockMember_1" xml:lang="en-US">Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockNoParValue_0" xml:lang="en-US">Common Stock, No Par Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued_0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue_0" xml:lang="en-US">Ordinary Shares no par value - Authorized: 650,000,000 shares as of December 31, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 228,090,300 shares at December 31, 2021 and 9,274,838 shares at December 31, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue_1" xml:lang="en-US">Ordinary Shares no par value - Authorized: 650,000,000 shares as of December 31, 2022 and 2021; Issued and outstanding: 232,636,700 Ordinary shares at December 31, 2022 and 228,090,300 Ordinary shares at December 31, 2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_0" xml:lang="en-US">Deferred taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComputerEquipmentMember_0" xml:lang="en-US">Computers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk_0" xml:lang="en-US">Concentration of credit risks</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_0" xml:lang="en-US">Principles of consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_0" xml:lang="en-US">Incremental borrowing rate based on credit rating</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_1" xml:lang="en-US">Gross deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_0" xml:lang="en-US">Research and development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_1" xml:lang="en-US">Net deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0" xml:lang="en-US">Net operating loss carry-forwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOther_0" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0" xml:lang="en-US">Share-based compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsCurrent_0" xml:lang="en-US">Short-term bank deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DomesticCountryMember_0" xml:lang="en-US">Federal [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent_0" xml:lang="en-US">Due to Related Parties, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent_1" xml:lang="en-US">Related Party Payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract_0" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic_0" xml:lang="en-US">Basic and diluted loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic_1" xml:lang="en-US">Basic loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted_0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted_1" xml:lang="en-US">Diluted loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_0" xml:lang="en-US">Earnings per ordinary share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_0" xml:lang="en-US">Net Loss Per Share Attributable to Ordinary Shareholders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0" xml:lang="en-US">Statutory tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0" xml:lang="en-US">Corporate tax rate (as a percent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xml:lang="en-US">Corporate tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0" xml:lang="en-US">Employee and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeStockOptionMember_0" xml:lang="en-US">Stock Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0" xml:lang="en-US">Fair value of financial instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0" xml:lang="en-US">Functional currency</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_0" xml:lang="en-US">Furniture and Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_1" xml:lang="en-US">Furniture and equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_1" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_2" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xml:lang="en-US">General and Administrative Expense [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0" xml:lang="en-US">General and administrative [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralInsuranceExpense_0" xml:lang="en-US">Insurance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0" xml:lang="en-US">Impairment of long-lived assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_0" xml:lang="en-US">Net loss per share attributable to ordinary shareholders, basic and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_1" xml:lang="en-US">Net loss per share attributable to ordinary shareholders, basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1" xml:lang="en-US">Net loss per share attributable to ordinary shareholders, diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_0" xml:lang="en-US">Income Statement Location [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_0" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_0" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_0" xml:lang="en-US">Income Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_0" xml:lang="en-US">Theoretical tax benefit on the above amount Decrease (increase) in tax refund resulting from:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_0" xml:lang="en-US">Income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1" xml:lang="en-US">Tax rate differential</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0" xml:lang="en-US">Theoretical tax benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1" xml:lang="en-US">Non-deductible expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0" xml:lang="en-US">Change in trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_0" xml:lang="en-US">Change in accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0" xml:lang="en-US">Change in employees and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0" xml:lang="en-US">Change in leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1" xml:lang="en-US">Change in operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseAgreementsMember_0" xml:lang="en-US">2020 Lien [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseExpirationDate1_0" xml:lang="en-US">Lease expiry date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseholdImprovementsMember_0" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseholdImprovementsMember_1" xml:lang="en-US">Leasehold improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeDisclosureAbstract_0" xml:lang="en-US">Lessee Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems_0" xml:lang="en-US">Lessee, Lease, Description [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable_0" xml:lang="en-US">Lessee, Lease, Description [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_1" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0" xml:lang="en-US">Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1" xml:lang="en-US">Schedule of maturity of lease liabilities under our non-cancelable operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1" xml:lang="en-US">Total future minimum lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0" xml:lang="en-US">2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1" xml:lang="en-US">2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0" xml:lang="en-US">2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1" xml:lang="en-US">2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_0" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_1" xml:lang="en-US">Lease term, option to extend</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_0" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_0" xml:lang="en-US">Lease term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities_1" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_0" xml:lang="en-US">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAssumed1_0" xml:lang="en-US">Liabilities assumed, net of non-cash assets received in Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LiabilitiesAssumed1_1" xml:lang="en-US">Liabilities assumed, net of non-cash assets received in Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent_0" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_0" xml:lang="en-US">Current liabilities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_1" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount_0" xml:lang="en-US">Payment for licensed agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_0" xml:lang="en-US">Category of Item Purchased [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentDescription_0" xml:lang="en-US">Description of application payment for licensed product</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NatureOfOperations_0" xml:lang="en-US">General</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US">Net cash provided by (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash flows from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US">Net cash provided by (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows from investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash flows from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0" xml:lang="en-US">Significant non- cash transaction:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1" xml:lang="en-US">B. Significant non- cash transaction:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoninterestExpenseDirectorsFees_0" xml:lang="en-US">Fees to Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OfficersCompensation_0" xml:lang="en-US">Salaries and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses_0" xml:lang="en-US">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses_1" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract_0" xml:lang="en-US">Operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss_0" xml:lang="en-US">Decrease in the carrying amount of the right-of-use asset due to impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss_1" xml:lang="en-US">Increase in the carrying amount of the right-of-use asset due to impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiability_0" xml:lang="en-US">Operating Lease, Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability_1" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability_2" xml:lang="en-US">Operating Lease, Liability, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_0" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_1" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0" xml:lang="en-US">Non-current operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1" xml:lang="en-US">Non-current&#160;operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_0" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_1" xml:lang="en-US">Operating lease right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsDescription_0" xml:lang="en-US">Decsription of occurrence for payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsLineItems_0" xml:lang="en-US">Other Commitments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsTable_0" xml:lang="en-US">Other Commitments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense_0" xml:lang="en-US">Other General and Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense_1" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherResearchAndDevelopmentExpense_0" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis_0" xml:lang="en-US">Plan Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameDomain_0" xml:lang="en-US">Plan Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_0" xml:lang="en-US">Preferred shares par value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesIssued_0" xml:lang="en-US">Preferred shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xml:lang="en-US">Other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xml:lang="en-US">Other accounts receivable and prepaid expenses, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseCurrent_0" xml:lang="en-US">Prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent_0" xml:lang="en-US">Long-term prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrivatePlacementMember_0" xml:lang="en-US">The Private Placement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_0" xml:lang="en-US">Proceeds from preferred shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants_0" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants_1" xml:lang="en-US">Exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromOtherEquity_0" xml:lang="en-US">Proceeds from Other Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromOtherEquity_1" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_0" xml:lang="en-US">Sale of asset held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromSaleOfTreasuryStock_0" xml:lang="en-US">Proceeds from Sale of Treasury Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromSaleOfTreasuryStock_1" xml:lang="en-US">Treasury stock at cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_0" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_0" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfessionalFees_0" xml:lang="en-US">Professional services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss_0" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ProfitLoss_1" xml:lang="en-US">Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProfitLoss_2" xml:lang="en-US">Net loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0" xml:lang="en-US">Property and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_0" xml:lang="en-US">Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_0" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_1" xml:lang="en-US">Property Plant And Equipment Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0" xml:lang="en-US">Property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_0" xml:lang="en-US">Annual rates of depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0" xml:lang="en-US">Schedule of Property And Equpment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1" xml:lang="en-US">Schedule of property and equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyCosts_0" xml:lang="en-US">Related Party Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_RelatedPartyCosts_1" xml:lang="en-US">Total related party expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyDomain_0" xml:lang="en-US">Related Party [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems_0" xml:lang="en-US">Related Party Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract_0" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0" xml:lang="en-US">Related Party [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0" xml:lang="en-US">Related Parties Balances and Transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract_0" xml:lang="en-US">Research and Development [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_1" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0" xml:lang="en-US">Research and development expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_1" xml:lang="en-US">Research and Development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_0" xml:lang="en-US">Research and Development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashCurrent_0" xml:lang="en-US">Restricted Cash, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RestrictedCashCurrent_1" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashNoncurrent_0" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedInvestments_0" xml:lang="en-US">Bank restricted deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_0" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember_0" xml:lang="en-US">Retained Earnings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember_1" xml:lang="en-US">Accumulated deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0" xml:lang="en-US">Right-of-use asset recognized with corresponding lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1" xml:lang="en-US">Right-of-use asset recognized with corresponding lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RoyaltyExpense_0" xml:lang="en-US">Royality expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalariesAndWages_0" xml:lang="en-US">Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SalariesAndWages_1" xml:lang="en-US">Salaries and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain_0" xml:lang="en-US">Sale of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0" xml:lang="en-US">Schedule of Weighted Average Number of Shares Excluded From Computation of Diluted Net Loss Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1" xml:lang="en-US">Schedule of weighted average number of shares excluded from computation of diluted net loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_0" xml:lang="en-US">Schedule of components of cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_0" xml:lang="en-US">Summary of the effect of share-based compensation on the statements of operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_1" xml:lang="en-US">Schedule of the effect of share-based compensation on the statements of operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0" xml:lang="en-US">Schedule of Significant Components of the Company's Deferred Tax Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" xml:lang="en-US">Schedule of significant components of the company's deferred tax asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1" xml:lang="en-US">Schedule of computation of basic and diluted net loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0" xml:lang="en-US">Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" xml:lang="en-US">Schedule of reconciliation of theoretical income tax expense to actual income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_0" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0" xml:lang="en-US">Schedule of net assets acquired based on their estimated fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_0" xml:lang="en-US">Schedule of Transaction With Related Parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1" xml:lang="en-US">Schedule of transaction with related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0" xml:lang="en-US">Summary of assumptions used to calculate the fair value of the options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xml:lang="en-US">Schedule of assumptions used to calculate the fair value of the options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_0" xml:lang="en-US">Summary of number and weighted average exercise prices of option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_1" xml:lang="en-US">Schedule of number and weighted average exercise prices of option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeriesCPreferredStockMember_0" xml:lang="en-US">Series C Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeveranceCosts1_0" xml:lang="en-US">Severance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation_0" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_0" xml:lang="en-US">Exercise price (in U.S. dollar)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0" xml:lang="en-US">Dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0" xml:lang="en-US">Expected life of options (in years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0" xml:lang="en-US">Expected volatility, maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0" xml:lang="en-US">Expected volatility, minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_0" xml:lang="en-US">Risk-free interest rate, maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_0" xml:lang="en-US">Risk-free interest rate, minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0" xml:lang="en-US">Weighted Average Remaining Contractual Life in Years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_0" xml:lang="en-US">Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0" xml:lang="en-US">Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0" xml:lang="en-US">Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0" xml:lang="en-US">Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Exercise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_0" xml:lang="en-US">Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharePrice_0" xml:lang="en-US">Weighted average share price (in U.S. dollar)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0" xml:lang="en-US">Summary of Significant Accounting Policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SoftwareDevelopmentMember_0" xml:lang="en-US">Website Development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SoftwareDevelopmentMember_1" xml:lang="en-US">Website development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis_0" xml:lang="en-US">Class of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_0" xml:lang="en-US">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems_0" xml:lang="en-US">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable_0" xml:lang="en-US">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0" xml:lang="en-US">Shareholders' equity:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1" xml:lang="en-US">Shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract_0" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0" xml:lang="en-US">Reverse stock split conversion ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0" xml:lang="en-US">Exercise of Options, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_0" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_1" xml:lang="en-US">Treasury share at cost (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0" xml:lang="en-US">Issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0" xml:lang="en-US">Exercise of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_0" xml:lang="en-US">Stock Issued During Period, Value, Treasury Stock Reissued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_1" xml:lang="en-US">Treasury share at cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventLineItems_0" xml:lang="en-US">Subsequent Event [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember_0" xml:lang="en-US">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventMember_1" xml:lang="en-US">Subsequent event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract_0" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_1" xml:lang="en-US">Events After Balance Sheet Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTable_0" xml:lang="en-US">Subsequent Event [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_0" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_0" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_0" xml:lang="en-US">Sale of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_0" xml:lang="en-US">Schedule of Roll Forward of Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_1" xml:lang="en-US">Schedule of roll forward of valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract_0" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract_1" xml:lang="en-US">Supplementary cash flows information:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount_0" xml:lang="en-US">Capital losses carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockMember_0" xml:lang="en-US">Treasury Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TreasuryStockMember_1" xml:lang="en-US">Treasury share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockShares_0" xml:lang="en-US">Treasury Stock, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates_0" xml:lang="en-US">Use of estimates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xml:lang="en-US">Net change in the total valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2" xml:lang="en-US">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2" xml:lang="en-US">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AdditionalWorkOrderAmount_1" xlink:to="lab_cmmb_AdditionalWorkOrderAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AdditionalWorkOrderAmount_2" xlink:to="lab_cmmb_AdditionalWorkOrderAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AdditionalWorkOrderAmount_3" xlink:to="lab_cmmb_AdditionalWorkOrderAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AggregateAmountCommitmentToPay_4" xlink:to="lab_cmmb_AggregateAmountCommitmentToPay_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AggregateAmountCommitmentToPay_5" xlink:to="lab_cmmb_AggregateAmountCommitmentToPay_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AggregateAmountOfCommitmentPaid_6" xlink:to="lab_cmmb_AggregateAmountOfCommitmentPaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AggregateAmountOfCommitmentPaid_7" xlink:to="lab_cmmb_AggregateAmountOfCommitmentPaid_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_8" xlink:to="lab_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_9" xlink:to="lab_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_10" xlink:to="lab_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositarySharesMember_11" xlink:to="lab_cmmb_AmericanDepositarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositarySharesMember_12" xlink:to="lab_cmmb_AmericanDepositarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AnnualRatesOfDepreciation_13" xlink:to="lab_cmmb_AnnualRatesOfDepreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AnnualRatesOfDepreciation_14" xlink:to="lab_cmmb_AnnualRatesOfDepreciation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AnnualRatesOfDepreciation_15" xlink:to="lab_cmmb_AnnualRatesOfDepreciation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AnnualRentAndManagementFees_16" xlink:to="lab_cmmb_AnnualRentAndManagementFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AnnualRentAndManagementFees_17" xlink:to="lab_cmmb_AnnualRentAndManagementFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtmAgreementMember_18" xlink:to="lab_cmmb_AtmAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtmAgreementMember_19" xlink:to="lab_cmmb_AtmAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BankGuaranteesToPropertyOwner_20" xlink:to="lab_cmmb_BankGuaranteesToPropertyOwner_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BankGuaranteesToPropertyOwner_21" xlink:to="lab_cmmb_BankGuaranteesToPropertyOwner_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_22" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_23" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_24" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_25" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_26" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_27" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CantorMember_28" xlink:to="lab_cmmb_CantorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CantorMember_29" xlink:to="lab_cmmb_CantorMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CapitalAdditionsOneMember_30" xlink:to="lab_cmmb_CapitalAdditionsOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CapitalAdditionsOneMember_31" xlink:to="lab_cmmb_CapitalAdditionsOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CapitalAdditionsOneMember_32" xlink:to="lab_cmmb_CapitalAdditionsOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInMerger_33" xlink:to="lab_cmmb_CashAcquiredInMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInMerger_34" xlink:to="lab_cmmb_CashAcquiredInMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_35" xlink:to="lab_cmmb_CashPaidAndReceivedDuringYearForAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_36" xlink:to="lab_cmmb_CashPaidAndReceivedDuringYearForAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_37" xlink:to="lab_cmmb_CashPaidAndReceivedDuringYearForAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_38" xlink:to="lab_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_39" xlink:to="lab_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_40" xlink:to="lab_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ConsultantsAndSubcontractorsExpense_41" xlink:to="lab_cmmb_ConsultantsAndSubcontractorsExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ConsultantsAndSubcontractorsExpense_42" xlink:to="lab_cmmb_ConsultantsAndSubcontractorsExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ConsultantsAndSubcontractorsExpense_43" xlink:to="lab_cmmb_ConsultantsAndSubcontractorsExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_44" xlink:to="lab_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_45" xlink:to="lab_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_46" xlink:to="lab_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CurrencyTransactionLossValuationAllowance_47" xlink:to="lab_cmmb_CurrencyTransactionLossValuationAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CurrencyTransactionLossValuationAllowance_48" xlink:to="lab_cmmb_CurrencyTransactionLossValuationAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CurrencyTransactionLossValuationAllowance_49" xlink:to="lab_cmmb_CurrencyTransactionLossValuationAllowance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_50" xlink:to="lab_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_51" xlink:to="lab_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_52" xlink:to="lab_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EarningsPerShareCalculationNumeratorAbstract_53" xlink:to="lab_cmmb_EarningsPerShareCalculationNumeratorAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EarningsPerShareCalculationNumeratorAbstract_54" xlink:to="lab_cmmb_EarningsPerShareCalculationNumeratorAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EarningsPerShareCalculationNumeratorAbstract_55" xlink:to="lab_cmmb_EarningsPerShareCalculationNumeratorAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransaction_56" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransaction_57" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_58" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_59" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_60" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_61" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_62" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_63" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_64" xlink:to="lab_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_65" xlink:to="lab_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_66" xlink:to="lab_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_67" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_68" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_69" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FormerChemomabSecurityHoldersMember_70" xlink:to="lab_cmmb_FormerChemomabSecurityHoldersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FormerChemomabSecurityHoldersMember_71" xlink:to="lab_cmmb_FormerChemomabSecurityHoldersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_GeneralAndAdministrativeDisclosureTextBlock_72" xlink:to="lab_cmmb_GeneralAndAdministrativeDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_GeneralAndAdministrativeDisclosureTextBlock_73" xlink:to="lab_cmmb_GeneralAndAdministrativeDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_GeneralAndAdministrativeDisclosureTextBlock_74" xlink:to="lab_cmmb_GeneralAndAdministrativeDisclosureTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_75" xlink:to="lab_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_76" xlink:to="lab_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_77" xlink:to="lab_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_78" xlink:to="lab_cmmb_IncomeTaxDisclosureLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_79" xlink:to="lab_cmmb_IncomeTaxDisclosureLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxDisclosureTable_80" xlink:to="lab_cmmb_IncomeTaxDisclosureTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxDisclosureTable_81" xlink:to="lab_cmmb_IncomeTaxDisclosureTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxesReceived_82" xlink:to="lab_cmmb_IncomeTaxesReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxesReceived_83" xlink:to="lab_cmmb_IncomeTaxesReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxesReceived_84" xlink:to="lab_cmmb_IncomeTaxesReceived_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxExpenseValuationAllowance_85" xlink:to="lab_cmmb_IncomeTaxExpenseValuationAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxExpenseValuationAllowance_86" xlink:to="lab_cmmb_IncomeTaxExpenseValuationAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncomeTaxExpenseValuationAllowance_87" xlink:to="lab_cmmb_IncomeTaxExpenseValuationAllowance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncrementalBorrowingRateOfLeases_88" xlink:to="lab_cmmb_IncrementalBorrowingRateOfLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncrementalBorrowingRateOfLeases_89" xlink:to="lab_cmmb_IncrementalBorrowingRateOfLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IncrementalBorrowingRateOfLeases_90" xlink:to="lab_cmmb_IncrementalBorrowingRateOfLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_InterestReceived_91" xlink:to="lab_cmmb_InterestReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_InterestReceived_92" xlink:to="lab_cmmb_InterestReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_InterestReceived_93" xlink:to="lab_cmmb_InterestReceived_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_InvestorsMember_94" xlink:to="lab_cmmb_InvestorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_InvestorsMember_95" xlink:to="lab_cmmb_InvestorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LaboratoryEquipmentMember_96" xlink:to="lab_cmmb_LaboratoryEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LaboratoryEquipmentMember_97" xlink:to="lab_cmmb_LaboratoryEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LaboratoryEquipmentMember_98" xlink:to="lab_cmmb_LaboratoryEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LienOnBankDeposit_99" xlink:to="lab_cmmb_LienOnBankDeposit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LienOnBankDeposit_100" xlink:to="lab_cmmb_LienOnBankDeposit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LongTermLeaseDeposit_101" xlink:to="lab_cmmb_LongTermLeaseDeposit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LongTermLeaseDeposit_102" xlink:to="lab_cmmb_LongTermLeaseDeposit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LongTermLeaseDeposit_103" xlink:to="lab_cmmb_LongTermLeaseDeposit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_104" xlink:to="lab_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_105" xlink:to="lab_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_106" xlink:to="lab_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_107" xlink:to="lab_cmmb_MaximumPercentageOfPaymentsOfRoyalties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_108" xlink:to="lab_cmmb_MaximumPercentageOfPaymentsOfRoyalties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_109" xlink:to="lab_cmmb_MaximumPercentageOfPaymentsOfRoyalties_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_110" xlink:to="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_111" xlink:to="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_112" xlink:to="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_113" xlink:to="lab_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_114" xlink:to="lab_cmmb_NatureOfOperationsDisclosureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_115" xlink:to="lab_cmmb_NatureOfOperationsDisclosureAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_116" xlink:to="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_117" xlink:to="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdssOptionsIssuableOutstanding_118" xlink:to="lab_cmmb_NumberOfAdssOptionsIssuableOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdssOptionsIssuableOutstanding_119" xlink:to="lab_cmmb_NumberOfAdssOptionsIssuableOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdssVestedAndExercisable_120" xlink:to="lab_cmmb_NumberOfAdssVestedAndExercisable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdssVestedAndExercisable_121" xlink:to="lab_cmmb_NumberOfAdssVestedAndExercisable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOptionsIssuableOutstanding_122" xlink:to="lab_cmmb_NumberOfOptionsIssuableOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOptionsIssuableOutstanding_123" xlink:to="lab_cmmb_NumberOfOptionsIssuableOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOptionsIssuableOutstanding_124" xlink:to="lab_cmmb_NumberOfOptionsIssuableOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOptionsVestedAndExercisable_125" xlink:to="lab_cmmb_NumberOfOptionsVestedAndExercisable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOptionsVestedAndExercisable_126" xlink:to="lab_cmmb_NumberOfOptionsVestedAndExercisable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOptionsVestedAndExercisable_127" xlink:to="lab_cmmb_NumberOfOptionsVestedAndExercisable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_128" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDs_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_129" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDs_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_130" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDs_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfStockAdssResveredForIssuance_131" xlink:to="lab_cmmb_NumberOfStockAdssResveredForIssuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfStockAdssResveredForIssuance_132" xlink:to="lab_cmmb_NumberOfStockAdssResveredForIssuance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfStockAdssResveredForIssuance_133" xlink:to="lab_cmmb_NumberOfStockAdssResveredForIssuance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfStockReservedForIssuance_134" xlink:to="lab_cmmb_NumberOfStockReservedForIssuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfStockReservedForIssuance_135" xlink:to="lab_cmmb_NumberOfStockReservedForIssuance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfStockReservedForIssuance_136" xlink:to="lab_cmmb_NumberOfStockReservedForIssuance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfVestedAndExercisable_137" xlink:to="lab_cmmb_NumberOfVestedAndExercisable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfVestedAndExercisable_138" xlink:to="lab_cmmb_NumberOfVestedAndExercisable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfVestedAndExercisable_139" xlink:to="lab_cmmb_NumberOfVestedAndExercisable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_140" xlink:to="lab_cmmb_NumberOfWarrantsPurchaseUpAdss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_141" xlink:to="lab_cmmb_NumberOfWarrantsPurchaseUpAdss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_142" xlink:to="lab_cmmb_NumberOfWarrantsPurchaseUpAdss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_143" xlink:to="lab_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_144" xlink:to="lab_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_145" xlink:to="lab_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesNoParValuePerShareMember_146" xlink:to="lab_cmmb_OrdinarySharesNoParValuePerShareMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesNoParValuePerShareMember_147" xlink:to="lab_cmmb_OrdinarySharesNoParValuePerShareMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_148" xlink:to="lab_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_149" xlink:to="lab_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_150" xlink:to="lab_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_151" xlink:to="lab_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_152" xlink:to="lab_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_153" xlink:to="lab_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsForInvestmentInDeposits_154" xlink:to="lab_cmmb_PaymentsForInvestmentInDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsForInvestmentInDeposits_155" xlink:to="lab_cmmb_PaymentsForInvestmentInDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsForInvestmentInDeposits_156" xlink:to="lab_cmmb_PaymentsForInvestmentInDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PercentageOfMonthlyDepositsRate_157" xlink:to="lab_cmmb_PercentageOfMonthlyDepositsRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PercentageOfMonthlyDepositsRate_158" xlink:to="lab_cmmb_PercentageOfMonthlyDepositsRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_159" xlink:to="lab_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_160" xlink:to="lab_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_161" xlink:to="lab_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromSaleOfAdss_162" xlink:to="lab_cmmb_ProceedsFromSaleOfAdss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromSaleOfAdss_163" xlink:to="lab_cmmb_ProceedsFromSaleOfAdss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ReceivablesFromGovernmentInstitutions_164" xlink:to="lab_cmmb_ReceivablesFromGovernmentInstitutions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ReceivablesFromGovernmentInstitutions_165" xlink:to="lab_cmmb_ReceivablesFromGovernmentInstitutions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ReceivablesFromGovernmentInstitutions_166" xlink:to="lab_cmmb_ReceivablesFromGovernmentInstitutions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_167" xlink:to="lab_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_168" xlink:to="lab_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_169" xlink:to="lab_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RecoverabilityOfVatAmount_170" xlink:to="lab_cmmb_RecoverabilityOfVatAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RecoverabilityOfVatAmount_171" xlink:to="lab_cmmb_RecoverabilityOfVatAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RecoverabilityOfVatAmount_172" xlink:to="lab_cmmb_RecoverabilityOfVatAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyMember_173" xlink:to="lab_cmmb_RelatedPartyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyMember_174" xlink:to="lab_cmmb_RelatedPartyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_175" xlink:to="lab_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_176" xlink:to="lab_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_177" xlink:to="lab_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_178" xlink:to="lab_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_179" xlink:to="lab_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_180" xlink:to="lab_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_181" xlink:to="lab_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_182" xlink:to="lab_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_183" xlink:to="lab_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_184" xlink:to="lab_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_185" xlink:to="lab_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_186" xlink:to="lab_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_187" xlink:to="lab_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_188" xlink:to="lab_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_189" xlink:to="lab_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_190" xlink:to="lab_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_191" xlink:to="lab_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_192" xlink:to="lab_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseArrangementMember_193" xlink:to="lab_cmmb_RepurchaseArrangementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseArrangementMember_194" xlink:to="lab_cmmb_RepurchaseArrangementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseArrangementMember_195" xlink:to="lab_cmmb_RepurchaseArrangementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_196" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_197" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_198" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_199" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_200" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_201" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStockLineItems_202" xlink:to="lab_cmmb_SaleOfStockLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStockLineItems_203" xlink:to="lab_cmmb_SaleOfStockLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStocksPricePerShare_204" xlink:to="lab_cmmb_SaleOfStocksPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStocksPricePerShare_205" xlink:to="lab_cmmb_SaleOfStocksPricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStocksPricePerShare_206" xlink:to="lab_cmmb_SaleOfStocksPricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStockTable_207" xlink:to="lab_cmmb_SaleOfStockTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStockTable_208" xlink:to="lab_cmmb_SaleOfStockTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_209" xlink:to="lab_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_210" xlink:to="lab_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_211" xlink:to="lab_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_212" xlink:to="lab_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_213" xlink:to="lab_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_214" xlink:to="lab_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_215" xlink:to="lab_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_216" xlink:to="lab_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_217" xlink:to="lab_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_218" xlink:to="lab_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_219" xlink:to="lab_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_220" xlink:to="lab_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_221" xlink:to="lab_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_222" xlink:to="lab_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_223" xlink:to="lab_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_224" xlink:to="lab_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_225" xlink:to="lab_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_226" xlink:to="lab_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_227" xlink:to="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_228" xlink:to="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SeverancePayPolicyTextBlock_229" xlink:to="lab_cmmb_SeverancePayPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SeverancePayPolicyTextBlock_230" xlink:to="lab_cmmb_SeverancePayPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SeverancePayPolicyTextBlock_231" xlink:to="lab_cmmb_SeverancePayPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_232" xlink:to="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_233" xlink:to="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_234" xlink:to="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_235" xlink:to="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_236" xlink:to="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_237" xlink:to="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_238" xlink:to="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_239" xlink:to="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_240" xlink:to="lab_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_241" xlink:to="lab_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_242" xlink:to="lab_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_243" xlink:to="lab_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_244" xlink:to="lab_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_245" xlink:to="lab_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_246" xlink:to="lab_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_247" xlink:to="lab_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_248" xlink:to="lab_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_249" xlink:to="lab_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_250" xlink:to="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_251" xlink:to="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_252" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_253" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_254" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_255" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_256" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_257" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_258" xlink:to="lab_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_259" xlink:to="lab_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_260" xlink:to="lab_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_261" xlink:to="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_262" xlink:to="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_263" xlink:to="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_264" xlink:to="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_265" xlink:to="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_266" xlink:to="lab_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_267" xlink:to="lab_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_268" xlink:to="lab_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_269" xlink:to="lab_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_270" xlink:to="lab_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_271" xlink:to="lab_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_272" xlink:to="lab_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandsFifteenPlanMember_273" xlink:to="lab_cmmb_TwoThousandsFifteenPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandsFifteenPlanMember_274" xlink:to="lab_cmmb_TwoThousandsFifteenPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandsFifteenPlanMember_275" xlink:to="lab_cmmb_TwoThousandsFifteenPlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandsSeventeenPlanMember_276" xlink:to="lab_cmmb_TwoThousandsSeventeenPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandsSeventeenPlanMember_277" xlink:to="lab_cmmb_TwoThousandsSeventeenPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandsSeventeenPlanMember_278" xlink:to="lab_cmmb_TwoThousandsSeventeenPlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_279" xlink:to="lab_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_280" xlink:to="lab_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_281" xlink:to="lab_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_282" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_283" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_284" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_285" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_286" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_287" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_288" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_289" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_290" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_291" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_292" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_293" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet_294" xlink:to="lab_us-gaap_IncomeTaxesPaidNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet_295" xlink:to="lab_us-gaap_IncomeTaxesPaidNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet_296" xlink:to="lab_us-gaap_IncomeTaxesPaidNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_297" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_298" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_299" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_300" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_301" xlink:to="lab_us-gaap_NetIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_302" xlink:to="lab_us-gaap_NetIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_303" xlink:to="lab_us-gaap_NetIncomeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_304" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_305" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_306" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_307" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts_308" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts_309" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_310" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_311" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_312" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_313" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_314" xlink:to="lab_us-gaap_TreasuryStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_315" xlink:to="lab_us-gaap_TreasuryStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_316" xlink:to="lab_us-gaap_TreasuryStockValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_317" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_318" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_319" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_320" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_321" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_322" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_323" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_324" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_325" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_326" xlink:to="lab_us-gaap_SharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_327" xlink:to="lab_us-gaap_SharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_328" xlink:to="lab_us-gaap_SharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_329" xlink:to="lab_us-gaap_StockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_330" xlink:to="lab_us-gaap_StockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_331" xlink:to="lab_us-gaap_StockholdersEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_332" xlink:to="lab_us-gaap_StockholdersEquity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_333" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_334" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_335" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_336" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL_337" xlink:to="lab_country_IL_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_338" xlink:to="lab_country_US_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR_339" xlink:to="lab_currency_EUR_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_ILS_340" xlink:to="lab_currency_ILS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_ILS_341" xlink:to="lab_currency_ILS_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD_342" xlink:to="lab_currency_USD_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_XXX_343" xlink:to="lab_currency_XXX_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_344" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId_345" xlink:to="lab_dei_AuditorFirmId_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation_346" xlink:to="lab_dei_AuditorLocation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName_347" xlink:to="lab_dei_AuditorName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_348" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_349" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_350" xlink:to="lab_dei_DocumentAnnualReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_351" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_352" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems_353" xlink:to="lab_dei_DocumentInformationLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable_354" xlink:to="lab_dei_DocumentInformationTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_355" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_356" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_357" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_358" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_359" xlink:to="lab_dei_EntityAddressAddressLine2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_360" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_361" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_362" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_363" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_364" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_365" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_366" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_367" xlink:to="lab_dei_EntityExTransitionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_368" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_369" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_370" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationFormerLegalOrRegisteredName_371" xlink:to="lab_dei_EntityInformationFormerLegalOrRegisteredName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_372" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat_373" xlink:to="lab_dei_EntityPublicFloat_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_374" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_375" xlink:to="lab_dei_EntityShellCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_376" xlink:to="lab_dei_EntitySmallBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_377" xlink:to="lab_dei_EntityTaxIdentificationNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_378" xlink:to="lab_dei_EntityVoluntaryFilers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_379" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag_380" xlink:to="lab_dei_IcfrAuditorAttestationFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_381" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_382" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_383" xlink:to="lab_dei_PreCommencementTenderOffer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_384" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_385" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_386" xlink:to="lab_dei_SolicitingMaterial_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_387" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_388" xlink:to="lab_dei_WrittenCommunications_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis_389" xlink:to="lab_srt_CurrencyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_390" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_391" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_392" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember_393" xlink:to="lab_srt_ScenarioForecastMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain_394" xlink:to="lab_srt_ScenarioUnspecifiedDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_395" xlink:to="lab_srt_StatementGeographicalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis_396" xlink:to="lab_srt_StatementScenarioAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis_397" xlink:to="lab_srt_TitleOfIndividualAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_398" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_399" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_400" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_401" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_402" xlink:to="lab_us-gaap_AdditionalPaidInCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_403" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_404" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_405" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_406" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_407" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_408" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_409" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_410" xlink:to="lab_us-gaap_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_411" xlink:to="lab_us-gaap_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_412" xlink:to="lab_us-gaap_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_413" xlink:to="lab_us-gaap_AssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_414" xlink:to="lab_us-gaap_AssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_415" xlink:to="lab_us-gaap_AssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_416" xlink:to="lab_us-gaap_AssetsCurrentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_417" xlink:to="lab_us-gaap_AssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_418" xlink:to="lab_us-gaap_AssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_419" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_420" xlink:to="lab_us-gaap_AwardTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_421" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_422" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_423" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_424" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_425" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_426" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalAdditionsMember_427" xlink:to="lab_us-gaap_CapitalAdditionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_428" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_429" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_430" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_431" xlink:to="lab_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_432" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_433" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_434" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_435" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_436" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_437" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain_438" xlink:to="lab_us-gaap_ClassOfStockDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_439" xlink:to="lab_us-gaap_CommitmentsAndContingencies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_440" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock_441" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_442" xlink:to="lab_us-gaap_CommonStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_443" xlink:to="lab_us-gaap_CommonStockMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNoParValue_444" xlink:to="lab_us-gaap_CommonStockNoParValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_445" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_446" xlink:to="lab_us-gaap_CommonStockSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_447" xlink:to="lab_us-gaap_CommonStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_448" xlink:to="lab_us-gaap_CommonStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_449" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember_450" xlink:to="lab_us-gaap_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk_451" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_452" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_453" xlink:to="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_454" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_455" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_456" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_457" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_458" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_459" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther_460" xlink:to="lab_us-gaap_DeferredTaxAssetsOther_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_461" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent_462" xlink:to="lab_us-gaap_DepositsAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_463" xlink:to="lab_us-gaap_Depreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember_464" xlink:to="lab_us-gaap_DomesticCountryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent_465" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent_466" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_467" xlink:to="lab_us-gaap_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_468" xlink:to="lab_us-gaap_EarningsPerShareBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_469" xlink:to="lab_us-gaap_EarningsPerShareBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_470" xlink:to="lab_us-gaap_EarningsPerShareDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_471" xlink:to="lab_us-gaap_EarningsPerShareDiluted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock_472" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_473" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_474" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_475" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_476" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_477" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_478" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_479" xlink:to="lab_us-gaap_EmployeeStockOptionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_480" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_481" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember_482" xlink:to="lab_us-gaap_FurnitureAndFixturesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember_483" xlink:to="lab_us-gaap_FurnitureAndFixturesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_484" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_485" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_486" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_487" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember_488" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralInsuranceExpense_489" xlink:to="lab_us-gaap_GeneralInsuranceExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_490" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_491" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_492" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_493" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_494" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_495" xlink:to="lab_us-gaap_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_496" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_497" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_498" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_499" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_500" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock_501" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_502" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_503" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_504" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_505" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_506" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_507" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_508" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_509" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_510" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_511" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAgreementsMember_512" xlink:to="lab_us-gaap_LeaseAgreementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseExpirationDate1_513" xlink:to="lab_us-gaap_LeaseExpirationDate1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember_514" xlink:to="lab_us-gaap_LeaseholdImprovementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember_515" xlink:to="lab_us-gaap_LeaseholdImprovementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_516" xlink:to="lab_us-gaap_LesseeDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_517" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_518" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock_519" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock_520" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_521" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_522" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_523" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_524" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_525" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_526" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_527" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_528" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_529" xlink:to="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_530" xlink:to="lab_us-gaap_LesseeOperatingLeaseOptionToExtend_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock_531" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_532" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_533" xlink:to="lab_us-gaap_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_534" xlink:to="lab_us-gaap_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_535" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_536" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_537" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1_538" xlink:to="lab_us-gaap_LiabilitiesAssumed1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1_539" xlink:to="lab_us-gaap_LiabilitiesAssumed1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_540" xlink:to="lab_us-gaap_LiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_541" xlink:to="lab_us-gaap_LiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_542" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_543" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_544" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_545" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_546" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentAmount_547" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_548" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentDescription_549" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_550" xlink:to="lab_us-gaap_NatureOfOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_551" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_552" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_553" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_554" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_555" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_556" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_557" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_558" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_559" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_560" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_561" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoninterestExpenseDirectorsFees_562" xlink:to="lab_us-gaap_NoninterestExpenseDirectorsFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficersCompensation_563" xlink:to="lab_us-gaap_OfficersCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_564" xlink:to="lab_us-gaap_OperatingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_565" xlink:to="lab_us-gaap_OperatingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_566" xlink:to="lab_us-gaap_OperatingExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss_567" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss_568" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_569" xlink:to="lab_us-gaap_OperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_570" xlink:to="lab_us-gaap_OperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_571" xlink:to="lab_us-gaap_OperatingLeaseLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_572" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_573" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_574" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_575" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_576" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_577" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDescription_578" xlink:to="lab_us-gaap_OtherCommitmentsDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_579" xlink:to="lab_us-gaap_OtherCommitmentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable_580" xlink:to="lab_us-gaap_OtherCommitmentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralAndAdministrativeExpense_581" xlink:to="lab_us-gaap_OtherGeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralAndAdministrativeExpense_582" xlink:to="lab_us-gaap_OtherGeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherResearchAndDevelopmentExpense_583" xlink:to="lab_us-gaap_OtherResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_584" xlink:to="lab_us-gaap_PlanNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_585" xlink:to="lab_us-gaap_PlanNameDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare_586" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_587" xlink:to="lab_us-gaap_PreferredStockSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_588" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_589" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_590" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_591" xlink:to="lab_us-gaap_PrepaidExpenseCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseNoncurrent_592" xlink:to="lab_us-gaap_PrepaidExpenseNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember_593" xlink:to="lab_us-gaap_PrivatePlacementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_594" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants_595" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants_596" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity_597" xlink:to="lab_us-gaap_ProceedsFromOtherEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity_598" xlink:to="lab_us-gaap_ProceedsFromOtherEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_599" xlink:to="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfTreasuryStock_600" xlink:to="lab_us-gaap_ProceedsFromSaleOfTreasuryStock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfTreasuryStock_601" xlink:to="lab_us-gaap_ProceedsFromSaleOfTreasuryStock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_602" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_603" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees_604" xlink:to="lab_us-gaap_ProfessionalFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_605" xlink:to="lab_us-gaap_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_606" xlink:to="lab_us-gaap_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_607" xlink:to="lab_us-gaap_ProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_608" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_609" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_610" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_611" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_612" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_613" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_614" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_615" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_616" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_617" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_618" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_619" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyCosts_620" xlink:to="lab_us-gaap_RelatedPartyCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyCosts_621" xlink:to="lab_us-gaap_RelatedPartyCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain_622" xlink:to="lab_us-gaap_RelatedPartyDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_623" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_624" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_625" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_626" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_627" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_628" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_629" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember_630" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_631" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_632" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_633" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_634" xlink:to="lab_us-gaap_RestrictedCashCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_635" xlink:to="lab_us-gaap_RestrictedCashCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent_636" xlink:to="lab_us-gaap_RestrictedCashNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedInvestments_637" xlink:to="lab_us-gaap_RestrictedInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_638" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_639" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_640" xlink:to="lab_us-gaap_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_641" xlink:to="lab_us-gaap_RetainedEarningsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_642" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_643" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense_644" xlink:to="lab_us-gaap_RoyaltyExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalariesAndWages_645" xlink:to="lab_us-gaap_SalariesAndWages_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalariesAndWages_646" xlink:to="lab_us-gaap_SalariesAndWages_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_647" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_648" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_649" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_650" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_651" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_652" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_653" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_654" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_655" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_656" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_657" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_658" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_659" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_660" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_661" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_662" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_663" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_664" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_665" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_666" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_667" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_668" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_669" xlink:to="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_670" xlink:to="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesCPreferredStockMember_671" xlink:to="lab_us-gaap_SeriesCPreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_672" xlink:to="lab_us-gaap_SeveranceCosts1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_673" xlink:to="lab_us-gaap_ShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_674" xlink:to="lab_us-gaap_ShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_675" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_676" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_677" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_678" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_679" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_680" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_681" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_682" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_683" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_684" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_685" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_686" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_687" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_688" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_689" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_690" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_691" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_692" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_693" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_694" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_695" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice_696" xlink:to="lab_us-gaap_SharePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_697" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember_698" xlink:to="lab_us-gaap_SoftwareDevelopmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember_699" xlink:to="lab_us-gaap_SoftwareDevelopmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_700" xlink:to="lab_us-gaap_StatementClassOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_701" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_702" xlink:to="lab_us-gaap_StatementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_703" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_704" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_705" xlink:to="lab_us-gaap_StatementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_706" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_707" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_708" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_709" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_710" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_711" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_712" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_713" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_714" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_715" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_716" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_717" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_718" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_719" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems_720" xlink:to="lab_us-gaap_SubsequentEventLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_721" xlink:to="lab_us-gaap_SubsequentEventMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_722" xlink:to="lab_us-gaap_SubsequentEventMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract_723" xlink:to="lab_us-gaap_SubsequentEventsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock_724" xlink:to="lab_us-gaap_SubsequentEventsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock_725" xlink:to="lab_us-gaap_SubsequentEventsTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable_726" xlink:to="lab_us-gaap_SubsequentEventTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_727" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_728" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_729" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_730" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_731" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_732" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_733" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount_734" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_735" xlink:to="lab_us-gaap_TreasuryStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_736" xlink:to="lab_us-gaap_TreasuryStockMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_737" xlink:to="lab_us-gaap_TreasuryStockShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_738" xlink:to="lab_us-gaap_UseOfEstimates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_739" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_740" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_741" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_742" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_743" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_744" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_745" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_746" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cmmb-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#BalanceSheetsParenthetical" roleURI="http://www.anchiano.com/role/BalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#StatementsOfOperations" roleURI="http://www.anchiano.com/role/StatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#StatementsOfChangesInEquity" roleURI="http://www.anchiano.com/role/StatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#StatementsOfCashFlows" roleURI="http://www.anchiano.com/role/StatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#General" roleURI="http://www.anchiano.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#CashAndCashEquivalents" roleURI="http://www.anchiano.com/role/CashAndCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#OtherReceivablesAndPrepaidExpenses" roleURI="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpenses"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#PropertyAndEquipmentNet" roleURI="http://www.anchiano.com/role/PropertyAndEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#Leases" roleURI="http://www.anchiano.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#CommitmentsAndContingentLiabilities" roleURI="http://www.anchiano.com/role/CommitmentsAndContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ShareCapital" roleURI="http://www.anchiano.com/role/ShareCapital"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ResearchAndDevelopment" roleURI="http://www.anchiano.com/role/ResearchAndDevelopment"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#GeneralAndAdministrative" roleURI="http://www.anchiano.com/role/GeneralAndAdministrative"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#IncomeTaxes" roleURI="http://www.anchiano.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#RelatedPartiesBalancesAndTransactions" roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactions"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#NetLossPerShareAttributableToOrdinaryShareholders" roleURI="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#GeneralTables" roleURI="http://www.anchiano.com/role/GeneralTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#CashAndCashEquivalentsTables" roleURI="http://www.anchiano.com/role/CashAndCashEquivalentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#OtherReceivablesAndPrepaidExpensesTables" roleURI="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#PropertyAndEquipmentNetTables" roleURI="http://www.anchiano.com/role/PropertyAndEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#LeasesTables" roleURI="http://www.anchiano.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ShareCapitalTables" roleURI="http://www.anchiano.com/role/ShareCapitalTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ResearchAndDevelopmentTables" roleURI="http://www.anchiano.com/role/ResearchAndDevelopmentTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#GeneralAndAdministrativeTables" roleURI="http://www.anchiano.com/role/GeneralAndAdministrativeTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#IncomeTaxesTables" roleURI="http://www.anchiano.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#RelatedPartiesBalancesAndTransactionsTables" roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#NetLossPerShareAttributableToOrdinaryShareholdersTables" roleURI="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#GeneralDetails" roleURI="http://www.anchiano.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails" roleURI="http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails" roleURI="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#CashAndCashEquivalentsDetails" roleURI="http://www.anchiano.com/role/CashAndCashEquivalentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#OtherReceivablesAndPrepaidExpensesDetails" roleURI="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#PropertyAndEquipmentNetDetails" roleURI="http://www.anchiano.com/role/PropertyAndEquipmentNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#LeasesNarrativeDetails" roleURI="http://www.anchiano.com/role/LeasesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails" roleURI="http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#CommitmentsAndContingentLiabilitiesDetails" roleURI="http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ShareCapitalNarrativeDetails" roleURI="http://www.anchiano.com/role/ShareCapitalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ShareCapitalShare-basedCompensationExpensesDetails" roleURI="http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails" roleURI="http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails" roleURI="http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails" roleURI="http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails" roleURI="http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#IncomeTaxesDetails" roleURI="http://www.anchiano.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails" roleURI="http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails" roleURI="http://www.anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails" roleURI="http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails" roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails" roleURI="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails" roleURI="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails" roleURI="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#EventsAfterBalanceSheetDateNarrativeDetails" roleURI="http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20221231.xsd#EventsAfterBalanceSheetDate" roleURI="http://www.anchiano.com/role/EventsAfterBalanceSheetDate"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_47"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentInformationTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_AmericanDepositarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1" xlink:to="loc_dei_DocumentInformationLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityCentralIndexKey_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_AmendmentFlag_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_DocumentType_8" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_CurrentFiscalYearEndDate_9" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_DocumentFiscalYearFocus_10" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_DocumentPeriodEndDate_11" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_DocumentAnnualReport_12" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_DocumentTransitionReport_13" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityFileNumber_14" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityRegistrantName_15" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_16" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityTaxIdentificationNumber_17" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityAddressAddressLine1_18" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityAddressAddressLine2_19" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityAddressCityOrTown_20" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityAddressCountry_21" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityAddressPostalZipCode_22" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_CityAreaCode_23" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_LocalPhoneNumber_24" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName_25" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_Security12bTitle_26" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_TradingSymbol_27" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_SecurityExchangeName_28" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_29" order="240" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityVoluntaryFilers_30" order="250" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityCurrentReportingStatus_31" order="260" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityInteractiveDataCurrent_32" order="270" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityFilerCategory_33" order="280" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntitySmallBusiness_34" order="290" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityEmergingGrowthCompany_35" order="300" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityExTransitionPeriod_36" order="310" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_IcfrAuditorAttestationFlag_37" order="320" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityShellCompany_38" order="330" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityPublicFloat_39" order="340" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_40" order="350" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_AuditorName_41" order="360" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_AuditorLocation_42" order="370" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_AuditorFirmId_43" order="380" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_WrittenCommunications_44" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_SolicitingMaterial_45" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_PreCommencementTenderOffer_46" order="410" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_5" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_47" order="420" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_RestrictedCashCurrent_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AssetsCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_AssetsNoncurrent_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_16" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_17" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_LiabilitiesCurrent_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_CommitmentsAndContingencies_24" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_Liabilities_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" xlink:to="loc_us-gaap_CommonStockValue_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" xlink:to="loc_us-gaap_TreasuryStockValue_27" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" xlink:to="loc_us-gaap_AdditionalPaidInCapital_28" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" xlink:to="loc_us-gaap_StockholdersEquity_30" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_32" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockNoParValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_SharesOutstanding_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_TreasuryStockShares_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_OperatingExpenses_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasic_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_23"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_TreasuryStockMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_12" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_cmmb_EffectOfReverseCapitalizationTransaction_13" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_16" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_17" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_19" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_20" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_NetIncomeLoss_21" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_22" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_23" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="loc_cmmb_PaymentsForInvestmentInDeposits_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LongTermLeaseDeposit" xlink:label="loc_cmmb_LongTermLeaseDeposit_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_18"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CashAcquiredInMerger" xlink:label="loc_cmmb_CashAcquiredInMerger_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CashPaidAndReceivedDuringYearForAbstract" xlink:label="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxesReceived" xlink:label="loc_cmmb_IncomeTaxesReceived_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_InterestReceived" xlink:label="loc_cmmb_InterestReceived_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="loc_us-gaap_LiabilitiesAssumed1_33"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ShareBasedCompensation_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_12" xlink:to="loc_cmmb_PaymentsForInvestmentInDeposits_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_12" xlink:to="loc_cmmb_LongTermLeaseDeposit_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_12" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_12" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_12" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_18" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_18" xlink:to="loc_cmmb_CashAcquiredInMerger_18" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_18" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_19" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_18" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_18" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_18" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27" xlink:to="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_27" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_27" xlink:to="loc_cmmb_IncomeTaxesReceived_27" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_27" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_28" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_CashPaidAndReceivedDuringYearForAbstract_27" xlink:to="loc_cmmb_InterestReceived_29" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_32" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_32" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_32" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_32" xlink:to="loc_us-gaap_LiabilitiesAssumed1_33" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General">
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_NatureOfOperations_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/SummaryOfSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/CashAndCashEquivalents">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpenses">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock" xlink:label="loc_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0" xlink:to="loc_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/PropertyAndEquipmentNet">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/Leases">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/CommitmentsAndContingentLiabilities">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ShareCapital">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ResearchAndDevelopment">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/GeneralAndAdministrative">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_GeneralAndAdministrativeDisclosureTextBlock" xlink:label="loc_cmmb_GeneralAndAdministrativeDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_cmmb_GeneralAndAdministrativeDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactions">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock" xlink:label="loc_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SeverancePayPolicyTextBlock" xlink:label="loc_cmmb_SeverancePayPolicyTextBlock_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_cmmb_SeverancePayPolicyTextBlock_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_17" order="160" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/GeneralTables">
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock" xlink:label="loc_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/CashAndCashEquivalentsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock" xlink:label="loc_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0" xlink:to="loc_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/PropertyAndEquipmentNetTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ResearchAndDevelopmentTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock" xlink:label="loc_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/GeneralAndAdministrativeTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock" xlink:label="loc_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/IncomeTaxesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock" xlink:label="loc_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOrdinarySharesConsistedInDs" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_4" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_FormerChemomabSecurityHoldersMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8" xlink:to="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8" xlink:to="loc_cmmb_NumberOfOrdinarySharesConsistedInDs_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8" xlink:to="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_11" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PercentageOfMonthlyDepositsRate" xlink:label="loc_cmmb_PercentageOfMonthlyDepositsRate_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncrementalBorrowingRateOfLeases" xlink:label="loc_cmmb_IncrementalBorrowingRateOfLeases_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_cmmb_PercentageOfMonthlyDepositsRate_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SeveranceCosts1_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_cmmb_IncrementalBorrowingRateOfLeases_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="loc_cmmb_LaboratoryEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AnnualRatesOfDepreciation" xlink:label="loc_cmmb_AnnualRatesOfDepreciation_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_cmmb_LaboratoryEquipmentMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7" xlink:to="loc_cmmb_AnnualRatesOfDepreciation_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/CashAndCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD" xlink:label="loc_currency_USD_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XXX" xlink:label="loc_currency_XXX_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_USD_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_ILS_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_XXX_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivablesFromGovernmentInstitutions" xlink:label="loc_cmmb_ReceivablesFromGovernmentInstitutions_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0" xlink:to="loc_cmmb_ReceivablesFromGovernmentInstitutions_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/PropertyAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LaboratoryEquipmentMember" xlink:label="loc_cmmb_LaboratoryEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_cmmb_LaboratoryEquipmentMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/LeasesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AnnualRentAndManagementFees" xlink:label="loc_cmmb_AnnualRentAndManagementFees_7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_BankGuaranteesToPropertyOwner" xlink:label="loc_cmmb_BankGuaranteesToPropertyOwner_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities" xlink:label="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_ILS_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_us-gaap_LeaseExpirationDate1_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_us-gaap_LesseeOperatingLeaseOptionToExtend_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_cmmb_AnnualRentAndManagementFees_7" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_cmmb_BankGuaranteesToPropertyOwner_8" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_us-gaap_OperatingLeaseLiability_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities_11" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_13" order="90" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeDisclosureAbstract" xlink:label="loc_us-gaap_LesseeDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeDisclosureAbstract_0" xlink:to="loc_us-gaap_OperatingLeaseLiability_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalAdditionsMember" xlink:label="loc_us-gaap_CapitalAdditionsMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CapitalAdditionsOneMember" xlink:label="loc_cmmb_CapitalAdditionsOneMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAgreementsMember" xlink:label="loc_us-gaap_LeaseAgreementsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR" xlink:label="loc_currency_EUR_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentDescription" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentDescription_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDescription" xlink:label="loc_us-gaap_OtherCommitmentsDescription_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct" xlink:label="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_MaximumPercentageOfPaymentsOfRoyalties" xlink:label="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_18"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized" xlink:label="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_21"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement" xlink:label="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_23"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateAmountCommitmentToPay" xlink:label="loc_cmmb_AggregateAmountCommitmentToPay_24"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateAmountOfCommitmentPaid" xlink:label="loc_cmmb_AggregateAmountOfCommitmentPaid_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AdditionalWorkOrderAmount" xlink:label="loc_cmmb_AdditionalWorkOrderAmount_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LienOnBankDeposit" xlink:label="loc_cmmb_LienOnBankDeposit_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestments" xlink:label="loc_us-gaap_RestrictedInvestments_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RecoverabilityOfVatAmount" xlink:label="loc_cmmb_RecoverabilityOfVatAmount_29"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_OtherCommitmentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:to="loc_us-gaap_CapitalAdditionsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:to="loc_cmmb_CapitalAdditionsOneMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:to="loc_us-gaap_LeaseAgreementsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_srt_CurrencyAxis_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_6" xlink:to="loc_currency_AllCurrenciesDomain_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6" xlink:to="loc_currency_EUR_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_6" xlink:to="loc_currency_ILS_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_10" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_srt_StatementScenarioAxis_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_12" xlink:to="loc_srt_ScenarioUnspecifiedDomain_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_12" xlink:to="loc_srt_ScenarioForecastMember_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_15" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentDescription_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_us-gaap_OtherCommitmentsDescription_16" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_cmmb_MaximumPercentageOfPaymentsOfRoyalties_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized_19" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_20" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_21" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement_22" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_us-gaap_RoyaltyExpense_23" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_cmmb_AggregateAmountCommitmentToPay_24" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_cmmb_AggregateAmountOfCommitmentPaid_25" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_cmmb_AdditionalWorkOrderAmount_26" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_cmmb_LienOnBankDeposit_27" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_us-gaap_RestrictedInvestments_28" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_15" xlink:to="loc_cmmb_RecoverabilityOfVatAmount_29" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockTable" xlink:label="loc_cmmb_SaleOfStockTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CantorMember" xlink:label="loc_cmmb_CantorMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_InvestorsMember" xlink:label="loc_cmmb_InvestorsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AtmAgreementMember" xlink:label="loc_cmmb_AtmAgreementMember_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandsFifteenPlanMember_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TwoThousandsSeventeenPlanMember" xlink:label="loc_cmmb_TwoThousandsSeventeenPlanMember_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockLineItems" xlink:label="loc_cmmb_SaleOfStockLineItems_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement" xlink:label="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_21"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ProceedsFromSaleOfAdss" xlink:label="loc_cmmb_ProceedsFromSaleOfAdss_22"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues" xlink:label="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_23"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfWarrantsPurchaseUpAdss" xlink:label="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_24"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStocksPricePerShare" xlink:label="loc_cmmb_SaleOfStocksPricePerShare_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockReservedForIssuance" xlink:label="loc_cmmb_NumberOfStockReservedForIssuance_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfStockAdssResveredForIssuance" xlink:label="loc_cmmb_NumberOfStockAdssResveredForIssuance_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdssOptionsIssuableOutstanding" xlink:label="loc_cmmb_NumberOfAdssOptionsIssuableOutstanding_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsIssuableOutstanding" xlink:label="loc_cmmb_NumberOfOptionsIssuableOutstanding_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfVestedAndExercisable" xlink:label="loc_cmmb_NumberOfVestedAndExercisable_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfAdssVestedAndExercisable" xlink:label="loc_cmmb_NumberOfAdssVestedAndExercisable_31"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_NumberOfOptionsVestedAndExercisable" xlink:label="loc_cmmb_NumberOfOptionsVestedAndExercisable_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_33"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_36"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_37"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_38"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RepurchaseOfAmericanDepositaryReceiptsShares" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_39"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_40"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_41"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_cmmb_SaleOfStockTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_cmmb_CantorMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" xlink:to="loc_cmmb_InvestorsMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" xlink:to="loc_us-gaap_PrivatePlacementMember_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" xlink:to="loc_cmmb_AtmAgreementMember_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" xlink:to="loc_cmmb_RepurchaseArrangementMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_10" xlink:to="loc_us-gaap_ClassOfStockDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_10" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockTable_1" xlink:to="loc_us-gaap_PlanNameAxis_13" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_13" xlink:to="loc_us-gaap_PlanNameDomain_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_13" xlink:to="loc_cmmb_TwoThousandsFifteenPlanMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_13" xlink:to="loc_cmmb_TwoThousandsSeventeenPlanMember_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockTable_1" xlink:to="loc_cmmb_SaleOfStockLineItems_17" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_us-gaap_PreferredStockSharesIssued_18" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_19" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_20" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_ProceedsFromSaleOfAdss_22" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues_23" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_NumberOfWarrantsPurchaseUpAdss_24" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_SaleOfStocksPricePerShare_25" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_NumberOfStockReservedForIssuance_26" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_NumberOfStockAdssResveredForIssuance_27" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_NumberOfAdssOptionsIssuableOutstanding_28" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_NumberOfOptionsIssuableOutstanding_29" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_NumberOfVestedAndExercisable_30" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_NumberOfAdssVestedAndExercisable_31" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_NumberOfOptionsVestedAndExercisable_32" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_33" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_34" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_35" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_36" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod_37" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_38" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares_39" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts_40" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_SaleOfStockLineItems_17" xlink:to="loc_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts_41" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice" xlink:label="loc_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger" xlink:label="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1" xlink:label="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:to="loc_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15" xlink:to="loc_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_SharePrice_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_10" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_11" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_12" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_13" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_14" order="70" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ConsultantsAndSubcontractorsExpense" xlink:label="loc_cmmb_ConsultantsAndSubcontractorsExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaap_OfficersCompensation_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceResearchAndDevelopmentExpense" xlink:label="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationResearchAndDevelopmentExpense" xlink:label="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_OtherResearchAndDevelopmentExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_cmmb_ConsultantsAndSubcontractorsExpense_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_us-gaap_OfficersCompensation_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_us-gaap_OtherResearchAndDevelopmentExpense_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaap_SalariesAndWages_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaap_ProfessionalFees_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseDirectorsFees" xlink:label="loc_us-gaap_NoninterestExpenseDirectorsFees_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralInsuranceExpense" xlink:label="loc_us-gaap_GeneralInsuranceExpense_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense" xlink:label="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_SalariesAndWages_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_ProfessionalFees_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_NoninterestExpenseDirectorsFees_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_GeneralInsuranceExpense_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxDisclosureTable" xlink:label="loc_cmmb_IncomeTaxDisclosureTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="loc_country_IL_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_country_US_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxDisclosureLineItems" xlink:label="loc_cmmb_IncomeTaxDisclosureLineItems_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ReceivedAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc" xlink:label="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_cmmb_IncomeTaxDisclosureTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureTable_1" xlink:to="loc_srt_StatementScenarioAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1" xlink:to="loc_srt_ScenarioForecastMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureTable_1" xlink:to="loc_srt_StatementGeographicalAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4" xlink:to="loc_srt_SegmentGeographicalDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4" xlink:to="loc_country_IL_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4" xlink:to="loc_country_US_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_8" xlink:to="loc_us-gaap_DomesticCountryMember_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureTable_1" xlink:to="loc_cmmb_IncomeTaxDisclosureLineItems_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_11" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_11" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_11" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_11" xlink:to="loc_cmmb_ReceivedAmountOfChemomabTherapeuticsInc_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_11" xlink:to="loc_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_IncomeTaxDisclosureLineItems_11" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_CurrencyTransactionLossValuationAllowance" xlink:label="loc_cmmb_CurrencyTransactionLossValuationAllowance_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance" xlink:label="loc_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_IncomeTaxExpenseValuationAllowance" xlink:label="loc_cmmb_IncomeTaxExpenseValuationAllowance_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_cmmb_CurrencyTransactionLossValuationAllowance_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_cmmb_IncomeTaxExpenseValuationAllowance_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized" xlink:label="loc_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded" xlink:label="loc_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyMember" xlink:label="loc_cmmb_RelatedPartyMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_cmmb_RelatedPartyMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty" xlink:label="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyCosts" xlink:label="loc_us-gaap_RelatedPartyCosts_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyCosts_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EarningsPerShareCalculationNumeratorAbstract" xlink:label="loc_cmmb_EarningsPerShareCalculationNumeratorAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract" xlink:label="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_cmmb_EarningsPerShareCalculationNumeratorAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_EarningsPerShareCalculationNumeratorAbstract_1" xlink:to="loc_us-gaap_NetIncomeLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract_3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20221231.xsd#cmmb_SaleOfStockValueOfSharesIssuedInTransaction" xlink:label="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1" xlink:to="loc_us-gaap_SubsequentEventMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_SubsequentEventLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_4" xlink:to="loc_cmmb_SaleOfStockValueOfSharesIssuedInTransaction_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/EventsAfterBalanceSheetDate">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>cmmb_img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cmmb_img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  W '(# 2(  A$! Q$!_\0
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M.>F0:D\9?ZC2?^PG;?\ H8H\ _\ (JVG^_-_Z->KM#DY[$7ES<MP_P"$F/\
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M"9;/$PYT[(TKXN-*7+:Y]H^,O]1I/_83MO\ T,4G@,A?"EJ20 'FR3_UU>N
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MC((.T<$=C17J-%>4\2V[V.U4D(54]5!^HI:**YS4;L7^ZOY4I12<E1GZ444
M+01GK110 @4#H /H*-HSG SZXHHH 7KUI H'0 ?A110 M026=K(^Z2VA=O5H
9P3111<"6.-(QB-%0>BC%.HHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171032803952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Chemomab Therapeutics Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-3676773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kiryat Atidim<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6158002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">77-331-0156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember', window );">American Depositary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CMMB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember', window );">Ordinary Shares, No Par Value Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033044720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 13,519<span></span>
</td>
<td class="nump">$ 15,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short-term bank deposit</a></td>
<td class="nump">26,374<span></span>
</td>
<td class="nump">45,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other receivables and prepaid expenses</a></td>
<td class="nump">1,766<span></span>
</td>
<td class="nump">1,527<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">41,736<span></span>
</td>
<td class="nump">62,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Long-term prepaid expenses</a></td>
<td class="nump">733<span></span>
</td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">1,665<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">43,063<span></span>
</td>
<td class="nump">64,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="nump">1,688<span></span>
</td>
<td class="nump">1,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">3,378<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee and related expenses</a></td>
<td class="nump">1,560<span></span>
</td>
<td class="nump">653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">6,749<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current&#160;operating lease liabilities</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">6,840<span></span>
</td>
<td class="nump">2,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary Shares no par value - Authorized: 650,000,000 shares as of December 31, 2022 and 2021; Issued and outstanding: 232,636,700 Ordinary shares at December 31, 2022 and 228,090,300 Ordinary shares at December 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury share at cost (11,640,460 shares as of December 31, 2022)</a></td>
<td class="num">(1,218)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">101,260<span></span>
</td>
<td class="nump">97,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(63,819)<span></span>
</td>
<td class="num">(36,173)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">36,223<span></span>
</td>
<td class="nump">61,466<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 43,063<span></span>
</td>
<td class="nump">$ 64,353<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033938288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common Stock, No Par Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="nump">228,090,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="nump">228,090,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">11,640,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033959888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 16,977<span></span>
</td>
<td class="nump">$ 6,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">11,556<span></span>
</td>
<td class="nump">6,033<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">28,533<span></span>
</td>
<td class="nump">12,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Financing (income) expenses, net</a></td>
<td class="num">(353)<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes</a></td>
<td class="nump">28,180<span></span>
</td>
<td class="nump">12,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Taxes on income (benefit)</a></td>
<td class="num">(534)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="nump">$ 27,646<span></span>
</td>
<td class="nump">$ 12,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per Ordinary Share</a></td>
<td class="nump">$ 0.121<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per Ordinary Share</a></td>
<td class="nump">$ 0.121<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Ordinary Shares outstanding, basic</a></td>
<td class="nump">227,589,288<span></span>
</td>
<td class="nump">207,468,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of Ordinary Shares outstanding, diluted</a></td>
<td class="nump">227,589,288<span></span>
</td>
<td class="nump">207,468,650<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171034262064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Ordinary shares [Member]</div></th>
<th class="th"><div>Treasury share [Member]</div></th>
<th class="th"><div>Additional paid in capital [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 34,497<span></span>
</td>
<td class="num">$ (23,695)<span></span>
</td>
<td class="nump">$ 10,802<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">9,274,838<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_EffectOfReverseCapitalizationTransaction', window );">Effect of reverse capitalization transaction</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,476<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_EffectOfReverseCapitalizationTransactionShares', window );">Effect of reverse capitalization transaction (In shares)</a></td>
<td class="nump">152,299,702<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues', window );">Issuance of shares and warrants, net of issuance costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">58,637<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">58,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues', window );">Stock And Warrants Issued During Period New Issues</a></td>
<td class="nump">66,381,520<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of Options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of Options, shares</a></td>
<td class="nump">134,240<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,478)<span></span>
</td>
<td class="num">(12,478)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">97,639<span></span>
</td>
<td class="num">(36,173)<span></span>
</td>
<td class="nump">$ 61,466<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,090,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">3,211<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 3,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues', window );">Issuance of shares and warrants, net of issuance costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues', window );">Stock And Warrants Issued During Period New Issues</a></td>
<td class="nump">2,576,400<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of Options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of Options, shares</a></td>
<td class="nump">1,970,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Treasury share at cost</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Treasury share at cost (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(27,646)<span></span>
</td>
<td class="num">(27,646)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">$ 101,260<span></span>
</td>
<td class="num">$ (63,819)<span></span>
</td>
<td class="nump">$ 36,223<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,636,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EffectOfReverseCapitalizationTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of effect due reverse capitalization transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EffectOfReverseCapitalizationTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EffectOfReverseCapitalizationTransactionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares isued due to effect of reverse capitalization transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EffectOfReverseCapitalizationTransactionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>it represents number of shares and warrants issued during period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171032914112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss for the year</a></td>
<td class="num">$ (27,646)<span></span>
</td>
<td class="num">$ (12,478)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">3,211<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Change in other receivables and prepaid expenses</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(2,058)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Change in trade payables</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">1,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Change in accrued expenses</a></td>
<td class="nump">2,823<span></span>
</td>
<td class="num">(1,279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Change in employees and related expenses</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Change in operating leases</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(20,370)<span></span>
</td>
<td class="num">(12,374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_PaymentsForInvestmentInDeposits', window );">Investment in deposits</a></td>
<td class="nump">19,601<span></span>
</td>
<td class="num">(45,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_LongTermLeaseDeposit', window );">Long-term lease deposit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Sale of asset held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(239)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">19,533<span></span>
</td>
<td class="num">(45,186)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_CashAcquiredInMerger', window );">Cash acquired in Merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Treasury share at cost</a></td>
<td class="num">(1,218)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Issuance of shares and warrants, net of issuance costs</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">58,637<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(808)<span></span>
</td>
<td class="nump">61,074<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash, cash equivalents and restricted cash</a></td>
<td class="num">(1,645)<span></span>
</td>
<td class="nump">3,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of the year</a></td>
<td class="nump">15,241<span></span>
</td>
<td class="nump">11,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of the year</a></td>
<td class="nump">13,596<span></span>
</td>
<td class="nump">15,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_CashPaidAndReceivedDuringYearForAbstract', window );"><strong>A. Cash paid and received during the year for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_IncomeTaxesReceived', window );">Income taxes received</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_InterestReceived', window );">Interest received</a></td>
<td class="nump">972<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>B. Significant non- cash transaction:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use asset recognized with corresponding lease liability</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities assumed, net of non-cash assets received in Merger</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_CashAcquiredInMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash acquired in merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_CashAcquiredInMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_CashPaidAndReceivedDuringYearForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>n/a</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_CashPaidAndReceivedDuringYearForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_IncomeTaxesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents income taxes received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_IncomeTaxesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_InterestReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_InterestReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_LongTermLeaseDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term lease deposit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_LongTermLeaseDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_PaymentsForInvestmentInDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payments for investm,ents in deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_PaymentsForInvestmentInDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of other assets recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037327952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>Nature Of Operations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">General</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 1 - General</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt">1.<span style="padding-left:28.5pt">Chemomab Therapeutics Ltd. (hereinafter - "the Company") is an Israeli-based company incorporated under the laws of the State of Israel in September 2011. The Company&#8217;s registered office is located in Kiryat Atidim, Tel Aviv, Israel.&#160;</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt;text-align:justify"><br/>The Company is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0px;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><br/>The wholly owned subsidiaries of the Company are: Chemomab Ltd. ("Chemomab"), Chemomab Therapeutics Israel Ltd. and Chemomab Therapeutics Inc.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt">2.<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="padding-left:28.5pt">The Company currently has no products approved for sale. The Company&#8217;s operations are funded primarily by its Shareholders. The Company has incurred operating losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval for its products. Continuation of the Company&#8217;s development programs depend on its future ability to raise sources of financing.</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.<span style="padding-left:28.5pt">Since </span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 2020, the COVID-19 pandemic has dramatically expanded into a worldwide pandemic, creating macro-economic uncertainty and disruption in the business and financial markets. Many countries around the world, including Israel, had taken&#160; measures designated to limit the continued spread of the COVID-19 pandemic, including the closure of workplaces, restricting travel, prohibiting assembling, closing international borders and quarantining populated areas. The Company's clinical trial sites have been affected by the COVID-19 pandemic, and as a result, commencement of the enrollment in our clinical trials of CM-101 in PSC was delayed, and the enrollment rate has been, and is still, affected as well. As a result, The Company expanded its patient recruiting efforts to additional territories. In addition, after enrollment in these trials, patients might still drop out because of possible COVID-19 implications. Based on management&#8217;s assessment, the extent to which the lingering effects of the COVID-19 pandemic will further impact the Company's operations will depend on future developments. These developments, which are highly uncertain and cannot be predicted with confidence,including the duration and severity of the impact on patient enrollment following the attenuation of the outbreak The Company is carefully monitoring the impacts arising from&#160; the COVID-19 pandemic and will adjust activities accordingly<span><span><span>.</span></span></span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.<span style="padding-left:28.5pt">On </span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 14, 2020, the Company (formerly known as Anchiano Therapeutics Ltd.) entered into an Agreement and Plan of Merger (the "Merger" and &#8220;Merger Agreement&#8221;) with Chemomab Ltd., an Israeli limited company, and CMB Acquisition Ltd., an Israeli limited company and a wholly owned subsidiary of the Company (&#8220;Merger Sub&#8221;). On March 16, 2021, (the &#8220;Effective Time&#8221;), the Company consummated the Merger pursuant to the Merger Agreement Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Chemomab Ltd., with Chemomab Ltd. surviving the Merger as the Company's wholly owned subsidiary. In connection with the Merger, on March 16, 2021, the Company changed its name from &#8220;Anchiano Therapeutics Ltd.&#8221; To &#8220;Chemomab Therapeutics Ltd" and the business conducted by Chemomab Ltd. became primarily the business conducted by the Company.</span></span></p>
    <div>
      <div style="width:100%;clear:both">
        <p style="margin:0pt">&#160;</p>
      </div>
    </div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0px;padding-left:72pt;margin-bottom:10pt">At the Effective Time(a) each Chemomab Ltd. ordinary share outstanding immediately prior to the Effective Time was converted solely into number of American Depository Shares equal to the exchange ratio described in the Merger Agreement, and each outstanding Chemomab Ltd. option was assumed by the Company, based on the same exchange ratio.</p>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For&#160;<span>accounting purposes, Chemomab Ltd. is considered to have acquired the Company based upon the terms of the Merger as well as other factors. The Merger has been accounted for as an asset acquisition (reverse recapitalization transaction) rather than a business combination, as the assets acquired, and the liabilities assumed by Chemomab Ltd. do not meet the definition of a business under U.S. GAAP. The net assets acquired in connection with the Merger were recorded at their estimated acquisition date fair market value as of March 16, 2021, the date of completion of the Merger.</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">The exchange ratio was calculated by a formula that was determined through arms-length negotiations between the Company and Chemomab Ltd. The combined Company assumed all of the outstanding options of Chemomab Ltd., vested and not vested, under the Chemomab&#160;Share Incentive Plan (the &#8220;2015 Plan&#8221;), with such options representing the right to purchase a number of ADSs equal to approximately 12.86 multiplied by the number of Chemomab Ltd. ordinary shares previously represented by such options.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:11pt">The following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion of the Merger (in USD thousands):</p>
    <div style="margin-left:72pt">

        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Cash and cash equivalents</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">2,427</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Asset held for sale</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,000</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Prepaid and other assets</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">236</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Accrued liabilities</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(1,187</p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt">)</p>
              </td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Net acquired assets</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">2,476</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171038178944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 2 - Summary of Significant Accounting Policies</span></p>

      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Basis of Preparation</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S GAAP&#8221;).</p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">B.</span><span style="font-weight:bold;padding-left:26.83pt">Use of estimates</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">C.</span><span style="font-weight:bold;padding-left:26.28pt">Foreign currency</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;dollar&#8221; or &#8220;$&#8221;), thus; the dollar is the functional currency of the Company.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate.</p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">D.</span><span style="font-weight:bold;padding-left:26.28pt">Cash and cash equivalents</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired.</p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">E.</span><span style="font-weight:bold;padding-left:26.83pt">Restricted cash</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt">Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments.</p>


      <div>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">F.</span><span style="font-weight:bold;padding-left:28.31pt">Property and equipment</span></p>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.</p>
        <div>
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt">Annual rates at depreciation are as follows:</p>
          <div style="margin-left:36pt">

              <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">%</span></p>
                    </td>
                    <td style="vertical-align:bottom">&#160;</td>
                  </tr>


                  <tr style="background-color:#CCEEFF">
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Computers</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">33</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Laboratory equipment</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">10</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:#CCEEFF">
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Furniture and equipment</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">7</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>

              </table>

          </div>
        </div>
      </div>

    <div/>

      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">G.</span><span style="font-weight:bold;padding-left:25.72pt">Impairment of long-lived assets</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company&#8217;s property and equipment are reviewed for impairment in accordance with ASC 360, &#8220;Property and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2022 and 2021, no impairment losses have been recorded.</p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">H.</span><span style="font-weight:bold;padding-left:25.72pt">Research and Development</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages.</p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">I.</span><span style="font-weight:bold;padding-left:26.83pt">Income taxes</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized.</p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">J.</span><span style="font-weight:bold;padding-left:28.5pt">Fair value of financial instruments</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price.</p>
      <div/>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#8217;s own credit risk.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#8217;s non<span style="font-weight:bold">- </span>financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented.</p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">K.</span><span style="font-weight:bold;padding-left:25.72pt">Share-based compensation</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The fair value for the Company&#8217;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt">The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">L.</span><span style="font-weight:bold;padding-left:26.83pt">Government-sponsored research and development</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Chemomab records grants received from the office of the Israel Innovation Authority (the &#8220;IIA&#8221;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses.</p>

    <div/>

      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">M.</span><span style="font-weight:bold;padding-left:24.06pt">Severance pay</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to Section 14 of the Severance Compensation Law, 1963 ("Section 14"), all employees of the Company are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately $142 thousand and $116 thousand for the year ended December 31, 2022 and 2021, respectively.</span></span></p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">N.</span><span style="font-weight:bold;padding-left:26.28pt">Concentrations of credit risk:</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash <span>and cash equivalents and short- term deposits are invested in banks. Management believes that the financial institutions that hold the Company&#8217;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments</span>.</span></span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</p>


      <div>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">O.</span><span style="font-weight:bold;padding-left:25.72pt">Leases</span></p>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Under </span></span>Topic 842, the Company determines if an arrangement is a lease at inception. Right-of-use (ROU) assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be 5% and 5.2% in 2022 and 2021, respectively. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company's lease agreements generally do not contain any residual value guarantees or restrictive covenants<span><span>.</span></span></span></span><br/>&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></span><br/>&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#8211; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G).</span></span></p>
      </div>

    <div/>

      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">P.</span><span style="font-weight:bold;padding-left:28.31pt">Principles of consolidation</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The <span>consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.</span></span></span></p>


      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">Q.</span><span style="font-weight:bold;padding-left:25.72pt">Earnings per ordinary share</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt">Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. &#160;Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options.</p>

  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037266640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Cash Equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 3 - Cash and Cash Equivalents</span></p>

      <div style="margin-left:36pt;margin-bottom:11pt">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">In USD</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">10,663</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">10,720</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">In NIS</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,756</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,116</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">In other currencies</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">100</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">3,350</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">13,519</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">15,186</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </div>

  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171038329712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables and Prepaid Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock', window );">Other Receivables and Prepaid Expenses</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 4 - Other Receivables and Prepaid Expenses</span></p>

      <div style="margin-left:36pt;margin-bottom:11pt">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Government institutions</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">459</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">179</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Prepaid expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">1,307</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,348</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">1,766</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,527</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </div>

  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other accounts receivable and prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035324640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 5 - Property and Equipment, Net</span></p>

      <div style="margin-left:36pt;margin-bottom:11pt">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Cost:</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Computers</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">70</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">43</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Furniture and equipment</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">33</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">27</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Laboratory equipment</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">399</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">364</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Website development</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">14</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">14</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Leasehold improvements</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">16</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">16</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><strong><strong><strong>532</strong><strong> </strong></strong><strong> </strong></strong><strong> </strong></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">464 </p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Less - accumulated depreciation</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold">165</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-weight:bold">)</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(107</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt">)</p>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><strong><strong><strong>367</strong><strong> </strong></strong><strong> </strong></strong><strong> </strong></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">357 </p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>

        </table>
      </div>

  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037286432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 6 - Leases</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">On May 10, 2020, Chemomab entered into an office and lab space lease agreement (hereinafter &#8211; &#8220;The Agreement&#8221; .(According to the Agreement, Chemomab &#160;rented a space in Atidim Park, Tel-Aviv for a period of three years, through <span style="-sec-ix-hidden:Fxbrl_20230131233234992">May 2023</span>. Chemomab was granted an option to extend the lease term by additional three years.&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">On October 24, 2021, Chemomab signed an amendment to the Agreement ("The Amendment"). According to the Amendment, On December 12, 2021 Chemomab returned the previous office and lab space to the property owner and rented a larger space in Atidim Park Tel-Aviv, for a term of 3 years, through <span style="-sec-ix-hidden:Fxbrl_20230131233722905">October 2024</span>. In addition, Chemomab was granted an option to extend the lease term by additional three years. The annual rent and management fees are approximately $122 thousand. Pursuant to the Amendment, the bank guarantee issued in 2020 was canceled and a substitute bank guarantee of approximately $77 thousand was issued to the property owner during 2022.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The above operating leases are included in &#8220;Operating lease right-of-use assets&#8221; on the Company&#8217;s Consolidated Balance sheets as of December 31, 2022 and 2021 and represent the Company&#8217;s right to use the underlying asset for the lease term. The Company&#8217;s obligations to pay lease payments are included in the current liabilities as &#8220;Operating lease liabilities&#8221; and in the non-current liabilities as &#8220;Non-current operating lease liabilities&#8221; on the Company&#8217;s Consolidated Balance sheets as of December 31, 2022 and 2021. Based on the present value of the lease payments for the remaining lease term of the Company&#8217;s existing lease agreement, the Company recognized operating right-of-use assets and operating lease liabilities of approximately $345 thousand on December 12, 2021.&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">During the years ended December 31, 2022 and 2021, the Company recognized an increase in right of use assets of $17 thousand and $345 thousand, respectively.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As&#160;of December 31, 2022, and 2021 operating right-of-use asset was $227 thousand and $345 thousand, respectively. The operating lease liabilities were $214 thousand and $343 thousand, respectively.</span></span></p>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">As most of the Chemomab&#8217;s leases do not provide an implicit rate, Chemomab uses its incremental borrowing rate based on the information available at the commencement date of each lease in determining the present value of lease payments. Chemomab&#8217;s incremental borrowing rate is a hypothetical rate based on its estimation of what its credit rating would be the rate was 5% in 2022 and 5.2% in 2021.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt">Maturities of lease liabilities under noncancellable leases as of December 31, 2022, are as follows: (in thousands):</p>
    <div style="margin-left:40pt;margin-bottom:11pt">

        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">2023</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">126 </span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">2024</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">93 </span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Total future minimum lease payments</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">219 </span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Less imputed interest:</p>
              </td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold">5</span></p>
              </td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px"><span style="font-weight:bold">)</span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Present value of operating lease liabilities</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">214 </span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>

        </table>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035356992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-weight:bold">Note 7 - Commitments and Contingent Liabilities</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Exclusive License Agreement (hereinafter- &#8220;the License Agreement&#8221;)</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">In December 2011, Chemomab entered into a License Agreement with the Medical Research, Infrastructure, Health Services Fund of the Tel-Aviv Souraski Medical Center (&#8220;Fund&#8221;), pursuant to which it was granted with an exclusive license to certain inventions (as defined in the License Agreement) including patents, knowhow and products and the right to sublicense to third parties the rights granted, pursuant to and subject to certain terms and limitation fully set in the License Agreement.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">Chemomab has agreed to pay the Fund a non-refundable and non-creditable sublicense fees as a percentage of all Attributed Income (as such term defined in the License Agreement), and shall further pay the Fund royalties from sales made by sublicensee;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt">(i)<span style="padding-left:26.56pt">Royalties in percentage of the Net sales or Service Income (as defined in the License Agreement), subject to </span>certain additional terms set forth therein.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:108pt;margin-bottom:0pt"><span>In addition, with respect to each Licensed Product (as defined therein), Chemomab has agreed to &#160;pay the Fund the following non-refundable, non-creditable amounts:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:144pt;margin-bottom:11pt">(a)<span style="padding-left:24.9pt">$100 thousand upon submission of a New Drug Application (&#8220;NDA&#8221;), Biological License Application (&#8220;BLA&#8221;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#8220;FDA&#8221;), $100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than $300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0pt;text-indent:-36pt;padding-left:144pt;margin-bottom:0pt">(b)<span style="padding-left:24.34pt">$200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than $600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:108pt;margin-bottom:0pt">As of December 31, 2022&#160;no payments were made to the Fund.</p>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">In addition to the payments described above, upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab, if any), but in any event not more than $3,000 thousand.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="padding-left:26.83pt">&#160; &#160;Chemomab partially financed its research and development expenditures under programs sponsored by the Israel </span>Innovation Authority (&#8220;IIA&#8221;) for the support of certain research and development activities conducted in Israel.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">In return for the IIA&#8217;s participation, Chemomab is committed to pay royalties at rate of 3% of sales of the developed product (linked to U.S. dollar), up to 100% of the amount of grants received (100% plus interest at LIBOR). In addition, the IIA may impose certain conditions to transfer technology or development out of Israel.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt">Chemomab did not receive any grants from the IIA in the years ended December 31, 2022, and 2021.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">Since Chemomab &#8217;s incorporation through December 31, 2022 Chemomab received $1,227 thousand from the IIA, which were recognized as a reduction of research and development expenses.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt">As of December 31, 2022, Chemomab has no commitment for royalties payable.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="font-weight:bold">B.</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="padding-left:26.28pt">In </span></span></span>June 2015, Chemomab entered into a license agreement with subcontractor (&#8220;the Subcontractor&#8221;), under which the Subcontractor granted to Chemomab certain licenses to use proprietary rights of the subcontractor, materials and know how in the techniques and use of the same, for purposes of research and development of Chemomab 's product CM-101, as well as commercialization thereof. Further to the agreement, the Subcontractor also provides manufacturing services of intermediates and active pharmaceutical ingredients. According to the related manufacturing agreement, the manufacturing of the product is carried out by the Subcontractor in accordance with Chemomab's specifications and timeline.&#160; From time to time, Chemomab and the Subcontractor have been signing additional agreements for additional manufacturing and final process lock of the product for clinical use Under the agreement, Chemomab is also obligated to pay the Subcontractor royalties determined as a percentage of net sales of each licensee product.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:0pt;padding-left:72pt;margin-bottom:0pt">During 2022 and 2021, Chemomab recorded expenses related to the above agreements in the amounts of $5,222 thousand and $2,590 thousand, respectively. The expenses were recorded under research and development expenses.</p>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:11pt"><span style="font-weight:bold">C.</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="padding-left:26.28pt">As&#160;</span></span>of December 31, 2022, the bank imposed restriction on a bank deposit in the amount of $77 thousand for the purpose of secure lease payments under an office lease agreement.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">D.</span><span><span style="padding-left:26.28pt">During&#160;</span></span><span>2022, the Israeli tax authority ("ITA&#8221;) notified the Company that it had initiated a routine VAT audit to include tax years 2017 through 202</span><span>2</span><span>. The ITA raised several claims, mainly in respect with the recoverability of VAT with respect to Merger Agreement related expenses and the classification of the Company as a holding company. On July 2022, the ITA proposed a settlement, which the Company rejected. As a result, the ITA issued assessments in the aggregate amount of $1,046 thousand. The Company filed an appeal against the ITA&#8217;s assessments. The Company has recorded an appropriate provision which considers inherent uncertainty of these matters and the judicial process. Therefore, the outcome may differ from the estimated liability recorded by the Company during the period</span><span>.</span></span></span></p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035315680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Share Capital</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 8 - Share Capital</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Right attached to shares</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-weight:bold;font-style:italic">Ordinary shares</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:72pt;margin-bottom:0pt">All of the issued and outstanding ordinary shares of the Company are duly authorized, validly issued, fully paid and non-assessable. The ordinary shares are not redeemable, and each ordinary share is entitled to one vote. The holders of the ordinary shares have the right to vote and participate in shareholders' meetings, the right to receive profits, and the right to participate in the accumulated earnings when the Company is dissolved.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt"><span style="font-weight:bold">1.</span><span style="font-weight:bold;padding-left:28.5pt">Voting</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-bottom:0pt;margin-left:108pt">The holders of ordinary shares are entitled to vote on all matters submitted to shareholders for a vote.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt"><span style="font-weight:bold">2.</span><span style="font-weight:bold;padding-left:28.5pt">Dividends</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-bottom:0pt;margin-left:108pt">The holders of the ordinary shares are entitled to receive dividends, when and as declared by the Board of Directors, and out of funds legally available.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-bottom:0pt;margin-left:108pt">Since its inception, the Company has not declared any dividends.</p>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"><span style="font-weight:bold">B.</span><span style="padding-left:26.83pt;font-weight:bold">Financing rounds</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span><span style="padding-left:28.5pt">In&#160;</span></span></span>connection with the Merger, on March 15, 2021, the Company entered into Securities Purchase Agreements with certain purchasers, pursuant to which the Company agreed to sell approximately $45.5 million of its American Depositary Shares (ADSs)&#160;in a private placement transaction, (or "The Private Placement"). The Private Placement closed on March 22, 2021, at which time the Company sold to the purchasers 2,619,270 ADSs together with warrants to purchase up to 261,929 ADSs at an exercise price of $17.35 per ADS. The warrants will expire five years from the date of issuance, and if exercised in full, will provide to the Company proceeds of approximately $4.5 million. 20 Ordinary Shares are equal to 1 American Depositary Share (ADS).</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>2.</span><span style="padding-left:28.5pt">On&#160;</span></span></span>April 30, 2021, the Company entered into an At the Market Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &amp; Co., ("Cantor"). According to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75 million through Cantor or the ATM Agreement. From April 30, 2021, through December 31, 2022, the Company issued 699,806 ADSs at an average price of $22.75 per ADS under the ATM Agreement, resulting in gross proceeds of $15,917 thousand.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>3.</span><span style="padding-left:28.5pt">On </span></span></span></span></span></span>April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $18,125,000&#160;of its ADSs in connection with the reactivation of the ATM Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject to certain exceptions, limits the amount of securities the Company is able to offer and sell under such registration statement to one-third of our unaffiliated public float. During the year ended &#160;December 31, 2022, the Company issued&#160;130,505 ADSs at an average price of $2.11 per ADS under the ATM Agreement, resulting in gross proceeds of $275 thousand.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>4.</span><span style="padding-left:28.5pt">On&#160;</span></span></span></span>September 19, 2022, the Company entered&#160; into a share purchase agreement (the &#8220;Repurchase Arrangement&#8221;) with Dr. Adi Mor, co-founder of Chemomab Ltd., Chief Scientific Officer and a director of the Company and Professor Kobi George, co-founder of Chemomab Ltd. (together with Dr. Adi Mor, the &#8220;Co-Founders&#8221;), whereby the Company agreed, subject to the requisite court approval required under Section 303(a) of the Israeli Companies Law, 5759-1999 (the &#8220;Companies Law&#8221;), which the Company received on November 14, 2022, to repurchase up to 582,023 of the Company's ADSs owned by the Co-Founders, for consideration not to exceed an aggregate amount of $2,500,000, depending on the market price of the ADSs at the time of any repurchase. Accordingly, on November 16, 2022, the company repurchased the entire amount of 582,023 ADSs from the Co-Founders at a weighted average price of $2.0848 and for total consideration of approximately $1,218 thousand.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-bottom:0pt;margin-left:108pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:110%">The Company accounted for the repurchased shares as treasury share&#160;in accordance with ASC 505-30, "Treasury Stock".</span></span></span></p>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">C.</span><span style="font-weight:bold;padding-left:26.28pt">Share-based compensation</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt">(1)<span style="padding-left:24.34pt">Share-based compensation plan:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:108pt;margin-bottom:0pt">The Company maintains (i) the 2011 Share Option Plan (the &#8220;2011 Plan&#8221;), (ii) the 2017 Equity-Based Incentive Plan (the &#8220;2017 Plan&#8221;) and (iii) the Chemomab 2015 Share Incentive Plan (the &#8220;2015 Plan&#8221;), which was assumed by the Company from Chemomab upon the effectiveness of the Merger. At that time, outstanding options under the 2015 Plan became exercisable for such number of ADSs of the Company as was determined based on the exchange ratio in the Merger Agreement, with a reciprocal adjustment to exercise price.<br/>&#160;</p>
    <p style="margin-top:0pt;margin-left:108pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>As of December 31, 2022, a total of 28,443,060 of our Ordinary Shares (equal to 1,422,153 of ADSs) were reserved for issuance under the 2015 Plan, of which 3,445,520 Ordinary Shares (equal to 172,276 ADSs) had been issued pursuant to previous exercises options, and 23,460,740 &#160;Ordinary Shares (equal to 1,173,037 ADSs) were issuable under outstanding options. Of such outstanding options, options to purchase 12,400,720 Ordinary Shares (equal to 620,036 ADSs) had vested and were exercisable as of that date, with a weighted average exercise price of $0.30 per Ordinary Share (or $5.96 per ADS). During the year ended December 31, 2022, options to purchase 1,240,120 Ordinary Shares (equal to 62,006 ADS) were canceled.</span></span></span></p>
    <p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
    <p style="margin-top:0pt;margin-left:108pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>As of December 31, 2022, a total of 12,511,620 of our Ordinary Shares (equal to 625,581 of our ADSs) were reserved for issuance under the 2017 Plan, of which 11,730,800 Ordinary Shares (equal to 586,540 ADSs) were issuable under outstanding options. Of such outstanding options, options to purchase 427,540 Ordinary Shares (equal to 21,377 ADSs) had vested and were exercisable as of that date, with a weighted average exercise price of $0.35 per Ordinary Share (or $6.98 per ADS). During the year ended December 31, 2022 no options were canceled.</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:11pt">(2)<span style="padding-left:24.34pt">The expenses that were recognized in the consolidated statements of operations for services received from employees </span>and service providers are as follows:</p>
    <div style="margin-left:108pt">

        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Research and development</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">448</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">137</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">General and administrative</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,763</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,882</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Total share-based compensation expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">3,211</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">2,019</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>

    </div>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:11pt">(3)<span style="padding-left:24.34pt">The number and weighted average exercise price of options are as follows:</span></p>
    <div style="margin-left:108pt">

        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted </span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">exercise </span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">price</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Number of </span><span style="font-weight:bold">options</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average </span><span style="font-weight:bold">remaining </span><span style="font-weight:bold">contractual </span><span style="font-weight:bold">life (in years)</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average </span><span style="font-weight:bold">exercise price</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Number of </span><span style="font-weight:bold">options</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average </span><span style="font-weight:bold">remaining </span><span style="font-weight:bold">contractual </span><span style="font-weight:bold">life (in years)</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Outstanding at January 1</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.38</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">27,003,260</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">8.12</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">0.07</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">10,455,580</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">7.8</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Acquired in Merger</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%;text-align:right">-</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">-</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">609,535</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Exercised</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.07</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold">1,970,000</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">)</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">-</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.08</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(134,220</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Forfeited</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.32</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold">1,240,120</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">)</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>-</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1.25</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(1,712,275</p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">)</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Granted</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.16</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">11,398,400</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">7.8</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">0.62</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">17,784,640</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">9.79</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Outstanding at December 31</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.33</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">35,191,540</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">7.42</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:10%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">0.38</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">27,003,260</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">8.12</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>

    </div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt">(4)<span style="padding-left:24.34pt">Fair value measurement:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:108pt;margin-bottom:11pt">The fair value of the options is measured at the grant date using the Black-Scholes Option pricing model and the assumptions used to calculate the fair value of the options are as follows:</p>
    <div style="margin-left:108pt">

        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">2022&#160;grants</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Weighted average share price (in U.S. dollar)<sup>(a)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">0.16</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Exercise price (in U.S. dollar)</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">0.10</span><span style="font-weight:bold">-</span><span style="font-weight:bold">0.257</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Expected life of options (in years)<sup>(b)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">5.51</span><span style="font-weight:bold">-</span><span style="font-weight:bold">6.28</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Expected volatility<sup>(c)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">83.69</span><span style="font-weight:bold">%-</span><span style="font-weight:bold">84.31</span><span style="font-weight:bold">%</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Risk-free interest rate<sup>(d)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">1.75</span><span style="font-weight:bold">%-</span><span style="font-weight:bold">4.14</span><span style="font-weight:bold">%</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Dividend yield</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">0</span><span style="font-weight:bold">%</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>

    </div>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt">(a)<span style="padding-left:24.34pt">The weighted average share price is based on the Company&#8217;s Ordinary Share valuation as at the grant date.</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt">(b)<span style="padding-left:24.34pt">Expected life for the periods presented was determined according to the simplified method since, at the date of </span>grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#8217; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt">(c)<span style="padding-left:24.34pt">Expected volatility is based on historical volatility over the most recent period commensurate with the expected </span>term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#8217;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#8217;s expected term.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:11pt">(d)<span style="padding-left:24.34pt">The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the </span>yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards.</p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033989520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research and Development</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 9 - Research and Development</span></p>

      <div style="margin-left:36pt;margin-bottom:11pt">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Consultants and subcontractors</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">13,052</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">3,894</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Salaries and related expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,867 </span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,789</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Rent and maintenance</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">245</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">114</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Share-based compensation</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">448</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">137</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Other expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">365</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">400</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">16,977</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">6,334</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </div>

  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI https://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035288496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General and Administrative Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_GeneralAndAdministrativeDisclosureTextBlock', window );">General and Administrative</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"><span style="font-weight:bold">Note 10 - General and Administrative&#160;</span></p>

      <div style="margin-left:36pt;margin-bottom:11pt">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Salaries and related expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">3,435</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">943</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Professional services</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,596</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,695</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Share-based compensation</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,763</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,882</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Fees to Directors</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">231</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span>244</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Insurance</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">1,084</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,024</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Rent and maintenance</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">24</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">29</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Other expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">1,423</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">216</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">11,556</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">6,033</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>

        </table>
      </div>

  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_GeneralAndAdministrativeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_GeneralAndAdministrativeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033820144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Note 11 - Income Taxes</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Tax rates</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary taxable income in Israel is subject to a corporate tax rate of 23%.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s US subsidiary, Chemomab Therapeutics Inc. ("Chemomab Inc.) is taxed separately under the U.S. tax laws.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Inc. is subject to a federal flat tax rate of 21% and state tax as applicable.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital gain is subject to capital gain tax according to the corporate tax rate in the year the assets are sold.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">B.</span><span style="font-weight:bold;padding-left:26.83pt">Tax assessments</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022, the Company&#8217;s tax reports through December 31, 2017&#160;are considered closed to audit inspections by the Israeli Tax Authority (&#8220;ITA&#8221;) due to statute of limitation rules effective in Israel.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has not yet been assessed by the ITA since inception.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">C.</span><span style="font-weight:bold;padding-left:26.28pt">Losses for tax purposes carried forward to future years</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As of December 31, 2022, the Company and its subsidiaries had approximately $159 million&#160;(approximately $143 million as of December 31, 2021) of net operating loss carryforwards which are available to reduce future taxable income with no limitation on the period of use.</span></span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On March 27, 2020 and December 27, 2020, the President of the United States signed and enacted into law the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and the Consolidated Appropriations Act, 2021 (CAA). Among other provisions, the CARES Act and the CAA provide relief to U.S. federal corporate taxpayers through temporary adjustments to net operating loss rules, changes to limitations on interest expense deductibility, and the acceleration of available refunds for minimum tax credit carryforwards. The CARES Act also includes provisions for a carryback of any net operating loss (NOL) arising in a taxable year beginning after December 31, 2017, and before January 1, 2021, to each of the five taxable years preceding the taxable year in which the loss arises (carryback period).</span></span></span></p>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Chemomab Therapeutics Inc., a wholly owned subsidiary of the Company, filed an application with the US Internal Revenue Service to carryback net operating losses. Chemomab Therapeutics Inc received $351 thousand in December 2022 on account of 2016 and 2017 and expects to receive the remainder $183 thousand in 2023. Accordingly, a tax benefit in the total amount of $534 thousand was recorded in the Company&#8217;s statement of operations during 2022.</span></span></span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">D.</span><span style="font-weight:bold;padding-left:26.28pt">Deferred taxes</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In respect of:</span></span></p>
    <div style="margin-left:72pt">

        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net operating loss carry-forwards</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">36,550</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,396</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation expense</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">1,774</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,147</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2,858</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,449</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">13</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross deferred tax assets</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">41,195</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36,030</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less - Valuation allowance</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(</span><span style="font-weight:bold">41,195</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,030)</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net deferred tax assets</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>

    </div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has established a valuation allowance to offset deferred tax assets on December 31, 2022 and 2021 due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The net change in the total valuation allowance for the year ended at December 31, 2022 was an increase of approximately $5.2 million.</span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">E.</span><span style="font-weight:bold;padding-left:26.83pt">Roll forward of valuation allowance</span></span></span></p>
    <div style="margin-left:72pt">

        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1, 2021</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">$</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">6,200</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency transaction loss</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2,425</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax assets acquired through merger</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,535</span></span></strong></td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2,870</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2021</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">$</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">36,030</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency transaction Income</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(1,316</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">6,481</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2022</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">$</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">41,195</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>

        </table>

    </div>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">F.</span><span style="font-weight:bold;padding-left:28.31pt">Reconciliation of theoretical income tax expense to actual income tax expense</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A reconciliation of the Company&#8217;s theoretical income tax expense to actual income tax expense is as follows:</span></span></p>
    <div style="margin-left:72pt">

        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income taxes</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(</span><span style="font-weight:bold">28,180</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,478</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statutory tax rate</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">23</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">%</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Theoretical tax benefit</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="font-weight:bold">6,481</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,870</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in temporary differences for which deferred taxes were not recognized</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(1,696</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,332</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax rate differential</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>20</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(101</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>744</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">239</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>6,879</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,064</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Actual income tax expense (Benefit)</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span>(534</span></span></span></strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:1.5px">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>

        </table>

    </div>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">G.</span><span style="font-weight:bold;padding-left:25.72pt">Accounting for uncertainty in income taxes</span></span></span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31, 2022, the Company did not have any unrecognized tax benefits and does not expect that the amount of unrecognized tax benefits will change significantly within the next 12 months. The Company&#8217;s accounting policy is to accrue interest and penalties related to unrecognized tax benefits as a component of income tax expense.</span></span></p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035388880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Balances and Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties Balances and Transactions</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 12 - Related Parties Balances and Transactions</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:10.28pt">Balances with Related Parties:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt">The following Related Party payables are included in the consolidated Balance Sheets:</p>
    <div style="margin-left:36pt">

        <div>
          <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td colspan="2" style="vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
                </td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
                </td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
                </td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>


              <tr style="background-color:#CCEEFF">
                <td style="vertical-align:bottom;width:76%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Employee and related expenses</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">891</span></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">278</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:76%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Accrued expenses</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">58</span></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">72</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
              </tr>
              <tr style="background-color:#CCEEFF">
                <td style="vertical-align:bottom;width:76%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:76%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
                <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">949</span></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
                <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">350</p>
                </td>
                <td style="vertical-align:bottom;width:1%">
                  <p>&#160;</p>
                </td>
              </tr>

          </table>
        </div>

      <p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On September 19, 2022, the Company entered into a share purchase agreement with the Company's Co- Founders, see Note 8B(4).</span></span></span></p>
    </div>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">B.</span><span style="font-weight:bold;padding-left:10.83pt">Transactions with Related Parties:</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt">The following transactions with related parties are included in the consolidated Statements of Operations:</p>
    <div style="margin-left:36pt;margin-bottom:11pt">

        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Salaries and related expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,409</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,255</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Share-based payments</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,466</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,775</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Professional Services</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">231</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">244</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Research and development</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">36</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">36</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">5,142</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">3,310</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037225296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Ordinary Shareholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable to Ordinary Shareholders</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders</span></p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Basic net loss per share is computed by dividing the net loss available to common stockholders by the weighted-average number of ordinary shares outstanding. Diluted net loss per share is computed similarly to basic net loss per share except that the denominator is increased to include the number of additional ordinary shares that would have been outstanding if the potential ordinary shares had been issued and if the additional ordinary shares of were dilutive. Diluted net loss per share is the same as basic net loss per share of ordinary share, as the effect of potentially dilutive securities is antidilutive.</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt">The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented:</p>
    <div style="margin-left:36pt">

        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">In USD thousands, except share and per </span><span style="font-weight:bold">share data</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Numerator:</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Net loss</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">27,646</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">12,478</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Denominator:</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;text-indent:-10pt;padding-left:10pt;margin-bottom:0pt">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">227,589,288</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">207,468,650</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Net loss per share attributable to ordinary shareholders, basic and diluted</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.121</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">0.060</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>

    </div>
    <div/>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt">The potential number of ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented since including them would have been anti-dilutive are as follows:</p>
    <div style="margin-left:36pt">

        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:center">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:center">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:center">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Number of shares</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Outstanding options to purchase ordinary shares</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">35,191,540</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">27,003,260</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037163024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Events After Balance Sheet Date</a></td>
<td class="text">
    <div>
      <p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Note 14&#160;- Subsequent Events</span></span></span></p>
      <p style="margin-top:11pt;margin-bottom:0pt;padding-left:36pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">On January 13, 2023 the Company filed with the SEC a registration statement on form S-1 for the issuance and sale of up to $20,000,000 of its ADSs.</p>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171034214832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">A.</span><span style="font-weight:bold;padding-left:26.28pt">Basis of Preparation</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S GAAP&#8221;).</p>
    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">B.</span><span style="font-weight:bold;padding-left:26.83pt">Use of estimates</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional currency</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">C.</span><span style="font-weight:bold;padding-left:26.28pt">Foreign currency</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;dollar&#8221; or &#8220;$&#8221;), thus; the dollar is the functional currency of the Company.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate.</p>
    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">D.</span><span style="font-weight:bold;padding-left:26.28pt">Cash and cash equivalents</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired.</p>
    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted cash</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">E.</span><span style="font-weight:bold;padding-left:26.83pt">Restricted cash</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt">Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments.</p>
    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text">
      <div>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">F.</span><span style="font-weight:bold;padding-left:28.31pt">Property and equipment</span></p>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.</p>
        <div>
          <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt">Annual rates at depreciation are as follows:</p>
          <div style="margin-left:36pt">

              <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">%</span></p>
                    </td>
                    <td style="vertical-align:bottom">&#160;</td>
                  </tr>


                  <tr style="background-color:#CCEEFF">
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Computers</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">33</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Laboratory equipment</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">10</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:#CCEEFF">
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Furniture and equipment</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">7</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>

              </table>

          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">G.</span><span style="font-weight:bold;padding-left:25.72pt">Impairment of long-lived assets</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company&#8217;s property and equipment are reviewed for impairment in accordance with ASC 360, &#8220;Property and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2022 and 2021, no impairment losses have been recorded.</p>
    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">H.</span><span style="font-weight:bold;padding-left:25.72pt">Research and Development</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages.</p>
    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">I.</span><span style="font-weight:bold;padding-left:26.83pt">Income taxes</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized.</p>
    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value of financial instruments</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">J.</span><span style="font-weight:bold;padding-left:28.5pt">Fair value of financial instruments</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price.</p>
      <div/>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#8217;s own credit risk.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#8217;s non<span style="font-weight:bold">- </span>financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented.</p>
    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based compensation</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">K.</span><span style="font-weight:bold;padding-left:25.72pt">Share-based compensation</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The fair value for the Company&#8217;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt">The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</p>
    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock', window );">Government-sponsored research and development</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">L.</span><span style="font-weight:bold;padding-left:26.83pt">Government-sponsored research and development</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Chemomab records grants received from the office of the Israel Innovation Authority (the &#8220;IIA&#8221;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses.</p>
    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SeverancePayPolicyTextBlock', window );">Severance Pay [Policy Text Block]</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">M.</span><span style="font-weight:bold;padding-left:24.06pt">Severance pay</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to Section 14 of the Severance Compensation Law, 1963 ("Section 14"), all employees of the Company are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately $142 thousand and $116 thousand for the year ended December 31, 2022 and 2021, respectively.</span></span></p>
    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risks</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">N.</span><span style="font-weight:bold;padding-left:26.28pt">Concentrations of credit risk:</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.</p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash <span>and cash equivalents and short- term deposits are invested in banks. Management believes that the financial institutions that hold the Company&#8217;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments</span>.</span></span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt">The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</p>
    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
      <div>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">O.</span><span style="font-weight:bold;padding-left:25.72pt">Leases</span></p>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Under </span></span>Topic 842, the Company determines if an arrangement is a lease at inception. Right-of-use (ROU) assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be 5% and 5.2% in 2022 and 2021, respectively. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company's lease agreements generally do not contain any residual value guarantees or restrictive covenants<span><span>.</span></span></span></span><br/>&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></span><br/>&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#8211; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G).</span></span></p>
      </div>
    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">P.</span><span style="font-weight:bold;padding-left:28.31pt">Principles of consolidation</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The <span>consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.</span></span></span></p>
    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per ordinary share</a></td>
<td class="text">
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"><span style="font-weight:bold">Q.</span><span style="font-weight:bold;padding-left:25.72pt">Earnings per ordinary share</span></p>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt">Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. &#160;Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options.</p>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_SeverancePayPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for severance pay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_SeverancePayPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037158544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>Nature Of Operations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of net assets acquired based on their estimated fair value</a></td>
<td class="text">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Cash and cash equivalents</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">2,427</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Asset held for sale</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,000</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Prepaid and other assets</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">236</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Accrued liabilities</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(1,187</p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt">)</p>
              </td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Net acquired assets</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">2,476</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037169136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock', window );">Schedule of annual rate of deprecation</a></td>
<td class="text">
              <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

                  <tr>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td style="vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">%</span></p>
                    </td>
                    <td style="vertical-align:bottom">&#160;</td>
                  </tr>


                  <tr style="background-color:#CCEEFF">
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Computers</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">33</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Laboratory equipment</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">10</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr style="background-color:#CCEEFF">
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Furniture and equipment</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">7</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%">
                      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement</p>
                    </td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                    <td style="vertical-align:top;width:9%">&#160;</td>
                    <td style="vertical-align:top;width:1%">&#160;</td>
                  </tr>

              </table>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the annual rate of deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035365168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Cash Equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of components of cash and cash equivalents</a></td>
<td class="text">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">In USD</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">10,663</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">10,720</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">In NIS</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,756</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,116</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">In other currencies</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">100</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">3,350</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">13,519</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">15,186</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037158544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Receivables and Prepaid Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock', window );">Schedule of other accounts receivable and prepaid expenses</a></td>
<td class="text">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Government institutions</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">459</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">179</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Prepaid expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">1,307</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,348</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">1,766</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,527</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of other accounts receivable and prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035375360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment, Net</a></td>
<td class="text">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Cost:</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Computers</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">70</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">43</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Furniture and equipment</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">33</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">27</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Laboratory equipment</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">399</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">364</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Website development</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">14</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">14</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Leasehold improvements</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">16</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">16</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><strong><strong><strong>532</strong><strong> </strong></strong><strong> </strong></strong><strong> </strong></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">464 </p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Less - accumulated depreciation</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold">165</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-weight:bold">)</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(107</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt">)</p>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><strong><strong><strong>367</strong><strong> </strong></strong><strong> </strong></strong><strong> </strong></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">357 </p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>

        </table>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033989520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of maturity of lease liabilities under our non-cancelable operating leases</a></td>
<td class="text">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">2023</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">126 </span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">2024</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">93 </span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Total future minimum lease payments</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">219 </span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Less imputed interest:</p>
              </td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold">5</span></p>
              </td>
              <td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px"><span style="font-weight:bold">)</span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Present value of operating lease liabilities</p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">214 </span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033349840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of the effect of share-based compensation on the statements of operations</a></td>
<td class="text">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Research and development</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">448</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">137</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">General and administrative</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,763</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,882</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Total share-based compensation expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">3,211</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">2,019</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Schedule of number and weighted average exercise prices of option</a></td>
<td class="text">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted </span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">exercise </span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">price</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Number of </span><span style="font-weight:bold">options</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average </span><span style="font-weight:bold">remaining </span><span style="font-weight:bold">contractual </span><span style="font-weight:bold">life (in years)</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average </span><span style="font-weight:bold">exercise price</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Number of </span><span style="font-weight:bold">options</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Weighted</span></p>
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">average </span><span style="font-weight:bold">remaining </span><span style="font-weight:bold">contractual </span><span style="font-weight:bold">life (in years)</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Outstanding at January 1</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.38</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">27,003,260</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">8.12</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">0.07</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">10,455,580</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">7.8</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Acquired in Merger</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%;text-align:right">-</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">-</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">609,535</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Exercised</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.07</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold">1,970,000</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">)</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">-</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.08</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(134,220</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Forfeited</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.32</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(</span><span style="font-weight:bold">1,240,120</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">)</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>-</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1.25</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">(1,712,275</p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">)</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Granted</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.16</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">11,398,400</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">7.8</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:10%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">0.62</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">17,784,640</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">9.79</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:10%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:27%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Outstanding at December 31</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.33</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">35,191,540</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">7.42</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:10%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">0.38</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">27,003,260</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">8.12</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used to calculate the fair value of the options</a></td>
<td class="text">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">2022&#160;grants</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Weighted average share price (in U.S. dollar)<sup>(a)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">0.16</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Exercise price (in U.S. dollar)</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">0.10</span><span style="font-weight:bold">-</span><span style="font-weight:bold">0.257</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Expected life of options (in years)<sup>(b)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">5.51</span><span style="font-weight:bold">-</span><span style="font-weight:bold">6.28</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Expected volatility<sup>(c)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">83.69</span><span style="font-weight:bold">%-</span><span style="font-weight:bold">84.31</span><span style="font-weight:bold">%</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Risk-free interest rate<sup>(d)</sup></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">1.75</span><span style="font-weight:bold">%-</span><span style="font-weight:bold">4.14</span><span style="font-weight:bold">%</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:84%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Dividend yield</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;text-align:center">&#160;</td>
              <td style="vertical-align:bottom;width:12%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-weight:bold">0</span><span style="font-weight:bold">%</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037163024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock', window );">Schedule of research and development</a></td>
<td class="text">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Consultants and subcontractors</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">13,052</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">3,894</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Salaries and related expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,867 </span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,789</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Rent and maintenance</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">245</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">114</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Share-based compensation</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">448</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">137</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Other expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">365</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">400</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">16,977</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">6,334</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035324352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General and Administrative Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock', window );">Schedule of general and administrative</a></td>
<td class="text">
      <div style="margin-left:36pt;margin-bottom:11pt">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Salaries and related expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">3,435</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">943</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Professional services</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,596</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,695</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Share-based compensation</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,763</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,882</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Fees to Directors</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">231</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span>244</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Insurance</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">1,084</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,024</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Rent and maintenance</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">24</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">29</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Other expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">1,423</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">216</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">11,556</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">6,033</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>

        </table>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171034298864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of significant components of the company's deferred tax asset</a></td>
<td class="text">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net operating loss carry-forwards</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">36,550</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,396</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation expense</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">1,774</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,147</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2,858</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,449</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">13</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross deferred tax assets</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">41,195</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36,030</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less - Valuation allowance</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(</span><span style="font-weight:bold">41,195</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,030)</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net deferred tax assets</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Schedule of roll forward of valuation allowance</a></td>
<td class="text">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1, 2021</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">$</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">6,200</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency transaction loss</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2,425</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax assets acquired through merger</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,535</span></span></strong></td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2,870</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2021</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">$</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">36,030</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Currency transaction Income</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(1,316</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax expense</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">6,481</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2022</span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">$</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">41,195</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of theoretical income tax expense to actual income tax expense</a></td>
<td class="text">
        <table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">USD thousands</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income taxes</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(</span><span style="font-weight:bold">28,180</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,478</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statutory tax rate</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">23</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">%</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Theoretical tax benefit</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="font-weight:bold">6,481</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,870</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></p>
              </td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in temporary differences for which deferred taxes were not recognized</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(1,696</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,332</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax rate differential</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>20</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(101</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>744</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">239</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(255, 255, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>6,879</strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,064</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)">&#160;</td>
            </tr>
            <tr style="background-color:rgb(204, 238, 255)">
              <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Actual income tax expense (Benefit)</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><span>(534</span></span></span></strong></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:1.5px">
                <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035372704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Balances and Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock', window );">Schedule of related party payables</a></td>
<td class="text">
        <div>
          <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td colspan="2" style="vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
                </td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
                </td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom">&#160;</td>
                <td style="vertical-align:bottom">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
                </td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td style="vertical-align:bottom;text-align:right">&#160;</td>
                <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
                </td>
                <td style="vertical-align:bottom">&#160;</td>
              </tr>


              <tr style="background-color:#CCEEFF">
                <td style="vertical-align:bottom;width:76%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Employee and related expenses</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">891</span></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">278</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:76%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Accrued expenses</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">58</span></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
                <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">72</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
              </tr>
              <tr style="background-color:#CCEEFF">
                <td style="vertical-align:bottom;width:76%">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:9%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:76%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
                <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">949</span></p>
                </td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%">&#160;</td>
                <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
                <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">350</p>
                </td>
                <td style="vertical-align:bottom;width:1%">
                  <p>&#160;</p>
                </td>
              </tr>

          </table>
        </div>
      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of transaction with related parties</a></td>
<td class="text">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">Year ended</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">December&#160;31,</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2022</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">2021</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-weight:bold">USD thousands</span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Salaries and related expenses</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,409</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,255</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Share-based payments</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">2,466</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">1,775</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Professional Services</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">231</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">244</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Research and development</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">36</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%">&#160;</td>
              <td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">36</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">5,142</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">3,310</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171037254000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Ordinary Shareholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computation of basic and diluted net loss per share</a></td>
<td class="text">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">In USD thousands, except share and per </span><span style="font-weight:bold">share data</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Numerator:</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Net loss</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">27,646</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">12,478</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Denominator:</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;text-indent:-10pt;padding-left:10pt;margin-bottom:0pt">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">227,589,288</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">207,468,650</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Net loss per share attributable to ordinary shareholders, basic and diluted</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">0.121</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">0.060</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of weighted average number of shares excluded from computation of diluted net loss per share</a></td>
<td class="text">
        <table cellpadding="0" cellspacing="0" style="width:90%" width="100%">

            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Year ended</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:center">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">December&#160;31,</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:center">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2022</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td style="vertical-align:bottom;text-align:right">&#160;</td>
              <td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2021</span></span></span></p>
              </td>
              <td style="vertical-align:bottom;text-align:center">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom">&#160;</td>
              <td style="vertical-align:bottom">&#160;</td>
              <td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Number of shares</span></span></span></p>
              </td>
              <td style="vertical-align:bottom">&#160;</td>
            </tr>


            <tr>
              <td style="vertical-align:bottom;width:76%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:9%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>
            <tr style="background-color:#CCEEFF">
              <td style="vertical-align:bottom;width:76%">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Outstanding options to purchase ordinary shares</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">35,191,540</span></p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
              <td style="vertical-align:bottom;width:1%;border-bottom:4px double black">&#160;</td>
              <td style="vertical-align:bottom;width:9%;border-bottom:4px double black">
                <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt">27,003,260</p>
              </td>
              <td style="vertical-align:bottom;width:1%">&#160;</td>
            </tr>

        </table>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171035300032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General (Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 16, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember', window );">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger', window );">Number of ADS issued and outstanding after the merger</a></td>
<td class="nump">12.86<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ADS issued and outstanding after the merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033967520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General (Schedule of net assets acquired based on their estimated fair value) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 16, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>Nature Of Operations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale', window );">Asset held for sale</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid and other assets</a></td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued liabilities</a></td>
<td class="num">(1,187)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_EstimatedFairValueOfNetAssetsAcquired', window );">Net acquired assets</a></td>
<td class="nump">$ 2,476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of of asset held for sale recogized prior to the completion of merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EstimatedFairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated fair value of the net assets acquired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EstimatedFairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033916048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_PercentageOfMonthlyDepositsRate', window );">Percentage of monthly deposits rate</a></td>
<td class="nump">8.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_IncrementalBorrowingRateOfLeases', window );">incremental borrowing rate of leases</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_IncrementalBorrowingRateOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents incremental borrowing rate of leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_IncrementalBorrowingRateOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_PercentageOfMonthlyDepositsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of monthly deposits rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_PercentageOfMonthlyDepositsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033061392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Annual rates of depreciation</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember', window );">Laboratory Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Annual rates of depreciation</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Annual rates of depreciation</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_AnnualRatesOfDepreciation', window );">Annual rates of depreciation</a></td>
<td class="text">over the shorter of the lease term or the estimated useful life of the improvement<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_AnnualRatesOfDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual rates of depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_AnnualRatesOfDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171030350880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and Cash Equivalents (Schedule of Cash and Cash Equivalents) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 13,519<span></span>
</td>
<td class="nump">$ 15,186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">10,663<span></span>
</td>
<td class="nump">10,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_ILS', window );">NIS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">2,756<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_XXX', window );">Other currencies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 3,350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_ILS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_ILS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_XXX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_XXX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171032810416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Receivables and Prepaid Expenses (Schedule of Other Receivables and Prepaid Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ReceivablesFromGovernmentInstitutions', window );">Government institutions</a></td>
<td class="nump">$ 459<span></span>
</td>
<td class="nump">$ 179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">1,307<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other accounts receivable and prepaid expenses, Total</a></td>
<td class="nump">$ 1,766<span></span>
</td>
<td class="nump">$ 1,527<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ReceivablesFromGovernmentInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government institutions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ReceivablesFromGovernmentInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031933088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net (Schedule of Property and Equipment, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 532<span></span>
</td>
<td class="nump">$ 464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less - accumulated depreciation</a></td>
<td class="num">(165)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property Plant And Equipment Net</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember', window );">Laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Website development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cmmb_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031989760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 10, 2020</div></th>
<th class="th"><div>Oct. 24, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 12, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiry date</a></td>
<td class="text">May 31,  2023<span></span>
</td>
<td class="text">Oct. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lease term, option to extend</a></td>
<td class="text">three years<span></span>
</td>
<td class="text">three years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_AnnualRentAndManagementFees', window );">Annual rent and management fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_BankGuaranteesToPropertyOwner', window );">Bank guarantees to property owner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 227<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities', window );">Operating Right Of Use Assets And Operating Lease Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Increase in the carrying amount of the right-of-use asset due to impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Incremental borrowing rate based on credit rating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_AnnualRentAndManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual rent and management fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_AnnualRentAndManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_BankGuaranteesToPropertyOwner">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bank guarantees to property owner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_BankGuaranteesToPropertyOwner</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating right-of-use assets and operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033048192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeDisclosureAbstract', window );"><strong>Lessee Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">$ 126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest:</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability, Total</a></td>
<td class="nump">$ 214<span></span>
</td>
<td class="nump">$ 343<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031948480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsDescription', window );">Decsription of occurrence for payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab, if any), but in any event not more than $3,000 thousand.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_MaximumPercentageOfPaymentsOfRoyalties', window );">Maximum percentage of payments of royalties (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized', window );">Cumulative Amounts Of Grants Received And Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royality expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,222<span></span>
</td>
<td class="nump">$ 2,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedInvestments', window );">Bank restricted deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_RecoverabilityOfVatAmount', window );">Recoverability of VAT amount</a></td>
<td class="nump">$ 1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember', window );">New Drug Application and Biological License Application [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentDescription', window );">Description of application payment for licensed product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">$100 thousand upon submission of a New Drug Application (&#8220;NDA&#8221;), Biological License Application (&#8220;BLA&#8221;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#8220;FDA&#8221;), $100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than $300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct', window );">Royalty payments on sale of product (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cmmb_CapitalAdditionsOneMember', window );">Capital Additions One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentDescription', window );">Description of application payment for licensed product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">$200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than $600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amounts of grants received from the IIA and recognized by the company, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_MaximumPercentageOfPaymentsOfRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum percentage of royalties payable on the amount of the grant received (dollar linked), plus interest at annual rate based on LIBOR.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_MaximumPercentageOfPaymentsOfRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of royalty payments on sale of product developed with funding received from the IIA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RecoverabilityOfVatAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents recoverability of VAT amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RecoverabilityOfVatAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the terms of a significant arrangement with a supplier (excluding an unconditional purchase obligation) to acquire goods or services over a period of time beyond one year or the normal operating cycle, if longer, which may include identification of the goods or services to be purchased, pricing, effects on pricing of failing to reach minimum quantities required to be purchased, cancellation rights, and termination provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the nature and terms of commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments which are not defined as or included in marketable (debt, equity, or other) securities whose use is restricted in whole or in part, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cmmb_CapitalAdditionsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cmmb_CapitalAdditionsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033635712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 15, 2021</div></th>
<th class="th"><div>Nov. 16, 2022</div></th>
<th class="th"><div>Sep. 19, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options to purchase ADS cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,240,120<span></span>
</td>
<td class="nump">1,712,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cmmb_TwoThousandsFifteenPlanMember', window );">2015 plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues', window );">Number of ADSs issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfStockReservedForIssuance', window );">Number of stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,443,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfStockAdssResveredForIssuance', window );">Number Of Stock Adss Resvered For Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,422,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfAdssOptionsIssuableOutstanding', window );">Number of ADSs options issuable outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,173,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfOptionsIssuableOutstanding', window );">Number of options issuable outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,460,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfAdssVestedAndExercisable', window );">Number of ADSs vested and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">620,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfOptionsVestedAndExercisable', window );">Number of options vested and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,400,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice', window );">Weighted average exercise price of ADSs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,445,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options to purchase ADS cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,240,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod', window );">Options to purchase ordinary shares cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cmmb_TwoThousandsSeventeenPlanMember', window );">2017 plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues', window );">Number of ADSs issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">586,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfStockReservedForIssuance', window );">Number of stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,511,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfStockAdssResveredForIssuance', window );">Number Of Stock Adss Resvered For Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfAdssVestedAndExercisable', window );">Number of ADSs vested and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfOptionsVestedAndExercisable', window );">Number of options vested and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice', window );">Weighted average exercise price of ADSs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,730,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">The Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ProceedsFromSaleOfAdss', window );">Proceeds from sale of ADS's</a></td>
<td class="nump">$ 45,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues', window );">Number of ADSs issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NumberOfWarrantsPurchaseUpAdss', window );">Number of warrants purchase ADS's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,619,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SaleOfStocksPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtmAgreementMember', window );">ATM agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement', window );">Aggregate offering price of at the market offering agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ProceedsFromSaleOfAdss', window );">Proceeds from sale of ADS's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,917,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues', window );">Number of ADSs issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">699,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SaleOfStocksPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_RepurchaseArrangementMember', window );">Repurchase Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SaleOfStockLineItems', window );"><strong>Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_RepurchaseOfAmericanDepositaryReceipts', window );">Repurchase of ADSs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares', window );">Number of shares repurchase of ADSs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">582,023<span></span>
</td>
<td class="nump">582,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts', window );">Weighted average price of repurchase of ADSs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts', window );">Total consideration of repurchase of ADSs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,218,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents as a aggregate offering price of at the market offering agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfAdssOptionsIssuableOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ADSs options issuable outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfAdssOptionsIssuableOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfAdssVestedAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ADSs vested and exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfAdssVestedAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfOptionsIssuableOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents number of options issuable outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfOptionsIssuableOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfOptionsVestedAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents number of options vested and exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfOptionsVestedAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfStockAdssResveredForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock option ADSs resvered for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfStockAdssResveredForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfStockReservedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents number of stock resvered for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfStockReservedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfWarrantsPurchaseUpAdss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants purchase ADS's.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfWarrantsPurchaseUpAdss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ProceedsFromSaleOfAdss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of ADS's.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ProceedsFromSaleOfAdss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RepurchaseOfAmericanDepositaryReceipts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of repurchase of american depositary receipts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RepurchaseOfAmericanDepositaryReceipts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RepurchaseOfAmericanDepositaryReceiptsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents repurchase of American Depositary Receipts shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RepurchaseOfAmericanDepositaryReceiptsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_SaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_SaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_SaleOfStocksPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by the company for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_SaleOfStocksPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents Share Based Compensation Arrangement By Share Based Payment Award ADS Forfeitures In Period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents Share Based Compensation Arrangement By Share Based Payment Award ADS Outstanding Period Increase Decrease Weighted Average Exercise Price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stocks of American Depository Shares ("ADS") issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents Total consideration of repurchase of american depositary receipts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents weighted average price of repurchase of american depositary receipts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the weighted average exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cmmb_TwoThousandsFifteenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cmmb_TwoThousandsFifteenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cmmb_TwoThousandsSeventeenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cmmb_TwoThousandsSeventeenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtmAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtmAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_RepurchaseArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cmmb_RepurchaseArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171034294288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Schedule of Share-based Compensation Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">$ 3,211<span></span>
</td>
<td class="nump">$ 2,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">$ 2,763<span></span>
</td>
<td class="nump">$ 1,882<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171034276016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Schedule of Number and Weighted Average Exercise Prices of Option) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the beginning</a></td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice', window );">Acquired in Merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise</a></td>
<td class="nump">0.07<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">0.32<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">0.16<span></span>
</td>
<td class="nump">0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the end</a></td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning</a></td>
<td class="nump">27,003,260<span></span>
</td>
<td class="nump">10,455,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger', window );">Acquired in Merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">609,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1', window );">Exercise</a></td>
<td class="num">(1,970,000)<span></span>
</td>
<td class="num">(134,220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(1,240,120)<span></span>
</td>
<td class="num">(1,712,275)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">11,398,400<span></span>
</td>
<td class="nump">17,784,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end</a></td>
<td class="nump">35,191,540<span></span>
</td>
<td class="nump">27,003,260<span></span>
</td>
<td class="nump">10,455,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life in Years</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">7 years 5 months 1 day<span></span>
</td>
<td class="text">8 years 1 month 13 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm', window );">Granted</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">9 years 9 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards granted during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of shares acquired in merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options acquired, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031781728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Schedule of Assumptions Used to Calculate the Fair Value of the Options) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Weighted average share price (in U.S. dollar)</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">83.69%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">84.31%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">4.14%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in U.S. dollar)</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of options (in years)</a></td>
<td class="text">5 years 6 months 3 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in U.S. dollar)</a></td>
<td class="nump">$ 0.257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of options (in years)</a></td>
<td class="text">6 years 3 months 10 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The weighted average share price is based on the Company&#8217;s ordinary share valuation as at the grant date.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Expected volatility is based on historical volatility over the most recent period commensurate with the expected term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#8217;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#8217;s expected term.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Expected life for the periods presented was determined according to the simplified method since, at the date of grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#8217; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031687248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development (Schedule of Research and Development) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ConsultantsAndSubcontractorsExpense', window );">Consultants And Subcontractors Expense</a></td>
<td class="nump">$ 13,052<span></span>
</td>
<td class="nump">$ 3,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Salaries and related expenses</a></td>
<td class="nump">2,867<span></span>
</td>
<td class="nump">1,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense', window );">Rent And Maintenance Research And Development Expense</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense', window );">Share-based compensation</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Other expenses</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total</a></td>
<td class="nump">$ 16,977<span></span>
</td>
<td class="nump">$ 6,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ConsultantsAndSubcontractorsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consultants and subcontractors expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ConsultantsAndSubcontractorsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RentAndMaintenanceResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development related rent and maintenance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RentAndMaintenanceResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareBasedCompensationResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development related share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareBasedCompensationResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031867808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative (Schedule of General and Administrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General and Administrative Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and related expenses</a></td>
<td class="nump">$ 3,435<span></span>
</td>
<td class="nump">$ 943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional services</a></td>
<td class="nump">2,596<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense', window );">Share-based compensation</a></td>
<td class="nump">2,763<span></span>
</td>
<td class="nump">1,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoninterestExpenseDirectorsFees', window );">Fees to Directors</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralInsuranceExpense', window );">Insurance</a></td>
<td class="nump">1,084<span></span>
</td>
<td class="nump">1,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense', window );">Rent and maintenance</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Other expenses</a></td>
<td class="nump">1,423<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Total</a></td>
<td class="nump">$ 11,556<span></span>
</td>
<td class="nump">$ 6,033<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General and administrative related rent and maintenance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General and administrative related share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralInsuranceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralInsuranceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoninterestExpenseDirectorsFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoninterestExpenseDirectorsFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesAndWages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesAndWages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031722192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ReceivedAmountOfChemomabTherapeuticsInc', window );">Received amount of Chemomab Therapeutics Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (534)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Corporate tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Capital losses carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159,000<span></span>
</td>
<td class="nump">$ 143,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S. [Member] | Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Corporate tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc', window );">Expects to receive amount of Chemomab Therapeutics Inc</a></td>
<td class="nump">$ 183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount expects to receive of Chemomab Therapeutics Inc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ReceivedAmountOfChemomabTherapeuticsInc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The received amount of Chemomab Therapeutics Inc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ReceivedAmountOfChemomabTherapeuticsInc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033047648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry-forwards</a></td>
<td class="nump">$ 36,550<span></span>
</td>
<td class="nump">$ 33,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation expense</a></td>
<td class="nump">1,774<span></span>
</td>
<td class="nump">1,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development costs</a></td>
<td class="nump">2,858<span></span>
</td>
<td class="nump">1,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">41,195<span></span>
</td>
<td class="nump">36,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less - valuation allowance</a></td>
<td class="num">(41,195)<span></span>
</td>
<td class="num">(36,030)<span></span>
</td>
<td class="num">$ (6,200)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031760048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at January 1</a></td>
<td class="nump">$ 36,030<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_CurrencyTransactionLossValuationAllowance', window );">Currency transaction income (loss)</a></td>
<td class="num">(1,316)<span></span>
</td>
<td class="nump">2,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance', window );">Tax assets acquired through merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_IncomeTaxExpenseValuationAllowance', window );">Income tax expense</a></td>
<td class="nump">6,481<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at December 31</a></td>
<td class="nump">$ 41,195<span></span>
</td>
<td class="nump">$ 36,030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_CurrencyTransactionLossValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance due to currency transaction loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_CurrencyTransactionLossValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_IncomeTaxExpenseValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance due to income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_IncomeTaxExpenseValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance due to tax assets acquired through merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031869296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Theoretical tax benefit on the above amount Decrease (increase) in tax refund resulting from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (28,180)<span></span>
</td>
<td class="num">$ (12,478)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Statutory tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Theoretical tax benefit</a></td>
<td class="num">$ (6,481)<span></span>
</td>
<td class="num">$ (2,870)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized', window );">Change in temporary differences for which deferred taxes were not recognized</a></td>
<td class="num">(1,696)<span></span>
</td>
<td class="num">(1,332)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Tax rate differential</a></td>
<td class="nump">20<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="nump">744<span></span>
</td>
<td class="nump">239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded', window );">Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards</a></td>
<td class="nump">6,879<span></span>
</td>
<td class="nump">4,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Actual income tax expense (Benefit)</a></td>
<td class="num">$ (534)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents as a change in temporary differences for which deferred taxes were not recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents losses and benefits for tax purposes for the year, for which deferred taxes were not recorded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171031886928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee and related expenses</a></td>
<td class="nump">$ 1,560<span></span>
</td>
<td class="nump">$ 653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">3,378<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cmmb_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee and related expenses</a></td>
<td class="nump">891<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Related Party Payables</a></td>
<td class="nump">$ 949<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cmmb_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cmmb_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171033018768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty', window );">Salaries and related expenses</a></td>
<td class="nump">$ 2,409<span></span>
</td>
<td class="nump">$ 1,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty', window );">Share-based payments</a></td>
<td class="nump">2,466<span></span>
</td>
<td class="nump">1,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty', window );">Professional services</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty', window );">Research and development</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyCosts', window );">Total related party expenses</a></td>
<td class="nump">$ 5,142<span></span>
</td>
<td class="nump">$ 3,310<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related party expenses related to professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related party expenses related to research and develeopment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related party expenses related to salaries and related expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related party expenses related to share based payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171030329456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_EarningsPerShareCalculationNumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 27,646<span></span>
</td>
<td class="nump">$ 12,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic</a></td>
<td class="nump">227,589,288<span></span>
</td>
<td class="nump">207,468,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, diluted</a></td>
<td class="nump">227,589,288<span></span>
</td>
<td class="nump">207,468,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Net loss per share attributable to ordinary shareholders, basic</a></td>
<td class="nump">$ 0.121<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Net loss per share attributable to ordinary shareholders, diluted</a></td>
<td class="nump">$ 0.121<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share Abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EarningsPerShareCalculationNumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share Calculation Numerator Abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EarningsPerShareCalculationNumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171036476080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Outstanding options to purchase ordinary shares</a></td>
<td class="nump">35,191,540<span></span>
</td>
<td class="nump">27,003,260<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140171032950160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Jan. 13, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_SaleOfStockValueOfSharesIssuedInTransaction', window );">Issuance and sale of of ADS upto</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_SaleOfStockValueOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of sale of stock value of shares issued in transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_SaleOfStockValueOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>zk2329164_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://www.anchiano.com/20221231"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cmmb-20221231.xsd" xlink:type="simple"/>
    <context id="C_20220101to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_srtCurrencyAxis_currencyUSD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_srtCurrencyAxis_currencyUSD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtCurrencyAxis_currencyILS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_srtCurrencyAxis_currencyILS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtCurrencyAxis_currencyXXX">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_srtCurrencyAxis_currencyXXX">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20200510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2020-05-10</instant>
        </period>
    </context>
    <context id="C_20200501to20200510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-10</endDate>
        </period>
    </context>
    <context id="C_20211001to20211024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-24</endDate>
        </period>
    </context>
    <context id="C_20211024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-10-24</instant>
        </period>
    </context>
    <context id="C_20211212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-12-12</instant>
        </period>
    </context>
    <context id="C_20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cmmb:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cmmb:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapSoftwareDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapSoftwareDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_countryUS_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtStatementGeographicalAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_srtStatementGeographicalAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_srtStatementScenarioAxis_srtScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_usgaapCapitalAdditionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:CapitalAdditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220701to20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_cmmbCapitalAdditionsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cmmb:CapitalAdditionsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230113_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-13</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cmmb:TwoThousandsFifteenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cmmb:TwoThousandsSeventeenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220901to20220919_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:RepurchaseArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-19</endDate>
        </period>
    </context>
    <context id="C_20220930_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:RepurchaseArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="C_20221101to20221116_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:RepurchaseArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-16</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtmAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtmAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-23</endDate>
        </period>
    </context>
    <context id="C_20210301to20210315_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-15</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cmmb:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cmmb:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Share">
        <measure>shares</measure>
    </unit>
    <unit id="USD_Per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="C_20220101to20221231" id="FFact_0000000000489">0001534248</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus contextRef="C_20220101to20221231" id="FFact_0000000000490">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="C_20220101to20221231" id="FFact_0000000000491">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103251859">8-K</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213104107012">Chemomab Therapeutics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103334932">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103327514">001-38807</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103321571">81-3676773</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103343937">Kiryat Atidim</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103349322">Building 7</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103356096">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103401995">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103406445">6158002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103413807">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103419762">77-331-0156</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213104227091">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213104232182">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213104235288">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213104238408">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"
      id="Fxbrl_20230213103433506">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"
      id="Fxbrl_20230213103437662">CMMB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"
      id="Fxbrl_20230213103445669">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"
      id="Fxbrl_20230213103508728">Ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"
      id="Fxbrl_20230213103458685">N/A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"
      id="Fxbrl_20230213103452851">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103758108">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213103815992">false</dei:EntityExTransitionPeriod>
    <dei:DocumentPeriodEndDate
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213161546834">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213174811365">2022</dei:DocumentFiscalYearFocus>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_20200501to20200510"
      id="Fxbrl_20230131233234992">2023-05-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_20211001to20211024"
      id="Fxbrl_20230131233722905">2024-10-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000038"
      unitRef="usd">13519000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000039"
      unitRef="usd">15186000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000040"
      unitRef="usd">26374000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000041"
      unitRef="usd">45975000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230213102216110_Fact_0000000000040"
      unitRef="usd">77000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230213102216110_Fact_0000000000041"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000042"
      unitRef="usd">1766000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000043"
      unitRef="usd">1527000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000044"
      unitRef="usd">41736000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000045"
      unitRef="usd">62688000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230207200450049_Fact_0000000000050"
      unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230207200450049_Fact_0000000000051"
      unitRef="usd">55000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000048"
      unitRef="usd">733000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230131220311598"
      unitRef="usd">908000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000052"
      unitRef="usd">367000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000053"
      unitRef="usd">357000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000054"
      unitRef="usd">227000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000055"
      unitRef="usd">345000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000056"
      unitRef="usd">1327000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000057"
      unitRef="usd">1665000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000058"
      unitRef="usd">43063000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000059"
      unitRef="usd">64353000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000060"
      unitRef="usd">1688000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000061"
      unitRef="usd">1336000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000062"
      unitRef="usd">3378000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000063"
      unitRef="usd">555000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000064"
      unitRef="usd">1560000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000065"
      unitRef="usd">653000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000066"
      unitRef="usd">123000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000067"
      unitRef="usd">106000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000068"
      unitRef="usd">6749000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000069"
      unitRef="usd">2650000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000070"
      unitRef="usd">91000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000071"
      unitRef="usd">237000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000072"
      unitRef="usd">91000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000073"
      unitRef="usd">237000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20221231"
      id="Fxbrl_20230207202310124"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20211231"
      id="Fxbrl_20230207202348403"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Liabilities
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000074"
      unitRef="usd">6840000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000075"
      unitRef="usd">2887000</us-gaap:Liabilities>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20230201163052384"
      unitRef="USD_Per_Share">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20230131220607422"
      unitRef="USD_Per_Share">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20230131221123913"
      unitRef="Share">650000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230131221114549"
      unitRef="Share">650000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SharesOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_s_20230213101830929"
      unitRef="Share">232636700</us-gaap:SharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230213101830930"
      unitRef="Share">232636700</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_s_20230131221353660"
      unitRef="Share">228090300</us-gaap:SharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20230131221353661"
      unitRef="Share">228090300</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230131221528825"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230131221535249"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230207202558860"
      unitRef="Share">11640460</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230207202444619"
      unitRef="usd">1218000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230207202534021"
      unitRef="usd">0</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000086"
      unitRef="usd">101260000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000087"
      unitRef="usd">97639000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000088"
      unitRef="usd">-63819000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000089"
      unitRef="usd">-36173000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000090"
      unitRef="usd">36223000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000091"
      unitRef="usd">61466000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000092"
      unitRef="usd">43063000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000093"
      unitRef="usd">64353000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000094"
      unitRef="usd">16977000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000095"
      unitRef="usd">6334000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000096"
      unitRef="usd">11556000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000097"
      unitRef="usd">6033000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000098"
      unitRef="usd">28533000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000099"
      unitRef="usd">12367000</us-gaap:OperatingExpenses>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230131223230473"
      unitRef="usd">353000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230131223237304"
      unitRef="usd">-111000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230207212310873_Fact_0000000000102"
      unitRef="usd">-28180000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230207212310873_Fact_0000000000103"
      unitRef="usd">-12478000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230131223639023"
      unitRef="usd">-534000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000101"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000102"
      unitRef="usd">-27646000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000103"
      unitRef="usd">-12478000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230131213305203"
      unitRef="USD_Per_Share">0.121</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000104"
      unitRef="USD_Per_Share">0.121</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230131213312166"
      unitRef="USD_Per_Share">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_0000000000105"
      unitRef="USD_Per_Share">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230214141238310"
      unitRef="Share">227589288</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000106"
      unitRef="Share">227589288</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230131213329528"
      unitRef="Share">207468650</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_0000000000107"
      unitRef="Share">207468650</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230207232832534"
      unitRef="Share">9274838</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004148281"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230208004108785"
      unitRef="Share">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004208753"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207232638785_Fact_0000000000128"
      unitRef="usd">34497000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230207232638785_Fact_0000000000129"
      unitRef="usd">-23695000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20230207232638785_Fact_0000000000130"
      unitRef="usd">10802000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004236209"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004232608"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207232932528"
      unitRef="usd">2019000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230208004229458"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230207232938175"
      unitRef="usd">2019000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <cmmb:EffectOfReverseCapitalizationTransactionShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230207232946871"
      unitRef="Share">152299702</cmmb:EffectOfReverseCapitalizationTransactionShares>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004310594"
      unitRef="usd">0</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:EffectOfReverseCapitalizationTransactionShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230208004631164"
      unitRef="Share">0</cmmb:EffectOfReverseCapitalizationTransactionShares>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004302609"
      unitRef="usd">0</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207232952864"
      unitRef="usd">2476000</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230208004258843"
      unitRef="usd">0</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230207232958504"
      unitRef="usd">2476000</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230207233006128"
      unitRef="Share">66381520</cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004339738"
      unitRef="usd">0</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230208004626295"
      unitRef="Share">0</cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004335122"
      unitRef="usd">0</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207233012248"
      unitRef="usd">58637000</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230208004332317"
      unitRef="usd">0</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230207233018475"
      unitRef="usd">58637000</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230207233039147"
      unitRef="Share">134240</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004521301"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230208004621028"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004724885"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207233033563"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230208004807831"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230207233028090"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004352160"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004349447"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230208004345432"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230207233044479"
      unitRef="usd">-12478000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230207233049858"
      unitRef="usd">-12478000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230207234506438"
      unitRef="Share">228090300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004359870"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230208004449318"
      unitRef="Share">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004357072"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207233106443"
      unitRef="usd">97639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230207234203847"
      unitRef="usd">-36173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230207233116634"
      unitRef="usd">61466000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230207234515566"
      unitRef="Share">228090300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004830175"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230208004835440"
      unitRef="Share">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004846448"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207233129314"
      unitRef="usd">97639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230207233133644"
      unitRef="usd">-36173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230207233141194"
      unitRef="usd">61466000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004855201"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004852649"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207233154315"
      unitRef="usd">3211000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230208004943313"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230207233147476"
      unitRef="usd">3211000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230207233201211"
      unitRef="Share">2576400</cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004904248"
      unitRef="usd">0</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230208004910523"
      unitRef="Share">0</cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004901083"
      unitRef="usd">0</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207233210018"
      unitRef="usd">267000</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230208004950211"
      unitRef="usd">0</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230207233216009"
      unitRef="usd">267000</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230207233237975"
      unitRef="Share">1970000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004927217"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230208004915442"
      unitRef="Share">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208004923369"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207233227671"
      unitRef="usd">143000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230208004959684"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230207233221400"
      unitRef="usd">143000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208004938057"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230207233301376"
      unitRef="Share">-11640460</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230207233406606"
      unitRef="usd">-1218000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230208004934609"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230208004932393"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230207233411324"
      unitRef="usd">-1218000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208005011611"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230208005008418"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230208005005802"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230207233416622"
      unitRef="usd">-27646000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230207233422744"
      unitRef="usd">-27646000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230207233430996"
      unitRef="Share">232636700</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230208005022333"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230207233657770"
      unitRef="Share">-11640460</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230207233728393"
      unitRef="usd">-1218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230207233439472"
      unitRef="usd">101260000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230207233445148"
      unitRef="usd">-63819000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230207233450251"
      unitRef="usd">36223000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000149"
      unitRef="usd">-27646000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000150"
      unitRef="usd">-12478000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000151"
      unitRef="usd">58000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000152"
      unitRef="usd">34000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000153"
      unitRef="usd">3211000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000154"
      unitRef="usd">2019000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000155"
      unitRef="usd">64000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000156"
      unitRef="usd">2058000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000157"
      unitRef="usd">352000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000158"
      unitRef="usd">1175000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000159"
      unitRef="usd">2823000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230201002431792"
      unitRef="usd">-1279000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000161"
      unitRef="usd">907000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000162"
      unitRef="usd">215000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000163"
      unitRef="usd">-11000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230201002424683"
      unitRef="usd">-2000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000165"
      unitRef="usd">-20370000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000166"
      unitRef="usd">-12374000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cmmb:PaymentsForInvestmentInDeposits
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000167"
      unitRef="usd">-19601000</cmmb:PaymentsForInvestmentInDeposits>
    <cmmb:PaymentsForInvestmentInDeposits
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000168"
      unitRef="usd">45951000</cmmb:PaymentsForInvestmentInDeposits>
    <cmmb:LongTermLeaseDeposit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000169"
      unitRef="usd">0</cmmb:LongTermLeaseDeposit>
    <cmmb:LongTermLeaseDeposit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230131235620864"
      unitRef="usd">4000</cmmb:LongTermLeaseDeposit>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000171"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230131235631064"
      unitRef="usd">1000000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000173"
      unitRef="usd">68000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000174"
      unitRef="usd">239000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000175"
      unitRef="usd">19533000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000176"
      unitRef="usd">-45186000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <cmmb:CashAcquiredInMerger
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000177"
      unitRef="usd">0</cmmb:CashAcquiredInMerger>
    <cmmb:CashAcquiredInMerger
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230131235649216"
      unitRef="usd">2427000</cmmb:CashAcquiredInMerger>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000179"
      unitRef="usd">143000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230131235658097"
      unitRef="usd">10000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230201000241409"
      unitRef="usd">1218000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000182"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000183"
      unitRef="usd">267000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000184"
      unitRef="usd">58637000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230201002754453"
      unitRef="usd">-808000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000186"
      unitRef="usd">61074000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230201002721687"
      unitRef="usd">-1645000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000188"
      unitRef="usd">3514000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000189"
      unitRef="usd">15241000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="FFact_0000000000190"
      unitRef="usd">11727000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000191"
      unitRef="usd">13596000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000192"
      unitRef="usd">15241000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cmmb:IncomeTaxesReceived
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230214142748754"
      unitRef="usd">351000</cmmb:IncomeTaxesReceived>
    <cmmb:IncomeTaxesReceived
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230214143241770"
      unitRef="usd">0</cmmb:IncomeTaxesReceived>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230214142431448"
      unitRef="usd">5000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230207233750059"
      unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <cmmb:InterestReceived
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230207233819452"
      unitRef="usd">972000</cmmb:InterestReceived>
    <cmmb:InterestReceived
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230207233829491"
      unitRef="usd">74000</cmmb:InterestReceived>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000193"
      unitRef="usd">17000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000194"
      unitRef="usd">345000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LiabilitiesAssumed1
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000195"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230131235456185"
      unitRef="usd">49000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:NatureOfOperations contextRef="C_20220101to20221231" id="FFact_0000000000208">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Note 1 - General&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"&gt;1.&lt;span style="padding-left:28.5pt"&gt;Chemomab Therapeutics Ltd. (hereinafter - "the Company") is an Israeli-based company incorporated under the laws of the State of Israel in September 2011. The Company&#x2019;s registered office is located in Kiryat Atidim, Tel Aviv, Israel.&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt;text-align:justify"&gt;&lt;br/&gt;The Company is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0px;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;br/&gt;The wholly owned subsidiaries of the Company are: Chemomab Ltd. ("Chemomab"), Chemomab Therapeutics Israel Ltd. and Chemomab Therapeutics Inc.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"&gt;2.&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="padding-left:28.5pt"&gt;The Company currently has no products approved for sale. The Company&#x2019;s operations are funded primarily by its Shareholders. The Company has incurred operating losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval for its products. Continuation of the Company&#x2019;s development programs depend on its future ability to raise sources of financing.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;span style="padding-left:28.5pt"&gt;Since &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 2020, the COVID-19 pandemic has dramatically expanded into a worldwide pandemic, creating macro-economic uncertainty and disruption in the business and financial markets. Many countries around the world, including Israel, had taken&#160; measures designated to limit the continued spread of the COVID-19 pandemic, including the closure of workplaces, restricting travel, prohibiting assembling, closing international borders and quarantining populated areas. The Company's clinical trial sites have been affected by the COVID-19 pandemic, and as a result, commencement of the enrollment in our clinical trials of CM-101 in PSC was delayed, and the enrollment rate has been, and is still, affected as well. As a result, The Company expanded its patient recruiting efforts to additional territories. In addition, after enrollment in these trials, patients might still drop out because of possible COVID-19 implications. Based on management&#x2019;s assessment, the extent to which the lingering effects of the COVID-19 pandemic will further impact the Company's operations will depend on future developments. These developments, which are highly uncertain and cannot be predicted with confidence,including the duration and severity of the impact on patient enrollment following the attenuation of the outbreak The Company is carefully monitoring the impacts arising from&#160; the COVID-19 pandemic and will adjust activities accordingly&lt;span&gt;&lt;span&gt;&lt;span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;span style="padding-left:28.5pt"&gt;On &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 14, 2020, the Company (formerly known as Anchiano Therapeutics Ltd.) entered into an Agreement and Plan of Merger (the "Merger" and &#x201c;Merger Agreement&#x201d;) with Chemomab Ltd., an Israeli limited company, and CMB Acquisition Ltd., an Israeli limited company and a wholly owned subsidiary of the Company (&#x201c;Merger Sub&#x201d;). On March 16, 2021, (the &#x201c;Effective Time&#x201d;), the Company consummated the Merger pursuant to the Merger Agreement Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Chemomab Ltd., with Chemomab Ltd. surviving the Merger as the Company's wholly owned subsidiary. In connection with the Merger, on March 16, 2021, the Company changed its name from &#x201c;Anchiano Therapeutics Ltd.&#x201d; To &#x201c;Chemomab Therapeutics Ltd" and the business conducted by Chemomab Ltd. became primarily the business conducted by the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div&gt;
      &lt;div style="width:100%;clear:both"&gt;
        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0px;padding-left:72pt;margin-bottom:10pt"&gt;At the Effective Time(a) each Chemomab Ltd. ordinary share outstanding immediately prior to the Effective Time was converted solely into number of American Depository Shares equal to the exchange ratio described in the Merger Agreement, and each outstanding Chemomab Ltd. option was assumed by the Company, based on the same exchange ratio.&lt;/p&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For&#160;&lt;span&gt;accounting purposes, Chemomab Ltd. is considered to have acquired the Company based upon the terms of the Merger as well as other factors. The Merger has been accounted for as an asset acquisition (reverse recapitalization transaction) rather than a business combination, as the assets acquired, and the liabilities assumed by Chemomab Ltd. do not meet the definition of a business under U.S. GAAP. The net assets acquired in connection with the Merger were recorded at their estimated acquisition date fair market value as of March 16, 2021, the date of completion of the Merger.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;The exchange ratio was calculated by a formula that was determined through arms-length negotiations between the Company and Chemomab Ltd. The combined Company assumed all of the outstanding options of Chemomab Ltd., vested and not vested, under the Chemomab&#160;Share Incentive Plan (the &#x201c;2015 Plan&#x201d;), with such options representing the right to purchase a number of ADSs equal to approximately 12.86 multiplied by the number of Chemomab Ltd. ordinary shares previously represented by such options.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:11pt"&gt;The following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion of the Merger (in USD thousands):&lt;/p&gt;
    &lt;div style="margin-left:72pt"&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Cash and cash equivalents&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;2,427&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Asset held for sale&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,000&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Prepaid and other assets&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;236&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Accrued liabilities&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;(1,187&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;)&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Net acquired assets&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;2,476&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
  </us-gaap:NatureOfOperations>
    <cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger
      contextRef="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"
      decimals="INF"
      id="Fxbrl_20230131220949272"
      unitRef="Share">12.86</cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201024915457">
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Cash and cash equivalents&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;2,427&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Asset held for sale&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,000&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Prepaid and other assets&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;236&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Accrued liabilities&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;(1,187&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;)&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Net acquired assets&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;2,476&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_0000000000202"
      unitRef="usd">2427000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_0000000000203"
      unitRef="usd">1000000</cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_0000000000204"
      unitRef="usd">236000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_0000000000205"
      unitRef="usd">1187000</cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <cmmb:EstimatedFairValueOfNetAssetsAcquired
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_0000000000206"
      unitRef="usd">2476000</cmmb:EstimatedFairValueOfNetAssetsAcquired>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000234">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Note 2 - Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;

      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Basis of Preparation&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S GAAP&#x201d;).&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Use of estimates&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Foreign currency&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#x201c;dollar&#x201d; or &#x201c;$&#x201d;), thus; the dollar is the functional currency of the Company.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate.&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;D.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired.&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;E.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments.&lt;/p&gt;


      &lt;div&gt;
        &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;F.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:28.31pt"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.&lt;/p&gt;
        &lt;div&gt;
          &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt"&gt;Annual rates at depreciation are as follows:&lt;/p&gt;
          &lt;div style="margin-left:36pt"&gt;

              &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;


                  &lt;tr style="background-color:#CCEEFF"&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Computers&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;33&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Laboratory equipment&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;10&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:#CCEEFF"&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Furniture and equipment&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;7&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

    &lt;div/&gt;

      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;G.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company&#x2019;s property and equipment are reviewed for impairment in accordance with ASC 360, &#x201c;Property and Equipment&#x201d;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2022 and 2021, no impairment losses have been recorded.&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;H.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Research and Development&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages.&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;I.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Income taxes&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized.&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;J.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:28.5pt"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#x2019;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price.&lt;/p&gt;
      &lt;div/&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#x2019;s own credit risk.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#x2019;s non&lt;span style="font-weight:bold"&gt;- &lt;/span&gt;financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented.&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;K.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Share-based compensation&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The fair value for the Company&#x2019;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;The Company has historically not paid dividends and has no foreseeable plans to pay dividends.&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;L.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Government-sponsored research and development&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Chemomab records grants received from the office of the Israel Innovation Authority (the &#x201c;IIA&#x201d;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses.&lt;/p&gt;

    &lt;div/&gt;

      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;M.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:24.06pt"&gt;Severance pay&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to Section 14 of the Severance Compensation Law, 1963 ("Section 14"), all employees of the Company are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately $142 thousand and $116 thousand for the year ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;N.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Concentrations of credit risk:&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash &lt;span&gt;and cash equivalents and short- term deposits are invested in banks. Management believes that the financial institutions that hold the Company&#x2019;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.&lt;/p&gt;


      &lt;div&gt;
        &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;O.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Leases&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Under &lt;/span&gt;&lt;/span&gt;Topic 842, the Company determines if an arrangement is a lease at inception. Right-of-use (ROU) assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be 5% and 5.2% in 2022 and 2021, respectively. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company's lease agreements generally do not contain any residual value guarantees or restrictive covenants&lt;span&gt;&lt;span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#x2013; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;

    &lt;div/&gt;

      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;P.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:28.31pt"&gt;Principles of consolidation&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The &lt;span&gt;consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Q.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Earnings per ordinary share&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt"&gt;Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. &#160;Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options.&lt;/p&gt;

  </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000209">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Basis of Preparation&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S GAAP&#x201d;).&lt;/p&gt;
    </us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="C_20220101to20221231" id="FFact_0000000000210">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Use of estimates&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.&lt;/p&gt;
    </us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000211">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Foreign currency&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The currency of the primary economic environment in which the operations of the Company are conducted is the U.S. dollar (&#x201c;dollar&#x201d; or &#x201c;$&#x201d;), thus; the dollar is the functional currency of the Company.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The transactions and balances of the Company denominated in U.S. dollars are presented at their original amounts as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Monetary assets and liabilities denominated in a non-U.S. dollar currency are translated using the current exchange rate and nonmonetary assets and liabilities and capital accounts denominated in a non-U.S. dollar currency are translated using historical exchange rates.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Statements of operations accounts denominated in a non-U.S. dollar currency are translated using the exchange rates in effect on the transaction dates, except for depreciation, which is translated using historical exchange rate.&lt;/p&gt;
    </us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000212">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;D.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired.&lt;/p&gt;
    </us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="C_20220101to20221231" id="FFact_0000000000213">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;E.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;Restricted cash is primarily invested in highly liquid deposits. These deposits were used to secure office rent payments.&lt;/p&gt;
    </us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201130501547">
      &lt;div&gt;
        &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;F.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:28.31pt"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Property and equipment are stated at cost less accumulated depreciation. Maintenance and repair expenses are charged to operation as incurred. Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets and commences once the assets are ready for their intended use.&lt;/p&gt;
        &lt;div&gt;
          &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt"&gt;Annual rates at depreciation are as follows:&lt;/p&gt;
          &lt;div style="margin-left:36pt"&gt;

              &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;


                  &lt;tr style="background-color:#CCEEFF"&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Computers&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;33&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Laboratory equipment&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;10&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:#CCEEFF"&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Furniture and equipment&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;7&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201131108956">
              &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;


                  &lt;tr style="background-color:#CCEEFF"&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Computers&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;33&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Laboratory equipment&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;10&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr style="background-color:#CCEEFF"&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Furniture and equipment&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;7&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%"&gt;
                      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Leasehold improvement - over the shorter of the lease term or the estimated useful life of the improvement&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:9%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="2"
      id="FFact_0000000000214"
      unitRef="Pure">0.33</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember"
      decimals="2"
      id="FFact_0000000000215"
      unitRef="Pure">0.10</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"
      decimals="2"
      id="FFact_0000000000216"
      unitRef="Pure">0.07</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <cmmb:AnnualRatesOfDepreciation
      contextRef="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"
      id="FFact_0000000000217">over the shorter of the lease term or the estimated useful life of the improvement</cmmb:AnnualRatesOfDepreciation>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000220">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;G.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company&#x2019;s property and equipment are reviewed for impairment in accordance with ASC 360, &#x201c;Property and Equipment&#x201d;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less selling costs. During the periods ended December 31, 2022 and 2021, no impairment losses have been recorded.&lt;/p&gt;
    </us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="C_20220101to20221231" id="FFact_0000000000221">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;H.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Research and Development&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Research and development costs are charged to operations as incurred. Most of the research and development expenses are for subcontractors and wages.&lt;/p&gt;
    </us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000222">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;I.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Income taxes&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the income taxes expense.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50 percent likely of being realized.&lt;/p&gt;
    </us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000223">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;J.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:28.5pt"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;ASC 820, Fair Value Measurements and Disclosures, relating to fair value measurements, defines fair value and established a framework for measuring fair value. The ASC 820 fair value hierarchy distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity and the reporting entity&#x2019;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price.&lt;/p&gt;
      &lt;div/&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;In addition, the fair value of assets and liabilities should include consideration of non-performance risk, which for the liabilities described below includes the Company&#x2019;s own credit risk.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The carrying amounts of cash and cash equivalents trade payables, other receivables and accrued expenses approximate their fair value due to the short-term maturity of such instruments. The fair value of long-term restricted deposits and restricted cash also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. None of the Company&#x2019;s non&lt;span style="font-weight:bold"&gt;- &lt;/span&gt;financial assets or liabilities are recorded at fair value on a non-recurring basis. No transfers between levels have occurred during the periods presented.&lt;/p&gt;
    </us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="C_20220101to20221231" id="FFact_0000000000224">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;K.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Share-based compensation&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company accounts for share-based compensation as an expense in the financial statements based on ASC 718. All awards are equity classified and therefore such costs are measured at the grant date fair value of the award and graded vesting attribution approach to recognize compensation cost over the vesting period. The Company recognizes compensation cost for an award with only service conditions that has a graded vesting schedule on a straight-line basis over the requisite service period for the entire award, provided that the cumulative amount of compensation cost recognized at any date at least equals the portion of the grant-date value of such award that is vested at that date.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The fair value for the Company&#x2019;s stock options granted to employees, consultants and directors was estimated using Black-Scholes option-pricing model at the grant date, using the inputs detailed in Note 8(C).&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;The Company has historically not paid dividends and has no foreseeable plans to pay dividends.&lt;/p&gt;
    </us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <cmmb:GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000225">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;L.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Government-sponsored research and development&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Chemomab records grants received from the office of the Israel Innovation Authority (the &#x201c;IIA&#x201d;) as a liability, if it is probable that the Chemomab will have to repay the grants received. If it is not probable that the grants will be repaid, Chemomab records the grants as a reduction to research and development expenses.&lt;/p&gt;
    </cmmb:GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock>
    <cmmb:SeverancePayPolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000229">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;M.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:24.06pt"&gt;Severance pay&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to Section 14 of the Severance Compensation Law, 1963 ("Section 14"), all employees of the Company are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made on their behalf with insurance companies. Upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. This plan has been accounted for as a defined contribution plan. Severance costs amounted to approximately $142 thousand and $116 thousand for the year ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    </cmmb:SeverancePayPolicyTextBlock>
    <cmmb:PercentageOfMonthlyDepositsRate
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20230215220314714"
      unitRef="Pure">0.0833</cmmb:PercentageOfMonthlyDepositsRate>
    <us-gaap:SeveranceCosts1
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230215220321806"
      unitRef="usd">142000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230215220329094"
      unitRef="usd">116000</us-gaap:SeveranceCosts1>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="C_20220101to20221231" id="FFact_0000000000230">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;N.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Concentrations of credit risk:&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash &lt;span&gt;and cash equivalents and short- term deposits are invested in banks. Management believes that the financial institutions that hold the Company&#x2019;s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The Company have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.&lt;/p&gt;
    </us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213125125767">
      &lt;div&gt;
        &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;O.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Leases&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Under &lt;/span&gt;&lt;/span&gt;Topic 842, the Company determines if an arrangement is a lease at inception. Right-of-use (ROU) assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company's incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be 5% and 5.2% in 2022 and 2021, respectively. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. When determining the probability of exercising such options, the Company considers contract-based, asset-based, entity-based, and market-based factors. For leases agreements, the Company has elected the practical expedient to account for the lease and non-lease maintenance components as a single lease component. Therefore, for those leases, the lease payments used to measure the lease liability include all the fixed consideration in the contract. The Company's lease agreements generally do not contain any residual value guarantees or restrictive covenants&lt;span&gt;&lt;span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For operating leases, the ROU asset is subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify;margin-left:36pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ROU assets for operating leases are periodically reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, Property, Plant, and Equipment &#x2013; Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize. See Note 2(G).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </us-gaap:LesseeLeasesPolicyTextBlock>
    <cmmb:IncrementalBorrowingRateOfLeases
      contextRef="C_20221231"
      decimals="2"
      id="Fxbrl_20230213132631771"
      unitRef="Pure">0.05</cmmb:IncrementalBorrowingRateOfLeases>
    <cmmb:IncrementalBorrowingRateOfLeases
      contextRef="C_20211231"
      decimals="3"
      id="Fxbrl_20230213132641931"
      unitRef="Pure">0.052</cmmb:IncrementalBorrowingRateOfLeases>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000232">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;P.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:28.31pt"&gt;Principles of consolidation&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The &lt;span&gt;consolidated financial statements include the accounts of the Company and its Subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    </us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000233">
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Q.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Earnings per ordinary share&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt"&gt;Basic earnings per ordinary share is calculated using only weighted average ordinary shares outstanding. Diluted earnings per share, if relevant, gives effect to dilutive potential ordinary shares outstanding during the year. &#160;Such dilutive shares consist of incremental shares, using the treasury stock method, from the assumed exercise of share options.&lt;/p&gt;
    </us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsDisclosureTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000244">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"&gt;&lt;span style="font-weight:bold"&gt;Note 3 - Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;In USD&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;10,663&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;10,720&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;In NIS&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,756&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,116&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;In other currencies&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;100&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;3,350&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;13,519&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;15,186&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;

  </us-gaap:CashAndCashEquivalentsDisclosureTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000243">
      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;In USD&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;10,663&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;10,720&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;In NIS&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,756&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,116&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;In other currencies&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;100&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;3,350&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;13,519&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;15,186&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    </us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231_srtCurrencyAxis_currencyUSD"
      decimals="-3"
      id="FFact_0000000000235"
      unitRef="usd">10663000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231_srtCurrencyAxis_currencyUSD"
      decimals="-3"
      id="FFact_0000000000236"
      unitRef="usd">10720000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231_srtCurrencyAxis_currencyILS"
      decimals="-3"
      id="FFact_0000000000237"
      unitRef="usd">2756000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231_srtCurrencyAxis_currencyILS"
      decimals="-3"
      id="FFact_0000000000238"
      unitRef="usd">1116000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="FFact_0000000000239"
      unitRef="usd">100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="FFact_0000000000240"
      unitRef="usd">3350000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000241"
      unitRef="usd">13519000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000242"
      unitRef="usd">15186000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000252">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"&gt;&lt;span style="font-weight:bold"&gt;Note 4 - Other Receivables and Prepaid Expenses&lt;/span&gt;&lt;/p&gt;

      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Government institutions&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;459&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;179&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Prepaid expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;1,307&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,348&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;1,766&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,527&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;

  </cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock>
    <cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000251">
      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Government institutions&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;459&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;179&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Prepaid expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;1,307&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,348&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;1,766&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,527&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    </cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock>
    <cmmb:ReceivablesFromGovernmentInstitutions
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000245"
      unitRef="usd">459000</cmmb:ReceivablesFromGovernmentInstitutions>
    <cmmb:ReceivablesFromGovernmentInstitutions
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000246"
      unitRef="usd">179000</cmmb:ReceivablesFromGovernmentInstitutions>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000247"
      unitRef="usd">1307000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000248"
      unitRef="usd">1348000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000249"
      unitRef="usd">1766000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000250"
      unitRef="usd">1527000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000270">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"&gt;&lt;span style="font-weight:bold"&gt;Note 5 - Property and Equipment, Net&lt;/span&gt;&lt;/p&gt;

      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Cost:&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Computers&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;70&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;43&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Furniture and equipment&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;33&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;27&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Laboratory equipment&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;399&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;364&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Website development&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;14&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;14&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Leasehold improvements&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;16&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;16&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;&lt;strong&gt;&lt;strong&gt;&lt;strong&gt;532&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;464 &lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Less - accumulated depreciation&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;165&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;(107&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;)&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;&lt;strong&gt;&lt;strong&gt;&lt;strong&gt;367&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;357 &lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;

  </us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000269">
      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Cost:&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Computers&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;70&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;43&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Furniture and equipment&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;33&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;27&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Laboratory equipment&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;399&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;364&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Website development&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;14&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;14&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Leasehold improvements&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;16&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;16&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;&lt;strong&gt;&lt;strong&gt;&lt;strong&gt;532&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;464 &lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Less - accumulated depreciation&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;165&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;(107&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;)&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;&lt;strong&gt;&lt;strong&gt;&lt;strong&gt;367&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;357 &lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    </us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="-3"
      id="FFact_0000000000253"
      unitRef="usd">70000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="-3"
      id="FFact_0000000000254"
      unitRef="usd">43000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"
      decimals="-3"
      id="FFact_0000000000255"
      unitRef="usd">33000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"
      decimals="-3"
      id="FFact_0000000000256"
      unitRef="usd">27000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember"
      decimals="-3"
      id="FFact_0000000000257"
      unitRef="usd">399000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_cmmbLaboratoryEquipmentMember"
      decimals="-3"
      id="FFact_0000000000258"
      unitRef="usd">364000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapSoftwareDevelopmentMember"
      decimals="-3"
      id="FFact_0000000000259"
      unitRef="usd">14000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapSoftwareDevelopmentMember"
      decimals="-3"
      id="FFact_0000000000260"
      unitRef="usd">14000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"
      decimals="-3"
      id="FFact_0000000000261"
      unitRef="usd">16000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"
      decimals="-3"
      id="FFact_0000000000262"
      unitRef="usd">16000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230201032006902"
      unitRef="usd">532000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000264"
      unitRef="usd">464000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000265"
      unitRef="usd">165000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000266"
      unitRef="usd">107000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230201033845372"
      unitRef="usd">367000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000268"
      unitRef="usd">357000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000294">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Note 6 - Leases&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;On May 10, 2020, Chemomab entered into an office and lab space lease agreement (hereinafter &#x2013; &#x201c;The Agreement&#x201d; .(According to the Agreement, Chemomab &#160;rented a space in Atidim Park, Tel-Aviv for a period of three years, through &lt;span style="-sec-ix-hidden:Fxbrl_20230131233234992"&gt;May 2023&lt;/span&gt;. Chemomab was granted an option to extend the lease term by additional three years.&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;On October 24, 2021, Chemomab signed an amendment to the Agreement ("The Amendment"). According to the Amendment, On December 12, 2021 Chemomab returned the previous office and lab space to the property owner and rented a larger space in Atidim Park Tel-Aviv, for a term of 3 years, through &lt;span style="-sec-ix-hidden:Fxbrl_20230131233722905"&gt;October 2024&lt;/span&gt;. In addition, Chemomab was granted an option to extend the lease term by additional three years. The annual rent and management fees are approximately $122 thousand. Pursuant to the Amendment, the bank guarantee issued in 2020 was canceled and a substitute bank guarantee of approximately $77 thousand was issued to the property owner during 2022.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;The above operating leases are included in &#x201c;Operating lease right-of-use assets&#x201d; on the Company&#x2019;s Consolidated Balance sheets as of December 31, 2022 and 2021 and represent the Company&#x2019;s right to use the underlying asset for the lease term. The Company&#x2019;s obligations to pay lease payments are included in the current liabilities as &#x201c;Operating lease liabilities&#x201d; and in the non-current liabilities as &#x201c;Non-current operating lease liabilities&#x201d; on the Company&#x2019;s Consolidated Balance sheets as of December 31, 2022 and 2021. Based on the present value of the lease payments for the remaining lease term of the Company&#x2019;s existing lease agreement, the Company recognized operating right-of-use assets and operating lease liabilities of approximately $345 thousand on December 12, 2021.&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;During the years ended December 31, 2022 and 2021, the Company recognized an increase in right of use assets of $17 thousand and $345 thousand, respectively.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As&#160;of December 31, 2022, and 2021 operating right-of-use asset was $227 thousand and $345 thousand, respectively. The operating lease liabilities were $214 thousand and $343 thousand, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;As most of the Chemomab&#x2019;s leases do not provide an implicit rate, Chemomab uses its incremental borrowing rate based on the information available at the commencement date of each lease in determining the present value of lease payments. Chemomab&#x2019;s incremental borrowing rate is a hypothetical rate based on its estimation of what its credit rating would be the rate was 5% in 2022 and 5.2% in 2021.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt"&gt;Maturities of lease liabilities under noncancellable leases as of December 31, 2022, are as follows: (in thousands):&lt;/p&gt;
    &lt;div style="margin-left:40pt;margin-bottom:11pt"&gt;

        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;2023&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;126 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;2024&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;93 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Total future minimum lease payments&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;219 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Less imputed interest:&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;5&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Present value of operating lease liabilities&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;214 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
  </us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="C_20200510" id="Fxbrl_20230131233210356">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="C_20200501to20200510"
      id="Fxbrl_20230131233301410">three years</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="C_20211024" id="Fxbrl_20230131233734834">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="C_20211001to20211024"
      id="Fxbrl_20230201000916081">three years</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <cmmb:AnnualRentAndManagementFees
      contextRef="C_20211001to20211024"
      decimals="-3"
      id="Fxbrl_20230131234005244"
      unitRef="usd">122000</cmmb:AnnualRentAndManagementFees>
    <cmmb:BankGuaranteesToPropertyOwner
      contextRef="C_20211001to20211024"
      decimals="-3"
      id="Fxbrl_20230131234014829"
      unitRef="usd">77000</cmmb:BankGuaranteesToPropertyOwner>
    <cmmb:OperatingRightOfUseAssetsAndOperatingLeaseLiabilities
      contextRef="C_20211212"
      decimals="-3"
      id="Fxbrl_20230131234456429"
      unitRef="usd">345000</cmmb:OperatingRightOfUseAssetsAndOperatingLeaseLiabilities>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230131234508150"
      unitRef="usd">17000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230131234513790"
      unitRef="usd">345000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230214143811730"
      unitRef="usd">227000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230214143818906"
      unitRef="usd">345000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230214143827206"
      unitRef="usd">214000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230214143833566"
      unitRef="usd">343000</us-gaap:OperatingLeaseLiability>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20230131234937485"
      unitRef="Pure">0.05</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="C_20210101to20211231"
      decimals="3"
      id="Fxbrl_20230131234957047"
      unitRef="Pure">0.052</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201025037730">
        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;2023&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;126 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;2024&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;93 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Total future minimum lease payments&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;219 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Less imputed interest:&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;5&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Present value of operating lease liabilities&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;214 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000288"
      unitRef="usd">126000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000289"
      unitRef="usd">93000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000290"
      unitRef="usd">219000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000291"
      unitRef="usd">5000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000292"
      unitRef="usd">214000</us-gaap:OperatingLeaseLiability>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000311">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Note 7 - Commitments and Contingent Liabilities&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Exclusive License Agreement (hereinafter- &#x201c;the License Agreement&#x201d;)&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;In December 2011, Chemomab entered into a License Agreement with the Medical Research, Infrastructure, Health Services Fund of the Tel-Aviv Souraski Medical Center (&#x201c;Fund&#x201d;), pursuant to which it was granted with an exclusive license to certain inventions (as defined in the License Agreement) including patents, knowhow and products and the right to sublicense to third parties the rights granted, pursuant to and subject to certain terms and limitation fully set in the License Agreement.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;Chemomab has agreed to pay the Fund a non-refundable and non-creditable sublicense fees as a percentage of all Attributed Income (as such term defined in the License Agreement), and shall further pay the Fund royalties from sales made by sublicensee;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"&gt;(i)&lt;span style="padding-left:26.56pt"&gt;Royalties in percentage of the Net sales or Service Income (as defined in the License Agreement), subject to &lt;/span&gt;certain additional terms set forth therein.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:108pt;margin-bottom:0pt"&gt;&lt;span&gt;In addition, with respect to each Licensed Product (as defined therein), Chemomab has agreed to &#160;pay the Fund the following non-refundable, non-creditable amounts:&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:144pt;margin-bottom:11pt"&gt;(a)&lt;span style="padding-left:24.9pt"&gt;$100 thousand upon submission of a New Drug Application (&#x201c;NDA&#x201d;), Biological License Application (&#x201c;BLA&#x201d;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#x201c;FDA&#x201d;), $100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than $300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0pt;text-indent:-36pt;padding-left:144pt;margin-bottom:0pt"&gt;(b)&lt;span style="padding-left:24.34pt"&gt;$200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than $600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:108pt;margin-bottom:0pt"&gt;As of December 31, 2022&#160;no payments were made to the Fund.&lt;/p&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;In addition to the payments described above, upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab, if any), but in any event not more than $3,000 thousand.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="padding-left:26.83pt"&gt;&#160; &#160;Chemomab partially financed its research and development expenditures under programs sponsored by the Israel &lt;/span&gt;Innovation Authority (&#x201c;IIA&#x201d;) for the support of certain research and development activities conducted in Israel.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;In return for the IIA&#x2019;s participation, Chemomab is committed to pay royalties at rate of 3% of sales of the developed product (linked to U.S. dollar), up to 100% of the amount of grants received (100% plus interest at LIBOR). In addition, the IIA may impose certain conditions to transfer technology or development out of Israel.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"&gt;Chemomab did not receive any grants from the IIA in the years ended December 31, 2022, and 2021.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;Since Chemomab &#x2019;s incorporation through December 31, 2022 Chemomab received $1,227 thousand from the IIA, which were recognized as a reduction of research and development expenses.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;As of December 31, 2022, Chemomab has no commitment for royalties payable.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="padding-left:26.28pt"&gt;In &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;June 2015, Chemomab entered into a license agreement with subcontractor (&#x201c;the Subcontractor&#x201d;), under which the Subcontractor granted to Chemomab certain licenses to use proprietary rights of the subcontractor, materials and know how in the techniques and use of the same, for purposes of research and development of Chemomab 's product CM-101, as well as commercialization thereof. Further to the agreement, the Subcontractor also provides manufacturing services of intermediates and active pharmaceutical ingredients. According to the related manufacturing agreement, the manufacturing of the product is carried out by the Subcontractor in accordance with Chemomab's specifications and timeline.&#160; From time to time, Chemomab and the Subcontractor have been signing additional agreements for additional manufacturing and final process lock of the product for clinical use Under the agreement, Chemomab is also obligated to pay the Subcontractor royalties determined as a percentage of net sales of each licensee product.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:0pt;padding-left:72pt;margin-bottom:0pt"&gt;During 2022 and 2021, Chemomab recorded expenses related to the above agreements in the amounts of $5,222 thousand and $2,590 thousand, respectively. The expenses were recorded under research and development expenses.&lt;/p&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:11pt"&gt;&lt;span style="font-weight:bold"&gt;C.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="padding-left:26.28pt"&gt;As&#160;&lt;/span&gt;&lt;/span&gt;of December 31, 2022, the bank imposed restriction on a bank deposit in the amount of $77 thousand for the purpose of secure lease payments under an office lease agreement.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:11pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;D.&lt;/span&gt;&lt;span&gt;&lt;span style="padding-left:26.28pt"&gt;During&#160;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;2022, the Israeli tax authority ("ITA&#x201d;) notified the Company that it had initiated a routine VAT audit to include tax years 2017 through 202&lt;/span&gt;&lt;span&gt;2&lt;/span&gt;&lt;span&gt;. The ITA raised several claims, mainly in respect with the recoverability of VAT with respect to Merger Agreement related expenses and the classification of the Company as a holding company. On July 2022, the ITA proposed a settlement, which the Company rejected. As a result, the ITA issued assessments in the aggregate amount of $1,046 thousand. The Company filed an appeal against the ITA&#x2019;s assessments. The Company has recorded an appropriate provision which considers inherent uncertainty of these matters and the judicial process. Therefore, the outcome may differ from the estimated liability recorded by the Company during the period&lt;/span&gt;&lt;span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
  </us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:LongTermPurchaseCommitmentDescription
      contextRef="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_usgaapCapitalAdditionsMember"
      id="Fxbrl_20230215222406006">$100 thousand upon submission of a New Drug Application (&#x201c;NDA&#x201d;), Biological License Application (&#x201c;BLA&#x201d;) or equivalent for each Licensed Product to the United States Food and Drug Administration (&#x201c;FDA&#x201d;), $100 thousand upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Europe and one hundred thousand dollars upon submission of similar application for each Licensed Product to an equivalent foreign regulatory agency in Asia. Payment in the aggregate shall not be more than $300 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once;</us-gaap:LongTermPurchaseCommitmentDescription>
    <us-gaap:LongTermPurchaseCommitmentDescription
      contextRef="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_cmmbCapitalAdditionsOneMember"
      id="Fxbrl_20230215222519809">$200 thousand upon the grant of FDA or equivalent agency marketing approval in Europe and/or Asia for each Licensed Product. Payment in the aggregate shall not be more than $600 thousand per each Licensed Product, provided that for each jurisdiction, payment shall be made only once.</us-gaap:LongTermPurchaseCommitmentDescription>
    <us-gaap:OtherCommitmentsDescription
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230215222713212">upon the occurrence of either (i) closing of a public offering of the ordinary shares of Chemomab; or (ii) a Change of Control Transaction, Chemomab shall pay the Fund a cash payment equal to one percent (1%) of the proceeds raised by Chemomab in its initial public offering, or 1% of the consideration received by Chemomab or its shareholders at the closing of a Change of Control Transaction (after deduction of amounts paid as liquidation preference to the shareholders of Chemomab on account of their investment in Chemomab, if any), but in any event not more than $3,000 thousand.</us-gaap:OtherCommitmentsDescription>
    <cmmb:PercentageOfRoyaltyPaymentsOnSaleOfProduct
      contextRef="C_20220101to20221231_usgaapLongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_usgaapCapitalAdditionsMember"
      decimals="2"
      id="Fxbrl_20230201002925810"
      unitRef="Pure">0.03</cmmb:PercentageOfRoyaltyPaymentsOnSaleOfProduct>
    <cmmb:MaximumPercentageOfPaymentsOfRoyalties
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20230201002935951"
      unitRef="Pure">1</cmmb:MaximumPercentageOfPaymentsOfRoyalties>
    <cmmb:CumulativeAmountsOfGrantsReceivedAndRecognized
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230201002951961"
      unitRef="usd">1227000</cmmb:CumulativeAmountsOfGrantsReceivedAndRecognized>
    <us-gaap:RoyaltyExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213125722009"
      unitRef="usd">5222000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213125731080"
      unitRef="usd">2590000</us-gaap:RoyaltyExpense>
    <us-gaap:RestrictedInvestments
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230213125744104"
      unitRef="usd">77000</us-gaap:RestrictedInvestments>
    <cmmb:RecoverabilityOfVatAmount
      contextRef="C_20220701to20220731"
      decimals="-3"
      id="Fxbrl_20230207215117039"
      unitRef="usd">1046000</cmmb:RecoverabilityOfVatAmount>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000385">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Note 8 - Share Capital&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Right attached to shares&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold;font-style:italic"&gt;Ordinary shares&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:72pt;margin-bottom:0pt"&gt;All of the issued and outstanding ordinary shares of the Company are duly authorized, validly issued, fully paid and non-assessable. The ordinary shares are not redeemable, and each ordinary share is entitled to one vote. The holders of the ordinary shares have the right to vote and participate in shareholders' meetings, the right to receive profits, and the right to participate in the accumulated earnings when the Company is dissolved.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;1.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:28.5pt"&gt;Voting&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-bottom:0pt;margin-left:108pt"&gt;The holders of ordinary shares are entitled to vote on all matters submitted to shareholders for a vote.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:28.5pt"&gt;Dividends&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-bottom:0pt;margin-left:108pt"&gt;The holders of the ordinary shares are entitled to receive dividends, when and as declared by the Board of Directors, and out of funds legally available.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-bottom:0pt;margin-left:108pt"&gt;Since its inception, the Company has not declared any dividends.&lt;/p&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;span style="padding-left:26.83pt;font-weight:bold"&gt;Financing rounds&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;span style="padding-left:28.5pt"&gt;In&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;connection with the Merger, on March 15, 2021, the Company entered into Securities Purchase Agreements with certain purchasers, pursuant to which the Company agreed to sell approximately $45.5 million of its American Depositary Shares (ADSs)&#160;in a private placement transaction, (or "The Private Placement"). The Private Placement closed on March 22, 2021, at which time the Company sold to the purchasers 2,619,270 ADSs together with warrants to purchase up to 261,929 ADSs at an exercise price of $17.35 per ADS. The warrants will expire five years from the date of issuance, and if exercised in full, will provide to the Company proceeds of approximately $4.5 million. 20 Ordinary Shares are equal to 1 American Depositary Share (ADS).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;span style="padding-left:28.5pt"&gt;On&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;April 30, 2021, the Company entered into an At the Market Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &amp;amp; Co., ("Cantor"). According to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75 million through Cantor or the ATM Agreement. From April 30, 2021, through December 31, 2022, the Company issued 699,806 ADSs at an average price of $22.75 per ADS under the ATM Agreement, resulting in gross proceeds of $15,917 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3.&lt;/span&gt;&lt;span style="padding-left:28.5pt"&gt;On &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $18,125,000&#160;of its ADSs in connection with the reactivation of the ATM Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject to certain exceptions, limits the amount of securities the Company is able to offer and sell under such registration statement to one-third of our unaffiliated public float. During the year ended &#160;December 31, 2022, the Company issued&#160;130,505 ADSs at an average price of $2.11 per ADS under the ATM Agreement, resulting in gross proceeds of $275 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4.&lt;/span&gt;&lt;span style="padding-left:28.5pt"&gt;On&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;September 19, 2022, the Company entered&#160; into a share purchase agreement (the &#x201c;Repurchase Arrangement&#x201d;) with Dr. Adi Mor, co-founder of Chemomab Ltd., Chief Scientific Officer and a director of the Company and Professor Kobi George, co-founder of Chemomab Ltd. (together with Dr. Adi Mor, the &#x201c;Co-Founders&#x201d;), whereby the Company agreed, subject to the requisite court approval required under Section 303(a) of the Israeli Companies Law, 5759-1999 (the &#x201c;Companies Law&#x201d;), which the Company received on November 14, 2022, to repurchase up to 582,023 of the Company's ADSs owned by the Co-Founders, for consideration not to exceed an aggregate amount of $2,500,000, depending on the market price of the ADSs at the time of any repurchase. Accordingly, on November 16, 2022, the company repurchased the entire amount of 582,023 ADSs from the Co-Founders at a weighted average price of $2.0848 and for total consideration of approximately $1,218 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-bottom:0pt;margin-left:108pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:110%"&gt;The Company accounted for the repurchased shares as treasury share&#160;in accordance with ASC 505-30, "Treasury Stock".&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Share-based compensation&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt"&gt;(1)&lt;span style="padding-left:24.34pt"&gt;Share-based compensation plan:&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:108pt;margin-bottom:0pt"&gt;The Company maintains (i) the 2011 Share Option Plan (the &#x201c;2011 Plan&#x201d;), (ii) the 2017 Equity-Based Incentive Plan (the &#x201c;2017 Plan&#x201d;) and (iii) the Chemomab 2015 Share Incentive Plan (the &#x201c;2015 Plan&#x201d;), which was assumed by the Company from Chemomab upon the effectiveness of the Merger. At that time, outstanding options under the 2015 Plan became exercisable for such number of ADSs of the Company as was determined based on the exchange ratio in the Merger Agreement, with a reciprocal adjustment to exercise price.&lt;br/&gt;&#160;&lt;/p&gt;
    &lt;p style="margin-top:0pt;margin-left:108pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;As of December 31, 2022, a total of 28,443,060 of our Ordinary Shares (equal to 1,422,153 of ADSs) were reserved for issuance under the 2015 Plan, of which 3,445,520 Ordinary Shares (equal to 172,276 ADSs) had been issued pursuant to previous exercises options, and 23,460,740 &#160;Ordinary Shares (equal to 1,173,037 ADSs) were issuable under outstanding options. Of such outstanding options, options to purchase 12,400,720 Ordinary Shares (equal to 620,036 ADSs) had vested and were exercisable as of that date, with a weighted average exercise price of $0.30 per Ordinary Share (or $5.96 per ADS). During the year ended December 31, 2022, options to purchase 1,240,120 Ordinary Shares (equal to 62,006 ADS) were canceled.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;
    &lt;p style="margin-top:0pt;margin-left:108pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;As of December 31, 2022, a total of 12,511,620 of our Ordinary Shares (equal to 625,581 of our ADSs) were reserved for issuance under the 2017 Plan, of which 11,730,800 Ordinary Shares (equal to 586,540 ADSs) were issuable under outstanding options. Of such outstanding options, options to purchase 427,540 Ordinary Shares (equal to 21,377 ADSs) had vested and were exercisable as of that date, with a weighted average exercise price of $0.35 per Ordinary Share (or $6.98 per ADS). During the year ended December 31, 2022 no options were canceled.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:11pt"&gt;(2)&lt;span style="padding-left:24.34pt"&gt;The expenses that were recognized in the consolidated statements of operations for services received from employees &lt;/span&gt;and service providers are as follows:&lt;/p&gt;
    &lt;div style="margin-left:108pt"&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Research and development&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;448&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;137&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;General and administrative&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,763&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,882&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Total share-based compensation expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;3,211&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;2,019&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:11pt"&gt;(3)&lt;span style="padding-left:24.34pt"&gt;The number and weighted average exercise price of options are as follows:&lt;/span&gt;&lt;/p&gt;
    &lt;div style="margin-left:108pt"&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Weighted &lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;average&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;exercise &lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;price&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Number of &lt;/span&gt;&lt;span style="font-weight:bold"&gt;options&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;average &lt;/span&gt;&lt;span style="font-weight:bold"&gt;remaining &lt;/span&gt;&lt;span style="font-weight:bold"&gt;contractual &lt;/span&gt;&lt;span style="font-weight:bold"&gt;life (in years)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;average &lt;/span&gt;&lt;span style="font-weight:bold"&gt;exercise price&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Number of &lt;/span&gt;&lt;span style="font-weight:bold"&gt;options&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;average &lt;/span&gt;&lt;span style="font-weight:bold"&gt;remaining &lt;/span&gt;&lt;span style="font-weight:bold"&gt;contractual &lt;/span&gt;&lt;span style="font-weight:bold"&gt;life (in years)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Outstanding at January 1&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.38&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;27,003,260&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;8.12&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;0.07&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;10,455,580&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;7.8&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Acquired in Merger&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;text-align:right"&gt;-&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;-&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;609,535&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Exercised&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.07&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;1,970,000&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(134,220&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Forfeited&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.32&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;1,240,120&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1.25&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;(1,712,275&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Granted&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.16&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;11,398,400&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;7.8&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:10%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;0.62&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;17,784,640&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;9.79&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Outstanding at December 31&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.33&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;35,191,540&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;7.42&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;0.38&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;27,003,260&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;8.12&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-left:72pt;margin-bottom:0pt"&gt;(4)&lt;span style="padding-left:24.34pt"&gt;Fair value measurement:&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;margin-left:108pt;margin-bottom:11pt"&gt;The fair value of the options is measured at the grant date using the Black-Scholes Option pricing model and the assumptions used to calculate the fair value of the options are as follows:&lt;/p&gt;
    &lt;div style="margin-left:108pt"&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;2022&#160;grants&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Weighted average share price (in U.S. dollar)&lt;sup&gt;(a)&lt;/sup&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;0.16&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Exercise price (in U.S. dollar)&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;0.10&lt;/span&gt;&lt;span style="font-weight:bold"&gt;-&lt;/span&gt;&lt;span style="font-weight:bold"&gt;0.257&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Expected life of options (in years)&lt;sup&gt;(b)&lt;/sup&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;5.51&lt;/span&gt;&lt;span style="font-weight:bold"&gt;-&lt;/span&gt;&lt;span style="font-weight:bold"&gt;6.28&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Expected volatility&lt;sup&gt;(c)&lt;/sup&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;83.69&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%-&lt;/span&gt;&lt;span style="font-weight:bold"&gt;84.31&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Risk-free interest rate&lt;sup&gt;(d)&lt;/sup&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;1.75&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%-&lt;/span&gt;&lt;span style="font-weight:bold"&gt;4.14&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Dividend yield&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;0&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"&gt;(a)&lt;span style="padding-left:24.34pt"&gt;The weighted average share price is based on the Company&#x2019;s Ordinary Share valuation as at the grant date.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"&gt;(b)&lt;span style="padding-left:24.34pt"&gt;Expected life for the periods presented was determined according to the simplified method since, at the date of &lt;/span&gt;grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#x2019; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:0pt"&gt;(c)&lt;span style="padding-left:24.34pt"&gt;Expected volatility is based on historical volatility over the most recent period commensurate with the expected &lt;/span&gt;term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#x2019;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#x2019;s expected term.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;text-indent:-36pt;padding-left:108pt;margin-bottom:11pt"&gt;(d)&lt;span style="padding-left:24.34pt"&gt;The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the &lt;/span&gt;yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards.&lt;/p&gt;
  </us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <cmmb:ProceedsFromSaleOfAdss
      contextRef="C_20210301to20210315_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20230213133908909"
      unitRef="usd">45500000</cmmb:ProceedsFromSaleOfAdss>
    <cmmb:NumberOfWarrantsPurchaseUpAdss
      contextRef="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20230213133843633"
      unitRef="Share">2619270</cmmb:NumberOfWarrantsPurchaseUpAdss>
    <cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues
      contextRef="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20230213133849363"
      unitRef="Share">261929</cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues>
    <cmmb:SaleOfStocksPricePerShare
      contextRef="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="2"
      id="Fxbrl_20230213133830904"
      unitRef="USD_Per_Share">17.35</cmmb:SaleOfStocksPricePerShare>
    <cmmb:ProceedsFromSaleOfAdss
      contextRef="C_20210301to20210323_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20230213133820824"
      unitRef="usd">4500000</cmmb:ProceedsFromSaleOfAdss>
    <cmmb:AggregateOfferingPriceOfAtMarketOfferingAgreement
      contextRef="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"
      decimals="-6"
      id="Fxbrl_20230213133808746"
      unitRef="usd">75000000</cmmb:AggregateOfferingPriceOfAtMarketOfferingAgreement>
    <cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues
      contextRef="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"
      decimals="INF"
      id="Fxbrl_20230213133801744"
      unitRef="Share">699806</cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues>
    <cmmb:SaleOfStocksPricePerShare
      contextRef="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"
      decimals="2"
      id="Fxbrl_20230213133754484"
      unitRef="USD_Per_Share">22.75</cmmb:SaleOfStocksPricePerShare>
    <cmmb:ProceedsFromSaleOfAdss
      contextRef="C_20210401to20210430_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"
      decimals="-3"
      id="Fxbrl_20230213133747440"
      unitRef="usd">15917000</cmmb:ProceedsFromSaleOfAdss>
    <cmmb:AggregateOfferingPriceOfAtMarketOfferingAgreement
      contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"
      decimals="0"
      id="Fxbrl_20230213133711976"
      unitRef="usd">18125000</cmmb:AggregateOfferingPriceOfAtMarketOfferingAgreement>
    <cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues
      contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"
      decimals="INF"
      id="Fxbrl_20230213133726969"
      unitRef="Share">130505</cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues>
    <cmmb:SaleOfStocksPricePerShare
      contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"
      decimals="INF"
      id="Fxbrl_20230213133719951"
      unitRef="USD_Per_Share">2.11</cmmb:SaleOfStocksPricePerShare>
    <cmmb:ProceedsFromSaleOfAdss
      contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_cmmbAtmAgreementMember"
      decimals="-3"
      id="Fxbrl_20230213133734136"
      unitRef="usd">275000</cmmb:ProceedsFromSaleOfAdss>
    <cmmb:RepurchaseOfAmericanDepositaryReceiptsShares
      contextRef="C_20220901to20220919_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember"
      decimals="INF"
      id="Fxbrl_20230213133614438"
      unitRef="Share">582023</cmmb:RepurchaseOfAmericanDepositaryReceiptsShares>
    <cmmb:RepurchaseOfAmericanDepositaryReceipts
      contextRef="C_20220930_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember"
      decimals="0"
      id="Fxbrl_20230213133621142"
      unitRef="usd">2500000</cmmb:RepurchaseOfAmericanDepositaryReceipts>
    <cmmb:RepurchaseOfAmericanDepositaryReceiptsShares
      contextRef="C_20221101to20221116_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember"
      decimals="INF"
      id="Fxbrl_20230213133633159"
      unitRef="Share">582023</cmmb:RepurchaseOfAmericanDepositaryReceiptsShares>
    <cmmb:WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts
      contextRef="C_20221101to20221116_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember"
      decimals="4"
      id="Fxbrl_20230213133700406"
      unitRef="USD_Per_Share">2.0848</cmmb:WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts>
    <cmmb:TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts
      contextRef="C_20221101to20221116_usgaapSubsidiarySaleOfStockAxis_cmmbRepurchaseArrangementMember"
      decimals="-3"
      id="Fxbrl_20230213133643190"
      unitRef="usd">1218000</cmmb:TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts>
    <cmmb:NumberOfStockReservedForIssuance
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207224906305"
      unitRef="Share">28443060</cmmb:NumberOfStockReservedForIssuance>
    <cmmb:NumberOfStockAdssResveredForIssuance
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207223247056"
      unitRef="Share">1422153</cmmb:NumberOfStockAdssResveredForIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225529762"
      unitRef="Share">3445520</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207223254041"
      unitRef="Share">172276</cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues>
    <cmmb:NumberOfOptionsIssuableOutstanding
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225556251"
      unitRef="Share">23460740</cmmb:NumberOfOptionsIssuableOutstanding>
    <cmmb:NumberOfAdssOptionsIssuableOutstanding
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207223300376"
      unitRef="Share">1173037</cmmb:NumberOfAdssOptionsIssuableOutstanding>
    <cmmb:NumberOfOptionsVestedAndExercisable
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225618055"
      unitRef="Share">12400720</cmmb:NumberOfOptionsVestedAndExercisable>
    <cmmb:NumberOfAdssVestedAndExercisable
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207223309640"
      unitRef="Share">620036</cmmb:NumberOfAdssVestedAndExercisable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207224602275"
      unitRef="USD_Per_Share">0.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207223316544"
      unitRef="USD_Per_Share">5.96</cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207224845387"
      unitRef="Share">1240120</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207223324626"
      unitRef="Share">62006</cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod>
    <cmmb:NumberOfStockReservedForIssuance
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225827725"
      unitRef="Share">12511620</cmmb:NumberOfStockReservedForIssuance>
    <cmmb:NumberOfStockAdssResveredForIssuance
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225729518"
      unitRef="Share">625581</cmmb:NumberOfStockAdssResveredForIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225858382"
      unitRef="Share">11730800</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225738550"
      unitRef="Share">586540</cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues>
    <cmmb:NumberOfOptionsVestedAndExercisable
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225916606"
      unitRef="Share">427540</cmmb:NumberOfOptionsVestedAndExercisable>
    <cmmb:NumberOfAdssVestedAndExercisable
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225743877"
      unitRef="Share">21377</cmmb:NumberOfAdssVestedAndExercisable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225929980"
      unitRef="USD_Per_Share">0.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
      contextRef="C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsSeventeenPlanMember"
      decimals="INF"
      id="Fxbrl_20230207225750293"
      unitRef="USD_Per_Share">6.98</cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201040228557">
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Research and development&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;448&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;137&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;General and administrative&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,763&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,882&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Total share-based compensation expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;3,211&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;2,019&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="FFact_0000000000338"
      unitRef="usd">448000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="FFact_0000000000339"
      unitRef="usd">137000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="FFact_0000000000340"
      unitRef="usd">2763000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="FFact_0000000000341"
      unitRef="usd">1882000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000342"
      unitRef="usd">3211000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000343"
      unitRef="usd">2019000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201040244110">
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Weighted &lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;average&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;exercise &lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;price&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Number of &lt;/span&gt;&lt;span style="font-weight:bold"&gt;options&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;average &lt;/span&gt;&lt;span style="font-weight:bold"&gt;remaining &lt;/span&gt;&lt;span style="font-weight:bold"&gt;contractual &lt;/span&gt;&lt;span style="font-weight:bold"&gt;life (in years)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;average &lt;/span&gt;&lt;span style="font-weight:bold"&gt;exercise price&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Number of &lt;/span&gt;&lt;span style="font-weight:bold"&gt;options&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;average &lt;/span&gt;&lt;span style="font-weight:bold"&gt;remaining &lt;/span&gt;&lt;span style="font-weight:bold"&gt;contractual &lt;/span&gt;&lt;span style="font-weight:bold"&gt;life (in years)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Outstanding at January 1&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.38&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;27,003,260&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;8.12&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;0.07&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;10,455,580&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;7.8&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Acquired in Merger&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;text-align:right"&gt;-&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;-&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;609,535&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Exercised&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.07&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;1,970,000&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(134,220&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Forfeited&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.32&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;1,240,120&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1.25&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;(1,712,275&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;)&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Granted&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.16&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;11,398,400&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;7.8&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:10%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;0.62&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;17,784,640&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;9.79&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:27%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Outstanding at December 31&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.33&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;35,191,540&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;7.42&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:10%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;0.38&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;27,003,260&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;8.12&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20211231"
      decimals="INF"
      id="FFact_0000000000345"
      unitRef="USD_Per_Share">0.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20211231"
      decimals="INF"
      id="FFact_0000000000346"
      unitRef="Share">27003260</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_20210101to20211231" id="FFact_0000000000347">P8Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20201231"
      decimals="INF"
      id="FFact_0000000000348"
      unitRef="USD_Per_Share">0.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20201231"
      decimals="INF"
      id="FFact_0000000000349"
      unitRef="Share">10455580</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_20200101to20201231" id="FFact_0000000000350">P7Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <cmmb:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20230214225414206"
      unitRef="USD_Per_Share">0</cmmb:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice>
    <cmmb:StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000351"
      unitRef="Share">0</cmmb:StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger>
    <cmmb:StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230201024457584"
      unitRef="Share">609535</cmmb:StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000352"
      unitRef="USD_Per_Share">0.07</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000353"
      unitRef="Share">1970000</cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230201024523067"
      unitRef="USD_Per_Share">0.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230201024530820"
      unitRef="Share">134220</cmmb:StockIssuedDuringPeriodSharesStockOptionsExercised1>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000356"
      unitRef="USD_Per_Share">0.32</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000357"
      unitRef="Share">1240120</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_0000000000358"
      unitRef="USD_Per_Share">1.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_0000000000359"
      unitRef="Share">1712275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000360"
      unitRef="USD_Per_Share">0.16</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000361"
      unitRef="Share">11398400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm contextRef="C_20220101to20221231" id="FFact_0000000000362">P7Y9M18D</cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_0000000000363"
      unitRef="USD_Per_Share">0.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_0000000000364"
      unitRef="Share">17784640</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm contextRef="C_20210101to20211231" id="FFact_0000000000365">P9Y9M14D</cmmb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_0000000000366"
      unitRef="USD_Per_Share">0.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_0000000000367"
      unitRef="Share">35191540</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_20220101to20221231" id="FFact_0000000000368">P7Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20211231"
      decimals="INF"
      id="FFact_0000000000369"
      unitRef="USD_Per_Share">0.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20211231"
      decimals="INF"
      id="FFact_0000000000370"
      unitRef="Share">27003260</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_20210101to20211231" id="FFact_0000000000371">P8Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201040432498">
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;2022&#160;grants&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Weighted average share price (in U.S. dollar)&lt;sup&gt;(a)&lt;/sup&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;0.16&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Exercise price (in U.S. dollar)&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;0.10&lt;/span&gt;&lt;span style="font-weight:bold"&gt;-&lt;/span&gt;&lt;span style="font-weight:bold"&gt;0.257&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Expected life of options (in years)&lt;sup&gt;(b)&lt;/sup&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;5.51&lt;/span&gt;&lt;span style="font-weight:bold"&gt;-&lt;/span&gt;&lt;span style="font-weight:bold"&gt;6.28&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Expected volatility&lt;sup&gt;(c)&lt;/sup&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;83.69&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%-&lt;/span&gt;&lt;span style="font-weight:bold"&gt;84.31&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Risk-free interest rate&lt;sup&gt;(d)&lt;/sup&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;1.75&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%-&lt;/span&gt;&lt;span style="font-weight:bold"&gt;4.14&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:84%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Dividend yield&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;text-align:center"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:12%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-weight:bold"&gt;0&lt;/span&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_0000000000373"
      unitRef="USD_Per_Share">0.16</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_srtRangeAxis_srtMinimumMember"
      decimals="INF"
      id="FFact_0000000000375"
      unitRef="USD_Per_Share">0.1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_srtRangeAxis_srtMaximumMember"
      decimals="INF"
      id="FFact_0000000000376"
      unitRef="USD_Per_Share">0.257</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember"
      id="FFact_0000000000377">P5Y6M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember"
      id="FFact_0000000000378">P6Y3M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_20220101to20221231"
      decimals="4"
      id="FFact_0000000000379"
      unitRef="Pure">0.8369</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_20220101to20221231"
      decimals="4"
      id="FFact_0000000000380"
      unitRef="Pure">0.8431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_20220101to20221231"
      decimals="4"
      id="FFact_0000000000381"
      unitRef="Pure">0.0175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_20220101to20221231"
      decimals="4"
      id="FFact_0000000000382"
      unitRef="Pure">0.0414</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000383"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000399">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"&gt;&lt;span style="font-weight:bold"&gt;Note 9 - Research and Development&lt;/span&gt;&lt;/p&gt;

      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Consultants and subcontractors&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;13,052&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;3,894&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Salaries and related expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,867 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,789&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Rent and maintenance&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;245&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;114&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Share-based compensation&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;448&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;137&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Other expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;365&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;400&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;16,977&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;6,334&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;

  </us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000398">
      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Consultants and subcontractors&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;13,052&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;3,894&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Salaries and related expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,867 &lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,789&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Rent and maintenance&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;245&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;114&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Share-based compensation&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;448&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;137&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Other expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;365&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;400&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;16,977&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;6,334&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    </cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock>
    <cmmb:ConsultantsAndSubcontractorsExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000386"
      unitRef="usd">13052000</cmmb:ConsultantsAndSubcontractorsExpense>
    <cmmb:ConsultantsAndSubcontractorsExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000387"
      unitRef="usd">3894000</cmmb:ConsultantsAndSubcontractorsExpense>
    <us-gaap:OfficersCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000388"
      unitRef="usd">2867000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000389"
      unitRef="usd">1789000</us-gaap:OfficersCompensation>
    <cmmb:RentAndMaintenanceResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000390"
      unitRef="usd">245000</cmmb:RentAndMaintenanceResearchAndDevelopmentExpense>
    <cmmb:RentAndMaintenanceResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000391"
      unitRef="usd">114000</cmmb:RentAndMaintenanceResearchAndDevelopmentExpense>
    <cmmb:ShareBasedCompensationResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000392"
      unitRef="usd">448000</cmmb:ShareBasedCompensationResearchAndDevelopmentExpense>
    <cmmb:ShareBasedCompensationResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000393"
      unitRef="usd">137000</cmmb:ShareBasedCompensationResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000394"
      unitRef="usd">365000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000395"
      unitRef="usd">400000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000396"
      unitRef="usd">16977000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000397"
      unitRef="usd">6334000</us-gaap:ResearchAndDevelopmentExpense>
    <cmmb:GeneralAndAdministrativeDisclosureTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000417">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:11pt"&gt;&lt;span style="font-weight:bold"&gt;Note 10 - General and Administrative&#160;&lt;/span&gt;&lt;/p&gt;

      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Salaries and related expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;3,435&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;943&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Professional services&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,596&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,695&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Share-based compensation&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,763&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,882&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Fees to Directors&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;231&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span&gt;244&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Insurance&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;1,084&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,024&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Rent and maintenance&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;24&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;29&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Other expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;1,423&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;216&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;11,556&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;6,033&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;

  </cmmb:GeneralAndAdministrativeDisclosureTextBlock>
    <cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000416">
      &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Salaries and related expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;3,435&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;943&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Professional services&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,596&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,695&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Share-based compensation&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,763&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,882&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Fees to Directors&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;231&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span&gt;244&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Insurance&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;1,084&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,024&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Rent and maintenance&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;24&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;29&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Other expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;1,423&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;216&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;11,556&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;6,033&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    </cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock>
    <us-gaap:SalariesAndWages
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000400"
      unitRef="usd">3435000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000401"
      unitRef="usd">943000</us-gaap:SalariesAndWages>
    <us-gaap:ProfessionalFees
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000402"
      unitRef="usd">2596000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000403"
      unitRef="usd">1695000</us-gaap:ProfessionalFees>
    <cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000404"
      unitRef="usd">2763000</cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense>
    <cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000405"
      unitRef="usd">1882000</cmmb:ShareBasedCompensationGeneralAndAdministrativeExpense>
    <us-gaap:NoninterestExpenseDirectorsFees
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000406"
      unitRef="usd">231000</us-gaap:NoninterestExpenseDirectorsFees>
    <us-gaap:NoninterestExpenseDirectorsFees
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230201004651041"
      unitRef="usd">244000</us-gaap:NoninterestExpenseDirectorsFees>
    <us-gaap:GeneralInsuranceExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000408"
      unitRef="usd">1084000</us-gaap:GeneralInsuranceExpense>
    <us-gaap:GeneralInsuranceExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000409"
      unitRef="usd">1024000</us-gaap:GeneralInsuranceExpense>
    <cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000410"
      unitRef="usd">24000</cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense>
    <cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000411"
      unitRef="usd">29000</cmmb:RentAndMaintenanceGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000412"
      unitRef="usd">1423000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000413"
      unitRef="usd">216000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000414"
      unitRef="usd">11556000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000415"
      unitRef="usd">6033000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000458">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Note 11 - Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Tax rates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ordinary taxable income in Israel is subject to a corporate tax rate of 23%.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s US subsidiary, Chemomab Therapeutics Inc. ("Chemomab Inc.) is taxed separately under the U.S. tax laws.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Chemomab Inc. is subject to a federal flat tax rate of 21% and state tax as applicable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capital gain is subject to capital gain tax according to the corporate tax rate in the year the assets are sold.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Tax assessments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2022, the Company&#x2019;s tax reports through December 31, 2017&#160;are considered closed to audit inspections by the Israeli Tax Authority (&#x201c;ITA&#x201d;) due to statute of limitation rules effective in Israel.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has not yet been assessed by the ITA since inception.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;C.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Losses for tax purposes carried forward to future years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2022, the Company and its subsidiaries had approximately $159 million&#160;(approximately $143 million as of December 31, 2021) of net operating loss carryforwards which are available to reduce future taxable income with no limitation on the period of use.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;On March 27, 2020 and December 27, 2020, the President of the United States signed and enacted into law the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and the Consolidated Appropriations Act, 2021 (CAA). Among other provisions, the CARES Act and the CAA provide relief to U.S. federal corporate taxpayers through temporary adjustments to net operating loss rules, changes to limitations on interest expense deductibility, and the acceleration of available refunds for minimum tax credit carryforwards. The CARES Act also includes provisions for a carryback of any net operating loss (NOL) arising in a taxable year beginning after December 31, 2017, and before January 1, 2021, to each of the five taxable years preceding the taxable year in which the loss arises (carryback period).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Chemomab Therapeutics Inc., a wholly owned subsidiary of the Company, filed an application with the US Internal Revenue Service to carryback net operating losses. Chemomab Therapeutics Inc received $351 thousand in December 2022 on account of 2016 and 2017 and expects to receive the remainder $183 thousand in 2023. Accordingly, a tax benefit in the total amount of $534 thousand was recorded in the Company&#x2019;s statement of operations during 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;D.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.28pt"&gt;Deferred taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:11pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In respect of:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div style="margin-left:72pt"&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net operating loss carry-forwards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;36,550&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,396&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;1,774&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,147&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2,858&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,449&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;41,195&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36,030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less - Valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;41,195&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,030)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has established a valuation allowance to offset deferred tax assets on December 31, 2022 and 2021 due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The net change in the total valuation allowance for the year ended at December 31, 2022 was an increase of approximately $5.2 million.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;E.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:26.83pt"&gt;Roll forward of valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div style="margin-left:72pt"&gt;

        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;6,200&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency transaction loss&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2,425&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax assets acquired through merger&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,535&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2,870&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;36,030&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency transaction Income&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;(1,316&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;6,481&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;41,195&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;F.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:28.31pt"&gt;Reconciliation of theoretical income tax expense to actual income tax expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:72pt;margin-bottom:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A reconciliation of the Company&#x2019;s theoretical income tax expense to actual income tax expense is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div style="margin-left:72pt"&gt;

        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss before income taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;28,180&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,478&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statutory tax rate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Theoretical tax benefit&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(&lt;span style="font-weight:bold"&gt;6,481&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,870&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in temporary differences for which deferred taxes were not recognized&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(1,696&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,332&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax rate differential&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;20&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(101&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible expenses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;744&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;239&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;6,879&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,064&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Actual income tax expense (Benefit)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(534&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:1.5px"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;G.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:25.72pt"&gt;Accounting for uncertainty in income taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:72pt;margin-bottom:11pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended December 31, 2022, the Company did not have any unrecognized tax benefits and does not expect that the amount of unrecognized tax benefits will change significantly within the next 12 months. The Company&#x2019;s accounting policy is to accrue interest and penalties related to unrecognized tax benefits as a component of income tax expense.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
  </us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryIL"
      decimals="2"
      id="FFact_0000000000418"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryUS_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember"
      decimals="2"
      id="FFact_0000000000419"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_20221231_srtStatementGeographicalAxis_countryIL"
      decimals="-6"
      id="Fxbrl_20230213140532094"
      unitRef="usd">159000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_20211231_srtStatementGeographicalAxis_countryIL"
      decimals="-6"
      id="Fxbrl_20230213140537759"
      unitRef="usd">143000000</us-gaap:TaxCreditCarryforwardAmount>
    <cmmb:ReceivedAmountOfChemomabTherapeuticsInc
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213140710654"
      unitRef="usd">351000</cmmb:ReceivedAmountOfChemomabTherapeuticsInc>
    <cmmb:ExpectsToReceiveAmountOfChemomabTherapeuticsInc
      contextRef="C_20230101to20231231_srtStatementScenarioAxis_srtScenarioForecastMember"
      decimals="-3"
      id="Fxbrl_20230213140716671"
      unitRef="usd">183000</cmmb:ExpectsToReceiveAmountOfChemomabTherapeuticsInc>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213140722797"
      unitRef="usd">-534000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201025152633">
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net operating loss carry-forwards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;36,550&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,396&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;1,774&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,147&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2,858&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,449&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;41,195&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36,030&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less - Valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;41,195&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,030)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000422"
      unitRef="usd">36550000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000423"
      unitRef="usd">33396000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000424"
      unitRef="usd">1774000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000425"
      unitRef="usd">1147000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000426"
      unitRef="usd">2858000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000427"
      unitRef="usd">1449000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000428"
      unitRef="usd">13000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000429"
      unitRef="usd">38000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000430"
      unitRef="usd">41195000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000431"
      unitRef="usd">36030000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000432"
      unitRef="usd">41195000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000433"
      unitRef="usd">36030000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230201010225989_Fact_0000000000426"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230201010225989_Fact_0000000000427"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_20220101to20221231"
      decimals="-5"
      id="Fxbrl_20230201010356964"
      unitRef="usd">5200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201025212924">
        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;6,200&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency transaction loss&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2,425&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax assets acquired through merger&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,535&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2,870&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;36,030&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency transaction Income&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;(1,316&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;6,481&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:88%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;41,195&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20201231"
      decimals="-3"
      id="FFact_0000000000438"
      unitRef="usd">6200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <cmmb:CurrencyTransactionLossValuationAllowance
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000439"
      unitRef="usd">2425000</cmmb:CurrencyTransactionLossValuationAllowance>
    <cmmb:TaxAssetsAcquiredThroughMergerValuationAllowance
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230201010515039"
      unitRef="usd">24535000</cmmb:TaxAssetsAcquiredThroughMergerValuationAllowance>
    <cmmb:IncomeTaxExpenseValuationAllowance
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000440"
      unitRef="usd">2870000</cmmb:IncomeTaxExpenseValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000441"
      unitRef="usd">36030000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <cmmb:CurrencyTransactionLossValuationAllowance
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230201010936607"
      unitRef="usd">-1316000</cmmb:CurrencyTransactionLossValuationAllowance>
    <cmmb:IncomeTaxExpenseValuationAllowance
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000444"
      unitRef="usd">6481000</cmmb:IncomeTaxExpenseValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000445"
      unitRef="usd">41195000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201025228669">
        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss before income taxes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;(&lt;/span&gt;&lt;span style="font-weight:bold"&gt;28,180&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,478&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statutory tax rate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-bottom:3px;margin-bottom:1.5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Theoretical tax benefit&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(&lt;span style="font-weight:bold"&gt;6,481&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,870&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in temporary differences for which deferred taxes were not recognized&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;(1,696&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,332&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax rate differential&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;20&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(101&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible expenses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;744&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;239&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;6,879&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;background-color:rgb(255, 255, 255)"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,064&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
              &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Actual income tax expense (Benefit)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(534&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:1.5px"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:2px solid black;background-color:rgb(204, 238, 255)"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000447"
      unitRef="usd">-28180000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000448"
      unitRef="usd">-12478000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="2"
      id="FFact_0000000000449"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_20210101to20211231"
      decimals="2"
      id="FFact_0000000000450"
      unitRef="Pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000451"
      unitRef="usd">-6481000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000452"
      unitRef="usd">-2870000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <cmmb:ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213113429979_Fact_0000000000453"
      unitRef="usd">-1696000</cmmb:ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized>
    <cmmb:ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213113429979_Fact_0000000000454"
      unitRef="usd">-1332000</cmmb:ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213113425908_Fact_0000000000453"
      unitRef="usd">20000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213113425908_Fact_0000000000454"
      unitRef="usd">-101000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213113423827_Fact_0000000000453"
      unitRef="usd">744000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213113423827_Fact_0000000000454"
      unitRef="usd">239000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213113421604_Fact_0000000000453"
      unitRef="usd">6879000</cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded>
    <cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213113421604_Fact_0000000000454"
      unitRef="usd">4064000</cmmb:LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230219165815757"
      unitRef="usd">-534000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230201011121606_Fact_0000000000454"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000477">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Note 12 - Related Parties Balances and Transactions&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:10.28pt"&gt;Balances with Related Parties:&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt"&gt;The following Related Party payables are included in the consolidated Balance Sheets:&lt;/p&gt;
    &lt;div style="margin-left:36pt"&gt;

        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;


              &lt;tr style="background-color:#CCEEFF"&gt;
                &lt;td style="vertical-align:bottom;width:76%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Employee and related expenses&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;891&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;278&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Accrued expenses&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;58&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;72&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:#CCEEFF"&gt;
                &lt;td style="vertical-align:bottom;width:76%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;949&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;350&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;
                  &lt;p&gt;&#160;&lt;/p&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

      &lt;p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;On September 19, 2022, the Company entered into a share purchase agreement with the Company's Co- Founders, see Note 8B(4).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;/div&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;span style="font-weight:bold;padding-left:10.83pt"&gt;Transactions with Related Parties:&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;text-indent:36pt;margin-bottom:11pt"&gt;The following transactions with related parties are included in the consolidated Statements of Operations:&lt;/p&gt;
    &lt;div style="margin-left:36pt;margin-bottom:11pt"&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Salaries and related expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,409&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,255&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Share-based payments&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,466&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,775&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Professional Services&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;231&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;244&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Research and development&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;36&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;36&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;5,142&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;3,310&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
  </us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230207220029774">
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;


              &lt;tr style="background-color:#CCEEFF"&gt;
                &lt;td style="vertical-align:bottom;width:76%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Employee and related expenses&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;891&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;278&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Accrued expenses&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;58&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;72&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:#CCEEFF"&gt;
                &lt;td style="vertical-align:bottom;width:76%"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;949&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                  &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;350&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="vertical-align:bottom;width:1%"&gt;
                  &lt;p&gt;&#160;&lt;/p&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      </cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember"
      decimals="-3"
      id="FFact_0000000000459"
      unitRef="usd">891000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember"
      decimals="-3"
      id="FFact_0000000000460"
      unitRef="usd">278000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember"
      decimals="-3"
      id="FFact_0000000000461"
      unitRef="usd">58000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember"
      decimals="-3"
      id="FFact_0000000000462"
      unitRef="usd">72000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember"
      decimals="-3"
      id="FFact_0000000000463"
      unitRef="usd">949000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="C_20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember"
      decimals="-3"
      id="FFact_0000000000464"
      unitRef="usd">350000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201025305978">
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-weight:bold"&gt;USD thousands&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Salaries and related expenses&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,409&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,255&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Share-based payments&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;2,466&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;1,775&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Professional Services&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;231&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;244&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Research and development&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;36&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;border-bottom:1.5pt solid rgb(0, 0, 0);width:9%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;36&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;5,142&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;3,310&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000466"
      unitRef="usd">2409000</cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000467"
      unitRef="usd">1255000</cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000468"
      unitRef="usd">2466000</cmmb:RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000469"
      unitRef="usd">1775000</cmmb:RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000470"
      unitRef="usd">231000</cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000471"
      unitRef="usd">244000</cmmb:RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000472"
      unitRef="usd">36000</cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty>
    <cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000473"
      unitRef="usd">36000</cmmb:RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000474"
      unitRef="usd">5142000</us-gaap:RelatedPartyCosts>
    <us-gaap:RelatedPartyCosts
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000475"
      unitRef="usd">3310000</us-gaap:RelatedPartyCosts>
    <us-gaap:EarningsPerShareTextBlock contextRef="C_20220101to20221231" id="FFact_0000000000488">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Note 13 - Net Loss Per Share Attributable to Ordinary Shareholders&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:0pt"&gt;Basic net loss per share is computed by dividing the net loss available to common stockholders by the weighted-average number of ordinary shares outstanding. Diluted net loss per share is computed similarly to basic net loss per share except that the denominator is increased to include the number of additional ordinary shares that would have been outstanding if the potential ordinary shares had been issued and if the additional ordinary shares of were dilutive. Diluted net loss per share is the same as basic net loss per share of ordinary share, as the effect of potentially dilutive securities is antidilutive.&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt"&gt;The following table sets forth the computation of basic and diluted net loss per share attributable to ordinary shareholders for the periods presented:&lt;/p&gt;
    &lt;div style="margin-left:36pt"&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;In USD thousands, except share and per &lt;/span&gt;&lt;span style="font-weight:bold"&gt;share data&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Numerator:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Net loss&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;27,646&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;12,478&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;text-indent:-10pt;padding-left:10pt;margin-bottom:0pt"&gt;Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;227,589,288&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;207,468,650&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Net loss per share attributable to ordinary shareholders, basic and diluted&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.121&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;0.060&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
    &lt;div/&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:36pt;margin-bottom:11pt"&gt;The potential number of ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented since including them would have been anti-dilutive are as follows:&lt;/p&gt;
    &lt;div style="margin-left:36pt"&gt;

        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Number of shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Outstanding options to purchase ordinary shares&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;35,191,540&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;27,003,260&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;

    &lt;/div&gt;
  </us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201025331788">
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;In USD thousands, except share and per &lt;/span&gt;&lt;span style="font-weight:bold"&gt;share data&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Numerator:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Net loss&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;27,646&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;12,478&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;text-indent:-10pt;padding-left:10pt;margin-bottom:0pt"&gt;Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;227,589,288&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;207,468,650&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Net loss per share attributable to ordinary shareholders, basic and diluted&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;0.121&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;0.060&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000478"
      unitRef="usd">-27646000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000479"
      unitRef="usd">-12478000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_s_20230215224008037"
      unitRef="Share">227589288</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230215224008037"
      unitRef="Share">227589288</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230131213429326"
      unitRef="Share">207468650</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_0000000000481"
      unitRef="Share">207468650</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230131213444247"
      unitRef="USD_Per_Share">0.121</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="FFact_0000000000482"
      unitRef="USD_Per_Share">0.121</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230131213458553"
      unitRef="USD_Per_Share">0.06</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="FFact_0000000000483"
      unitRef="USD_Per_Share">0.06</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201025347421">
        &lt;table cellpadding="0" cellspacing="0" style="width:90%" width="100%"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Year ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="2" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
              &lt;td colspan="6" style="border-bottom:1.5pt solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Number of shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;


            &lt;tr&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr style="background-color:#CCEEFF"&gt;
              &lt;td style="vertical-align:bottom;width:76%"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"&gt;Outstanding options to purchase ordinary shares&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold"&gt;35,191,540&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%;border-bottom:4px double black"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:9%;border-bottom:4px double black"&gt;
                &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:right;margin-top:0pt;margin-bottom:0pt"&gt;27,003,260&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      </us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="FFact_0000000000485"
      unitRef="Share">35191540</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20210101to20211231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="FFact_0000000000486"
      unitRef="Share">27003260</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230201020943165">
    &lt;div&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Note 14&#160;- Subsequent Events&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:11pt;margin-bottom:0pt;padding-left:36pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;On January 13, 2023 the Company filed with the SEC a registration statement on form S-1 for the issuance and sale of up to $20,000,000 of its ADSs.&lt;/p&gt;
    &lt;/div&gt;
  </us-gaap:SubsequentEventsTextBlock>
    <cmmb:SaleOfStockValueOfSharesIssuedInTransaction
      contextRef="C_20230113_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      decimals="0"
      id="Fxbrl_20230213104715713"
      unitRef="usd">20000000</cmmb:SaleOfStockValueOfSharesIssuedInTransaction>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#FFact_0000000000373"
          xlink:label="FFact_0000000000373"
          xlink:type="locator"/>
        <link:footnote id="FN20230201025135527" xlink:label="FN20230201025135527" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The weighted average share price is based on the Company&#x2019;s ordinary share valuation as at the grant date. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000373"
          xlink:to="FN20230201025135527"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000377"
          xlink:label="FFact_0000000000377"
          xlink:type="locator"/>
        <link:footnote id="FN20230201025203207" xlink:label="FN20230201025203207" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Expected life for the periods presented was determined according to the simplified method since, at the date of grant, the Company did not have enough history to make an estimate. This method effectively assumes that exercise occurs over the period from vesting until expiration, and therefore the expected term is the midpoint between the service period and the contractual term of the award. The simplified method is applicable to service conditions and for performance conditions that are probable of achievement. If meeting the performance condition is not probable, the Company will use the awards&#x2019; contractual term if the service period is implied, or the simplified method, if the service period is explicitly stated.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000377"
          xlink:to="FN20230201025203207"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000378"
          xlink:label="FFact_0000000000378"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000378"
          xlink:to="FN20230201025203207"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000379"
          xlink:label="FFact_0000000000379"
          xlink:type="locator"/>
        <link:footnote id="FN20230201025249960" xlink:label="FN20230201025249960" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Expected volatility is based on historical volatility over the most recent period commensurate with the expected term of the option. As the Company has a short trading history for its ordinary shares, when the Company's trading period is shorter than the expected term, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company&#x2019;s industry that the Company considers to be comparable to its own business over a period equivalent to the option&#x2019;s expected term.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000379"
          xlink:to="FN20230201025249960"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000380"
          xlink:label="FFact_0000000000380"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000380"
          xlink:to="FN20230201025249960"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000381"
          xlink:label="FFact_0000000000381"
          xlink:type="locator"/>
        <link:footnote id="FN20230201025314607" xlink:label="FN20230201025314607" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The risk-free rate for the expected term of the options is based on the Black-Scholes option-pricing model on the yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000381"
          xlink:to="FN20230201025314607"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000382"
          xlink:label="FFact_0000000000382"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000382"
          xlink:to="FN20230201025314607"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>68
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MD#,P\[P!O)]+:38W^0>J?U;T_P-02P,$%     @ 53%55O3MWD+J!0  >1H
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M72"GMH=CT@%IRV \CMT8<= 247 F2IJF<LW\SMPK.XGRA(0=I XIJ"3CGL6
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M;;5A!?4?H)W("K/L+08J<2M;*=/>6>]:%ARLWB]MM>252".BV)#WOA,^%?R
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M=QK5>[0=>%.&6__">/J&"(\Y?;2A90-ZOS1T36P&'*#[#)S] U!+ P04
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M8IC%I#7M(WH;QZE+3G9OI%VRR]MK-HVGXRP.V>!C3^[:WB!BUY$O^/&=$UQ
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MV2%\(&_NC$A0KN0"6$)""3!F]-<IZC.8[N3R\>?=3J4"@/_@34O03P*4PSQ
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MKO^![E6PGW^'+\2 ?L+@Z^+-3C7SY.WC=X#\K*FQ(#[O3R:C(([[\<5YL-@
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M:96[*>Z'$Q:)\B-"AW;>7.+A>_4A;'49ZV;29O:G_(!7;(>%!&V<&CT:,E#
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M0T/#B05-:516@<YWDNJD6U@'I[F_^ Q02P,$%     @ 53%55A^KDB H!
M3 L  !D   !X;"]W;W)K<VAE971S+W-H965T,3DN>&ULM5;;CMLV$'WW5Q J
MT">M=?$UCFU@-YNB 1IGD6T2%$4?:'%D$4N1*DG9NW_?(27+WJSM%&GZ8HL4
MSYDSPYG1S'=*/Y@"P)+'4DBS" IKJUD4F:R DIJ^JD#BFUSIDEI<ZDUD*@V4
M>5 IHC2.QU%)N0R6<[]WIY=S55O!)=QI8NJRI/KI!H3:+8(DV&]\Y)O"NHUH
M.:_H!N[!?JKN-*ZBCH7Q$J3A2A(-^2*X3F8W0W?>'_C,86>.GHGS9*W4@UN\
M8XL@=H) 0&8= \6_+;P!(1P1ROB[Y0PZDPYX_+QG_\7[CKZLJ8$W2GSAS!:+
M8!H0!CFMA?VH=K]"Z\_(\65*&/]+=LW9T20@66VL*ELP*BBY;/[I8QN'(\ T
M/@-(6T#J=3>&O,I;:NERKM6.:'<:V=R#=]6C41R7[E+NK<:W''%VN<)[_TT9
M0^Y D_N":B#7UFJ^KBU="R!6D0^:<8D7UKPNE&"@S3RR:-UQ1%EKZ::QE)ZQ
ME*3DO9*V,.2M9,">$T0HN].>[K7?I!<9;R'KDT$2DC1.TPM\@RX6 \\W.,/W
MEFK)Y>8X%G]>KXW5F#I_G7*XH1N>IG/E-#,5S6 18+T8T%L(EC__E(SCUQ?$
M#CNQPTOL/_3B+EHZ[<=*62#)@%R1[Q5";JCA&9$(%PY>(=QX.#<D4V556V!D
M_408WW+$;X@MX'"<;BD7>P-XO,02QVK)'O;TB'2 G:]+8%=T"QK;#)%UN493
M*B=J+\N;-01[EK%4.EM]<LN%%_ -?8:7*$.+)R=C?<XC>,R@LJB'6B^*@518
MS-0J[=BXS+"A&J1#$ER(FD'C;:>5,L9=&Z/BA6S/NE.U8*1 )\D:0![[0GCN
MR2J\,FGY"8:"L@;%C:E1!>+VH MV4=4.T#GF(H6M]5LQ<W2&ELAISD?JQ;6$
M[KB#0IYC)W<'.D?$4V><&,AJC5)1&-JB^/Z@ZW>$YTK@!\BGD<\: ];@IK:%
M9V\NE/HO!9IH]+DXL/,^T:_2_+GP?1ZBC2;\H+EBB'<U))%RUOL#J";@NN'Q
M([8U\->.K>WYPO4Y]Y/TWDGRZ?X6>55M4*4)]RG6*D/A!YT,/PR]55UB_F/"
MS7JKUI5>.@G'PW$O2</A9(JFNJ2<];[\^[*I7>)RV8;01?A[8Q6^C'LO19&C
MZ:LPG4[1]4DX'$_#\2CNG/@1-N)^@C&-^_$X]KERJ)3S7C=5!TUQNX)E)->J
M/)5,_U\*8?N1&;0MHVV1Y8M>X(KAJBL4;]:T]6#^2Q*NNN T,>E].&HZJG+N
M&^=45>NLP/;V=0Q[@U&8O$K"T3!VJ1C'@S#%&SCU<8R.)AS,XXV?XUP;KJ5M
MAIUNMQL5KYL)Z7"\F3/?4[WA*$Q CM"X/QD%1#>S6[.PJO+STEI9G+[\8X'C
M+FAW -_G"M.C73@#W0"]_ =02P,$%     @ 53%55M1GRL%H @  2@4  !D
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MA-U92=4P8UVUCG2K@)6^J.$1C>,L:E@M<#[UL3N53V5G>"W@3B'=-0U3?^;
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MYO$HWD[<BG6-?B+)9RU?PQW@UW9I:)0,**5H0%FA%3-0S>.+T70Q\?DAX9N
MC=V)F5>RTOK!#SZ7\SCUA$!"@1Z!T^\1+D%*#T0T?O68\;"E+]R-M^C703MI
M67$+EUI^%R76\_A]S$JHN)-XJS>?H-=SZO$*+6WXLDV?F\:L<!9UTQ<3@T:H
M[L^?^G/XGX*L+\@"[VZCP/**(\]G1F^8\=F$YH,@-503.:%\4^[0T*J@.LR_
M $FR[.B>KR38XUF"!.J7DJ('6'0 V0L HXS=:(6U91]5">7?  FQ&2AE6TJ+
M["#B%10G;#QZP[(TRP[@C0>)XX W?E&BM0#L2MA":NL,L!\7*XN&+L3/?7H[
MM,E^-&^2J6UY ?.87&#!/$*<OWXU.DL_'. Z&;A.#J'G=V2ZTDE@NJ(NHS,"
MGWTL?9N8%'PEI$!!'7-TVH9I9YC2ZFW!50'2]Y"17PU'H=9=D=TG\2")_1*I
M&>-HE)U%%$RB\W%TKY%+5CGT)THW4S2NZ7FV_)E\BS;*1N>1/WXFFM8AE$PH
M!(+$:73$3J/C:.GQ%;)'+ET0_0_[7<F$-F'[SCC9N?X-F'4PN66%=@H[)PRS
MPSMRT=GG3WKW"-UPLQ;*TN85E:8G[TYC9CIC=P/4;3#32B-9,X0UO85@? *M
M5UKC=N W&%[7_#=02P,$%     @ 53%55MXL2@)Z!   F H  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&ULM59M;]LV$/[.7T%HZ&8#LBQ2K\X2 WEK
MMP'MBJ19,0S[0$MGFX@DNB1E)_]^1\EQG,8Q^F5 (I/4W</G>,]1=[I1^MXL
M 2Q]J*O&G'E+:U<GX[$IEE +$Z@5-/AFKG0M+$[U8FQ6&D39.=75F(=A.JZ%
M;+SI:;?V64]/56LKV<!G34U;UT(_7D"E-F<>\YX6;N1B:=W">'JZ$@NX!7NW
M^JQQ-MZAE+*&QDC54 WS,^^<G5RDSKXS^$O"QNR-J8MDIM2]F_Q>GGFA(P05
M%-8A"/Q9PR54E0-"&M^VF-YN2^>X/WY"?]_%CK',A(%+57V5I5V>>;E'2YB+
MMK(W:O,;;.-)'%ZA*M,]Z69K&WJT:(U5]=89&=2RZ7_%P_8<?L2!;QUXQ[O?
MJ&-Y):R8GFJUH=I9(YH;=*%VWDA.-BXIMU;C6XE^=GJ[%!KHI5A)*RHZ^")F
M%9CAZ=@BMK,8%UN<BQZ'OX'#./VH&KLT]+HIH7P),$92.V;\B=D%/XIX!45
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MKI5&2R5?@'C&%:QRO[.J][ OY">I_#\E_]95UQHI/?&()!HJFG Z"*:^*YJ
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M U,;3L0*7%-HU!M3S51S"343(ROWX5])0]>(&^9T;Z.R&VA]+:7936R"[I_
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MDT;5=:W*.Z)J"LDE\MT/R',\KP,^>3W<W87;JC]MD[RV29[A&[RU25W.:JK
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M)-,;T[;SY(K1&>-,,PQ]R!*0Y*:0Y)O(3F.:Q<#I#)$W.4BJ6;8H0>H#.9Z
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M+QC;7.(O $@3@/-S(?1SQ]PR]4]%] =02P,$%     @ 53%55B>X'6N>!@
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M$*%P OP^E]*4+[A =14X^A=02P,$%     @ 53%55N";W'AX"@  37T  !D
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M@#;UH;0 15,5K?,M2Y]OW7WY8(2;1+X^,: 'C784FF9!:0Q*XU":@-)\*"U
MT525Z\S+0EX5T8+&75":!Z4Q*(U#:0)*\Z&T $53=:YC,4L?B]UM\MWRIIBX
MC==KF>RB39V'A9F1;:5Q")-O,JM_?MZ1]PH/S<J@- ]*8Q6M.1\P.\T'M,:N
M'-I7]/0E<T*=3E\?VC= T511ZRS,TF=A8V>PH'D8E.9!::RB*3XX"S+K\1":
M=?7TI;,^"Z%)%XJF6E@G7=:@"R$.F,""!EQ0F@>E,:M[=4%WL9BW/PS(H5U%
M3U=BF8[97L,"[1J@:.KM#.I0RM9?U'#PF;Z>,]8^*,V#TEA%:YZ;4WK5O@D
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MTP:N#'!_Q9C<3]0!1>\^^@M02P,$%     @ 53%55IVH'C*#!   +Q8  !D
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M7Z')MKJ;6U>V/S5W7754099G]?YP/R?4EGFA"&XK@JL5X2;ZODV8F$U)CNZ
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MX']VT-\[Z+^P:H *A/XOJW6)Z/G-]?J(&O8MTG/VJ/WZ%8N5W2G(<E=!G';
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M PHP9;BS%@E5,ON*7RLKL%J!O>B)=UCW.D] %^J!:IV7 490[\NX%(75]H9
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M!)ZYDL;#C\T3%>/\!-W! 8='Z3X)39@7"A]M$1AGV7"=>L+R*!EN)>'!$=R
MW+B;B3*+<,=U>T;UH_WMY\J=^8/Q:WLK<D?[;YGV2O61R WE"C%8&\GH8F*0
M9'M+:3M:;-U!?R^TN3:X9FUN=B!M@'F^%D(_=>P$_5VQ^!=02P,$%     @
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MM6*M^_>CNU$3F-!_Z"-$\BNECU5ZR<$(3*H%IM2Z.-T#3O<5 E8M:@JH2;7
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MCZIGMWIAY+8:?U;2T#!5?68T[Z*R O1_+:4Y+NP!S00]^Q=02P,$%     @
M53%55AVDZE+5 @  O@D  !D   !X;"]W;W)K<VAE971S+W-H965T-30N>&UL
MM59=;YLP%/TK%JNF3MK*5R"A(TAMLFF55BEJVNVAVH,#-PFJP<QVDN;?SS8$
MD4"S5LM>P(9[#N<>[K4=;BA[XDL @9XSDO.AL12BN#1-'B\AP_R"%I#+-W/*
M,BSDE"U,7C# B09EQ'0LRS<SG.9&%.IG$Q:%="5(FL.$(;[*,LRVUT#H9FC8
MQN[!7;I8"O7 C,("+V *XJ&8,#DS:Y8DS2#G*<T1@_G0N+(O1X&*UP$_4MCP
MQABI3&:4/JG)33(T+"4(",1",6!Y6\,("%%$4L;OBM.H/ZF S?&._:O.7>8R
MPQQ&E/Q,$[$<&@,#)3#'*R+NZ.8;5/EXBB^FA.LKVE2QEH'B%1<TJ\!209;F
MY1T_5SXT ';O!8!3 9S7 MP*X.I$2V4ZK3$6. H9W2"FHB6;&FAO-%IFD^;J
M+TX%DV]3B1/1'1 L($$3S$0*'%UC@O-8#G">H'N&<XZUWQR=3V4%)2L"B,Y1
M$[:5URV>$> ?T/D8!$Z)''U"#],Q.C_[@,Y0FJ/[)5UQR<E#4TC9ZN-F7$F\
M+B4Z+T@<0WR!7/LC<BS'Z8"/7@^W]^&F-*MVS*D=<S2?^PK'MDV+T.-W&8IN
M!&3\5U>:)6^OFU>UZR4O< Q#0_8C![8&(WK_SO:MSUU)GXALSP*WML ]QAY]
MR0I"MP"Z2%CE!SS+E85#YP\NZ3Q-I]:5=61[OA6:ZV9&[2#?<^N8/:&]6FCO
MJ-"K.&:KOV@K&?S&9UVW/SC0U@[R/*];FU=K\XYJVZ^CQUO(9L ZZ^8HSUOK
MYD1D>RG[=<K^?VH=_Y06G(ALSX)^;4'_M*W3;U7>(+ /JK,=XS0J>$_GH-8Y
M^.?.&;2;XK!OVB%]IUM84 L+WM VNYVG2U[06D^"7G"@KQWC>M:!0+.QNZJ3
MS2UFBU1NB 3F$F5=]"6<E:>%<B)HH3?<&15R^];#I3Q@ 5,!\OV<4K&;J#V\
M/K)%?P!02P,$%     @ 53%55LY@O+X" P  A @  !D   !X;"]W;W)K<VAE
M971S+W-H965T-34N>&ULK9;?;]HP$,?_%2NKIE9:FU\06 >1"MVT/51"T*X/
MTQY,<A"K29S9!MK_?F<G9!!"U(>]@'_<??.YLW.7T8Z+%YD */*:I;D<6XE2
MQ:UMRRB!C,H;7D"..RLN,JIP*M:V+ 30V#AEJ>TY3F!GE.56.#)K,Q&.^$:E
M+(>9('*3952\32#EN['E6ON%.5LG2B_8X:B@:UB >BIF F=VK1*S#'+)>$X$
MK,;6G7L['6I[8_"3P4X>C(F.9,GYBY[\B,>6HX$@A4AI!8I_6YA"FFHAQ/A3
M:5KU([7CX7BO_LW$CK$LJ80I3Y]9K)*Q-;1(#"NZ2=6<[[Y#%4]?ZT4\E>:7
M["I;QR+11BJ>5<Y(D+&\_*>O51X.'-S@C(-7.7A-A]X9![]R\$V@)9D)ZYXJ
M&HX$WQ&AK5%-#TQNC#=&PW)]B@LE<)>AGPKGD%(%,9E1H1A(,J$IS2,<T#PF
MCX+FDII\2W*YP!L4;U(@?'6X0YZ92DA#YXI<WH.B+,71-7E:W)/+BRMR05A.
M'A.^D:@N1[;" #2&'56PDQ+6.P/K>N2!YRJ1Y&L>0WPL8&/D=?C>/OR)UZEX
M#]$-\=U/Q',\KP5H^GYWMP/'KT_#-WK^.T[C[3C]O^Z64@F<_6[+6RG;:Y?5
ME>!6%C2"L86ON@2Q!2O\^,$-G"]M,?\GL:,,].H,]+K4PP7>/\&J^R>J=, K
M%BT)K3>FE.L;.5VRMJ'7<SZ/[.UA1*=&KM?OUT9'I/V:M-]-FE !U[J$Q*2@
M;UC95"M@J1(< 09! _#4R!T,S@ &-6#0"3@3? 52EUN:$GU.+&I/87!*Z+L-
MP!:;7J^=;U#S#3KYYGAYJ(@2<]0Q;+&C%#J+;8B#D\?[S11VFAP!#FO 82?@
M(U>8N?TE+,P[V745AR>WK._VO ;FJ9'ONTX#U#XHZ!F(M>ESDD1\DZNRN-6K
M=2N],QVDL3[!%EMVQ'\R97]^H&+-L*ZDL$))YV: 2*+L>>5$\<*TC257V(3,
M,,'/!!#: /=7G*O]1#^@_O (_P)02P,$%     @ 53%55M=,Q]-' P  I0H
M !D   !X;"]W;W)K<VAE971S+W-H965T-38N>&ULS59MC^(V$/XKH_14[4E[
MFQ<@"5M 6J"G5NJUJZ/;^VR2@5B7V-1VX/KO.W9""MN ^+"5^@7\,L_C>6;L
MR4P.4GW5!:*!;U4I]-0KC-D]^K[."JR8?I [%+2SD:IBAJ9JZ^N=0I8[4%7Z
M41#$?L6X\&83M_:L9A-9FY(+?%:@ZZIBZJ\YEO(P]4+ON/"9;PMC%_S99,>V
MN$+SLGM6-/,[EIQ7*#27 A1NIMY3^+@86WMG\ ?'@SX9@U6REO*KG?R<3[W
M.H0E9L8R,/K;XP++TA*1&W^VG%YWI 6>CH_L'YUVTK)F&A>R_,)S4TR]U(,<
M-ZPNS6=Y^ E;/2/+E\E2NU\XM+:!!UFMC:Q:,'E0<='\LV]M'$X 87P!$+6
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MJ*_#)5S87TE=S:V('\.J;E'&E9=UI_59V'?37AE9[]^OVK\;]O%?4$L#!!0
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 53%55IE<G",0!@
MG"<  !,              ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " !5,556\#2QC(@%  "X&   &               @($,"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 53%55O3MWD+J!0
M>1H  !@              ("!R@T  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( %4Q558PVI\@K@(  /T'   8              " @>H3
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !5,55616=V
MF]8#  ">#   &               @('.%@  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ 53%55@F"<<;]!0  VR$  !@
M ("!VAH  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( %4Q
M559R7<R)H@8  /,<   8              " @0TA  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    " !5,556)2]J]<,)  !I%P  &
M        @('E)P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ 53%55DHR$^:5$0  03   !@              ("!WC$  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( %4Q55:YS "%7@(  '$%   8
M              " @:E#  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    " !5,556,'N3JF0"  "4!0  &0              @($]1@  >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( %4Q55:2H0TVJ0(
M .X%   9              " @=A(  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ 53%55N'W@?-L!0  $@X  !D              ("!
MN$L  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !5,556
M"LMCP ,)   &%P  &0              @(%;40  >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( %4Q559KT<FU'@D  '(7   9
M      " @95:  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ 53%55B;(LIFA @  YP4  !D              ("!ZF,  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !5,556T,*>$[X"   @!@
M&0              @('"9@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( %4Q55;Y4IN[E@D  /,7   9              " @;=I  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ 53%55@C,47-=
M P   P@  !D              ("!A',  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    " !5,556'ZN2("@$  !,"P  &0
M@($8=P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( %4Q
M55;49\K!: (  $H%   9              " @7=[  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ 53%55E>\B$+3$@  %SD  !D
M         ("!%GX  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    " !5,556F_BF.HP"  !O!0  &0              @($@D0  >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( %4Q55;X\)@4A@(  (<%
M   9              " @>.3  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ 53%55LJC8M9R @  <04  !D              ("!H)8
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !5,556V *2
M27@"  "!!0  &0              @(%)F0  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( %4Q558(I"3RM (  -X%   9
M  " @?B;  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
M53%55L M/Q-\ @  :04  !D              ("!XYX  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    " !5,556WBQ* GH$  "8"@  &0
M            @(&6H0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( %4Q559V&20DK@(  -H%   9              " @4>F  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 53%55G5'57[* @
M$ 8  !D              ("!+*D  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    " !5,556%3&[?&X$  #'"@  &0              @($M
MK   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( %4Q55:[
M%G6_Y (  .P&   9              " @=*P  !X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ 53%55N;.[1,U P  %0@  !D
M     ("![;,  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M" !5,556QZ;@/&8"   R!0  &0              @(%9MP  >&PO=V]R:W-H
M965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( %4Q559#I@6[I (  %<&   9
M              " @?:Y  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L!
M A0#%     @ 53%55@S2LTG! @  3P<  !D              ("!T;P  'AL
M+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !5,556L"D&LRL#
M  #/"P  &0              @(')OP  >&PO=V]R:W-H965T<R]S:&5E=#,W
M+GAM;%!+ 0(4 Q0    ( %4Q558<=&"CEP(  /0(   9              "
M@2O#  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ 53%5
M5I\ES&F, @  M 8  !D              ("!^<4  'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    " !5,556$*I:[<T#  !P$P  &0
M        @(&\R   >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( %4Q559YD#WCG 0  )$8   9              " @<#,  !X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ 53%55B!6>T72 @  8 @
M !D              ("!D]$  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    " !5,556)[@=:YX&   6'   &0              @(&<U
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( %4Q55;@F]QX
M> H  $U]   9              " @7';  !X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ 53%55OL"].\J P  QPL  !D
M ("!(.8  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " !5
M,556G:@>,H,$   O%@  &0              @(&!Z0  >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( %4Q559#1--+E08   @6   9
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M970U,2YX;6Q02P$"% ,4    " !5,556CCXO)1<#  ">"   &0
M    @(&V P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M %4Q5583OG$8ZP,  $T+   9              " @00' 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ 53%55AVDZE+5 @  O@D  !D
M             ("!)@L! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    " !5,556SF"\O@(#  "$"   &0              @($R#@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( %4Q55;73,?31P,
M *4*   9              " @6L1 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ 53%55KJ7PD&, @  ! 8  !D              ("!
MZ10! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " !5,556
MA&V49AL"  #.!   &0              @(&L%P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    ( %4Q559"^Q6R2@,  / 4   -
M      "  ?X9 0!X;"]S='EL97,N>&UL4$L! A0#%     @ 53%55I>*NQS
M    $P(   L              ( !<QT! %]R96QS+RYR96QS4$L! A0#%
M  @ 53%55AXRKKZV!   GR8   \              ( !7!X! 'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( %4Q5583)^RZ[P$  *4B   :
M  "  3\C 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M %4Q559B(^<8V $  $@B   3              "  68E 0!;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@    !" $( !1(  &\G 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>82</ContextCount>
  <ElementCount>271</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>33</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementsOfChangesInEquity</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - Statements of Cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementsOfCashFlows</Role>
      <ShortName>Statements of Cash flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - Cash and Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/CashAndCashEquivalents</Role>
      <ShortName>Cash and Cash Equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - Other Receivables and Prepaid Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpenses</Role>
      <ShortName>Other Receivables and Prepaid Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/CommitmentsAndContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0014 - Disclosure - Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/ShareCapital</Role>
      <ShortName>Share Capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0015 - Disclosure - Research and Development</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/ResearchAndDevelopment</Role>
      <ShortName>Research and Development</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0016 - Disclosure - General and Administrative</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/GeneralAndAdministrative</Role>
      <ShortName>General and Administrative</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0017 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0018 - Disclosure - Related Parties Balances and Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactions</Role>
      <ShortName>Related Parties Balances and Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0019 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders</Role>
      <ShortName>Net Loss Per Share Attributable to Ordinary Shareholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0020 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/EventsAfterBalanceSheetDate</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0021 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0022 - Disclosure - General (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/GeneralTables</Role>
      <ShortName>General (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/General</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0023 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0024 - Disclosure - Cash and Cash Equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/CashAndCashEquivalentsTables</Role>
      <ShortName>Cash and Cash Equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/CashAndCashEquivalents</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0025 - Disclosure - Other Receivables and Prepaid Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables</Role>
      <ShortName>Other Receivables and Prepaid Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpenses</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0026 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0027 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0028 - Disclosure - Share Capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/ShareCapitalTables</Role>
      <ShortName>Share Capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/ShareCapital</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0029 - Disclosure - Research and Development (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/ResearchAndDevelopmentTables</Role>
      <ShortName>Research and Development (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/ResearchAndDevelopment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0030 - Disclosure - General and Administrative (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/GeneralAndAdministrativeTables</Role>
      <ShortName>General and Administrative (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/GeneralAndAdministrative</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0031 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/IncomeTaxes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0032 - Disclosure - Related Parties Balances and Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables</Role>
      <ShortName>Related Parties Balances and Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactions</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0033 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Ordinary Shareholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0034 - Disclosure - General (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/GeneralDetails</Role>
      <ShortName>General (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/GeneralTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0035 - Disclosure - General (Schedule of net assets acquired based on their estimated fair value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails</Role>
      <ShortName>General (Schedule of net assets acquired based on their estimated fair value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/GeneralTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0036 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0037 - Disclosure - Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0038 - Disclosure - Cash and Cash Equivalents (Schedule of Cash and Cash Equivalents) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/CashAndCashEquivalentsDetails</Role>
      <ShortName>Cash and Cash Equivalents (Schedule of Cash and Cash Equivalents) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/CashAndCashEquivalentsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0039 - Disclosure - Other Receivables and Prepaid Expenses (Schedule of Other Receivables and Prepaid Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails</Role>
      <ShortName>Other Receivables and Prepaid Expenses (Schedule of Other Receivables and Prepaid Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0040 - Disclosure - Property and Equipment, Net (Schedule of Property and Equipment, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net (Schedule of Property and Equipment, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0041 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/LeasesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0042 - Disclosure - Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails</Role>
      <ShortName>Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/LeasesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0043 - Disclosure - Commitments and Contingent Liabilities (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingent Liabilities (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/CommitmentsAndContingentLiabilities</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0044 - Disclosure - Share Capital (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/ShareCapitalNarrativeDetails</Role>
      <ShortName>Share Capital (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/ShareCapitalTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0045 - Disclosure - Share Capital (Schedule of Share-based Compensation Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails</Role>
      <ShortName>Share Capital (Schedule of Share-based Compensation Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/ShareCapitalTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0046 - Disclosure - Share Capital (Schedule of Number and Weighted Average Exercise Prices of Option) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails</Role>
      <ShortName>Share Capital (Schedule of Number and Weighted Average Exercise Prices of Option) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/ShareCapitalTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0047 - Disclosure - Share Capital (Schedule of Assumptions Used to Calculate the Fair Value of the Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails</Role>
      <ShortName>Share Capital (Schedule of Assumptions Used to Calculate the Fair Value of the Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/ShareCapitalTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0048 - Disclosure - Research and Development (Schedule of Research and Development) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails</Role>
      <ShortName>Research and Development (Schedule of Research and Development) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/ResearchAndDevelopmentTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0049 - Disclosure - General and Administrative (Schedule of General and Administrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails</Role>
      <ShortName>General and Administrative (Schedule of General and Administrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/GeneralAndAdministrativeTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0050 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/IncomeTaxesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0051 - Disclosure - Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails</Role>
      <ShortName>Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/IncomeTaxesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0052 - Disclosure - Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails</Role>
      <ShortName>Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/IncomeTaxesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0053 - Disclosure - Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/IncomeTaxesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0054 - Disclosure - Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails</Role>
      <ShortName>Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0055 - Disclosure - Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails</Role>
      <ShortName>Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0056 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0057 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="zk2329164.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0058 - Disclosure - Subsequent Events (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails</Role>
      <ShortName>Subsequent Events (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/EventsAfterBalanceSheetDate</ParentRole>
      <Position>58</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cmmb-20221231.xsd</File>
    <File>cmmb-20221231_cal.xml</File>
    <File>cmmb-20221231_def.xml</File>
    <File>cmmb-20221231_lab.xml</File>
    <File>cmmb-20221231_pre.xml</File>
    <File doctype="8-K" isDefinitelyFs="true" isUsgaap="true" original="zk2329164.htm">zk2329164.htm</File>
    <File doctype="8-K" isDefinitelyFs="true" isUsgaap="true" original="exhibit_99-1.htm">exhibit_99-1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cmmb_img01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="411">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>74
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zk2329164.htm exhibit_99-1.htm": {
   "nsprefix": "cmmb",
   "nsuri": "http://www.anchiano.com/20221231",
   "dts": {
    "schema": {
     "local": [
      "cmmb-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "cmmb-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cmmb-20221231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20221231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "exhibit_99-1.htm",
      "zk2329164.htm"
     ]
    }
   },
   "keyStandard": 200,
   "keyCustom": 71,
   "axisStandard": 16,
   "axisCustom": 0,
   "memberStandard": 23,
   "memberCustom": 10,
   "hidden": {
    "total": 5,
    "http://fasb.org/us-gaap/2022": 2,
    "http://xbrl.sec.gov/dei/2022": 3
   },
   "contextCount": 82,
   "entityCount": 1,
   "segmentCount": 33,
   "elementCount": 446,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 411,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "report": {
    "R1": {
     "role": "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
     "longName": "0001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2329164.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2329164.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets",
     "longName": "0002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:DepositsAssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.anchiano.com/role/BalanceSheetsParenthetical",
     "longName": "0003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:CommonStockNoParValue",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:CommonStockNoParValue",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.anchiano.com/role/StatementsOfOperations",
     "longName": "0004 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:OperatingExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.anchiano.com/role/StatementsOfChangesInEquity",
     "longName": "0005 - Statement - Consolidated Statements of Changes in Equity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "strong",
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "strong",
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.anchiano.com/role/StatementsOfCashFlows",
     "longName": "0006 - Statement - Statements of Cash flows",
     "shortName": "Statements of Cash flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.anchiano.com/role/General",
     "longName": "0007 - Disclosure - General",
     "shortName": "General",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.anchiano.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "0008 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.anchiano.com/role/CashAndCashEquivalents",
     "longName": "0009 - Disclosure - Cash and Cash Equivalents",
     "shortName": "Cash and Cash Equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpenses",
     "longName": "0010 - Disclosure - Other Receivables and Prepaid Expenses",
     "shortName": "Other Receivables and Prepaid Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.anchiano.com/role/PropertyAndEquipmentNet",
     "longName": "0011 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.anchiano.com/role/Leases",
     "longName": "0012 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.anchiano.com/role/CommitmentsAndContingentLiabilities",
     "longName": "0013 - Disclosure - Commitments and Contingent Liabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.anchiano.com/role/ShareCapital",
     "longName": "0014 - Disclosure - Share Capital",
     "shortName": "Share Capital",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.anchiano.com/role/ResearchAndDevelopment",
     "longName": "0015 - Disclosure - Research and Development",
     "shortName": "Research and Development",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.anchiano.com/role/GeneralAndAdministrative",
     "longName": "0016 - Disclosure - General and Administrative",
     "shortName": "General and Administrative",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.anchiano.com/role/IncomeTaxes",
     "longName": "0017 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactions",
     "longName": "0018 - Disclosure - Related Parties Balances and Transactions",
     "shortName": "Related Parties Balances and Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders",
     "longName": "0019 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders",
     "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.anchiano.com/role/EventsAfterBalanceSheetDate",
     "longName": "0020 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "0021 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.anchiano.com/role/GeneralTables",
     "longName": "0022 - Disclosure - General (Tables)",
     "shortName": "General (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "0023 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.anchiano.com/role/CashAndCashEquivalentsTables",
     "longName": "0024 - Disclosure - Cash and Cash Equivalents (Tables)",
     "shortName": "Cash and Cash Equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables",
     "longName": "0025 - Disclosure - Other Receivables and Prepaid Expenses (Tables)",
     "shortName": "Other Receivables and Prepaid Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.anchiano.com/role/PropertyAndEquipmentNetTables",
     "longName": "0026 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.anchiano.com/role/LeasesTables",
     "longName": "0027 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.anchiano.com/role/ShareCapitalTables",
     "longName": "0028 - Disclosure - Share Capital (Tables)",
     "shortName": "Share Capital (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.anchiano.com/role/ResearchAndDevelopmentTables",
     "longName": "0029 - Disclosure - Research and Development (Tables)",
     "shortName": "Research and Development (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.anchiano.com/role/GeneralAndAdministrativeTables",
     "longName": "0030 - Disclosure - General and Administrative (Tables)",
     "shortName": "General and Administrative (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.anchiano.com/role/IncomeTaxesTables",
     "longName": "0031 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables",
     "longName": "0032 - Disclosure - Related Parties Balances and Transactions (Tables)",
     "shortName": "Related Parties Balances and Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables",
     "longName": "0033 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Tables)",
     "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.anchiano.com/role/GeneralDetails",
     "longName": "0034 - Disclosure - General (Narrative) (Details)",
     "shortName": "General (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember",
      "name": "cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember",
      "name": "cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails",
     "longName": "0035 - Disclosure - General (Schedule of net assets acquired based on their estimated fair value) (Details)",
     "shortName": "General (Schedule of net assets acquired based on their estimated fair value) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_20210316",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20210316",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
     "longName": "0036 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)",
     "shortName": "Summary of Significant Accounting Policies (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:PercentageOfMonthlyDepositsRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "span",
       "p",
       "cmmb:SeverancePayPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:PercentageOfMonthlyDepositsRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "span",
       "p",
       "cmmb:SeverancePayPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails",
     "longName": "0037 - Disclosure - Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)",
     "shortName": "Summary of Significant Accounting Policies (Schedule of Annual rates of Depreciation) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "cmmb:ScheduleOfAnnualRateOfDeprecationTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.anchiano.com/role/CashAndCashEquivalentsDetails",
     "longName": "0038 - Disclosure - Cash and Cash Equivalents (Schedule of Cash and Cash Equivalents) (Details)",
     "shortName": "Cash and Cash Equivalents (Schedule of Cash and Cash Equivalents) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231_srtCurrencyAxis_currencyUSD",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails",
     "longName": "0039 - Disclosure - Other Receivables and Prepaid Expenses (Schedule of Other Receivables and Prepaid Expenses) (Details)",
     "shortName": "Other Receivables and Prepaid Expenses (Schedule of Other Receivables and Prepaid Expenses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "cmmb:ReceivablesFromGovernmentInstitutions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
       "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231",
      "name": "cmmb:ReceivablesFromGovernmentInstitutions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "cmmb:ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
       "cmmb:OtherAccountsReceivableAndPrepaidExpensesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
     "longName": "0040 - Disclosure - Property and Equipment, Net (Schedule of Property and Equipment, Net) (Details)",
     "shortName": "Property and Equipment, Net (Schedule of Property and Equipment, Net) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "strong",
       "strong",
       "strong",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "strong",
       "strong",
       "strong",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.anchiano.com/role/LeasesNarrativeDetails",
     "longName": "0041 - Disclosure - Leases (Narrative) (Details)",
     "shortName": "Leases (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_20200510",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20200510",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails",
     "longName": "0042 - Disclosure - Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)",
     "shortName": "Leases (Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
     "longName": "0043 - Disclosure - Commitments and Contingent Liabilities (Narrative) (Details)",
     "shortName": "Commitments and Contingent Liabilities (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:OtherCommitmentsDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:OtherCommitmentsDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.anchiano.com/role/ShareCapitalNarrativeDetails",
     "longName": "0044 - Disclosure - Share Capital (Narrative) (Details)",
     "shortName": "Share Capital (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231_usgaapPlanNameAxis_cmmbTwoThousandsFifteenPlanMember",
      "name": "cmmb:StockIssuedDuringPeriodAmericanDepositorySharesNewIssues",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails",
     "longName": "0045 - Disclosure - Share Capital (Schedule of Share-based Compensation Expenses) (Details)",
     "shortName": "Share Capital (Schedule of Share-based Compensation Expenses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails",
     "longName": "0046 - Disclosure - Share Capital (Schedule of Number and Weighted Average Exercise Prices of Option) (Details)",
     "shortName": "Share Capital (Schedule of Number and Weighted Average Exercise Prices of Option) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_20211231",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails",
     "longName": "0047 - Disclosure - Share Capital (Schedule of Assumptions Used to Calculate the Fair Value of the Options) (Details)",
     "shortName": "Share Capital (Schedule of Assumptions Used to Calculate the Fair Value of the Options) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:SharePrice",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:SharePrice",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails",
     "longName": "0048 - Disclosure - Research and Development (Schedule of Research and Development) (Details)",
     "shortName": "Research and Development (Schedule of Research and Development) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ConsultantsAndSubcontractorsExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:ConsultantsAndSubcontractorsExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "cmmb:ScheduleOfResearchAndDevelopmentTableTextBlock",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails",
     "longName": "0049 - Disclosure - General and Administrative (Schedule of General and Administrative) (Details)",
     "shortName": "General and Administrative (Schedule of General and Administrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:SalariesAndWages",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock",
       "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:SalariesAndWages",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "cmmb:ScheduleOfGeneralAndAdministrativeTableTextBlock",
       "cmmb:GeneralAndAdministrativeDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.anchiano.com/role/IncomeTaxesDetails",
     "longName": "0050 - Disclosure - Income Taxes (Narrative) (Details)",
     "shortName": "Income Taxes (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails",
     "longName": "0051 - Disclosure - Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)",
     "shortName": "Income Taxes (Schedule of Significant Components of the Company's Deferred Tax Asset) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails",
     "longName": "0052 - Disclosure - Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)",
     "shortName": "Income Taxes (Schedule of Roll Forward of Valuation Allowance) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_20211231",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:CurrencyTransactionLossValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails",
     "longName": "0053 - Disclosure - Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)",
     "shortName": "Income Taxes (Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails",
     "longName": "0054 - Disclosure - Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)",
     "shortName": "Related Parties Balances and Transactions (Schedule of Related Party Payables) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_cmmbRelatedPartyMember",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "cmmb:ScheduleOfRelatedPartyPayablesTableTextBlock",
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails",
     "longName": "0055 - Disclosure - Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)",
     "shortName": "Related Parties Balances and Transactions (Schedule of Transaction With Related Parties) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "cmmb:RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails",
     "longName": "0056 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)",
     "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Computation of Basic and Diluted Net Loss) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231",
      "name": "us-gaap:IncomeLossFromContinuingOperationsPerBasicShare",
      "unitRef": "USD_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails",
     "longName": "0057 - Disclosure - Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)",
     "shortName": "Net Loss Per Share Attributable to Ordinary Shareholders (Schedule of Weighted Average Number of Shares) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_usgaapEmployeeStockOptionMember",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails",
     "longName": "0058 - Disclosure - Subsequent Events (Narrative) (Details)",
     "shortName": "Subsequent Events (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_20230113_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember",
      "name": "cmmb:SaleOfStockValueOfSharesIssuedInTransaction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230113_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember",
      "name": "cmmb:SaleOfStockValueOfSharesIssuedInTransaction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-1.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r13"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      },
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails": {
       "parentTag": "us-gaap_DueToRelatedPartiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails",
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_AccruedRoyaltiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccruedRoyaltiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized liability for royalties",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r105"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less - accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r120"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r380"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid In Capital [Member]",
        "verboseLabel": "Additional paid in capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r257",
      "r415",
      "r416",
      "r417",
      "r458"
     ]
    },
    "cmmb_AdditionalWorkOrderAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "AdditionalWorkOrderAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional work order amount.",
        "label": "Additional Work Order Amount",
        "verboseLabel": "Additional work order"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of warrants",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r60"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AggregateAmountCommitmentToPay": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "AggregateAmountCommitmentToPay",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount commitment to pay.",
        "label": "Aggregate amount commitment to pay"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AggregateAmountOfCommitmentPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "AggregateAmountOfCommitmentPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of commitment paid.",
        "label": "Aggregate amount of commitment paid"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AggregateOfferingPriceOfAtMarketOfferingAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "AggregateOfferingPriceOfAtMarketOfferingAgreement",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a aggregate offering price of at the market offering agreement.",
        "label": "Aggregate Offering Price Of At Market Offering Agreement",
        "terseLabel": "Aggregate offering price of at the market offering agreement"
       }
      }
     },
     "auth_ref": []
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation expenses",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AmericanDepositarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "AmericanDepositarySharesMember",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares [Member]",
        "label": "American Depositary Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AnnualRatesOfDepreciation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "AnnualRatesOfDepreciation",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rates of depreciation.",
        "label": "Annual Rates Of Depreciation",
        "verboseLabel": "Annual rates of depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AnnualRentAndManagementFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "AnnualRentAndManagementFees",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rent and management fees.",
        "label": "Annual rent and management fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding options to purchase ordinary shares",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r100",
      "r121",
      "r137",
      "r178",
      "r180",
      "r182",
      "r186",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r285",
      "r289",
      "r294",
      "r380",
      "r424",
      "r425",
      "r466"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r126",
      "r137",
      "r186",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r285",
      "r289",
      "r294",
      "r380",
      "r424",
      "r425",
      "r466"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:",
        "terseLabel": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r186",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r285",
      "r289",
      "r294",
      "r424",
      "r425",
      "r466"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_AtmAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "AtmAgreementMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ATM agreement [Member]",
        "label": "ATM agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm Id",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r389",
      "r390",
      "r391"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r389",
      "r390",
      "r391"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AuditorName",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r389",
      "r390",
      "r391"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253"
     ]
    },
    "cmmb_BankGuaranteesToPropertyOwner": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "BankGuaranteesToPropertyOwner",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank guarantees to property owner.",
        "label": "Bank guarantees to property owner"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of presentation",
        "terseLabel": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r374",
      "r375"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80",
      "r283",
      "r374",
      "r375"
     ]
    },
    "cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails": {
       "parentTag": "cmmb_EstimatedFairValueOfNetAssetsAcquired",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of of asset held for sale recogized prior to the completion of merger.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Asset Held For Sale",
        "verboseLabel": "Asset held for sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails": {
       "parentTag": "cmmb_EstimatedFairValueOfNetAssetsAcquired",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails": {
       "parentTag": "cmmb_EstimatedFairValueOfNetAssetsAcquired",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid and other assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails": {
       "parentTag": "cmmb_EstimatedFairValueOfNetAssetsAcquired",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "negatedLabel": "Accrued liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_CantorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "CantorMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents about Cantor.",
        "label": "Cantor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalAdditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CapitalAdditionsMember",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Drug Application and Biological License Application [Member]",
        "documentation": "Contractual obligation to increase property, plant and equipment either through construction or future purchases."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_CapitalAdditionsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "CapitalAdditionsOneMember",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FDA or equivalent agency marketing approval [Member]",
        "label": "Capital Additions One [Member]",
        "verboseLabel": "FDA or equivalent agency marketing approval [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_CashAcquiredInMerger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "CashAcquiredInMerger",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash acquired in merger.",
        "label": "Cash acquired in Merger"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r118",
      "r366"
     ]
    },
    "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashAndCashEquivalentsDisclosureTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "verboseLabel": "Restricted cash",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r89"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of the year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of the year",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r36",
      "r42"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash, cash equivalents and restricted cash",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r85"
     ]
    },
    "cmmb_CashPaidAndReceivedDuringYearForAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "CashPaidAndReceivedDuringYearForAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "n/a",
        "label": "Cash Paid And Received During Year For [Abstract]",
        "terseLabel": "A. Cash paid and received during the year for:"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ChangeInTemporaryDifferencesForDeferredTaxesNotRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a change in temporary differences for which deferred taxes were not recognized.",
        "label": "Change In Temporary Differences For Deferred Taxes Not Recognized",
        "terseLabel": "Change in temporary differences for which deferred taxes were not recognized"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r137",
      "r156",
      "r157",
      "r159",
      "r161",
      "r168",
      "r169",
      "r186",
      "r202",
      "r205",
      "r206",
      "r207",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r294",
      "r365",
      "r397",
      "r412",
      "r419"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingent liabilities",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r93",
      "r104"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommitmentsDisclosureTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingent Liabilities",
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "verboseLabel": "Ordinary shares [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r416",
      "r458"
     ]
    },
    "us-gaap_CommonStockNoParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockNoParValue",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, No Par Value",
        "documentation": "Face amount per share of no-par value common stock."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares no par value - Authorized: 650,000,000 shares as of December 31, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 228,090,300 shares at December 31, 2021 and 9,274,838 shares at December 31, 2020",
        "terseLabel": "Ordinary Shares no par value - Authorized: 650,000,000 shares as of December 31, 2022 and 2021; Issued and outstanding: 232,636,700 Ordinary shares at December 31, 2022 and 228,090,300 Ordinary shares at December 31, 2021",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r380"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred taxes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computers [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of credit risks",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r173"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r368"
     ]
    },
    "cmmb_ConsultantsAndSubcontractorsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ConsultantsAndSubcontractorsExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consultants and subcontractors expenses.",
        "label": "Consultants And Subcontractors Expense",
        "verboseLabel": "Consultants and subcontractors"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_CumulativeAmountsOfGrantsReceivedAndRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "CumulativeAmountsOfGrantsReceivedAndRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amounts of grants received from the IIA and recognized by the company, as of the balance sheet date.",
        "label": "Cumulative Amounts Of Grants Received And Recognized",
        "verboseLabel": "Cumulative amounts of grants received"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_CurrencyTransactionLossValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "CurrencyTransactionLossValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance due to currency transaction loss.",
        "label": "Currency Transaction Loss Valuation Allowance",
        "terseLabel": "Currency transaction income (loss)"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DebtInstrumentInterestRateIncreaseDecrease",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental borrowing rate based on credit rating",
        "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Gross deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development costs",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r457"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating loss carry-forwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r457"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r457"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation expense",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r457"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails",
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less - valuation allowance",
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "us-gaap_DepositsAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DepositsAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term bank deposit",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r51"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r390",
      "r391"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DueToRelatedPartiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to Related Parties, Current",
        "totalLabel": "Related Party Payables",
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r204",
      "r205",
      "r206",
      "r210",
      "r211",
      "r212",
      "r315",
      "r414"
     ]
    },
    "currency_EUR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "localname": "EUR",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted loss per Ordinary Share",
        "terseLabel": "Basic loss per Ordinary Share",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r154",
      "r156",
      "r159",
      "r160",
      "r161",
      "r165",
      "r292",
      "r293",
      "r336",
      "r339",
      "r369"
     ]
    },
    "cmmb_EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "EarningsPerShareCalculationDenominatorForBasicNetIncomeLossPerShareAbstract",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share Abstract",
        "label": "Earnings Per Share Calculation Denominator For Basic Net Income Loss Per Share [Abstract]",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_EarningsPerShareCalculationNumeratorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "EarningsPerShareCalculationNumeratorAbstract",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share Calculation Numerator Abstract",
        "label": "Earnings Per Share Calculation Numerator [Abstract]",
        "verboseLabel": "Numerator:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted loss per Ordinary Share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r156",
      "r159",
      "r160",
      "r161",
      "r165",
      "r292",
      "r293",
      "r336",
      "r339",
      "r369"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per ordinary share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholders"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Share Attributable to Ordinary Shareholders",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r166"
     ]
    },
    "cmmb_EffectOfReverseCapitalizationTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "EffectOfReverseCapitalizationTransaction",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of effect due reverse capitalization transaction.",
        "label": "Effect of reverse capitalization transaction"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_EffectOfReverseCapitalizationTransactionShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "EffectOfReverseCapitalizationTransactionShares",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares isued due to effect of reverse capitalization transaction.",
        "label": "Effect Of Reverse Capitalization Transaction Shares",
        "verboseLabel": "Effect of reverse capitalization transaction (In shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statutory tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate tax rate (as a percent)",
        "terseLabel": "Corporate tax rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r263",
      "r277"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails": {
       "parentTag": "us-gaap_DueToRelatedPartiesCurrent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails",
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee and related expenses",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well Known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r394"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r114",
      "r130",
      "r131",
      "r132",
      "r140",
      "r141",
      "r142",
      "r144",
      "r150",
      "r152",
      "r167",
      "r187",
      "r218",
      "r255",
      "r256",
      "r257",
      "r273",
      "r274",
      "r291",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r311",
      "r342",
      "r343",
      "r344"
     ]
    },
    "cmmb_EstimatedFairValueOfNetAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "EstimatedFairValueOfNetAssetsAcquired",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralScheduleOfNetAssetsAcquiredBasedOnTheirEstimatedFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated fair value of the net assets acquired.",
        "label": "Estimated Fair Value Of Net Assets Acquired",
        "totalLabel": "Net acquired assets"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_ExpectsToReceiveAmountOfChemomabTherapeuticsInc": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ExpectsToReceiveAmountOfChemomabTherapeuticsInc",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount expects to receive of Chemomab Therapeutics Inc.",
        "label": "Expects To Receive Amount Of Chemomab Therapeutics Inc",
        "terseLabel": "Expects to receive amount of Chemomab Therapeutics Inc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of financial instruments",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Functional currency",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r302"
     ]
    },
    "cmmb_FormerChemomabSecurityHoldersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "FormerChemomabSecurityHoldersMember",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents former Chemomab security holders.",
        "label": "Former Chemomab Security Holders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Equipment [Member]",
        "terseLabel": "Furniture and equipment [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_GeneralAndAdministrativeDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "GeneralAndAdministrativeDisclosureTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of general and administrative expenses.",
        "label": "General And Administrative Disclosure [Text Block]",
        "verboseLabel": "General and Administrative"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 10.0
      },
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails",
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "terseLabel": "General and administrative",
        "totalLabel": "Total",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "GeneralAndAdministrativeExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_GeneralInsuranceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "GeneralInsuranceExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance",
        "documentation": "The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales)."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "cmmb_GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "GovernmentSponsoredResearchAndDevelopmentPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Government Sponsored Research And Development [Policy Text Block]",
        "verboseLabel": "Government-sponsored research and development"
       }
      }
     },
     "auth_ref": []
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "localname": "IL",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "currency_ILS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "localname": "ILS",
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ILS [Member]",
        "terseLabel": "NIS [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r389",
      "r390",
      "r391"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of long-lived assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r55"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails",
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss before income tax",
        "negatedTotalLabel": "Loss before taxes",
        "positiveTerseLabel": "Loss before income taxes",
        "positiveVerboseLabel": "Loss before taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r88",
      "r95",
      "r109",
      "r178",
      "r179",
      "r181",
      "r183",
      "r337",
      "r371"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per share attributable to ordinary shareholders, basic and diluted",
        "terseLabel": "Net loss per share attributable to ordinary shareholders, basic",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r94",
      "r96",
      "r106",
      "r133",
      "r143",
      "r145",
      "r146",
      "r147",
      "r148",
      "r156",
      "r159",
      "r160",
      "r293",
      "r336"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Net loss per share attributable to ordinary shareholders, diluted",
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r106",
      "r108",
      "r133",
      "r143",
      "r145",
      "r146",
      "r147",
      "r148",
      "r156",
      "r159",
      "r160",
      "r161",
      "r293",
      "r336",
      "r339"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r193"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_IncomeTaxDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "IncomeTaxDisclosureLineItems",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_IncomeTaxDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "IncomeTaxDisclosureTable",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information pertaining to income taxes.",
        "label": "Income Tax Disclosure [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r264",
      "r265",
      "r271",
      "r275",
      "r278",
      "r280",
      "r281",
      "r282"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails",
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails",
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveTerseLabel": "Taxes on income (benefit)",
        "positiveVerboseLabel": "Actual income tax expense (Benefit)",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax benefit",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r151",
      "r152",
      "r177",
      "r262",
      "r276",
      "r279",
      "r340"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Theoretical tax benefit on the above amount Decrease (increase) in tax refund resulting from:"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_IncomeTaxExpenseValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "IncomeTaxExpenseValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance due to income tax expense.",
        "label": "Income Tax Expense Valuation Allowance",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r260",
      "r261",
      "r265",
      "r266",
      "r270",
      "r272"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Tax rate differential",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Theoretical tax benefit",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Non-deductible expenses",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income taxes paid",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "cmmb_IncomeTaxesReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "IncomeTaxesReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents income taxes received.",
        "label": "Income Taxes Received",
        "verboseLabel": "Income taxes received"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in trade payables",
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in accrued expenses",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in employees and related expenses",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in leases",
        "terseLabel": "Change in operating leases",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r462"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in other receivables and prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cmmb_IncrementalBorrowingRateOfLeases": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "IncrementalBorrowingRateOfLeases",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents incremental borrowing rate of leases.",
        "label": "Incremental Borrowing Rate Of Leases",
        "verboseLabel": "incremental borrowing rate of leases"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_InterestReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "InterestReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest received.",
        "label": "Interest Received",
        "terseLabel": "Interest received"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_InvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "InvestorsMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investors [Member]",
        "label": "Investors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment [Member]",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LeaseAgreementsMember",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2020 Lien [Member]",
        "documentation": "Contractual agreement that stipulates the lessee pay the lessor for use of an asset."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_LeaseExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LeaseExpirationDate1",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease expiry date",
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_LesseeDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r307"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Leases [Policy Text Block]",
        "verboseLabel": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturity of Lease Liabilities Under Our Non-cancelable Operating Leases",
        "terseLabel": "Schedule of maturity of lease liabilities under our non-cancelable operating leases",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2023",
        "terseLabel": "2024",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2022",
        "terseLabel": "2023",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less imputed interest:",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Option to Extend",
        "terseLabel": "Lease term, option to extend",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease term",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r137",
      "r186",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r286",
      "r289",
      "r290",
      "r294",
      "r370",
      "r424",
      "r466",
      "r467"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r91",
      "r102",
      "r380",
      "r413",
      "r422",
      "r459"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAssumed1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesAssumed1",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities assumed, net of non-cash assets received in Merger",
        "verboseLabel": "Liabilities assumed, net of non-cash assets received in Merger",
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r117",
      "r137",
      "r186",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r286",
      "r289",
      "r290",
      "r294",
      "r380",
      "r424",
      "r466",
      "r467"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r137",
      "r186",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r286",
      "r289",
      "r290",
      "r294",
      "r424",
      "r466",
      "r467"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_LienOnBankDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "LienOnBankDeposit",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lien on bank deposit.",
        "label": "Lien on bank deposit"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_LongTermLeaseDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "LongTermLeaseDeposit",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term lease deposit.",
        "label": "Long Term Lease Deposit",
        "verboseLabel": "Long-term lease deposit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongTermPurchaseCommitmentAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment for licensed agreement",
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Category of Item Purchased [Axis]",
        "documentation": "Information by category of items purchased under a long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LongTermPurchaseCommitmentDescription",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of application payment for licensed product",
        "documentation": "Describes the terms of a significant arrangement with a supplier (excluding an unconditional purchase obligation) to acquire goods or services over a period of time beyond one year or the normal operating cycle, if longer, which may include identification of the goods or services to be purchased, pricing, effects on pricing of failing to reach minimum quantities required to be purchased, cancellation rights, and termination provisions."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "LossesAndBenefitsForTaxPurposesForYearForWhichDeferredTaxesWereNotRecorded",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfReconciliationOfTheoreticalIncomeTaxExpenseToActualIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents losses and benefits for tax purposes for the year, for which deferred taxes were not recorded.",
        "label": "Losses And Benefits For Tax Purposes For The Year For Which Deferred Taxes Were Not Recorded",
        "terseLabel": "Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r201",
      "r221",
      "r322",
      "r341",
      "r363",
      "r364",
      "r372",
      "r376",
      "r382",
      "r426",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473"
     ]
    },
    "cmmb_MaximumPercentageOfPaymentsOfRoyalties": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "MaximumPercentageOfPaymentsOfRoyalties",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum percentage of royalties payable on the amount of the grant received (dollar linked), plus interest at annual rate based on LIBOR.",
        "label": "Maximum Percentage Of Payments Of Royalties",
        "verboseLabel": "Maximum percentage of payments of royalties (as a percent)"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.",
        "label": "Merger Agreement With Cmb Acquisition Ltd Subsidiary Of Ours And Chemomb [Member]",
        "verboseLabel": "Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r201",
      "r221",
      "r322",
      "r341",
      "r363",
      "r364",
      "r372",
      "r376",
      "r382",
      "r426",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.anchiano.com/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r176"
     ]
    },
    "cmmb_NatureOfOperationsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NatureOfOperationsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Nature Of Operations Disclosure [Abstract]",
        "verboseLabel": "NATURE OF OPERATIONS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r35"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails",
      "http://www.anchiano.com/role/StatementsOfChangesInEquity",
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net loss",
        "negatedTotalLabel": "Net loss for the year",
        "label": "Net loss for the year",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r35",
      "r97",
      "r107",
      "r115",
      "r127",
      "r128",
      "r132",
      "r137",
      "r143",
      "r145",
      "r146",
      "r147",
      "r148",
      "r151",
      "r152",
      "r158",
      "r178",
      "r179",
      "r181",
      "r183",
      "r186",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r293",
      "r294",
      "r371",
      "r424"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant non- cash transaction:",
        "terseLabel": "B. Significant non- cash transaction:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoninterestExpenseDirectorsFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NoninterestExpenseDirectorsFees",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees to Directors",
        "documentation": "Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financing (income) expenses, net",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Financing expenses (income), net",
        "totalLabel": "Nonoperating Income (Expense), Total",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfAdsIssuedAndOutstandingAfterMerger",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ADS issued and outstanding after the merger.",
        "label": "Number of ADS issued and outstanding after the merger"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_NumberOfAdssOptionsIssuableOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfAdssOptionsIssuableOutstanding",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ADSs options issuable outstanding.",
        "label": "Number of ADSs options issuable outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_NumberOfAdssVestedAndExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfAdssVestedAndExercisable",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ADSs vested and exercisable.",
        "label": "Number of ADSs vested and exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_NumberOfOptionsIssuableOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfOptionsIssuableOutstanding",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents number of options issuable outstanding.",
        "label": "Number Of Options Issuable Outstanding",
        "verboseLabel": "Number of options issuable outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_NumberOfOptionsVestedAndExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfOptionsVestedAndExercisable",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents number of options vested and exercisable.",
        "label": "Number Of Options Vested And Exercisable",
        "verboseLabel": "Number of options vested and exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_NumberOfOrdinarySharesConsistedInDs": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfOrdinarySharesConsistedInDs",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the number of ordinary shares consisted in one American depository share (ADS).",
        "label": "Number Of Ordinary Shares Consisted In Ds",
        "verboseLabel": "Number of ordinary shares represented by each ADS (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_NumberOfStockAdssResveredForIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfStockAdssResveredForIssuance",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock option ADSs resvered for issuance.",
        "label": "Number Of Stock Adss Resvered For Issuance",
        "verboseLabel": "Number of stock option ADSs reversed for issuance"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_NumberOfStockReservedForIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfStockReservedForIssuance",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents number of stock resvered for issuance.",
        "label": "Number Of Stock Reserved For Issuance",
        "verboseLabel": "Number of stock reserved for issuance"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_NumberOfVestedAndExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfVestedAndExercisable",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents number of vested and exercisable.",
        "label": "Number Of Vested And Exercisable",
        "verboseLabel": "Number of vested and exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_NumberOfWarrantsPurchaseUpAdss": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "NumberOfWarrantsPurchaseUpAdss",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants purchase ADS's.",
        "label": "Number Of Warrants Purchase Up Adss",
        "verboseLabel": "Number of warrants purchase ADS's"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficersCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OfficersCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salaries and related expenses",
        "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease in the carrying amount of the right-of-use asset due to impairment",
        "terseLabel": "Increase in the carrying amount of the right-of-use asset due to impairment",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails",
      "http://www.anchiano.com/role/LeasesScheduleOfMaturityOfLeaseLiabilitiesUnderOurNon-cancelableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities",
        "totalLabel": "Operating Lease, Liability, Total",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current operating lease liabilities",
        "verboseLabel": "Non-current\u00a0operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails",
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r303"
     ]
    },
    "cmmb_OperatingRightOfUseAssetsAndOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "OperatingRightOfUseAssetsAndOperatingLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating right-of-use assets and operating lease liabilities.",
        "label": "Operating Right Of Use Assets And Operating Lease Liabilities",
        "verboseLabel": "Operating right-of-use assets and operating lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares, No Par Value Per Share [Member]",
        "label": "Ordinary Shares, No Par Value Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_OtherAccountsReceivableAndPrepaidExpensesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "OtherAccountsReceivableAndPrepaidExpensesTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other accounts receivable and prepaid expenses.",
        "label": "Other Accounts Receivable And Prepaid Expenses [Text Block]",
        "verboseLabel": "Other Receivables and Prepaid Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherCommitmentsDescription",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decsription of occurrence for payments",
        "documentation": "Description of the nature and terms of commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other General and Administrative Expense",
        "verboseLabel": "Other expenses",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses",
        "documentation": "Amount of other research and development expense."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "cmmb_PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "PaymentOnLongTermPurchaseCommitmentCommencementOfAgreement",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment on commencement of agreement.",
        "label": "Payment On Long Term Purchase Commitment Commencement Of Agreement",
        "verboseLabel": "Payment on commencement of agreement"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_PaymentsForInvestmentInDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "PaymentsForInvestmentInDeposits",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payments for investm,ents in deposits.",
        "negatedLabel": "Investment in deposits",
        "label": "Payments for Investment in Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury share at cost",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "cmmb_PercentageOfMonthlyDepositsRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "PercentageOfMonthlyDepositsRate",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of monthly deposits rate.",
        "label": "Percentage of monthly deposits rate"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_PercentageOfRoyaltyPaymentsOnSaleOfProduct": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "PercentageOfRoyaltyPaymentsOnSaleOfProduct",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of royalty payments on sale of product developed with funding received from the IIA.",
        "label": "Percentage Of Royalty Payments On Sale Of Product",
        "verboseLabel": "Royalty payments on sale of product (as a percent)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred shares par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r213"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred shares issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r213"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PrepaidExpenseAndOtherAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 10.0
      },
      "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails",
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other receivables and prepaid expenses",
        "totalLabel": "Other accounts receivable and prepaid expenses, Total",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r188",
      "r189",
      "r367"
     ]
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PrepaidExpenseNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term prepaid expenses",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from preferred shares",
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromOtherEquity",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Other Equity",
        "verboseLabel": "Issuance of shares and warrants, net of issuance costs",
        "documentation": "Amount of cash inflow from the issuance of equity classified as other."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cmmb_ProceedsFromSaleOfAdss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ProceedsFromSaleOfAdss",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of ADS's.",
        "label": "Proceeds from sale of ADS's"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromSaleOfOtherAssetsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of asset held for sale",
        "documentation": "Amount of cash inflow from the sale of other assets recognized in investing activities."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r69"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of warrants",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional services",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Loss before taxes",
        "verboseLabel": "Net loss for the year",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r127",
      "r128",
      "r134",
      "r137",
      "r143",
      "r151",
      "r152",
      "r178",
      "r179",
      "r181",
      "r183",
      "r186",
      "r202",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r211",
      "r212",
      "r284",
      "r287",
      "r288",
      "r293",
      "r294",
      "r337",
      "r371",
      "r377",
      "r378",
      "r406",
      "r424"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Type [Axis]",
        "verboseLabel": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment, Net",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r351",
      "r352",
      "r353"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r119"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 30.0
      },
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "totalLabel": "Property Plant And Equipment Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r103",
      "r338",
      "r380"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r351",
      "r352"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentSalvageValuePercentage",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual rates of depreciation",
        "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property And Equpment, Net",
        "terseLabel": "Schedule of property and equipment, Net",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r201",
      "r219",
      "r221",
      "r250",
      "r251",
      "r252",
      "r321",
      "r322",
      "r341",
      "r363",
      "r364",
      "r372",
      "r376",
      "r382",
      "r423",
      "r426",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "RangeMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r201",
      "r219",
      "r221",
      "r250",
      "r251",
      "r252",
      "r321",
      "r322",
      "r341",
      "r363",
      "r364",
      "r372",
      "r376",
      "r382",
      "r423",
      "r426",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473"
     ]
    },
    "cmmb_ReceivablesFromGovernmentInstitutions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ReceivablesFromGovernmentInstitutions",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government institutions.",
        "label": "Receivables From Government Institutions",
        "verboseLabel": "Government institutions"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_ReceivedAmountOfChemomabTherapeuticsInc": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ReceivedAmountOfChemomabTherapeuticsInc",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The received amount of Chemomab Therapeutics Inc.",
        "label": "Received Amount Of Chemomab Therapeutics Inc",
        "terseLabel": "Received amount of Chemomab Therapeutics Inc"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_RecoverabilityOfVatAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RecoverabilityOfVatAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents recoverability of VAT amount.",
        "label": "Recoverability Of Vat Amount",
        "verboseLabel": "Recoverability of VAT amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Costs",
        "totalLabel": "Total related party expenses",
        "documentation": "Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r204",
      "r205",
      "r206",
      "r210",
      "r211",
      "r212",
      "r414"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails",
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r314",
      "r315"
     ]
    },
    "cmmb_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party [Member]",
        "label": "Related Party [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RelatedPartyTransactionProfessionalServicesFromTransactionsWithRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "parentTag": "us-gaap_RelatedPartyCosts",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party expenses related to professional services.",
        "label": "Related Party Transaction Professional Services From Transactions With Related Party",
        "verboseLabel": "Professional services"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RelatedPartyTransactionResearchAndDevelopmentExpenseFromTransactionsWithRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "parentTag": "us-gaap_RelatedPartyCosts",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party expenses related to research and develeopment expense.",
        "label": "Related Party Transaction Research And Development Expense From Transactions With Related Party",
        "verboseLabel": "Research and development"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RelatedPartyTransactionSalariesAndRelatedExpensesFromTransactionsWithRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "parentTag": "us-gaap_RelatedPartyCosts",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party expenses related to salaries and related expenses.",
        "label": "Related Party Transaction Salaries And Related Expenses From Transactions With Related Party",
        "verboseLabel": "Salaries and related expenses"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RelatedPartyTransactionShareBasedPaymentsFromTransactionsWithRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails": {
       "parentTag": "us-gaap_RelatedPartyCosts",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfTransactionWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party expenses related to share based payments.",
        "label": "Related Party Transaction Share Based Payments From Transactions With Related Party",
        "verboseLabel": "Share-based payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails",
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r314",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r465"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties Balances and Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313",
      "r315",
      "r316",
      "r317"
     ]
    },
    "cmmb_RentAndMaintenanceGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RentAndMaintenanceGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and administrative related rent and maintenance expenses.",
        "label": "Rent And Maintenance General And Administrative Expense",
        "verboseLabel": "Rent and maintenance"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_RentAndMaintenanceResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RentAndMaintenanceResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development related rent and maintenance expenses.",
        "label": "Rent And Maintenance Research And Development Expense",
        "terseLabel": "Rent and maintenance"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_RepurchaseArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RepurchaseArrangementMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Repurchase Arrangement.",
        "label": "Repurchase Arrangement [Member]",
        "verboseLabel": "Repurchase Arrangement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_RepurchaseOfAmericanDepositaryReceipts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RepurchaseOfAmericanDepositaryReceipts",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of repurchase of american depositary receipts.",
        "label": "Repurchase Of American Depositary Receipts",
        "verboseLabel": "Repurchase of ADSs"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_RepurchaseOfAmericanDepositaryReceiptsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "RepurchaseOfAmericanDepositaryReceiptsShares",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents repurchase of American Depositary Receipts shares",
        "label": "Repurchase Of American Depositary Receipts Shares",
        "verboseLabel": "Number of shares repurchase of ADSs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails",
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "totalLabel": "Total",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r112",
      "r474"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expenses [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "verboseLabel": "Research and Development",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/ResearchAndDevelopment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash, Current",
        "verboseLabel": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r411"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r401",
      "r411"
     ]
    },
    "us-gaap_RestrictedInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RestrictedInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank restricted deposit",
        "documentation": "Investments which are not defined as or included in marketable (debt, equity, or other) securities whose use is restricted in whole or in part, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r350"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r60",
      "r101",
      "r345",
      "r346",
      "r380"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "verboseLabel": "Accumulated deficit [Member]",
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r140",
      "r141",
      "r142",
      "r144",
      "r150",
      "r152",
      "r187",
      "r255",
      "r256",
      "r257",
      "r273",
      "r274",
      "r291",
      "r342",
      "r344"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use asset recognized with corresponding lease liability",
        "verboseLabel": "Right-of-use asset recognized with corresponding lease liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r379"
     ]
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royality expenses",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_SalariesAndWages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SalariesAndWages",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold",
        "verboseLabel": "Salaries and related expenses",
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "cmmb_SaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "SaleOfStockLineItems",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Sale Of Stock [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_SaleOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "SaleOfStockTable",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Sale Of Stock [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_SaleOfStockValueOfSharesIssuedInTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "SaleOfStockValueOfSharesIssuedInTransaction",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of sale of stock value of shares issued in transaction.",
        "label": "Sale Of Stock Value Of Shares Issued In Transaction",
        "terseLabel": "Issuance and sale of of ADS upto"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_SaleOfStocksPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "SaleOfStocksPricePerShare",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by the company for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale Of Stocks Price Per Share",
        "verboseLabel": "Share price per share"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r222",
      "r418"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r153",
      "r222",
      "r398",
      "r418"
     ]
    },
    "cmmb_ScheduleOfAnnualRateOfDeprecationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ScheduleOfAnnualRateOfDeprecationTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the annual rate of deprecation.",
        "label": "Schedule Of Annual Rate Of Deprecation [Table Text Block]",
        "terseLabel": "Schedule of annual rate of deprecation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Number of Shares Excluded From Computation of Diluted Net Loss Per Share",
        "terseLabel": "Schedule of weighted average number of shares excluded from computation of diluted net loss per share",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of components of cash and cash equivalents",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of the effect of share-based compensation on the statements of operations",
        "terseLabel": "Schedule of the effect of share-based compensation on the statements of operations",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Significant Components of the Company's Deferred Tax Asset",
        "terseLabel": "Schedule of significant components of the company's deferred tax asset",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Computation of Basic and Diluted Net Loss Per Share",
        "terseLabel": "Schedule of computation of basic and diluted net loss per share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense",
        "terseLabel": "Schedule of reconciliation of theoretical income tax expense to actual income tax expense",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalShare-basedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r70"
     ]
    },
    "cmmb_ScheduleOfGeneralAndAdministrativeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ScheduleOfGeneralAndAdministrativeTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrativeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of general and administrative expenses.",
        "label": "Schedule Of General And Administrative [Table Text Block]",
        "terseLabel": "Schedule of general and administrative"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ScheduleOfOtherAccountsReceivableAndPrepaidExpensesTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/OtherReceivablesAndPrepaidExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of other accounts receivable and prepaid expenses.",
        "label": "Schedule Of Other Accounts Receivable And Prepaid Expenses [Table Text Block]",
        "verboseLabel": "Schedule of other accounts receivable and prepaid expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails",
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAnnualRatesOfDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/GeneralTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of net assets acquired based on their estimated fair value",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "cmmb_ScheduleOfRelatedPartyPayablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ScheduleOfRelatedPartyPayablesTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party payables.",
        "label": "Schedule Of Related Party Payables [Table Text Block]",
        "terseLabel": "Schedule of related party payables"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsScheduleOfRelatedPartyPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/RelatedPartiesBalancesAndTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Transaction With Related Parties",
        "terseLabel": "Schedule of transaction with related parties",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_ScheduleOfResearchAndDevelopmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ScheduleOfResearchAndDevelopmentTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/ResearchAndDevelopmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of research and development expenses.",
        "label": "Schedule Of Research And Development [Table Text Block]",
        "terseLabel": "Schedule of research and development"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of assumptions used to calculate the fair value of the options",
        "terseLabel": "Schedule of assumptions used to calculate the fair value of the options",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of number and weighted average exercise prices of option",
        "terseLabel": "Schedule of number and weighted average exercise prices of option",
        "documentation": "Tabular disclosure of the change in stock options."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Exchange on which Security is Registered",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents security holders of Anchiano as of immediately prior to the merger.",
        "label": "Security holders of Anchiano as of immediately prior to the merger [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "auth_ref": [
      "r184",
      "r185",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r373",
      "r381",
      "r428"
     ]
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SeriesCPreferredStockMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C Preferred Stock [Member]",
        "documentation": "Series C preferred stock."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r427"
     ]
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Severance costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "cmmb_SeverancePayPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "SeverancePayPolicyTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for severance pay.",
        "label": "Severance Pay [Policy Text Block]",
        "verboseLabel": "Severance pay"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsForfeituresInPeriod",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents Share Based Compensation Arrangement By Share Based Payment Award ADS Forfeitures In Period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Ads Forfeitures In Period",
        "verboseLabel": "Options to purchase ordinary shares cancelled"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents Share Based Compensation Arrangement By Share Based Payment Award ADS Outstanding Period Increase Decrease Weighted Average Exercise Price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Ads Outstanding Period Increase Decrease Weighted Average Exercise Price",
        "verboseLabel": "Weighted average exercise price of ADSs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price (in U.S. dollar)",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life in Years"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails",
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited",
        "label": "Options to purchase ADS cancelled",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r233"
     ]
    },
    "cmmb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards granted during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants In Period, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at the end",
        "periodStartLabel": "Outstanding at the beginning",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price",
        "documentation": "Change in the weighted average exercise price of options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of options",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at the end",
        "periodStartLabel": "Outstanding at the beginning",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253"
     ]
    },
    "cmmb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInMergerWeightedAverageExercisePrice",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of shares acquired in merger.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award, Options, Acquired In Merger, Weighted Average Exercise Price",
        "terseLabel": "Acquired in Merger"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r234"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r233"
     ]
    },
    "cmmb_ShareBasedCompensationGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ShareBasedCompensationGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails": {
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/GeneralAndAdministrativeScheduleOfGeneralAndAdministrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and administrative related share-based compensation.",
        "label": "Share Based Compensation General And Administrative Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-based compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r247",
      "r248",
      "r249",
      "r250",
      "r253",
      "r258",
      "r259"
     ]
    },
    "cmmb_ShareBasedCompensationResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ShareBasedCompensationResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails": {
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/ResearchAndDevelopmentScheduleOfResearchAndDevelopmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development related share-based compensation.",
        "label": "Share Based Compensation Research And Development Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharePrice",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average share price (in U.S. dollar)",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfAssumptionsUsedToCalculateFairValueOfOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life of options (in years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapital"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r71"
     ]
    },
    "cmmb_ShareholdingPercentageImmediatelyFollowingMerger": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "ShareholdingPercentageImmediatelyFollowingMerger",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "shareholding percentage immediately following the merger.",
        "label": "Shareholding percentage immediately following the merger"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical",
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r136"
     ]
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://www.anchiano.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Website Development [Member]",
        "terseLabel": "Website development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r137",
      "r156",
      "r157",
      "r159",
      "r161",
      "r168",
      "r169",
      "r186",
      "r202",
      "r205",
      "r206",
      "r207",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r294",
      "r365",
      "r397",
      "r412",
      "r419"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r59",
      "r114",
      "r130",
      "r131",
      "r132",
      "r140",
      "r141",
      "r142",
      "r144",
      "r150",
      "r152",
      "r167",
      "r187",
      "r218",
      "r255",
      "r256",
      "r257",
      "r273",
      "r274",
      "r291",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r311",
      "r342",
      "r343",
      "r344"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r347",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r373",
      "r381",
      "r428"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails",
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r153",
      "r222",
      "r398",
      "r399",
      "r418"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementTable",
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalentsDetails",
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfWeightedAverageNumberOfSharesDetails",
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r167",
      "r323"
     ]
    },
    "cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "StockAndWarrantsIssuedDuringPeriodNewIssues",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "it represents number of shares and warrants issued during period",
        "label": "Stock And Warrants Issued During Period New Issues",
        "verboseLabel": "Issuance of shares and warrants, net of issuance costs (In shares)"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "StockAndWarrantsIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Stock And Warrants Issued During Period Value New Issues",
        "verboseLabel": "Issuance of shares and warrants, net of issuance costs"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_StockIssuedDuringPeriodAmericanDepositorySharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "StockIssuedDuringPeriodAmericanDepositorySharesNewIssues",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stocks of American Depository Shares (\"ADS\") issued during the period.",
        "label": "Stock Issued During Period American Depository Shares New Issues",
        "verboseLabel": "Number of ADSs issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails",
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Number of shares issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r59",
      "r60"
     ]
    },
    "cmmb_StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsAcquiredInMerger",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options acquired, including both vested and non-vested options.",
        "label": "Stock Issued During Period Shares Stock Options Acquired In Merger",
        "verboseLabel": "Acquired in Merger"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of Options, shares",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r59",
      "r60",
      "r234"
     ]
    },
    "cmmb_StockIssuedDuringPeriodSharesStockOptionsExercised1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised1",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalSummaryOfNumberAndWeightedAverageExercisePricesOfOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "negatedLabel": "Exercise",
        "label": "Stock Issued During Period Shares Stock Options Exercised 1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued",
        "terseLabel": "Treasury share at cost (in shares)",
        "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r59",
      "r60"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r59",
      "r60"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r60",
      "r65"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of Options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r59",
      "r60"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueTreasuryStockReissued",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Treasury Stock Reissued",
        "terseLabel": "Treasury share at cost",
        "documentation": "Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r59",
      "r60",
      "r62"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets",
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total shareholders' equity",
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r49",
      "r380",
      "r413",
      "r422",
      "r459"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' equity:",
        "terseLabel": "Shareholders' equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse stock split conversion ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r319"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r319"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r319"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.anchiano.com/role/EventsAfterBalanceSheetDateNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r319"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/EventsAfterBalanceSheetDate"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Events After Balance Sheet Date",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r320"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Roll Forward of Valuation Allowance",
        "terseLabel": "Schedule of roll forward of valuation allowance",
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SupplementalCashFlowElementsAbstract",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplementary cash flows information:"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_TaxAssetsAcquiredThroughMergerValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "TaxAssetsAcquiredThroughMergerValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesScheduleOfRollForwardOfValuationAllowanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance due to tax assets acquired through merger.",
        "label": "Tax Assets Acquired Through Merger Valuation Allowance",
        "verboseLabel": "Tax assets acquired through merger"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital losses carryforwards",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r421",
      "r464"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.anchiano.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.anchiano.com/role/GeneralDetails"
     ],
     "auth_ref": []
    },
    "cmmb_TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "TotalConsiderationOfRepurchaseOfAmericanDepositaryReceipts",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents Total consideration of repurchase of american depositary receipts.",
        "label": "Total Consideration Of Repurchase Of American Depositary Receipts",
        "verboseLabel": "Total consideration of repurchase of ADSs"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TreasuryStockMember",
     "presentation": [
      "http://www.anchiano.com/role/StatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock [Member]",
        "verboseLabel": "Treasury share [Member]",
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r62"
     ]
    },
    "us-gaap_TreasuryStockShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TreasuryStockShares",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Shares",
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r62"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.anchiano.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury share at cost (11,640,460 shares as of December 31, 2022)",
        "label": "Treasury Stock, Value",
        "terseLabel": "Treasury stock (11,640,460 shares as of December 31, 2022)",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r62",
      "r63"
     ]
    },
    "cmmb_TwoThousandsFifteenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "TwoThousandsFifteenPlanMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 plan [Member]",
        "label": "Two Thousands Fifteen Plan [Member]",
        "verboseLabel": "2015 plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cmmb_TwoThousandsSeventeenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "TwoThousandsSeventeenPlanMember",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 plan.",
        "label": "Two Thousands Seventeen Plan [Member]",
        "terseLabel": "2017 plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "localname": "US",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "U.S. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "currency_USD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "localname": "USD",
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "USD [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.anchiano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r48",
      "r171",
      "r172",
      "r174",
      "r175"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.anchiano.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Net change in the total valuation allowance",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails",
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average number of Ordinary Shares outstanding, diluted",
        "verboseLabel": "Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r161"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.anchiano.com/role/NetLossPerShareAttributableToOrdinaryShareholdersScheduleOfComputationOfBasicAndDilutedNetLossDetails",
      "http://www.anchiano.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average number of Ordinary Shares outstanding, basic",
        "verboseLabel": "Weighted-average number of ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r161"
     ]
    },
    "cmmb_WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.anchiano.com/20221231",
     "localname": "WeightedAveragePriceOfRepurchaseOfAmericanDepositaryReceipts",
     "presentation": [
      "http://www.anchiano.com/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents weighted average price of repurchase of american depositary receipts.",
        "label": "Weighted Average Price Of Repurchase Of American Depositary Receipts",
        "verboseLabel": "Weighted average price of repurchase of ADSs"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "currency_XXX": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "localname": "XXX",
     "presentation": [
      "http://www.anchiano.com/role/CashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other currencies [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-03(13))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "730",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "230",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "940",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.14)",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(8))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "220",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "730",
   "URI": "https://asc.fasb.org/subtopic&trid=2197926"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "105",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "15",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "340",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "340",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "35",
   "Paragraph": "1D",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "35",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "14",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "19",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "270",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "19",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "17",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "848",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "910",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "924",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "235",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "948",
   "SubTopic": "310",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "954",
   "SubTopic": "210",
   "Section": "45",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "954",
   "SubTopic": "210",
   "Section": "45",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "954",
   "SubTopic": "210",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "958",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "958",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "958",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "360",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "360",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "360",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "360",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "360",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "360",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "360",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "360",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "970",
   "SubTopic": "360",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "976",
   "SubTopic": "310",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "978",
   "SubTopic": "310",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "55",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "53",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "852",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "55",
   "Paragraph": "29F",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r400": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r401": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r402": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r403": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r404": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r405": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r406": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r407": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r408": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r409": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r410": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r411": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r412": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r413": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r414": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r415": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r416": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r417": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r418": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r419": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r420": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r421": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r422": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r423": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "410",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r424": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r425": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r426": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r427": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r428": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r429": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r430": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r431": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r432": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r433": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r434": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r435": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r436": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r437": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r438": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r439": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r440": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r441": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r442": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r443": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r444": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r445": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r446": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r447": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r453": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r454": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r455": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r456": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r457": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r458": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r459": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r460": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r461": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r462": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r463": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r464": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r465": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r466": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "852",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r467": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "852",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r468": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r469": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r470": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r471": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r472": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r473": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r474": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "912",
   "SubTopic": "730",
   "Section": "25",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>75
<FILENAME>0001178913-23-000670-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-23-000670-xbrl.zip
M4$L#!!0    ( %4Q558Z!?H) !0  %S<   1    8VUM8BTR,#(R,3(S,2YX
M<V3M75]SV[@1?^^G8/W2ZTP5Q\[EVF22ZRBQG7K&L3RVTER?.A )29Q0@ X
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MIE2@1&U?B?+]@!#!:3FUM@^3HZBD)SI=TI3+ 22_BN<"8W(G<UG!GQUT_9I
M-86%& [Q4JN6LE^*588S^4G_K8UZ/S9_]*CIW2D/EW(<_?/_ %!+ P04
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M%BD-"]';MO-&CK&4'B<(F?PC_85[%$@U<QR>(L[78"EC[RP'>R-XYU1E733
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M(!* "%MM9JK?>\ R]CKJCUI"4PIG-6FFV:H71+)9,BLA>/0"*-:EOA(:QR^
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MM/-BEA;3MEP%VOD34YUI6^("W5/.5&S:ELI ^Y0S-9RV93AH@OQ('RK*:6#
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M$5@[FK?]N=](6='1/'L!O9^4NGN2KGJS=Y:"O0P(T(ZF$Q_:?ZAUPVPI ,O
M("UIJ&%!6M).FY_:1R0U50&F7=TT&$R[VF@PF';US[0 6:HCZ^&CR02_>I&=
M*G=2!E4!IEW-,QA,NSIG*)B6@FJ(;]U6>?0[JI$;4CZ1@F"P([K":*XT3>H"
M4+L::$"@=K70@$#M:B+Z,?0W*I[Z@Y34 X!VM=   .WJGP$ VM4\^Z@<N:ZQ
M%(=C &!VM8M%8';UR=>PH$_1KU=%]!B6Y,L2UXDN:/):LW>6 EP,!,ZNYK ,
MSHZVX&<XV<--\O!83>=?2A'U+(OKO]%+MU:(,Q7FO1H#*G;TR2BHV-$\HZ!B
M1T=M&I%7^77(GH6)E[OZ4VBSV@#6CKYR!-:.#IM6CZ281!&-$,*<C&C0PBR^
M+L@R3.H0A)W^W_U; A)V])UG$G9THU\2ED)>\*O':29<+83&:=)+X+\P:A4M
M-^_,.[!_BT#*CNX=&2D[.GMDI.QH;W'SC=L0ZCN(/UV(1 M*Y=91#>#9T<B#
MP;.C90>#9T>OMET</N=9]9BNQ3?00UD)3U\-X-G1I(/!LZ,CV]]A;B'KVD\D
MPXC@T_EUD<<K]8VM>0L VHY.= O:4C@)QZ MZ;@BCPB)R_,B7[ OZ/:5\M(
MQI)NL@/&CDYI#"CZA>:9XT565DFUHG<:*FQ&E0&J'?WB!*H=7>,$JAV]4\=+
MW"\XA6%U@&M'#SF#:T<O.8-K1R.A7RU(&SOB6$_GOX65/J6CLL+LG:6 $58A
MV=$F5B'9T2DW)*6Y?\.B6NM/8'9+ @A;NN0@$+:T1--T*Z86J-$Y*4N:??26
M%$])Q%;75I$2'3C;U4W0'_@)H&U+X[PRVK:TURNC;4L+2C')(U+P\S#+_ _Z
M%G2$+?WZZCO"EN9^[1UA*="& AQLG<(BH:^.> EQ3&RY%_;_$'2!+?OD%7>!
M?7OHU76!?6ML.[CH<5CB7_C)IF7JO3\ E >U_<9)>5"[;YR4;=E\/.MNDE6$
MQE14Q7_K2#;2NR&@8,M^\TC!EN7ED8(MFVG[RUH3QIR MIG9.TM!9KS!MV6E
M>()OR\)8\@O@"7J?/1CDR-94 5BVM+YE6+8TLV58MK2G^,9T/EF0(HE"<;,;
M%FMZ^KI47PV;U0:PMO2>$["V-)P3L+9TF<GG],']^[0!P&UI,,? WUN*].,!
MN!VMQ:Y@Z:N RZXXI[*R ,2._K$ Q([&:35>7L,@U+Z<!F@V*P D.]K&*B0[
MFL8J)#OZI/4%;2C:[7( P(Z.. " G76_U3#/P\%6"Q9.X,(D U"/)@"VG57?
M-6Q+,6><P[:TXD>/)%Y1QYLL6X4IBQ<*BJ8@$<O<@S+9Z;;<LQF ;TE/^()O
M2;OX@F])$]7?51UJ],5OU@X0L*2W_!&PI.7\$;"D)>L/F[]\Z,EHSX:!HB4]
M/&:*EG3VB"E:BI#3(&D?^U^':^K*V)=-=QL W+:&=P;<MFYW!MRV5I<?UO:'
MWMT*@+>MTYV"MZW/G8*WI,LW<WZA,1<])F&63^#?%XL%B1.0X'0-^^6\N,M9
M\#?]*?,!30(M2QI^;+0L:75,<XH7,K"8&&99TE0!6)8TL658EJ+\6(=E23?6
M]_PG^0+-!Y80I;F1.5[ON ),GL,";&-\,C<G"0;"+"^R:P*BI@P);?DS0-^2
MAGVM]"WIZ==*WY*F/P!7*^8?0T5SS]#(_.R_7PG&FB#Q!"?Q ^$!:0@]ZQVB
MHPX"!%UJR?[X5Y<V76K)*OI7ES9=:LDBVY<!#P+YB<8C$NO1%N0;L@B3# B>
MY!D-!+T*4PPH8+T[#P$#76G)"OQ75[ZW%%_L7UTY>V\I&EHG^K(#/HWR7^"=
M$]L[#;).V@0!7>=H1_!'[#I'NXD_8M<-N1/9T^5XK\: RI"["L=4AK3F'5,9
MTHK>RR5YCZ: QI"6JT,:0UJ-#FE8M-@>\Y1O9WC8F];YZWF.J87AK_I4)WW;
MF;VW%/'.(P%+U@H-TYW%(D8L\Q0Z717U!O.*/--?JKTGS9L V)8L!=>P+6EI
MU[ M:>3.;U)O,PO8-]L! I;TL#\"EK2O/P*6]"Y^>/=K6W[I>1WYUHC('NT!
M(4L:>#R$+.GBT1"R%(E/ 8!]COY1L6'KR:B[0:!D45N/A9)%33X62A:UO D"
M<100OSN83-,4T+"H]7W2L*C[?=*P8P'<A2\\Y#X7V[O'(E\]/#+91:W-SJEP
MFZ!+W-*W'2!@QP+P2,".QO=(P(Z&O\NK,*4YN&*>=17]TPYYA[I_B[/WEN(?
MCHR4'3T_,E)V-/W=<W[WF*_*,(O+\V1>$9)=IV&F=]335@)H=C3V(-#L:.%!
MH-G1K.VOH*]=UA^<I!K LZ0QAX)G21\.!<^.MMNZM:*W58<N0H>T"<3L:,'Q
M$;,4V6^$Q'IJP\>J6I9__O[[E_LB_6X>EO??Y<7#]ZOR[4,8+K]'QM^3M"K%
M;V@?4/[\%[-)%*T6*_I,@[U=3*BJ@W^GA-I4&8:*+JKD'R&/4;HD^)H#I@\&
MR3D#>VRI2')B^Q/0.SW5ZC]9[_34[ ?WSBF9DP*M<6&>&UGT/6H#IYXFP:O@
MU-.6>!6<>AH@KX)33ZOE8$X7690OR&5>TLB'Z*B69*LD>^#Y F$K<DSF>4%8
M.<!.RK.7J@ASG@*/1F&YRN&O657D*4![N !CIR"E;@$:\*O0ASU-JW_UH:0/
M>UIQ_^K#W3[L&R#Q7WTHZ4/7MND?L0]=6[!_Q#YT;>>V4%Z'27Q%NJFW"P-B
MUU;LX8A=VZB'(W9M@6X_([K(>% ,85QRUS],^$SC:%!#4\]JCP:!N0<[=23,
M75N7EP2^3.3YN]=?LC@I::P4!!Q!464.IX/: ]ZN+<)Q\/[0-U3HP;QA96E4
MF8;/1CG Z=I2VA>G:VMD7YRN-3Z8'KD03@9$[1+>60?PN];_MO&[M@9LXW=M
M&]C&[UK#U]ESY[4##YZ)G>2E5H_KJ@$+U]IZ&!:N=:^ <Y=S[Y=];AG,&YE]
MZ!N<]14R=*V?#WW:;!;Y9,"O09^YMA7^"'WFVFZYP^W3JE@W\8PUE'<+ V+7
MELKAB%W;)H<C=FV-G(3E(_X/5\"G,"4TF&=9%4D$.RS\ \TIU_Y%JZ2&W$'M
M0C^XMFK&V@^N[:*Q]H-KR^K0-;\56>AJI?! &^Q;LP]]@^S^T_?7:[/Z?/?7
M:[/X6AQZAC%QC #ZUK5E^,_4MZYMV'^FOG5M;;.78BU\7;W0+@MX7=O:A^)U
M;1,?BM>U[4HW4H\L!C5:C](TP^K"@-BYE7DHXK[AH$> V+FE=3!B/WXY=^$+
M/^0_)AF9)T9.#YLU +LW?Q@+V+UYQEC [LU'Q@+V0_1B2:+O'O*G[^D=?;%F
MT/D/#6K^B]G%I>RI3/U'P'*(SNN'Y<NM!LN76\!RB#ZKL:R*@F21 ,-_:J'A
MOYF=?;F1X6G]&1 =HJ]Z([JXE/90Z\^S#WT#ICI =(B^Z8WHR^VI#A'\&1 =
MHD]Z(_KK7_^J0P1_!D2': F!*"8) P/_:'# #[,);"EBW%:<IZ',AMPI X@.
M6?L-$*UB#)9SGA2+"]G-STX90'3(BFZ,Z!*;2J0I*26E )6-M;H3U56XD.TP
MMTH &ANKM1K-"9ACDX*$)WFL@M,N GALK-@:/'025>=)&87IWTA8G&7Q:5@I
ML2F* TX;Z[@:YVD>K>BNGB6C),N\D!D&JJ*S#WW#.^Z)C_4,NR ]A]_)[A.T
MY0&IC=7>%"F.H3G.NC2@M*$!NE%>9/.\6-"5XE*3M+NK"N =5C](/J[*T*PK
M#CB'U1KBPTSB])-=6A80#JM%Q%=I9N*$19XUF.W;Q0'GL'JE_C"TV(4-B@">
M837+65:AXHCC CV*V7]0_F6QJ[3E >FP.D?UY?<]D;X'I,-JG8TOHUZ>%G?Y
ML\JR492>?>@;OO @E&RW9P21;PP_](U%> B^Z[RLPO1_)TN-!:2N %B'U3OL
MTR<$DVBD%UE,7OZ+Z#MSJRP@'%;3\*_FBT6>T:,^DR-NLXJ ?5CMPR$P(Y*M
MT_#9VRJLE :(K@K@'587L8^?+4CQ !_]5.3/U2/>0(697B:D-0#ML!J)?_NE
M485*MT!=<<#I0E.=)RE17OO+B@$N%WH)/UB<@*7SD'<LHQLE 9T+780GG@5,
M FHRXBP@?!7O7$ZU-6<?^@;?VQ-];>Z>PS](<4D>PG1:W)"'I,3WK[%FF]ZG
M">#C0J?11[MAA-DUP#8.^2K5@5]6!?"ZT&O7J_LTB<[3/-2#;)4#9"[T&1L^
MC$#>*0&;10&?"YUU^TC2U&3I;Q<$;"[TT^TB3-/C50DFL?35F:(DH'.AC^["
MEXL81#R9)^S$SV#15]0!Q"XTTV]Y"@MC6+ %7M^C6V4!H0L=]15D[+\RV%O<
MDK#,,Q+3$,3Z/E74 <3#ZJV+:%[P$]9)51&P->G:K3Y&5U>8?>@;&*\G5CR4
M3J\?H7>T0KI=#' -JVVN"X)V.\DBZNW$1NZ.P):CF,[G2IQ=U0#WL%IG"T!O
MQ)M8A]5#(@'\N_?W=TFE/+G;+@:XAM4_XH-G+]$CNKMI]*.L*. ;5@?=8A[U
M!#=EG\&F+)(P5:';*0C8AM5 L+7!?>WM>G&?JV!ME %$PVJ8KS ^%<E0R%<9
M5VXJ#2,M"PBM^*251=7RR8"?&ISP [_HB=:3ET0&;[L(H++B=]:!ZG/XDBQ6
M"V4\W)TRLP]V(F-UX4JR;ESM,H#+B@]9!ZX;7 4T0UC_'?!8\1#KP',;D2PL
MDAQV;B0*RTK;8?+"@-2*/Y@ATB]9N201V*$D/LTQQ6X'V)WR@->*#U@77MS0
MH\K\1/*'(EP^PGJ1:D9>61[P6O'[,L4K.LX$:[LLX+3B^]R!D^KXZ?PBBY.G
M)%YI^U1:%G"Z]GF>1-3E"[.14)5+RLE]29-":USIU)6 @6LO: ZFO [7>"N*
M*IJH#U<,:@$'UW[1@*98D5B$_8$.-6(@KS/[T7EL(([E)E^':0O))(LQ<)TI
M%6UU8.4\'G@<TZ-NV+^%27R1G83+I)*:K!TU +OS:-UR)$HE:E0/>+CVKQZ*
MAVM?ZTG\?U9E):)RR,'QM(HL19266\^V@*]K_^P-C#<D@GF,ES/M6%9W.3Y[
MOBYR4( D/EY_*3&;6AT(;8+GWG1=,]%( WP.>LWUBRF,N!UA^'OY([;NP$EF
M#0 SYW8&F MQDJ[P+H,?/208Z#1*5S :+#+J8KFJ>'*AL[#(8%#*:U)0)IU1
M]*RT#_WBW'HY#/?Q6MZ PO)T\%7H0^?64U=,31XC\T?GT9S,D3FW;5@..8.5
M=:,@('5NR5  !O9PNQS@=&ZI[(G3N272_KZQ &R5!]S.+0I+N)WK=(K#;!^T
M5130.M?3!Z%UKCVW(!B+Q6X50.]<;V'4 ?3W[=+6[7*S'YW'N@$S,BFG\ZU3
MGS7[_W?DI3J&[_ZN(6#6 #!SK07=,7.M-87C!@T R3SV.J1,40.PN]:D @G8
MH/=)%C(__2A_R))_P):-^WK@J=UF(MQ)UCX,@[^M%G6H+;.@7<-^&'K2M:[_
MX_:D:^O#*B&N>6A)'MV_;YH +WB@W]W':Z3'6>*4J^P\^)-7 .0^(BQ"]VV%
M]C.P4/05@8F/&(D20-5)6!1KT'E=@3^-Z@,OU_:7(U[.8];(<9TF993FY:H@
M)H:-<1O S[75)L=F;K09U0=>KFTV5[Q<VW-R7#OA4*6X>],U:Q9ZP;4M-LY>
M<&U''107E[TYVLV0A,?6L-X*5\:;L")G\SGIU++N@$!/OZI(UZ^ZIYU;>FE8
MB@P92L<O=6% [-RBRQ>+A%V7XMI <Q(^D P]>730U;6 @W/K38VF,5-,S.T^
M[<Q^/"CBTX$\>YIPVHK Q+G=UCPG[M[&;9<%O,[ML0/Q.K>S&@Q7^758=.Y?
M9.4!MW/+:/N9^615/>8%GF28H=^N!1R<VS7;:#J]>!0U +MS2Z%!TD-DA+0X
MU[8'H?6@:9=Y1F@*+9'!\RY\,;Y^-ZH/O#QHW^6J(D6=2<IDA935F/UX4+2M
M_;!G$0W$04]-D_+W$^C4I,)_:?$K:P$'][HT*V$/%U,T/8X(--6 A6L->TKN
MJXL,A)@'N&)IK=&8W[;X-9S,&P&&KG7RSIS]5.C3?<HK '+76MD><M>Z> <(
MYE#.,7DN;#-)6$2XXSPE3R3-NS+I]6T*V+K6WCL0]?G"9<4!M6LM;@>U:VV^
M Z-)VPRB3L_]YWF![AJ])HJZ%>#H6K/OHL,+P%YTL,+LQX,BF5E!#O_8RIJ^
MD1(DBWD,\%+N+8U93OOPMO YZ#77EL0I6>8E@#+U7Y26!]SN;8=E0:)$%3Y8
M5@Q0.M?_^0*,D23B\9,ZK61I><#M7/NO"#ZD2/$MP758F#U)4U<"!LZM .L,
M7&OVG4<*W=M%515 [UK#[SP:",LDZ@&=E@?<KG6\+=RN]?8VCE-\GJ$]@5+4
MF/UX4'PWW]A=Z\]M).:;\8Z:P,6U3MU&M ^+-G[7VI9= 29/I$[V<D-C%^*=
MS@I <D-;'D:E?R/ T+5>EH,3+QZ9F3.ISDD,&%,:^10PK#<*]Z;>JW7H$]>:
M_C7TB7/;8;%,\S4AW);I%5F@LR[P<6Y-<$RWI'A*(J)(\LA>O](WBXTW+',A
MP-T5C02N2@LPT)>@KYQ;,((!7GRPK):=^PYE'<#OVI(Y#Q-V%_F9)HRGX5SZ
M/LPP;F/VXT%Q O?BEQ<D><A$3"P:4QFCO()&F60Q_3%E"J8'WWW;!/ZN+:;S
M%5@,%7I59/%Y\H+_ZO;K5E<"!J[M)/L,7%M*GTB&^@J@3.)%DM$@N:CDND,,
M=-0$+JYMHB&YN+9EAN3BV@;I0&1PG&'8 G!S;8]T(.M<#(SJ R_7M@/'=9&!
MT@RSR%SNMFL =M=VP\5B"5H?-?VT.$W*95Z&Z71^F6</E]"S,7_?9*Q2]VEN
M]J.=&))]6-<1;EC<CMUM*IBE]%"*FK(ZPOU: JZN+0>?7/UD1>Y R(^]K+!M
MMP5\_612]L?73_;E.EZE@394U #L?K(OUT@N^5ZXXX6YIA9P<&V=U"<TW&^T
M4L4OUE< Y*YMCQI(+S]W32W@X-K.D* QTLF::L#"N<4ASRDN6W": \'-D\,>
M W?P1V8_.8\,6B/J87<IJ@!Z/_;&3G_RPY:-,][3!#,/X+M[;830/5L$[G[L
MCW%P]V.+["!5S,3][Q:L?@?ZR8\-LX/_*L]B$J^B*KE/#7:0/5H!CGYL';<<
M/=A"6^\K9?&Q]?0,&@!F'FRE76!;<;/[\MJJ#JP\6$];L-1W=KW8J9L!EAZL
MJRUXC:,L_BS0Z9['&[<Q^\EY=%#7_%Q;3Q3 Y*$@=+O7?4$B+0^X75L^% <L
MQ@FSJC&3N2PQMJXXH'9MLU 8CWD:7RR61?[4I\_EM8"#:WMB" ZN[85+4I:$
M]-J:JZH >M>6 (-RR9:4,BH2Z@I@XC?141.XN-;]<D1W:([TYD%K 0?7FKZ%
MIL?5A:86<'"MQP?@X#P&*D.CT*V?83M6T%2D:.D:<^O5&G!VK[_]<W:O^S4H
M82_#PFEH7YV;-@'LW-L(+MFYMQ[,H/V-A,4=?-,&S;HMX.O'TO#'UX]M8HCQ
M.;?%]CD'KGYL%S]<_=@XFPB9"^I=?O92D4SW$*2[,C#R8_$,R,AY3%$9J')?
MM5^V-+SSZ*$R0'>D6$SG>*-FM%/3509&SFT6H\.^C;,\YS% ]\'HW'YH1<;.
M8NH)CZ<*I"@Q9HWV&*ZK*K!Q;AT,RL:Y[N^ 9'+*8M@$L'.N[7=BLFL/''=+
M V;G6ML"9N=ZN<\S*,F[IY^<1W\\'+%S_;H#HM_<W,[8])/SN(_V&7C4MD:I
MG*3E ;='#7P0;H^ZME<R*FT]X.%<R^;9 YJSUZLB>@QI_!H>0K8S 6=756#C
M7*LJ(1VO3\**/.3%>CK'VPE1(NYP =VS1>#N7#LKD;8N-?9BVJH/O%QK\"L\
M*";3N=%+_MW"LY^<1YN\(I4L\?!YDH59M)%X6,?$N!%@Z%KCNV?HVB(P!V>P
MZ/=O#!B[MB 4("^R)PQ/==B82AH!AJYM#?<,75LEYN#VEUI-8\#8M?VB "E)
M\MZ?J:018.C:IG'/T+7E8@YN?ZG5- :,G=LT8/H#R&8J87P K@RH[XP)4=,V
M9C\YC\OIFI]S^R?/$AYUFKMPGR8%B>!#Y3G13T1]3>#BVM*9SN=)1(JR'>Q&
M0T!6'%"[ME;J^<Q[4=?G.V4!KVO;XU"\KBV)'0P&,U99!_"[M@LV+^R:A_V7
M^HCFNFK PK7N'X:%:_W>W\==Z='N/,:F1>S.8VS:Q.Y:PRJ0=-^(Z"L"$^?Z
M=3 FWG3N)B"C<_O.NL#'FTX>B(\WG4TQW20/C]5T#ML?&K?&F,M6/>#A5W?;
MX^%<>V-6A'9./J-S>$TMX.!<=V^AN31X%Z*L _B=Z^\M+%UO0:3E9S\YCQA)
M<>P?&LZD.K!RKM6=L'*NX1&6/#N0(2=M96#D6M-?IV%V%2Y(Q^5HNQB@=*V_
MQ><[,_!N%@2DKC7S=<&SQ% ?M.NPF!8T*%), ]:*..HZ!D8- #/7NGH3F&$B
M3'4E8.!:2P,8V!^+_#TP ^F,-$[7:%(=6+G6VSI8W5L/@]K R;4N=\#)>2S'
M351]632X76OR31Q&6R95%4#O6F-?%\D3K)Z@%R)BE,I47@&0.]?,F(N0Q#3*
M(2Z9&']U.M]<4$&VV2\(_)'^1LMLGP:!N7-M+P7Z-2R*$.STW@Q%16#BWAH8
MBHE[[=\ HLMIYT,#10W [E[OV\/N7KLW2&[#%!W>&F76SY^E;U/ UKW>WX9X
M5] <#^L^BYNDYNRC\^B(0W)Q;P.T$#591,JS%U)$2=FQ!>BH"WS<6P4-)KZH
M"CBF,VB[&K#P8"',25E"9X9IAS/"=E% ZT&KSY.N^\RF$"#TH*U[(O2@A7LB
M]*!KEZ2HUG@04X$UB8IS:1@#N[,N\/&@?^68CM=W\-FN8[/NVL#)@Y8=FI/S
M>'M*5/UB4/=I!EAZT,-R>)^*SC5!4Q&8>-# <D FUT[=E8&1!VTL!W6EO<K4
M50,6'K3T "P\:'(Y'/,09:9- #L/5H <&FP6GL('(FX*(O@5_+@/27E+P'4T
M]L1!8]@>O=%8%-88N;8G6CG5US1!IH; 3MG91^?Q_@[%ZUKKMS%TWH#N%@;$
MKK5[&T0K7:6);N^J"FQ<:W8%)),[PZZJP,:UAE=!.EZW_]*Q"3!O!!BZUOXJ
M</VV CU: 8ZN;0"Y'XF11.HJ A/7&GY?=QJ])\U'YY'NAN+A7IMK\'1>GQK4
MGGUT'N%.BXH9]/MR8K6!DWNK8'A.[NT&AJJ],F4T.?NJ(L5M/J^>PX+T7<?W
M;!/XN[<T8!E.(E [^+*UVT=$6AYPN[<I[.!V;RFT<1CYMJBJ 'H/-@"'PFYO
MJ1NS$?16><#M0>-7Q2K"J.#9 VZJ8#[B+"V>B-D.H;LZL'*O_RO8;)'X+"PR
M %9.HFBU6%$;\I3,DRC12U5796#DWA+8!&6@_&459A^=1]:SA]RY5M]\RS*]
M9[@NLK.7Z#','LAY7O1_[7= J] 'SJV $?:!<TL@7X=IM3;8/FP4!*2N=?]M
MF(8%B[OZ-7S0>B%L%P6TKC7^86A=:WCF_4.]9O!5 SH"U0<1G2>!W96!D6O=
M?QL]DGB%P"99E<28ICMY(K<DPA0AT-DP&=-53&*6VQMM=!IW8CH7*[-X 6%B
M^MO_&/28:[OB]?>8:[NE(8$F.F[VX#]X4_($,T*\].O7&R8-S3XZCS_8 M@*
MTH(V,2@S.@['&*>29X*8H,?: TNA-DDI(CIV3<'M5LIC>M.T3X>YPP/][MI*
M^U>_LWYW;1DV/$_YJX6[\(6_P,K:&4WWZ+E>+0)WUQ;AF+@[MS%KI-MZ!L0U
MB? 0$U45$NC-O5>+P-VYQ3HB[L[MWP;I?$[P90+92(N^F7![GP[HW2ST@C^;
M>4R]X,\.%HFL;TGQE$1$KK;:B@V9/&3)/T #DB+)8ZK2NN)##/(]Z#=_UK#:
M><BX*_1-S#XZCS_90&LZ_2(&0,D\(3%79A&@!.VVJ=1XJI(]IHN5+T%?^;-:
MS=PWS,6B1WO VY_5J,*YEQ"8- 5L_=F)/MCZLPPWKH7HE1"%W'.M[VP%./JS
M !6JI[6?.U[O;O>>PR(V[X$#OP']X\]*E.-JOSI$CV9&"!?EY;[SP<:'H*?\
M69*OK:?\69MMJ#=YFI[G12WL/;O"I"7@ZL]"=,[5>:14L.$QB]=FU(O.ZV%-
M+>#@W(XC3Z3 B!!4*^DR\VV5!*S.;2^I-M%!EE8 Y,[M*&O(G=M$71I<I<#/
MPZ2@3WY:*[%XX'Y=P-:W-WL;'X4>=&YQV26S).AT=9I@G@HP*<&@=->1N]^&
M_G1NH2'@^VY.]WTX80HS[>(WV$>A!YU;;D-(Q6\Y;&ZHAPO*Q>?P)5FL%JY%
M4PH">MBYQ>> 7)*-H(<9".AAYW:F37(W2?G[>4'(!<^QXD&"-1!F'YW'$1Z>
MFEOIU4" WG5N<^]+[=+ H_GPQJ%'QF'9&X#FN\))'"<5#4C4O+TP>5(YZ'>A
M'\>QSS#G\XF&!+S(V%535R"0 ;X&??9J=C@CZK-7LZ?A+*:KJJS"+$ZR!T;D
M(HLP+!TY)>R_7PEZ6)-X@F<.#V3PC:,-7# .7O9"=OBV#M;<='#K@]!SKV8/
MM$M$)Q-(<NZR5PW!0(][V1/MLX7N)'E#T &=/N#*J.9=A2GNK=\/L:'?'PWT
M^>AV2<K[MZW FK7&&6IAM@ID]M%Y1/:#"<)2."<)YJ'WWM<]H4!OCVX'U45Q
MTXSRU='F**"/Q[$G8\@G&5I&Z*_TA-'ML[(S1L >K0'G<>R?W'+VLO]YS-.8
M%"4+30[8=L2V-+JR[=D4L/6R<S&:V&+>.;?IDX<LF2<1.D5&4;[*\ TIE0[T
MGC<9!:,&@)ESFUO$QVBB9W3?EJOJ '[G%JQE_,ZM0<S]A A.TK LN5]%1W N
M99W9S\ZCX-=8V-J"BVJ>T8='AAQD]8"'<^M%X#$ZS]TI#(B=VP("!'N]>)[F
MST;'JYIJP,*Y=F_@G"=9F$5)F%[G)3W![<=&61U8.=?? E:G6^9&04#J7/?B
MVK%A'H )E*[H:5M>T&ZLJB*Y7U74LRO'@#BXA\Y30/$@[FZ,1LKFAZ"GG-L
MK[:GG-L4.P2N\HKLQ;Q=$9@XMRZD@%BNPV6:5"=Y!AM#3+MQ@_L(K;=*SZ:
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M1HONII] 3PZ#!!2TR%](&F-2L# ETO&\>VSO*-#>PEK!(U0+YGD1E% 1U@:
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M3X^HIX!4ZC6=,I*IL$\GZ)\!T]3%;*C')O&,"/VCXM2E0^1S?LTK3OJ.N [
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ME077I GH!GO19;1>&!*19U;B1*X')M(Y&-Q=@P;V9+Z#2ND198-689]RQ.&
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MXV99G79B\;B)5)<=6W]KG0C]D:7E4[)J8M*7+@F/FSIUV;'UMTX\;H+4:2<
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M)Q4MS<'F-%T&296)BRA(KD(C-6N&5>LF(1!4'NJ'K?\.Q@O(PD _;/UX,%[
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MU6GP\HIL..M?"^'HZP45-\"J;]L%&2,F1AL7M[.=5UNKZO\?U6OYC4K_DZ#
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MKM:;&BSCN5.2L04?@B3(*[GF/X.Y/A^"I3NMLK+BAFS"*LO81ZJ#7.;8D[Y
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M%7W6!.^T6UM$OMD$ 5\ 7'6(=]JMS2&-$,+[51R);<[A,._4ALVIQ$;7^ >
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MF1%SM?%J'YIXR.U7*];] "32420@F3 89FFC6Q1:*_:HO"=1"N<$)NS:/(*
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M*2Z$,7;[:U#:751;XRX'"*%F8\JNQAF50N>@R/GRXAH?US2Z)E\?5@,YUX.
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MPCA*]@5%]<HC#81;;V+]1"Z'AUC):RSI+(C/P0+S:H6MKUXPJ%A28>2C+:T
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MATT>+7OB*DWTD) 30MZ,S"&$>4W%^#;.5:SLL';50CJ; 56!G9,!5C"EKC)
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M657O=W7@."AG6R2 -@5 ]X+FU0(S!+UKF]_]<8P"= 26!;T2TR:\7]%AJW%
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MW( \WEW%47'3#H+FIB54*!F&/D%CA&)KV_N>E798/ %4M@V#ROCMVB8_;C_
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M0N?0[XT[@]&D,QK6V0?U6_"!!MR#G_WQQC#OV0]55*A+N'Q.5!/OV5(^VT#
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M1[SUS#,-4W--ZNW @#04Q)DESBK'[T2:"8MH=TN^9E!YB300.WK800*#"DB
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MU]$I-;Q/KK-$0KV9QXJ]7H<G.V7'SPFHM#27620_5JZTJ$IOE+J?HP#6*Z>
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MBC9,;V5I3[B9=#-?MF^)7_;MI>1VSNW[2HJ,^ZHZ'O9ZPU2^42YN/M7-$?+
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MQ=7JL]?$Q$K7Y-IS-6J9W9GF8:UK_BTHV;KCKK!@&GS(ZJ4Q>+6T!R]4N1G
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MLTBCLI0[?>J[=+<TY8<>C[Y^0Y[P)N(5U< 5Q%<5$5\5\5417Q7Q51%?%>7
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MN^D5W =2?0'6=KL]I9OA'I<^F;PS0^\93NH3Y\V'8 9GE%Z)@1WVLN0E Q"
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M$"W^^F X?TB/H4%Q <C)]T,J?*E8IF@R,9P)L2F>4!D8/@!G"L(@]RR0V4Y
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MEU5O_)TKW&E5G.>\@=J=U<&+TI_8B^K-ORZQ*%<>AL.?VY)_S1)'JDEA*P\
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MK!#V,:X<+0/<A8UN6(0>BBY_+1VFS9A?_%B3N/IR":);1HI^)F K&DR[ PT
MML2G\++L"W?: 0N290)Q.VFIP7066' B-XHN86:0$TX-3)=#*\Z/$N5@5U1(
MSXEIT8 X;4M)^S=*"[#"YL:$>I-IR.P1TS584Z/<? V/T*'"2^]9VF#VP\3
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MOS!W36)+@/GTJX;OAW.^? B4(@6N!/@U"6U<,EB[': N>!Y0WK;=9_]= E!
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M*&QGHTE+V=(#<<B4AB^8W>9BG,^81[=1$K2J.A@-5N:5\13 C^Q5S2 A]8_
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M^]73ZFIKN"I:S67DYZ:W[TNGE9Y![0YDO3^4^X4C"=MEUQ^95B3,]N,^SG'
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MA1"G"@1CE [HDR3.1FQ;G9Q\Z3IH<4_A$W:U%*L!.I-7:,TK%FJ5ZU%V?=T
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MQJ#@6/,-D9JU_K7%^M=NM[]5)L5F0.U!HT%JTGN:I.>ZJT8=;@3E;8;X?KP
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MPULW@:N)['D0V2Y0V>'AFE+W:I&[/6"MN4'-#=[NNNV-:2?]Q%C!5KA,UM;
MY6'2>#]R=3TN%UF48L H?'2;--AY(O^3!;!':0KU8H&X)* R[/A\$_#_R;6C
M>)CSWY2 N"<%U%VWL=][G%"<AVKA^3" W AML.8L-6?9%*!V&WUW(_P[=2.J
M;4>EFC[7TKJ[X?8?)]RBEOSK@.%&<Y8GU<W[H53SWL&&H-96D^?]^V;^-/?"
M? ^\9]OPY5-%-81G6CM^M4H1*_=BF.M!T6FW>GDS%BZ3[H49?EYJ&M$YL/O$
M3 60O:"R\7ESA*BT3*P23ZT1U-R*%;S._K0P$(,@Y-7#%/.],:P>,?AV%$=-
M&AZ&34;\R4_=HI=7PP'.XHT=K/T>SHI=+&OHDO?IV()6#1N"5LO*E+M5>.5V
M5L(K>*V_(E[9P6RWQ*V?W-;1S=C4*5!N,[%IDQGVV6TSG)X!9=D86Y4!=F>F
M[1[95,.H>DUS&YR9VC("N:AQG*3-5":3O,6-16S3+ &*4+A,[-0:7,$03%8U
MF]1L\JX'R5SRIUZ_U5GYZ/1QR/G#T S5/M>!B+X7G9#JYI#5S2'[=7/(IR=Z
MWM\VGOT9<:NJ6/\[BYUVZ[!@7=C'-F!&B,I3VVJK2^V:8D]*7W%S7)Q,B9#X
MV/&[<]7 ]]WKWY=7,O$"YGTJC;'9U-3T$#?BBML]V5R2%#1E^J.+B6D?!1I@
MSG:?O2BS]9*[(H@69_MN<8X+.-$_+!H\KX(4<RV5\87/27"!O?4^AP+F1UFW
M"]/Z$I:-TI#:3BLO"0:X&QG&ER]8-BJ586]/Y634"0R'.H>YE',\2B0/=!FD
M8^=$1&F<-.BCGVR3!19%L!+>?[(@86+"43Y(L!>2;5#S'\8I]AX C.?]11*<
MJ,WU,Z6OWZ5N24>]OO+NNW9O6NROAZV_V<@%3+X$)N5?4!M:Q*Z\T7>:P"MD
MEN)80#A^YB'U K!]H(>6<P:&K.\'*:N1^<S<8!PH,&^*"Y^;%V%<+U:H/BH5
M>P%IF40%M@WM"% [!X _W$,TFCU7=@G'"1PED-164)A#U>SMFCBQDB8.\ U#
M8*'492TC9!@"Q=!@!=1S7,'O/3%% N8?X>"R!(5<05T.K 7T206'/0:M<#1V
M/@@0@(8Q]UH.K'PL8-GLIP"\ LQ#FP7E.'6AA///)EJ:TMXF8D92@9!F()W+
M)(Y&S!4!M[PX"WV]'MW'CI<(HA;^1#:KXC@B/@N SK$1L'2(?YGNC(D<96#;
MQ(GNA'N!_9A!U "2+<5T-8?=C-$*3(U@")0"?!S0=(*J O"\/\K.F)(II0>&
M8\Z&(.JR), =H@""*4#L?)=, "A2L(=V,,BVI/'S6K#_&S"1$/@5(!8@CFPX
MP= !4@!120@#9S*BSN,@FPUH$WB.?$=E0SB: &4L=B/UQD1#V(4;D(;<<K.Y
M0V4E1!8]$B-2$PQ^&TTAYX=* A*PJH+G9=X#^PIP,,Y2!=H-T1F>J$;1%J@P
M@]36=Z@UN!S*!,4[$EAJJ4.T87$A@A!)MT$4 A9W',)6A-$A-/5H]R!@(@!
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M]"4#!:7G]G?%B]W>"Z2E21:.R)RR(%%PS6.T]QAN-YZ[/H(Q>AMR7@DL#I?
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M8=1)4AWOGG]N4OZF,4;D!.0R*NLC5JQZC?<UWJ]#:<!H%%1\,38(?=7TAXR
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M!K$_@_^,TTGXUOG_4$L! A0#%     @ 53%55CH%^@D %   7-P  !$
M         ( !     &-M;6(M,C R,C$R,S$N>'-D4$L! A0#%     @ 53%5
M5F%RN"$Z#0  RK4  !4              ( !+Q0  &-M;6(M,C R,C$R,S%?
M8V%L+GAM;%!+ 0(4 Q0    ( %4Q559CA00TZ"$  /[U 0 5
M  "  9PA  !C;6UB+3(P,C(Q,C,Q7V1E9BYX;6Q02P$"% ,4    " !5,556
M4!-YN(*6  "H=P< %0              @ &W0P  8VUM8BTR,#(R,3(S,5]L
M86(N>&UL4$L! A0#%     @ 53%55A-9([YK/@  Q@8$ !4
M ( !;-H  &-M;6(M,C R,C$R,S%?<')E+GAM;%!+ 0(4 Q0    ( %4Q55:M
M8Y2P$ H  /\*   .              "  0H9 0!C;6UB7VEM9S Q+FIP9U!+
M 0(4 Q0    ( %4Q559%,EMKL<X  '1A#0 0              "  48C 0!E
M>&AI8FET7SDY+3$N:'1M4$L! A0#%     @ 53%55A]WK$$=00  0S\"  T
M             ( !)?(! 'IK,C,R.3$V-"YH=&U02P4&      @ "    @
&;3,"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
